id,parameter_data_id,covidence_id,parameter_type,parameter_unit,exponent,parameter_value,parameter_value_type,parameter_uncertainty_lower_value,parameter_uncertainty_upper_value,parameter_uncertainty_type,parameter_uncertainty_single_value,parameter_uncertainty_singe_type,parameter_lower_bound,parameter_upper_bound,genome_site,case_definition,cfr_ifr_denominator,cfr_ifr_method,cfr_ifr_numerator,data_available,distribution_par1_type,distribution_par1_uncertainty,distribution_par1_value,distribution_par2_type,distribution_par2_uncertainty,distribution_par2_value,distribution_type,genomic_sequence_available,inverse_param,inverse_param_2,method_disaggregated,method_disaggregated_by,method_disaggregated_only,method_from_supplement,method_moment_value,method_r,name_data_entry,parameter_statistical_approach,parameter_from_figure,population_age_max,population_age_min,population_country,population_group,population_location,population_sample_size,population_sample_type,population_sex,population_study_end_day,population_study_end_month,population_study_end_year,population_study_start_day,population_study_start_month,population_study_start_year,r_pathway,riskfactor_adjusted,riskfactor_name,riskfactor_occupation,riskfactor_outcome,riskfactor_significant,seroprevalence_adjusted,third_sample_param_yn,trimester_exposed,urban_rural_area,article_id,parameter_class,parameter_bounds,comb_uncertainty_type,comb_uncertainty,population_country_original,delay_short,genomic_lineage,prnt_on_elisa,metaanalysis_inclusion,women_or_infants,pregnancy_outcome_type,survey_start_date,survey_end_date,survey_date
027e7846400ea3c6e36728afd902892d,db24c976c695bdc1da1339e437b31761,17,Seroprevalence - IgG,Percentage (%),0,0,Mean,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,494,NA,0,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,86,1,Iran,Mixed groups,Hormozgan province,494,Mixed settings,Both,NA,Jun,2017,NA,Sep,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Both urban and rural areas,3,Seroprevalence,NA,NA,NA,Iran,NA,NA,FALSE,NA,NA,NA,Sep 2016,Jun 2017,Sep 2016 - Jun 2017
f2a3e4fbe223909633a61319bba873dd,a1d62bf61e2ae1038c1d900d82bb3e24,162,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,0.1,Unspecified,0,0.5,95% CI,NA,NA,NA,NA,NA,NA,31,NA,1,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Richard Sheppard,Observed sample statistic,FALSE,5,0.5,DRC,Children,NA,NA,Population based,Unspecified,NA,NA,2014,NA,NA,2013,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,1,Seroprevalence,NA,95% CI,0 - 0.5,DRC,NA,NA,TRUE,NA,NA,NA,2013,2014,2013 - 2014
f2a3e4fbe223909633a61319bba873dd,d13e49114e5a63c258e090c5cbafa7e2,162,Seroprevalence - IgG,Percentage (%),0,3.5,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,978,NA,34,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Richard Sheppard,Observed sample statistic,FALSE,5,0.5,DRC,Children,NA,978,Population based,Unspecified,NA,NA,2014,NA,NA,2013,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,1,Seroprevalence,NA,NA,NA,DRC,NA,NA,FALSE,NA,NA,NA,2013,2014,2013 - 2014
737a54d9c321db38dc3b7c4a2ad26782,143e657d5cbe0e443b0dee94d2a4016a,174,Seroprevalence - Western blot,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,21,NA,2,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Thailand,Persons under investigation,NA,21,Hospital based,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,55,Seroprevalence,NA,NA,NA,Thailand,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
4cdd4fd17b66a67ef6df4c1b397c4b12,e81eb10ae0002de5a84f490e65f9b57c,248,Reproduction number (Basic R0) - Vector-borne,No units,0,2.475,Mean,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,Next generation matrix,Anna Vicco,Estimated model parameter,FALSE,NA,NA,Brazil,Persons under investigation,NA,NA,Population based,Unspecified,2,Jun,2016,6,Feb,2016,Animal-animal,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,7,Reproduction number,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,6 Feb 2016,2 Jun 2016,6 Feb 2016 - 2 Jun 2016
4cdd4fd17b66a67ef6df4c1b397c4b12,cbf0f13065d20365bfc333ac659a0191,248,Reproduction number (Basic R0) - Sexual,No units,0,0.0538,Mean,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,Next generation matrix,Anna Vicco,Estimated model parameter,FALSE,NA,NA,Brazil,Persons under investigation,NA,NA,Population based,Unspecified,2,Jun,2016,6,Feb,2016,Human-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,7,Reproduction number,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,6 Feb 2016,2 Jun 2016,6 Feb 2016 - 2 Jun 2016
4cdd4fd17b66a67ef6df4c1b397c4b12,9d41c8e51481adeeaac24b946f01c01b,248,Reproduction number (Basic R0),No units,0,2.502,Mean,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,Next generation matrix,Anna Vicco,Estimated model parameter,FALSE,NA,NA,Brazil,Persons under investigation,NA,NA,Population based,Unspecified,2,Jun,2016,6,Feb,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,7,Reproduction number,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,6 Feb 2016,2 Jun 2016,6 Feb 2016 - 2 Jun 2016
a61a014f4cb51abe3475d8d0b31a9841,2e4a7017f7b093b2828d2ef48b320bf0,268,Reproduction number (Basic R0),No units,0,2.45,NA,1.57,3.65,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Start outbreak,Growth rate,Anna Vicco,Estimated model parameter,FALSE,NA,NA,Brazil,NA,Rio de Janeiro,NA,NA,NA,NA,NA,NA,NA,NA,2002,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,6,Reproduction number,NA,95% CI,1.57 - 3.65,Brazil,NA,NA,FALSE,NA,NA,NA,2002,Unspecified,2002 - Unspecified
a61a014f4cb51abe3475d8d0b31a9841,57e0c1fd2ec81327415c6d9d674344d2,268,Reproduction number (Basic R0),No units,0,1.82,NA,1.19,2.68,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Start outbreak,Growth rate,Anna Vicco,Estimated model parameter,FALSE,NA,NA,Brazil,NA,Rio de Janeiro,NA,NA,NA,NA,NA,NA,NA,NA,2012,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,6,Reproduction number,NA,95% CI,1.19 - 2.68,Brazil,NA,NA,FALSE,NA,NA,NA,2012,Unspecified,2012 - Unspecified
a61a014f4cb51abe3475d8d0b31a9841,27221d3dae48cdda87804eb2a3fe6fda,268,Growth rate (r),Per week,0,0.823,Maximum likelihood,NA,NA,NA,0.053,Standard Deviation,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Start outbreak,Growth rate,Anna Vicco,Estimated model parameter,FALSE,NA,NA,Brazil,NA,Rio de Janeiro,NA,NA,NA,NA,NA,NA,18,Oct,2015,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,6,Growth rate,NA,Standard Deviation,0.053,Brazil,NA,NA,FALSE,NA,NA,NA,18 Oct 2015,Unspecified,18 Oct 2015 - Unspecified
a61a014f4cb51abe3475d8d0b31a9841,b8adc6a7e436b949395db76c2f1187a5,268,Reproduction number (Basic R0),No units,0,2.33,Maximum likelihood,1.97,2.97,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Other, Region",FALSE,FALSE,Start outbreak,Growth rate,Anna Vicco,Estimated model parameter,FALSE,NA,NA,Multi-country: Brazil and Colombia,NA,Rio de Janeiro,NA,NA,NA,NA,NA,NA,18,Oct,2015,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,6,Reproduction number,NA,95% CI,1.97 - 2.97,"Brazil, Colombia",NA,NA,FALSE,NA,NA,NA,18 Oct 2015,Unspecified,18 Oct 2015 - Unspecified
ee934959539e091ce1336413de058608,ae0c198afd81a7e6f3873b1d83153451,390,Reproduction number (Basic R0),No units,0,NA,Unspecified,NA,NA,NA,NA,NA,1.24,1.47,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,TRUE,FALSE,Unspecified,Compartmental model,Anna Vicco,Estimated model parameter,FALSE,NA,NA,United States,Persons under investigation,Florida,NA,Population based,Unspecified,29,Sep,2016,19,Jul,2016,Other,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,13,Reproduction number,1.24 - 1.47,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,19 Jul 2016,29 Sep 2016,19 Jul 2016 - 29 Sep 2016
c602375a042ba9b694f322f42f98a7e0,5794a27dc5afc3fe24ce26721073360a,390,Human delay - infectious period (inverse parameter),Per day,0,NA,Unspecified,NA,NA,NA,NA,NA,0.02,0.1,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,TRUE,FALSE,TRUE,"Method, Other",TRUE,FALSE,Unspecified,Compartmental model,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,United States,Persons under investigation,Florida,NA,Population based,Unspecified,29,Sep,2016,19,Jul,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,2,Human delay,0.02 - 0.1,NA,NA,United States,Infectious period,NA,FALSE,NA,NA,NA,19 Jul 2016,29 Sep 2016,19 Jul 2016 - 29 Sep 2016
b44921073b49d6abdae772e0c41017b0,e7f8faf6e5963dceac6fdc6e8d3ed8f4,422,Reproduction number (Basic R0),No units,0,3.8,Mean,2.4,5.6,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Other,Rob Johnson,Estimated model parameter,FALSE,NA,NA,Colombia,Persons under investigation,Barranquilla,359,Hospital based,Unspecified,NA,Nov,2015,1,Oct,2015,Other,NA,NA,NA,NA,NA,NA,FALSE,NA,Urban area,6,Reproduction number,NA,95% CI,2.4 - 5.6,Colombia,NA,NA,FALSE,NA,NA,NA,1 Oct 2015,Nov 2015,1 Oct 2015 - Nov 2015
b44921073b49d6abdae772e0c41017b0,015540c3b59561d38db06fc501b42ca8,422,Relative contribution - sexual,Percentage (%),0,23,Unspecified,1,47,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Rob Johnson,Estimated model parameter,FALSE,NA,NA,Colombia,Persons under investigation,Barranquilla,359,Hospital based,Unspecified,NA,Nov,2015,1,Oct,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Urban area,6,Relative contribution,NA,95% CI,0.01 - 0.47,Colombia,NA,NA,FALSE,NA,NA,NA,1 Oct 2015,Nov 2015,1 Oct 2015 - Nov 2015
b44921073b49d6abdae772e0c41017b0,495102075691889b75370af57e375fe6,422,Growth rate (r),Per day,0,0.076,Unspecified,0.066,0.087,95% CI,NA,NA,0.071,0.111,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Rob Johnson,Estimated model parameter,FALSE,NA,NA,Colombia,Persons under investigation,Barranquilla,359,Hospital based,Unspecified,NA,Nov,2015,1,Oct,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Urban area,6,Growth rate,0.071 - 0.111,95% CI,0.066 - 0.087,Colombia,NA,NA,FALSE,NA,NA,NA,1 Oct 2015,Nov 2015,1 Oct 2015 - Nov 2015
9c04dfe6a2f9acb363185a96d87928d1,a4d527401338d508b74aad35a668e24e,430,Human delay - latent period (inverse parameter),No units,0,0.04,Maximum likelihood,0.02,0.07,Other,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,TRUE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Anna-Maria Hartner,Estimated model parameter,FALSE,NA,NA,Colombia,Unspecified,NA,NA,Unspecified,Unspecified,NA,NA,2016,NA,NA,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,5,Human delay,NA,Other,0.02 - 0.07,Colombia,Latent period,NA,FALSE,NA,NA,NA,2015,2016,2015 - 2016
9c04dfe6a2f9acb363185a96d87928d1,776e026eb4a84b6f14c119089b893e0c,430,Mosquito delay - extrinsic incubation period (inverse parameter),No units,0,0.0038,Maximum likelihood,0.0013,0.0144,Other,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,TRUE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Anna-Maria Hartner,Estimated model parameter,FALSE,NA,NA,Colombia,Unspecified,NA,NA,Unspecified,Unspecified,NA,NA,2016,NA,NA,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,5,Mosquito,NA,Other,0.0013 - 0.0144,Colombia,NA,NA,FALSE,NA,NA,NA,2015,2016,2015 - 2016
0073a765a1a9833a1a65f059c6c0b8de,1a1d436ee72e98f3c858e1d0ff3dcabb,454,Attack rate,Percentage (%),0,NA,Median,NA,NA,NA,NA,NA,1,43,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Region,TRUE,FALSE,Unspecified,NA,Christian,Estimated model parameter,FALSE,NA,NA,Multi-country: Central and South America (n = 8),Persons under investigation,NA,NA,Hospital based,NA,1,Feb,2016,NA,Jan,2014,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,6,Attack rate,1 - 43,NA,NA,"Brazil, Colombia, El Salvador, Haiti, Honduras, Mexico, Puerto Rico, Venezuela",NA,NA,FALSE,NA,NA,NA,Jan 2014,1 Feb 2016,Jan 2014 - 1 Feb 2016
0073a765a1a9833a1a65f059c6c0b8de,36e98e3d2958903a7edcb762753fbd96,454,Attack rate,Percentage (%),0,NA,Median,NA,NA,NA,NA,NA,5,49,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Region,TRUE,FALSE,Unspecified,NA,Christian,Estimated model parameter,FALSE,NA,NA,Multi-country: Central and South America (n = 8),Persons under investigation,NA,NA,Hospital based,NA,28,Feb,2017,1,Feb,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,6,Attack rate,5 - 49,NA,NA,"Brazil, Colombia, El Salvador, Haiti, Honduras, Mexico, Puerto Rico, Venezuela",NA,NA,FALSE,NA,NA,NA,1 Feb 2016,28 Feb 2017,1 Feb 2016 - 28 Feb 2017
d4f95e1d7c8a2be7da8ba800b8daaf61,9a487db24f0eaf52d2e2146835641a67,483,Seroprevalence - NS1 BOB ELISA,Percentage (%),0,36.1,Central,34.5,37.8,95% CI,NA,NA,22,58,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Other, Region, Sex",FALSE,FALSE,Post outbreak,NA,Patrick,Estimated model parameter,FALSE,14,2,Nicaragua,Children,"District II, Managua",NA,Household based,Both,NA,Jul,2017,NA,Feb,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,1,Seroprevalence,22 - 58,95% CI,34.5 - 37.8,Nicaragua,NA,NA,FALSE,NA,NA,NA,Feb 2017,Jul 2017,Feb 2017 - Jul 2017
d4f95e1d7c8a2be7da8ba800b8daaf61,32efd2471dbff7d1afc04890dfc517e3,483,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Patrick,NA,FALSE,14,2,Nicaragua,Children,"District II, Managua",NA,Household based,Both,NA,Jul,2017,NA,Feb,2017,NA,Not adjusted,Age;Other;Sex,NA,Serology,Significant,NA,FALSE,NA,Unspecified,1,Risk factors,NA,NA,NA,Nicaragua,NA,NA,FALSE,NA,NA,NA,Feb 2017,Jul 2017,Feb 2017 - Jul 2017
d4f95e1d7c8a2be7da8ba800b8daaf61,542297cb0ea1e1e94948c66951b8eefe,483,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Patrick,NA,FALSE,14,2,Nicaragua,Children,"District II, Managua",NA,Household based,Both,NA,Jul,2017,NA,Feb,2017,NA,Not adjusted,Other,NA,Serology,Not significant,NA,FALSE,NA,Unspecified,1,Risk factors,NA,NA,NA,Nicaragua,NA,NA,FALSE,NA,NA,NA,Feb 2017,Jul 2017,Feb 2017 - Jul 2017
d4f95e1d7c8a2be7da8ba800b8daaf61,ace718aecf2b31bc1187ff8c7bfb4c9c,483,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Patrick,NA,FALSE,14,2,Nicaragua,Children,"District II, Managua",NA,Household based,Both,NA,Jul,2017,NA,Feb,2017,NA,Adjusted,Other;Sex,NA,Serology,Significant,NA,FALSE,NA,Unspecified,1,Risk factors,NA,NA,NA,Nicaragua,NA,NA,FALSE,NA,NA,NA,Feb 2017,Jul 2017,Feb 2017 - Jul 2017
d4f95e1d7c8a2be7da8ba800b8daaf61,d2263a21bfd26df9236ccac67a2454fb,483,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Patrick,NA,FALSE,14,2,Nicaragua,Children,"District II, Managua",NA,Household based,Both,NA,Jul,2017,NA,Feb,2017,NA,Adjusted,Age;Other,NA,Serology,Not significant,NA,FALSE,NA,Unspecified,1,Risk factors,NA,NA,NA,Nicaragua,NA,NA,FALSE,NA,NA,NA,Feb 2017,Jul 2017,Feb 2017 - Jul 2017
d4f95e1d7c8a2be7da8ba800b8daaf61,927d0466f09a9194ad90cfc0fe3295e8,483,Seroprevalence - NS1 BOB ELISA,Percentage (%),0,45.8,Central,43.4,48.3,95% CI,NA,NA,NA,67,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Sex",FALSE,FALSE,Post outbreak,NA,Patrick,Estimated model parameter,FALSE,80,2,Nicaragua,General population,"District II, Managua",NA,Household based,Both,NA,Jul,2017,NA,Feb,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,1,Seroprevalence,NA,95% CI,43.4 - 48.3,Nicaragua,NA,NA,FALSE,NA,NA,NA,Feb 2017,Jul 2017,Feb 2017 - Jul 2017
d4f95e1d7c8a2be7da8ba800b8daaf61,111451d24eac4ed9455f120e13083d2c,483,Seroprevalence - NS1 BOB ELISA,Percentage (%),0,56.4,Central,53.1,59.6,95% CI,NA,NA,25,79.7,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Other, Region, Sex",FALSE,FALSE,Post outbreak,NA,Patrick,Estimated model parameter,FALSE,80,15,Nicaragua,Other,"District II, Managua",NA,Household based,Both,NA,Jul,2017,NA,Feb,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,1,Seroprevalence,25 - 79.7,95% CI,53.1 - 59.6,Nicaragua,NA,NA,FALSE,NA,NA,NA,Feb 2017,Jul 2017,Feb 2017 - Jul 2017
d4f95e1d7c8a2be7da8ba800b8daaf61,ca4c3a7cbf0d46e03e504c1cc64f5664,483,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Patrick,NA,FALSE,80,15,Nicaragua,Other,"District II, Managua",NA,Household based,Both,NA,Jul,2017,NA,Feb,2017,NA,Not adjusted,Age,NA,Serology,Significant,NA,FALSE,NA,Unspecified,1,Risk factors,NA,NA,NA,Nicaragua,NA,NA,FALSE,NA,NA,NA,Feb 2017,Jul 2017,Feb 2017 - Jul 2017
d4f95e1d7c8a2be7da8ba800b8daaf61,6edbb434cfc26b724fbd6947d03f9ff3,483,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Patrick,NA,FALSE,80,15,Nicaragua,Other,"District II, Managua",NA,Household based,Both,NA,Jul,2017,NA,Feb,2017,NA,Not adjusted,Age;Other;Sex,NA,Serology,Not significant,NA,FALSE,NA,Unspecified,1,Risk factors,NA,NA,NA,Nicaragua,NA,NA,FALSE,NA,NA,NA,Feb 2017,Jul 2017,Feb 2017 - Jul 2017
d4f95e1d7c8a2be7da8ba800b8daaf61,98293c83a9bb3150fa68839439b0df57,483,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Patrick,NA,FALSE,80,15,Nicaragua,Other,"District II, Managua",NA,Household based,Both,NA,Jul,2017,NA,Feb,2017,NA,Adjusted,Age;Sex,NA,Serology,Significant,NA,FALSE,NA,Unspecified,1,Risk factors,NA,NA,NA,Nicaragua,NA,NA,FALSE,NA,NA,NA,Feb 2017,Jul 2017,Feb 2017 - Jul 2017
d4f95e1d7c8a2be7da8ba800b8daaf61,0fbcd0bd1ba34d1f2600928929fe0f03,483,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Patrick,NA,FALSE,80,15,Nicaragua,Other,"District II, Managua",NA,Household based,Both,NA,Jul,2017,NA,Feb,2017,NA,Adjusted,Age;Other,NA,Serology,Not significant,NA,FALSE,NA,Unspecified,1,Risk factors,NA,NA,NA,Nicaragua,NA,NA,FALSE,NA,NA,NA,Feb 2017,Jul 2017,Feb 2017 - Jul 2017
129e48deef857098eb2836bb14b08db9,cc588e23e33f3c212121908fa1604ebe,506,Mutations - evolutionary rate,Substitutions/site/year,-3,NA,Other,NA,NA,NA,NA,NA,0.53,4.39,Whole genome sequence,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,TRUE,FALSE,FALSE,FALSE,Other,TRUE,FALSE,Unspecified,NA,Sequoia,Estimated model parameter,FALSE,NA,NA,"Multi-country: Americas (n = 9), Asia (n = 5), Oceania (n = 1), Africa (n = 5), Europe (n = 1)",NA,NA,58,NA,NA,NA,NA,2016,NA,NA,1947,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,7,Mutations,0.53 - 4.39,NA,NA,"Brazil, Cambodia, Central African Republic, China, Colombia, Guatemala, Haiti, Italy, Malaysia, Mexico, Federated States of Micronesia, Nigeria, Panama, Philippines, Puerto Rico, Senegal, South Africa, Suriname, Thailand, Uganda, United States",NA,NA,FALSE,NA,NA,NA,1947,2016,1947 - 2016
958031189d9f9730be43aaa251832cdb,95a56d4fa6fab6b9e603d1b31b6e16ea,538,"Reproduction number (Effective, Re)",No units,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,Whole genome sequences,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Genomics,Shazia Ruybal-Pesantez,NA,TRUE,NA,NA,Multi-country: Central America (n = 5),General population,NA,61,Unspecified,Unspecified,NA,Aug,2016,NA,Jan,2016,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,2,Reproduction number,NA,NA,NA,"El Salvador, Guatemala, Honduras, Mexico, Nicaragua",NA,NA,FALSE,NA,NA,NA,Jan 2016,Aug 2016,Jan 2016 - Aug 2016
3db29b0eb07ec54e749db8c394da948f,4e333172a553fe021f354bf4ae78ff9a,556,Mosquito delay - extrinsic incubation period (inverse parameter),Per day,0,NA,Mean,NA,NA,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,TRUE,FALSE,TRUE,Other,TRUE,FALSE,Unspecified,NA,Richard Sheppard,Estimated model parameter,TRUE,NA,NA,Mexico,Other,"Tapachula, Chiapas",NA,Other,NA,NA,NA,2016,NA,NA,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,4,Mosquito,NA,NA,NA,Mexico,NA,NA,FALSE,NA,NA,NA,2016,2016,2016
057fc032e713a1ef9855b67a09b2ee8f,796df754eaffc7206d47e10c2b9ea2c4,588,Reproduction number (Basic R0) - Vector-borne,No units,0,4.2743,Mean,0.1663,12.9415,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Next generation matrix,Kelly M,Estimated model parameter,FALSE,NA,NA,El Salvador,Persons under investigation,NA,NA,Population based,NA,22,Jun,2016,NA,NA,2015,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,10,Reproduction number,NA,95% CrI,0.1663 - 12.9415,El Salvador,NA,NA,FALSE,NA,NA,NA,2015,22 Jun 2016,2015 - 22 Jun 2016
c63906f7ff8555c44504339cae791136,d33b767dc2c9613bcfd46a93e176438b,588,Reproduction number (Basic R0),No units,0,2.2055,Mean,1.4664,3.1658,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Next generation matrix,Sequoia,Estimated model parameter,FALSE,NA,NA,El Salvador,Persons under investigation,NA,NA,Population based,NA,22,Jun,2016,NA,NA,2015,Human-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,4,Reproduction number,NA,95% CrI,1.4664 - 3.1658,El Salvador,NA,NA,FALSE,NA,NA,NA,2015,22 Jun 2016,2015 - 22 Jun 2016
c63906f7ff8555c44504339cae791136,09b583b1af7cb31ff117398aa2a645de,588,Reproduction number (Basic R0),No units,0,2.4225,Mean,1.6526,3.4704,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Next generation matrix,Sequoia,Estimated model parameter,FALSE,NA,NA,Suriname,Persons under investigation,NA,NA,Population based,NA,22,Jun,2016,NA,NA,2015,Human-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,4,Reproduction number,NA,95% CrI,1.6526 - 3.4704,Suriname,NA,NA,FALSE,NA,NA,NA,2015,22 Jun 2016,2015 - 22 Jun 2016
c63906f7ff8555c44504339cae791136,cc45511c6d579e77d132a1b320804262,588,Reproduction number (Basic R0) - Sexual,No units,0,2.4588,Mean,0.1519,7.4016,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Next generation matrix,Sequoia,Estimated model parameter,FALSE,NA,NA,El Salvador,Persons under investigation,NA,NA,Population based,NA,22,Jun,2016,NA,NA,2015,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,4,Reproduction number,NA,95% CrI,0.1519 - 7.4016,El Salvador,NA,NA,FALSE,NA,NA,NA,2015,22 Jun 2016,2015 - 22 Jun 2016
c63906f7ff8555c44504339cae791136,37f354a53de6fa996cb8721c15de7c1c,588,Reproduction number (Basic R0) - Sexual,No units,0,1.6667,Mean,0.1473,4.8498,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Next generation matrix,Sequoia,Estimated model parameter,FALSE,NA,NA,Suriname,Persons under investigation,NA,NA,Population based,NA,22,Jun,2016,NA,NA,2015,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,4,Reproduction number,NA,95% CrI,0.1473 - 4.8498,Suriname,NA,NA,FALSE,NA,NA,NA,2015,22 Jun 2016,2015 - 22 Jun 2016
c63906f7ff8555c44504339cae791136,eecc01dc3b19ba7b5ad3971971166ce6,588,Reproduction number (Basic R0) - Vector-borne,No units,0,6.0925,Mean,0.6002,15.7379,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Next generation matrix,Sequoia,Estimated model parameter,FALSE,NA,NA,Suriname,Persons under investigation,NA,NA,Population based,NA,22,Jun,2016,NA,NA,2015,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,4,Reproduction number,NA,95% CrI,0.6002 - 15.7379,Suriname,NA,NA,FALSE,NA,NA,NA,2015,22 Jun 2016,2015 - 22 Jun 2016
c63906f7ff8555c44504339cae791136,bb4ad4e531b369fd432898b890b60706,588,Human delay - incubation period,Days,0,5.5626,Mean,2.0001,15.5402,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Sequoia,Estimated model parameter,FALSE,NA,NA,El Salvador,Persons under investigation,NA,11825,Population based,NA,22,Jun,2016,NA,NA,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,4,Human delay,NA,95% CrI,2.0001 - 15.5402,El Salvador,Incubation period,NA,FALSE,NA,NA,NA,2015,22 Jun 2016,2015 - 22 Jun 2016
c63906f7ff8555c44504339cae791136,b0f009645b86518d89456eee236e7fe7,588,Human delay - incubation period,Days,0,6.6144,Mean,2.0001,16.8145,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Sequoia,Estimated model parameter,FALSE,NA,NA,Suriname,Persons under investigation,NA,3042,Population based,NA,22,Jun,2016,NA,NA,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,4,Human delay,NA,95% CrI,2.0001 - 16.8145,Suriname,Incubation period,NA,FALSE,NA,NA,NA,2015,22 Jun 2016,2015 - 22 Jun 2016
c63906f7ff8555c44504339cae791136,25b5b8b8c051dd5d3b910bfbd23b0648,588,Mosquito delay - extrinsic incubation period,Days,0,8.4171,Mean,4.0001,17.0355,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Sequoia,Estimated model parameter,FALSE,NA,NA,El Salvador,Persons under investigation,NA,NA,Population based,NA,22,Jun,2016,NA,NA,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,4,Mosquito,NA,95% CrI,4.0001 - 17.0355,El Salvador,NA,NA,FALSE,NA,NA,NA,2015,22 Jun 2016,2015 - 22 Jun 2016
c63906f7ff8555c44504339cae791136,9a60b234ae72f703ea2a7e2b28163182,588,Mosquito delay - extrinsic incubation period,Days,0,8.3111,Mean,4,16.9617,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Sequoia,Estimated model parameter,FALSE,NA,NA,Suriname,Persons under investigation,NA,NA,Population based,NA,22,Jun,2016,NA,NA,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,4,Mosquito,NA,95% CrI,4 - 16.9617,Suriname,NA,NA,FALSE,NA,NA,NA,2015,22 Jun 2016,2015 - 22 Jun 2016
528b20d4462de9e8165d52ba5d241b68,f612acd35f9680db61185f16ebf71929,659,Seroprevalence - IgG,Percentage (%),0,0,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,215,Naive,0,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Rob Johnson,Observed sample statistic,FALSE,75,18,Sweden,General population,Gothenburg,215,Population based,Both,NA,NA,2015,NA,NA,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,2,Seroprevalence,NA,NA,NA,Sweden,NA,NA,FALSE,NA,NA,NA,2015,2015,2015
528b20d4462de9e8165d52ba5d241b68,9114cd113cade686a80cf4008b2365cf,659,Seroprevalence - IgG,Percentage (%),0,1.4,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,874,Naive,12,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Rob Johnson,Observed sample statistic,FALSE,62,17,Rwanda,General population,4 provinces and Kigali,874,Population based,Both,NA,NA,2015,NA,NA,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,2,Seroprevalence,NA,NA,NA,Rwanda,NA,NA,FALSE,NA,NA,NA,2015,2015,2015
13e6e0baa7839057f9df04b839a2f46c,f72ac5984501bdd51e9b53fce82aebac,660,Human delay - Onset to Return to area with active vectors,Days,0,2,Median,-7,10,Range,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,France,Persons under investigation,"Mainland, travel-related",625,Population based,Unspecified,15,Jul,2016,1,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,50,Human delay,NA,Range,-7 - 10,France,Onset to return to area with active vectors,NA,FALSE,NA,NA,NA,1 Jan 2016,15 Jul 2016,1 Jan 2016 - 15 Jul 2016
13e6e0baa7839057f9df04b839a2f46c,bd4e70752c307305c0d0f2f835dfecef,660,Human delay - Onset to Implementation of vector control measures,Days,0,13,Median,4,58,Range,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,France,Persons under investigation,"Mainland, travel-related",625,Population based,Unspecified,15,Jul,2016,1,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,50,Human delay,NA,Range,4 - 58,France,Onset to implementation of vector control measures,NA,FALSE,NA,NA,NA,1 Jan 2016,15 Jul 2016,1 Jan 2016 - 15 Jul 2016
13e6e0baa7839057f9df04b839a2f46c,74b400e49d2d3c5683c9e561fdcebfb5,660,Human delay - Reporting to Intervention,Days,0,5,Median,2,38,Range,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,France,Persons under investigation,"Mainland, travel-related",625,Population based,Unspecified,15,Jul,2016,1,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,50,Human delay,NA,Range,2 - 38,France,Reporting to intervention,NA,FALSE,NA,NA,NA,1 Jan 2016,15 Jul 2016,1 Jan 2016 - 15 Jul 2016
66b5dca69d56506c3f7753e9b0e2e547,32ae96083610466e3896d7223e9a4725,705,Seroprevalence - Neutralisation/PRNT,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,969,NA,16,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,United States,Other,Veterans Health Administration in US and Caribbean,183,Hospital based,Both,31,Oct,2016,1,Dec,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,51,Seroprevalence,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,1 Dec 2015,31 Oct 2016,1 Dec 2015 - 31 Oct 2016
66b5dca69d56506c3f7753e9b0e2e547,8a23e532afcdfb4eb0a998fb517aae21,705,Human delay - Admission to care to Discharge from care,Days,0,6,Median,1,214,Range,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Unspecified,Other,VA Caribbean Healthcare System,91,Hospital based,Both,31,Oct,2016,1,Dec,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,51,Human delay,NA,Range,1 - 214,NA,Admission to care to discharge from care,NA,FALSE,NA,NA,NA,1 Dec 2015,31 Oct 2016,1 Dec 2015 - 31 Oct 2016
66b5dca69d56506c3f7753e9b0e2e547,ac14d577e38ab36b4de934991a52a7bd,705,Human delay - Admission to Critical Care/ICU to Discharge from Critical Care/ICU,Days,0,4,Median,1,30,Range,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Unspecified,Other,VA Caribbean Healthcare System,20,Hospital based,Both,31,Oct,2016,1,Dec,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,51,Human delay,NA,Range,1 - 30,NA,Admission to critical care/icu to discharge from critical care/icu,NA,FALSE,NA,NA,NA,1 Dec 2015,31 Oct 2016,1 Dec 2015 - 31 Oct 2016
66b5dca69d56506c3f7753e9b0e2e547,8155814650a53fe757e80ae313251bf4,705,Human delay - Admission to care to Discharge from care,Days,0,4,Median,1,6,Range,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Unspecified,Other,VA hospitals in US,3,Hospital based,Both,31,Oct,2016,1,Dec,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,51,Human delay,NA,Range,1 - 6,NA,Admission to care to discharge from care,NA,FALSE,NA,NA,NA,1 Dec 2015,31 Oct 2016,1 Dec 2015 - 31 Oct 2016
66b5dca69d56506c3f7753e9b0e2e547,64ef2d01a8677e1d4a96be29624a9841,705,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,NA,FALSE,NA,NA,Unspecified,Other,Veterans Health Administration in US and Caribbean,94,Hospital based,Both,31,Oct,2016,1,Dec,2015,NA,Not adjusted,Age;Comorbidity;Other,NA,Hospitalisation,Significant,NA,FALSE,NA,NA,51,Risk factors,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,NA,1 Dec 2015,31 Oct 2016,1 Dec 2015 - 31 Oct 2016
66b5dca69d56506c3f7753e9b0e2e547,485e8e684827a82175605ccd242833c3,705,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,NA,FALSE,NA,NA,Unspecified,Other,Veterans Health Administration in US and Caribbean,46,Hospital based,Both,31,Oct,2016,1,Dec,2015,NA,Not adjusted,Comorbidity;Hospitalisation,NA,Other neurological symptoms in general population,Significant,NA,FALSE,NA,NA,51,Risk factors,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,NA,1 Dec 2015,31 Oct 2016,1 Dec 2015 - 31 Oct 2016
66b5dca69d56506c3f7753e9b0e2e547,4d81830e17c62ae2af9e50f097c12a3d,705,Human delay - Diagnosis/test result to Death,Days,0,39,Median,3,104,Range,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Unspecified,Other,VA Caribbean Healthcare System,19,Hospital based,Both,31,Oct,2016,1,Dec,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,51,Human delay,NA,Range,3 - 104,NA,Diagnosis/test result to death,NA,FALSE,NA,NA,NA,1 Dec 2015,31 Oct 2016,1 Dec 2015 - 31 Oct 2016
2aaf84f22333d21778482b5444591452,32df2963305970d95d6d3db387dd1d42,728,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,9.1,Mean,3.95,11.01,95% CI,NA,NA,0,18.2,NA,Confirmed,662,Naive,60,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Other, Region",FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,4,1,Indonesia,Children,"Aceh, North Sumatra, West Sumatra, Jambi, Lampung, Banten, DKI Jakarta, West Java, Central Java, East Java, Bali, East Kalimantan, South Sulawesi, Southeast Sulawesi",662,Population based,Unspecified,NA,Nov,2014,NA,Oct,2014,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Urban area,3,Seroprevalence,0 - 18.2,95% CI,3.95 - 11.01,Indonesia,NA,NA,FALSE,NA,NA,NA,Oct 2014,Nov 2014,Oct 2014 - Nov 2014
7d49b13bdf0eef103b35bbb481615a9d,46ef61d39549600d3d1ef8264f2e20dd,729,Reproduction number (Basic R0),No units,0,1.89,Mean,1.21,2.13,95% CI,NA,NA,1.73,2.38,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,FALSE,FALSE,Mid outbreak,Compartmental model,Anna Vicco,Estimated model parameter,FALSE,NA,NA,Colombia,Pregnant women,NA,18364,Population based,Female,NA,NA,2016,NA,NA,2015,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,9,Reproduction number,1.73 - 2.38,95% CI,1.21 - 2.13,Colombia,NA,NA,FALSE,NA,NA,NA,2015,2016,2015 - 2016
7d49b13bdf0eef103b35bbb481615a9d,a7cebcb9970e11ab1108f3f2e045e208,729,Reproduction number (Basic R0) - Sexual,No units,0,0.42,Mean,0.29,0.64,95% CI,NA,NA,0.15,0.42,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,FALSE,FALSE,Mid outbreak,Compartmental model,Anna Vicco,Estimated model parameter,FALSE,NA,NA,Colombia,Pregnant women,NA,18364,Population based,Female,NA,NA,2016,NA,NA,2015,Human-human,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,9,Reproduction number,0.15 - 0.42,95% CI,0.29 - 0.64,Colombia,NA,NA,FALSE,NA,NA,NA,2015,2016,2015 - 2016
7d49b13bdf0eef103b35bbb481615a9d,1e3f5d586d5f38c5974aa4be8c5a561c,729,Reproduction number (Basic R0) - Vector-borne,No units,0,1.51,Mean,1.23,1.87,95% CI,NA,NA,1.51,2.02,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,FALSE,FALSE,Mid outbreak,Compartmental model,Anna Vicco,Estimated model parameter,FALSE,NA,NA,Colombia,Pregnant women,NA,18364,Population based,Female,NA,NA,2016,NA,NA,2015,Animal-animal,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,9,Reproduction number,1.51 - 2.02,95% CI,1.23 - 1.87,Colombia,NA,NA,FALSE,NA,NA,NA,2015,2016,2015 - 2016
d1c8fa74274f86b9b9d63823639839f9,9c9ae3277b8790834573949e7bc1c335,729,Relative contribution - sexual,Percentage (%),0,15.36,Mean,12.83,17.14,95% CI,NA,NA,5.31,15.36,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,FALSE,FALSE,Mid outbreak,Compartmental model,Shazia Ruybal-Pesantez,Estimated model parameter,FALSE,NA,NA,Colombia,Pregnant women,NA,18364,Population based,Female,NA,NA,2016,NA,NA,2015,Human-human,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,6,Relative contribution,5.31 - 15.36,95% CI,12.83 - 17.14,Colombia,NA,NA,FALSE,NA,NA,NA,2015,2016,2015 - 2016
bc91229f5ddf0b5f8987d8c6fba90289,4c8244ab9aa657d6960a1ad28436d57a,790,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,NA,FALSE,NA,NA,Brazil,Children,Aracaju city in Sergipe,64,Hospital based,Unspecified,5,Jan,2016,1,Sep,2015,NA,Adjusted,Infection during pregnancy;Occupation,Other,Microcephaly,Significant,NA,FALSE,NA,Unspecified,52,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,1 Sep 2015,5 Jan 2016,1 Sep 2015 - 5 Jan 2016
bb3ad16c40a86faba6a3c88534572237,e59a840dcd8d3b9da34147c110fe66e5,816,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Kelly M,NA,FALSE,NA,NA,Colombia,Other,Barranquilla,40,Hospital based,Both,2,Apr,2016,1,Oct,2015,NA,Adjusted,Infection;Other,NA,Guillain Barre syndrome,Significant,NA,FALSE,NA,Unspecified,54,Risk factors,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,1 Oct 2015,2 Apr 2016,1 Oct 2015 - 2 Apr 2016
bb3ad16c40a86faba6a3c88534572237,3aebe2472d7d615feef34aa2d93b097b,816,Human delay - Onset of antecedent symptoms to Onset of neurologic symptoms,Days,0,6,Median,0,55,Range,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Colombia,Other,Barranquilla,47,Hospital based,Both,2,Apr,2016,1,Oct,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,54,Human delay,NA,Range,0 - 55,Colombia,Onset of antecedent symptoms to onset of neurologic symptoms,NA,FALSE,NA,NA,NA,1 Oct 2015,2 Apr 2016,1 Oct 2015 - 2 Apr 2016
bb3ad16c40a86faba6a3c88534572237,b12238ab44f13a9c63eaa876f7d1f8e4,816,Human delay - Onset of neurologic symptoms to Admission to care,Days,0,9,Median,0,56,Range,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Colombia,Other,Barranquilla,47,Hospital based,Both,2,Apr,2016,1,Oct,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,54,Human delay,NA,Range,0 - 56,Colombia,Onset of neurologic symptoms to admission to care,NA,FALSE,NA,NA,NA,1 Oct 2015,2 Apr 2016,1 Oct 2015 - 2 Apr 2016
bb3ad16c40a86faba6a3c88534572237,76caeabe701c5951264b5d9115537e50,816,Human delay - Admission to care to Discharge from care,Days,0,22,Median,3,102,Range,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Colombia,Other,Barranquilla,47,Hospital based,Both,2,Apr,2016,1,Oct,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,54,Human delay,NA,Range,3 - 102,Colombia,Admission to care to discharge from care,NA,FALSE,NA,NA,NA,1 Oct 2015,2 Apr 2016,1 Oct 2015 - 2 Apr 2016
76c37cf84cd088925e88676734e5cb41,c744077acb33a5248b428c93952fd342,845,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,NA,FALSE,NA,NA,Thailand,General population,NA,1717,Population based,Both,NA,Dec,2017,NA,Jan,2016,NA,Not adjusted,Age;Other,NA,Infection,Significant,NA,FALSE,NA,NA,3,Risk factors,NA,NA,NA,Thailand,NA,NA,FALSE,NA,NA,NA,Jan 2016,Dec 2017,Jan 2016 - Dec 2017
76c37cf84cd088925e88676734e5cb41,04109132b55d73e63a18b415cb57da84,845,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,NA,FALSE,NA,NA,Thailand,General population,NA,1717,Population based,Both,NA,Dec,2017,NA,Jan,2016,NA,Not adjusted,Other;Sex,NA,Infection,Not significant,NA,FALSE,NA,NA,3,Risk factors,NA,NA,NA,Thailand,NA,NA,FALSE,NA,NA,NA,Jan 2016,Dec 2017,Jan 2016 - Dec 2017
91c0ccd849ecd0e58b497422175c741d,a7bcd00b5a4973f376638ca9f67e211d,873,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Richard Sheppard,NA,FALSE,NA,NA,United States,Household contacts of survivors,"Puerto Rico: Ponce, San Juan, Guayama",362,Household based,Both,NA,Jul,2017,NA,May,2016,NA,Not adjusted,Age;Occupation;Other;Sex,NA,Infection,Not significant,NA,FALSE,NA,Unspecified,6,Risk factors,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,May 2016,Jul 2017,May 2016 - Jul 2017
91c0ccd849ecd0e58b497422175c741d,0313588e46bd3c7bb3e664d1c06e151c,873,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Richard Sheppard,NA,FALSE,NA,NA,United States,Household contacts of survivors,"Puerto Rico: Ponce, San Juan, Guayama",362,Household based,Both,NA,Jul,2017,NA,May,2016,NA,Not adjusted,Other,NA,Infection,Significant,NA,FALSE,NA,Unspecified,6,Risk factors,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,May 2016,Jul 2017,May 2016 - Jul 2017
91c0ccd849ecd0e58b497422175c741d,f2c6ff1c4dbef4cb98a3bb2d17f806ca,873,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Richard Sheppard,NA,FALSE,NA,NA,United States,Household contacts of survivors,"Puerto Rico: Ponce, San Juan, Guayama",362,Household based,Both,NA,Jul,2017,NA,May,2016,NA,Adjusted,Age;Other,NA,Infection,Significant,NA,FALSE,NA,Unspecified,6,Risk factors,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,May 2016,Jul 2017,May 2016 - Jul 2017
91c0ccd849ecd0e58b497422175c741d,816c0c10f19aa12f367e5286233dd000,873,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Richard Sheppard,NA,FALSE,NA,NA,United States,Household contacts of survivors,"Puerto Rico: Ponce, San Juan, Guayama",362,Household based,Both,NA,Jul,2017,NA,May,2016,NA,Adjusted,Other,NA,Infection,Not significant,NA,FALSE,NA,Unspecified,6,Risk factors,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,May 2016,Jul 2017,May 2016 - Jul 2017
3c0289911d911bae105ce5f728536c31,88f53b1d71df422567638f2d2979c5fc,873,Seroprevalence - IgM,Percentage (%),0,30.9,Unspecified,26.3,35.9,95% CI,NA,NA,NA,NA,NA,NA,362,NA,112,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,Observed sample statistic,FALSE,NA,NA,United States,Household contacts of survivors,"Puerto Rico: Ponce, San Juan, Guayama",362,Household based,Both,NA,Jul,2017,NA,May,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,2,Seroprevalence,NA,95% CI,26.3 - 35.9,United States,NA,NA,FALSE,NA,NA,NA,May 2016,Jul 2017,May 2016 - Jul 2017
1e812fe133213abee5e5f1f185968745,0f1be14a5c1575a4a3a8c829de0d0760,890,Human delay - Onset to Admission to care,Days,0,4,Median,1,16,IQR,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Keith,Estimated model parameter,FALSE,82,0,Colombia,Persons under investigation,San Andrés,928,Hospital based,Both,30,Jan,2016,6,Sep,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,3,Human delay,NA,IQR,1 - 16,Colombia,Onset to admission to care,NA,FALSE,NA,NA,NA,6 Sep 2015,30 Jan 2016,6 Sep 2015 - 30 Jan 2016
1e812fe133213abee5e5f1f185968745,30fa3b7fb3bc7ad949d824735314198d,890,Human delay - Onset to Admission to care,Days,0,1,Median,1,2,IQR,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Keith,Estimated model parameter,FALSE,92,0,Colombia,Persons under investigation,Girardot,1936,Hospital based,Both,22,Jan,2016,19,Oct,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Urban area,3,Human delay,NA,IQR,1 - 2,Colombia,Onset to admission to care,NA,FALSE,NA,NA,NA,19 Oct 2015,22 Jan 2016,19 Oct 2015 - 22 Jan 2016
1e812fe133213abee5e5f1f185968745,3f7fa886c00ea3b126c5dc4bf6f5127d,890,Attack rate,Percentage (%),0,1.213,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Sex",FALSE,FALSE,Unspecified,NA,Keith,Observed sample statistic,FALSE,82,0,Colombia,Persons under investigation,San Andrés,928,Hospital based,Both,30,Jan,2016,6,Sep,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,3,Attack rate,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,6 Sep 2015,30 Jan 2016,6 Sep 2015 - 30 Jan 2016
1e812fe133213abee5e5f1f185968745,0a990f399ffdc32aae2d9234a0f16d78,890,Attack rate,Percentage (%),0,1.843,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Sex",FALSE,FALSE,Unspecified,NA,Keith,Observed sample statistic,FALSE,92,0,Colombia,Persons under investigation,Girardot,1936,Hospital based,Both,22,Jan,2016,19,Oct,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Urban area,3,Attack rate,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,19 Oct 2015,22 Jan 2016,19 Oct 2015 - 22 Jan 2016
1e812fe133213abee5e5f1f185968745,2402b9d9546545d2ce954b8334d29b49,890,Reproduction number (Basic R0),No units,0,1.41,NA,1.15,1.74,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Other,Keith,Estimated model parameter,FALSE,82,0,Colombia,Persons under investigation,San Andrés,928,Hospital based,Both,30,Jan,2016,6,Sep,2015,Human-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,3,Reproduction number,NA,95% CI,1.15 - 1.74,Colombia,NA,NA,FALSE,NA,NA,NA,6 Sep 2015,30 Jan 2016,6 Sep 2015 - 30 Jan 2016
1e812fe133213abee5e5f1f185968745,a41252e9030bd36f158395de982448d9,890,Reproduction number (Basic R0),No units,0,4.61,NA,4.11,5.16,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Other,Keith,Estimated model parameter,FALSE,92,0,Colombia,Persons under investigation,Girardot,1936,Hospital based,Both,22,Jan,2016,19,Oct,2015,Human-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Urban area,3,Reproduction number,NA,95% CI,4.11 - 5.16,Colombia,NA,NA,FALSE,NA,NA,NA,19 Oct 2015,22 Jan 2016,19 Oct 2015 - 22 Jan 2016
1e812fe133213abee5e5f1f185968745,80dcd1cec2dd1f86fa00cf6448c52811,890,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Keith,NA,FALSE,92,0,Colombia,Persons under investigation,Girardot,1936,Hospital based,Both,22,Jan,2016,19,Oct,2015,NA,Adjusted,Age;Sex,NA,Infection,Significant,NA,FALSE,NA,Urban area,3,Risk factors,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,19 Oct 2015,22 Jan 2016,19 Oct 2015 - 22 Jan 2016
1e812fe133213abee5e5f1f185968745,25407b680e31001a519607231ac907ee,890,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Keith,NA,FALSE,82,0,Colombia,Persons under investigation,San Andrés,928,Hospital based,Both,30,Jan,2016,6,Sep,2015,NA,Adjusted,Age;Sex,NA,Infection,Significant,NA,FALSE,NA,Unspecified,3,Risk factors,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,6 Sep 2015,30 Jan 2016,6 Sep 2015 - 30 Jan 2016
a403d3640eb4f5c6b9fb8e67208fbff9,25d0e47513436d1f995c22697b8edfb3,913,Attack rate,Percentage (%),0,73,Unspecified,70,76,95% CI,NA,NA,29,83,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Region,FALSE,FALSE,Unspecified,NA,Keith,Estimated model parameter,FALSE,NA,NA,Brazil,General population,"Salvador, Bahia",1453,Population based,Both,NA,NA,2015,NA,NA,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Urban area,4,Attack rate,29 - 83,95% CI,70 - 76,Brazil,NA,NA,FALSE,NA,NA,NA,2015,2015,2015
a403d3640eb4f5c6b9fb8e67208fbff9,e041f6410cfb9dbcccf4323bcad0f15a,913,Reproduction number (Basic R0),No units,0,1.8,Unspecified,1.7,1.9,95% CI,NA,NA,1.2,2.1,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Region,FALSE,FALSE,Unspecified,Other,Keith,Estimated model parameter,FALSE,NA,NA,Brazil,General population,"Salvador, Bahia",1453,Population based,Both,NA,NA,2015,NA,NA,2015,Human-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Urban area,4,Reproduction number,1.2 - 2.1,95% CI,1.7 - 1.9,Brazil,NA,NA,FALSE,NA,NA,NA,2015,2015,2015
360ce41004559fe9bae5ec63c796b14b,1cc06649bae77734bf5a41df61cb72bb,913,"Reproduction number (Effective, Re)",No units,0,NA,NA,NA,NA,NA,NA,NA,0.7,2.2,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Time,TRUE,FALSE,Unspecified,Branching process,Patrick,Estimated model parameter,FALSE,NA,NA,Brazil,General population,"Salvador, Bahia",NA,Population based,Both,NA,NA,2015,NA,NA,2015,Human-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Urban area,2,Reproduction number,0.7 - 2.2,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,2015,2015,2015
360ce41004559fe9bae5ec63c796b14b,8bc26c1022950f6839322faa461fb80d,913,Seroprevalence - IgG,Percentage (%),0,7,Unspecified,4,10,95% CI,NA,NA,NA,NA,NA,NA,249,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Patrick,Observed sample statistic,FALSE,NA,NA,Brazil,General population,"Salvador, Bahia",249,Population based,Both,NA,Oct,2014,NA,Oct,2014,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Urban area,2,Seroprevalence,NA,95% CI,4 - 10,Brazil,NA,NA,FALSE,NA,NA,NA,Oct 2014,Oct 2014,Oct 2014
360ce41004559fe9bae5ec63c796b14b,11b108047ecad6636e52f07291e9961e,913,Seroprevalence - IgG,Percentage (%),0,8,Unspecified,6,10,95% CI,NA,NA,NA,NA,NA,NA,675,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Patrick,Observed sample statistic,FALSE,NA,NA,Brazil,General population,"Salvador, Bahia",675,Population based,Both,NA,Mar,2015,NA,Mar,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Urban area,2,Seroprevalence,NA,95% CI,6 - 10,Brazil,NA,NA,FALSE,NA,NA,NA,Mar 2015,Mar 2015,Mar 2015
360ce41004559fe9bae5ec63c796b14b,3034aeab8539735b18b974251eca9940,913,Seroprevalence - IgG,Percentage (%),0,63,Unspecified,60,65,95% CI,NA,NA,NA,NA,NA,NA,1453,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Region",FALSE,FALSE,Post outbreak,NA,Patrick,Observed sample statistic,FALSE,NA,NA,Brazil,General population,"Salvador, Bahia",1453,Population based,Both,NA,Oct,2015,NA,Oct,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Urban area,2,Seroprevalence,NA,95% CI,60 - 65,Brazil,NA,NA,FALSE,NA,NA,NA,Oct 2015,Oct 2015,Oct 2015
360ce41004559fe9bae5ec63c796b14b,cca2e8df522190591384b0b1e353b1ff,913,Seroprevalence - IgG,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,642,NA,393,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Other",FALSE,TRUE,Post outbreak,NA,Patrick,Observed sample statistic,FALSE,NA,NA,Brazil,Other,"Salvador, Bahia",642,Population based,Both,NA,Oct,2015,NA,Oct,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Urban area,2,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Oct 2015,Oct 2015,Oct 2015
360ce41004559fe9bae5ec63c796b14b,a0253ef1fb36ef8612fceed5e857c205,913,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,1,Unspecified,0,4,95% CI,NA,NA,NA,NA,NA,NA,101,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Patrick,Observed sample statistic,FALSE,NA,NA,Brazil,General population,"Salvador, Bahia",101,Population based,Both,NA,Mar,2015,NA,Mar,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Urban area,2,Seroprevalence,NA,95% CI,0 - 4,Brazil,NA,NA,FALSE,NA,NA,NA,Mar 2015,Mar 2015,Mar 2015
360ce41004559fe9bae5ec63c796b14b,d6738878793587e1989d706ab8ca18bf,913,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Patrick,NA,FALSE,NA,NA,Brazil,Other,"Salvador, Bahia",642,Population based,Both,NA,Oct,2015,NA,Oct,2015,NA,Not adjusted,Other,NA,Serology,Significant,NA,FALSE,NA,Urban area,2,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Oct 2015,Oct 2015,Oct 2015
360ce41004559fe9bae5ec63c796b14b,77d79106e38091dc049238ea7a791465,913,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Patrick,NA,FALSE,NA,NA,Brazil,Other,"Salvador, Bahia",642,Population based,Both,NA,Oct,2015,NA,Oct,2015,NA,Not adjusted,Age;Other;Sex,NA,Serology,Not significant,NA,FALSE,NA,Urban area,2,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Oct 2015,Oct 2015,Oct 2015
360ce41004559fe9bae5ec63c796b14b,1b21016685c3937f2be2c291ace36fa9,913,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Patrick,NA,FALSE,NA,NA,Brazil,Other,"Salvador, Bahia",642,Population based,Both,NA,Oct,2015,NA,Oct,2015,NA,Not adjusted,Prior immunity to arboviruses,NA,Serology,Significant,NA,FALSE,NA,Urban area,2,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Oct 2015,Oct 2015,Oct 2015
360ce41004559fe9bae5ec63c796b14b,6c4e85bfc8d6be548b1b0b3b593701cc,913,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Patrick,NA,FALSE,NA,NA,Brazil,Other,"Salvador, Bahia",642,Population based,Both,NA,Oct,2015,NA,Oct,2015,NA,Not adjusted,Age;Prior immunity to arboviruses,NA,Serology,Not significant,NA,FALSE,NA,Urban area,2,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Oct 2015,Oct 2015,Oct 2015
360ce41004559fe9bae5ec63c796b14b,cc752544ee979e3763700381f3c4b476,913,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Patrick,NA,FALSE,NA,NA,Brazil,Other,"Salvador, Bahia",642,Population based,Both,NA,Oct,2015,NA,Oct,2015,NA,Adjusted,Prior immunity to arboviruses,NA,Serology,Significant,NA,FALSE,NA,Urban area,2,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Oct 2015,Oct 2015,Oct 2015
360ce41004559fe9bae5ec63c796b14b,6c59124abf8e0abb2ff1bd7d45ba9791,913,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Patrick,NA,FALSE,NA,NA,Brazil,Other,"Salvador, Bahia",642,Population based,Both,NA,Oct,2015,NA,Oct,2015,NA,Adjusted,Age,NA,Serology,Not significant,NA,FALSE,NA,Urban area,2,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Oct 2015,Oct 2015,Oct 2015
360ce41004559fe9bae5ec63c796b14b,e025968f36606686c3482faefaac3e36,924,Seroprevalence - HAI/HI,Percentage (%),0,6,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,132,Naive,8,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Region,TRUE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,40,20,Uganda,General population,Karamoja District,132,Community based,Both,NA,May,1984,NA,May,1984,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,8,Seroprevalence,NA,NA,NA,Uganda,NA,NA,FALSE,NA,NA,NA,May 1984,May 1984,May 1984
16f97fa8a34ea65fbc4020042bcb2cce,47c6aeb614fcffcd4369451d66a85f5f,927,Reproduction number (Basic R0),No units,0,2.1,Mean,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Other,Kelly M,Observed sample statistic,FALSE,NA,NA,France,Persons under investigation,Guadeloupe,717,Population based,NA,10,Mar,2016,29,Jan,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,12,Reproduction number,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,29 Jan 2016,10 Mar 2016,29 Jan 2016 - 10 Mar 2016
16f97fa8a34ea65fbc4020042bcb2cce,026d38ffddd90bd6a971c65db2389a0c,927,Reproduction number (Basic R0),No units,0,7.2,Mean,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Other,Kelly M,Observed sample statistic,FALSE,NA,NA,France,Persons under investigation,Martinique,102,Population based,NA,21,Jan,2016,21,Dec,2015,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,12,Reproduction number,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,21 Dec 2015,21 Jan 2016,21 Dec 2015 - 21 Jan 2016
16f97fa8a34ea65fbc4020042bcb2cce,4a1ff32ffc256bfa8b3db11058bd580e,927,Reproduction number (Basic R0),No units,0,1.8,Mean,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Other,Kelly M,Observed sample statistic,FALSE,NA,NA,Dominican Republic,Persons under investigation,NA,573,Population based,NA,27,Feb,2016,30,Jan,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,12,Reproduction number,NA,NA,NA,Dominican Republic,NA,NA,FALSE,NA,NA,NA,30 Jan 2016,27 Feb 2016,30 Jan 2016 - 27 Feb 2016
16f97fa8a34ea65fbc4020042bcb2cce,320428dd8d195f7c6e4bacde65d2dd28,927,Reproduction number (Basic R0),No units,0,2.1,Mean,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Other,Kelly M,Observed sample statistic,FALSE,NA,NA,Mexico,Persons under investigation,NA,129,Population based,NA,13,Mar,2016,1,Jan,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,12,Reproduction number,NA,NA,NA,Mexico,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,13 Mar 2016,1 Jan 2016 - 13 Mar 2016
16f97fa8a34ea65fbc4020042bcb2cce,0bf4abf6c34a4ccb339e0085f3b6cf2a,927,Reproduction number (Basic R0),No units,0,5,Mean,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Other,Kelly M,Observed sample statistic,FALSE,NA,NA,Guatemala,Persons under investigation,NA,386,Population based,NA,15,Feb,2016,16,Nov,2015,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,12,Reproduction number,NA,NA,NA,Guatemala,NA,NA,FALSE,NA,NA,NA,16 Nov 2015,15 Feb 2016,16 Nov 2015 - 15 Feb 2016
16f97fa8a34ea65fbc4020042bcb2cce,98238c4fb25cdc24d821ca9eb093478c,927,Reproduction number (Basic R0),No units,0,1.9,Mean,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Other,Kelly M,Observed sample statistic,FALSE,NA,NA,Panama,Persons under investigation,NA,49,Population based,NA,13,Mar,2016,1,Jan,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,12,Reproduction number,NA,NA,NA,Panama,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,13 Mar 2016,1 Jan 2016 - 13 Mar 2016
16f97fa8a34ea65fbc4020042bcb2cce,5d31c59cdbc1d1ac7b8c9daeb40f27f5,927,Reproduction number (Basic R0),No units,0,3.7,Mean,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Other,Kelly M,Observed sample statistic,FALSE,NA,NA,United States,Persons under investigation,Puerto Rico,198,Population based,NA,24,Feb,2016,26,Nov,2015,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,12,Reproduction number,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,26 Nov 2015,24 Feb 2016,26 Nov 2015 - 24 Feb 2016
16f97fa8a34ea65fbc4020042bcb2cce,1ab5e66382ed12ea653d681144136478,927,Reproduction number (Basic R0),No units,0,4.8,Mean,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Other,Kelly M,Observed sample statistic,FALSE,NA,NA,El Salvador,Persons under investigation,NA,5618,Population based,NA,13,Mar,2016,1,Jan,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,12,Reproduction number,NA,NA,NA,El Salvador,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,13 Mar 2016,1 Jan 2016 - 13 Mar 2016
16f97fa8a34ea65fbc4020042bcb2cce,1e14f5a2f097e0bcedcaab290341eff1,927,Reproduction number (Basic R0),No units,0,3.2,Mean,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Other,Kelly M,Observed sample statistic,FALSE,NA,NA,Colombia,Persons under investigation,NA,1593,Population based,NA,13,Mar,2016,1,Jan,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,12,Reproduction number,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,13 Mar 2016,1 Jan 2016 - 13 Mar 2016
16f97fa8a34ea65fbc4020042bcb2cce,7846e58f955d799759e32c9fb8fd83c2,927,Reproduction number (Basic R0),No units,0,7,Mean,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Other,Kelly M,Observed sample statistic,FALSE,NA,NA,Ecuador,Persons under investigation,NA,96,Population based,NA,13,Mar,2016,1,Jan,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,12,Reproduction number,NA,NA,NA,Ecuador,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,13 Mar 2016,1 Jan 2016 - 13 Mar 2016
03e7ee71c8aef2a1e34f01c5d5270383,3255f7fba218f0ef329834bd12e6a6e8,946,Reproduction number (Basic R0),No units,0,NA,Mean,NA,NA,NA,NA,NA,1.54,1.9,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Method, Time",TRUE,TRUE,Post outbreak,Other,Dominic Dee,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,Guadeloupe,NA,Community based,Unspecified,29,Jan,2017,24,Jan,2015,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,5,Reproduction number,1.54 - 1.9,NA,NA,France,NA,NA,FALSE,NA,NA,NA,24 Jan 2015,29 Jan 2017,24 Jan 2015 - 29 Jan 2017
03e7ee71c8aef2a1e34f01c5d5270383,3e0fa0ab08291a5b222d258d40b0e9f6,946,Reproduction number (Basic R0),No units,0,NA,Mean,NA,NA,NA,NA,NA,1.3,1.62,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Method, Time",TRUE,TRUE,Post outbreak,Other,Dominic Dee,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,Martinique,NA,Community based,Unspecified,5,Feb,2017,20,Dec,2015,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,5,Reproduction number,1.3 - 1.62,NA,NA,France,NA,NA,FALSE,NA,NA,NA,20 Dec 2015,5 Feb 2017,20 Dec 2015 - 5 Feb 2017
03e7ee71c8aef2a1e34f01c5d5270383,7d9beee3163332a27a332b982569bc44,946,Reproduction number (Basic R0),No units,0,NA,Mean,NA,NA,NA,NA,NA,1.34,1.57,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Method, Time",TRUE,TRUE,Post outbreak,Other,Dominic Dee,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,Saint Martin,NA,Community based,Unspecified,19,Feb,2017,24,Jan,2015,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,5,Reproduction number,1.34 - 1.57,NA,NA,France,NA,NA,FALSE,NA,NA,NA,24 Jan 2015,19 Feb 2017,24 Jan 2015 - 19 Feb 2017
a2862e701515a50c03b7fbe6fac4be3a,d20daee590675dbbec508ece4832abd7,946,Reproduction number (Basic R0),No units,0,2.03,Mean,1.63,2.36,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,TRUE,Post outbreak,Other,Kelly M,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,"Australes, French Polynesia",NA,Community based,Unspecified,30,Mar,2017,1,Dec,2015,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,3,Reproduction number,NA,95% CrI,1.63 - 2.36,France,NA,NA,FALSE,NA,NA,NA,1 Dec 2015,30 Mar 2017,1 Dec 2015 - 30 Mar 2017
a2862e701515a50c03b7fbe6fac4be3a,116c353353ac37bbdd50c88892d47bf7,946,Reproduction number (Basic R0),No units,0,2.12,Mean,1.82,2.47,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,TRUE,Post outbreak,Other,Kelly M,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,"Marquesas Islands, French Polynesia",NA,Community based,Unspecified,23,Mar,2017,27,Oct,2015,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,3,Reproduction number,NA,95% CrI,1.82 - 2.47,France,NA,NA,FALSE,NA,NA,NA,27 Oct 2015,23 Mar 2017,27 Oct 2015 - 23 Mar 2017
a2862e701515a50c03b7fbe6fac4be3a,6307573c7e46e4e7380020f086e61965,946,Reproduction number (Basic R0),No units,0,2.1,Mean,1.78,2.47,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,TRUE,Post outbreak,Other,Kelly M,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,"Mo'orea, French Polynesia",NA,Community based,Unspecified,9,Mar,2017,27,Oct,2015,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,3,Reproduction number,NA,95% CrI,1.78 - 2.47,France,NA,NA,FALSE,NA,NA,NA,27 Oct 2015,9 Mar 2017,27 Oct 2015 - 9 Mar 2017
a2862e701515a50c03b7fbe6fac4be3a,b62ee48987557a1c098b724a1639504f,946,Reproduction number (Basic R0),No units,0,2.1,Mean,1.8,2.43,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,TRUE,Post outbreak,Other,Kelly M,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,"Sous-le-vent Islands, French Polynesia",NA,Community based,Unspecified,23,Mar,2017,27,Oct,2015,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,3,Reproduction number,NA,95% CrI,1.8 - 2.43,France,NA,NA,FALSE,NA,NA,NA,27 Oct 2015,23 Mar 2017,27 Oct 2015 - 23 Mar 2017
a2862e701515a50c03b7fbe6fac4be3a,ccb99b167d74235ecf07344ea58811ab,946,Reproduction number (Basic R0),No units,0,2.1,Mean,1.86,2.35,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,TRUE,Post outbreak,Other,Kelly M,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,"Tahiti, French Polynesia",NA,Community based,Unspecified,16,Mar,2017,13,Oct,2015,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,3,Reproduction number,NA,95% CrI,1.86 - 2.35,France,NA,NA,FALSE,NA,NA,NA,13 Oct 2015,16 Mar 2017,13 Oct 2015 - 16 Mar 2017
a2862e701515a50c03b7fbe6fac4be3a,a9bb21a3a95f6a134ab8ec73542893c3,946,Reproduction number (Basic R0),No units,0,2.05,Mean,1.71,2.37,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,TRUE,Post outbreak,Other,Kelly M,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,"Tuamotu, French Polynesia",NA,Community based,Unspecified,2,Mar,2017,20,Oct,2015,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,3,Reproduction number,NA,95% CrI,1.71 - 2.37,France,NA,NA,FALSE,NA,NA,NA,20 Oct 2015,2 Mar 2017,20 Oct 2015 - 2 Mar 2017
a2862e701515a50c03b7fbe6fac4be3a,dba8bff0a0a83dc3e288e197157f4bc2,946,Human delay - generation time,Weeks,0,2.5,Mean,NA,NA,NA,0.7,Standard Deviation,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,Gamma,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Estimated model parameter,FALSE,NA,NA,France,NA,"Guadeloupe, Martinique, Saint-Martin",NA,NA,NA,NA,NA,2017,NA,NA,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,3,Human delay,NA,Standard Deviation,0.7,NA,Generation time,NA,FALSE,NA,NA,NA,2015,2017,2015 - 2017
4a1b4eb91bc7c144f5766c5022434ab3,79d6c329dfc9a042763bfa5ad900d3ac,947,Reproduction number (Basic R0),No units,0,1.88,Mean,1.59,2.22,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Region,FALSE,FALSE,Unspecified,Branching process,Anna Vicco,Estimated model parameter,TRUE,NA,NA,France,Persons under investigation,French Polynesia and French West Indies,100000,Population based,NA,NA,Oct,2016,NA,Oct,2013,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,10,Reproduction number,NA,95% CrI,1.59 - 2.22,France,NA,NA,FALSE,NA,NA,NA,Oct 2013,Oct 2016,Oct 2013 - Oct 2016
1d346821df9d4e65b786d7ba806bd2be,d672cd644d12cdb9901106b3126e832b,947,Human delay - serial interval,Weeks,0,NA,Mean,NA,NA,NA,NA,NA,2.2,4.7,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Region,FALSE,FALSE,Unspecified,NA,Christian,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,French Polynesia,NA,Population based,NA,NA,Oct,2016,NA,Oct,2013,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,5,Human delay,2.2 - 4.7,NA,NA,France,Serial interval,NA,FALSE,NA,NA,NA,Oct 2013,Oct 2016,Oct 2013 - Oct 2016
c2a94bed1bb681795dc8803c87175477,b52e0315e207eff1fb07d1ad8a53a75f,1028,Reproduction number (Basic R0),No units,0,2.75,Unspecified,2.53,2.98,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,TRUE,Mid outbreak,NA,Tristan Naidoo,Estimated model parameter,FALSE,NA,NA,France,Unspecified,French Polynesia,NA,Unspecified,Unspecified,NA,NA,NA,NA,NA,2013,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,4,Reproduction number,NA,95% CI,2.53 - 2.98,France,NA,NA,FALSE,NA,NA,NA,2013,Unspecified,2013 - Unspecified
9fe0bdcc0c0299550cef9a5f3f3efb1e,f40968620150be893278a0ae1d0769e7,1043,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,95,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,21,NA,20,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,France,Pregnant women,"Tahiti, Mo'orea, French Polynesia",21,Hospital based,Female,31,Aug,2014,1,Jun,2013,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,55,Seroprevalence,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,1 Jun 2013,31 Aug 2014,1 Jun 2013 - 31 Aug 2014
9fe0bdcc0c0299550cef9a5f3f3efb1e,84f71dd6d0d665789158bd4c2f770f38,1043,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,76,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,102,NA,78,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,France,Pregnant women,"Tahiti, Mo'orea, French Polynesia",102,Hospital based,Female,31,Aug,2014,1,Jun,2013,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,55,Seroprevalence,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,1 Jun 2013,31 Aug 2014,1 Jun 2013 - 31 Aug 2014
9fe0bdcc0c0299550cef9a5f3f3efb1e,23a4ff6e3f70c743ced29ffc69c18fc1,1043,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Kelly M,NA,FALSE,NA,NA,France,Children,"Tahiti, Mo'orea, French Polynesia",21,Hospital based,Both,31,Aug,2014,1,Jun,2013,NA,Adjusted,Infection during pregnancy,NA,Zika congenital syndrome/other birth defects,Significant,NA,FALSE,Unspecified,Unspecified,55,Risk factors,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,1 Jun 2013,31 Aug 2014,1 Jun 2013 - 31 Aug 2014
513747d7433fd36aac44bda7d815a64a,6ed136892980de7933b152d126e7f206,1048,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,NA,FALSE,NA,NA,Brazil,Other,"Salvador, Bahia",41,Hospital based,Both,31,Aug,2015,1,Jan,2015,NA,Not adjusted,Infection;Other,NA,Guillain Barre syndrome,Significant,NA,FALSE,NA,Urban area,56,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,1 Jan 2015,31 Aug 2015,1 Jan 2015 - 31 Aug 2015
513747d7433fd36aac44bda7d815a64a,a28ba166e74d8e980377dfb2db613662,1048,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,NA,FALSE,NA,NA,Brazil,Other,"Salvador, Bahia",41,Hospital based,Both,31,Aug,2015,1,Jan,2015,NA,Not adjusted,Comorbidity;Other;Sex,NA,Guillain Barre syndrome,Not significant,NA,FALSE,NA,Urban area,56,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,1 Jan 2015,31 Aug 2015,1 Jan 2015 - 31 Aug 2015
513747d7433fd36aac44bda7d815a64a,e371c4389e3daf8ede1d7caa0453998c,1048,Human delay - Onset of previous illness to Onset of neurologic symptoms,Days,0,8,Median,5,15,IQR,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Brazil,Other,"Salvador, Bahia",50,Hospital based,Both,31,Aug,2015,1,Jan,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Urban area,56,Human delay,NA,IQR,5 - 15,Brazil,Onset of previous illness to onset of neurologic symptoms,NA,FALSE,NA,NA,NA,1 Jan 2015,31 Aug 2015,1 Jan 2015 - 31 Aug 2015
513747d7433fd36aac44bda7d815a64a,8be4c291469eda26ceedb20e1d7667a7,1048,Human delay - Onset of neurologic symptoms to Nadir of neurologic symptoms,Days,0,6,Median,4,9,IQR,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Brazil,Other,"Salvador, Bahia",50,Hospital based,Both,31,Aug,2015,1,Jan,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Urban area,56,Human delay,NA,IQR,4 - 9,Brazil,Onset of neurologic symptoms to nadir of neurologic symptoms,NA,FALSE,NA,NA,NA,1 Jan 2015,31 Aug 2015,1 Jan 2015 - 31 Aug 2015
513747d7433fd36aac44bda7d815a64a,d498b3ece6b3ae53c2d03040f9fe8f1c,1048,Seroprevalence - IgM,Percentage (%),0,41,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,41,NA,17,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,TRUE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Brazil,Other,"Salvador, Bahia",41,Hospital based,Both,31,Aug,2015,1,Jan,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Urban area,56,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,1 Jan 2015,31 Aug 2015,1 Jan 2015 - 31 Aug 2015
513747d7433fd36aac44bda7d815a64a,ebc35f534d0b63ec0015a39f1f6d5466,1048,Seroprevalence - IgM,Percentage (%),0,36,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,84,NA,30,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,TRUE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Brazil,Other,"Salvador, Bahia",84,Hospital based,Both,31,Aug,2015,1,Jan,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Urban area,56,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,1 Jan 2015,31 Aug 2015,1 Jan 2015 - 31 Aug 2015
513747d7433fd36aac44bda7d815a64a,114f2dae719751f30e55710582d9dc1b,1048,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,88,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,41,NA,36,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,TRUE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Brazil,Other,"Salvador, Bahia",41,Hospital based,Both,31,Aug,2015,1,Jan,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Urban area,56,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,1 Jan 2015,31 Aug 2015,1 Jan 2015 - 31 Aug 2015
513747d7433fd36aac44bda7d815a64a,bcbee80d373a14d7b328fabe7e18d647,1048,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,76,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,84,NA,64,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,TRUE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Brazil,Other,"Salvador, Bahia",84,Hospital based,Both,31,Aug,2015,1,Jan,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Urban area,56,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,1 Jan 2015,31 Aug 2015,1 Jan 2015 - 31 Aug 2015
e473baea093f738af900c386559be04b,23ab4ec80c0aa1a0f781429b94809f13,1093,Seroprevalence - IgM,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,13845,Unspecified,9,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Keith,NA,FALSE,90,1,Senegal,Persons under investigation,Kedougou,13845,Hospital based,Both,NA,Mar,2013,NA,Jul,2009,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,NA,Rural area,8,Seroprevalence,NA,NA,NA,Senegal,NA,NA,FALSE,NA,NA,NA,Jul 2009,Mar 2013,Jul 2009 - Mar 2013
ab74f3885726f18aaddae6d49fe605a6,47d3f89fa5577b2b228c5961ba1f25f3,1121,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,sangeeta,NA,FALSE,NA,NA,Sudan,Other,NA,845,Community based,Both,NA,NA,2012,NA,NA,2012,NA,Adjusted,Age,NA,Serology,Significant,NA,FALSE,NA,Both urban and rural areas,2,Risk factors,NA,NA,NA,Sudan,NA,NA,FALSE,NA,NA,NA,2012,2012,2012
ab74f3885726f18aaddae6d49fe605a6,a4e80b9ba669baf60a7a01eb40bd2ef7,1121,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,sangeeta,NA,FALSE,NA,NA,Sudan,Other,NA,845,Community based,Both,NA,NA,2012,NA,NA,2012,NA,Adjusted,Age;Other;Sex,NA,Serology,Not significant,NA,FALSE,NA,Both urban and rural areas,2,Risk factors,NA,NA,NA,Sudan,NA,NA,FALSE,NA,NA,NA,2012,2012,2012
ab74f3885726f18aaddae6d49fe605a6,e868fd45151d62e4f5ede8ea0aad5842,1121,Seroprevalence - IgG,Percentage (%),0,62.7,Other,59.4,66.1,95% CI,NA,NA,6,83,NA,NA,845,Naive,530,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Region, Sex",FALSE,FALSE,Unspecified,NA,sangeeta,Observed sample statistic,FALSE,NA,NA,Sudan,Other,NA,845,Community based,Both,NA,NA,2012,NA,NA,2012,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Both urban and rural areas,2,Seroprevalence,6 - 83,95% CI,59.4 - 66.1,Sudan,NA,NA,FALSE,NA,NA,NA,2012,2012,2012
d36dc27eae88afd31b5fa9bcf48ffcbd,d5fdf52e5f7ae950130c95da19beb09d,1121,Seroprevalence - Neutralisation/PRNT,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,530,NA,1,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Patrick,Observed sample statistic,FALSE,NA,NA,Sudan,Other,NA,530,Community based,Both,NA,NA,2012,NA,NA,2012,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Both urban and rural areas,3,Seroprevalence,NA,NA,NA,Sudan,NA,NA,TRUE,NA,NA,NA,2012,2012,2012
29e4a48f916644f974ef1a6e242c3625,13d204ca3b1e5116931ad95949e9df87,1154,Attack rate,Unspecified,0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Sequoia,Estimated model parameter,TRUE,NA,NA,"Brazil,Ecuador,Federated States of Micronesia",NA,NA,NA,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,9,Attack rate,NA,NA,NA,"Brazil, Ecuador, Federated States of Micronesia",NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
d4d46aa2f58f4b9d69596b3c3d169bbc,8caf88d11d527fef1661126d4fbc1df3,1237,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Keith,NA,FALSE,NA,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,Infection during pregnancy,Unspecified,Microcephaly,Not significant,NA,FALSE,NA,NA,10,Risk factors,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
5d690c3245743df42d1015e299140af1,71e9567bfb497642b6c696d48ad3cd53,1308,Attack rate,Unspecified,0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on Github,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Estimated model parameter,TRUE,NA,NA,Unspecified,General population,Latin America and Caribbean,NA,Population based,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Both urban and rural areas,8,Attack rate,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
5d690c3245743df42d1015e299140af1,2f926cecc23832c160cbb629fc1ac553,1308,Reproduction number (Basic R0),No units,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on Github,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Ross-Macdonald formula,Kelly M,Estimated model parameter,TRUE,NA,NA,Unspecified,General population,Latin America and Caribbean,NA,Population based,NA,NA,NA,NA,NA,NA,NA,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Both urban and rural areas,8,Reproduction number,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
31118c6d905713b6a52db240bf0117df,91a401db8a6b0ab1c8febceb2aa9488b,1352,Seroprevalence - IgG,Percentage (%),0,17.3,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,359,Unspecified,62,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Richard Sheppard,Observed sample statistic,FALSE,63,16,Laos,Blood donors,Vientiane capital,359,Population based,Both,NA,NA,2004,NA,NA,2003,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,3,Seroprevalence,NA,NA,NA,Laos,NA,NA,FALSE,NA,NA,NA,2003,2004,2003 - 2004
31118c6d905713b6a52db240bf0117df,acc9d0cf47fc0f98b628e2775836341e,1352,Seroprevalence - IgG,Percentage (%),0,27.9,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,687,Unspecified,192,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Richard Sheppard,Observed sample statistic,FALSE,79,17,Laos,Blood donors,Vientiane capital,687,Population based,Both,NA,NA,2015,NA,NA,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,3,Seroprevalence,NA,NA,NA,Laos,NA,NA,FALSE,NA,NA,NA,2015,2015,2015
31118c6d905713b6a52db240bf0117df,7f0c4dc355fa788b2005232720975431,1352,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,NA,Unspecified,NA,NA,95% CI,NA,NA,3.9,10.1,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Sex, Time",FALSE,FALSE,Endemic,NA,Richard Sheppard,Observed sample statistic,FALSE,NA,15,Laos,Blood donors,Vientiane capital,NA,Population based,Both,NA,NA,2015,NA,NA,2003,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,3,Seroprevalence,3.9 - 10.1,NA,NA,Laos,NA,NA,TRUE,NA,NA,NA,2003,2015,2003 - 2015
31118c6d905713b6a52db240bf0117df,a914b18ba083c49cc1d0f4d2f7dbc1b5,1352,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Richard Sheppard,NA,FALSE,NA,15,Laos,Blood donors,Vientiane capital,NA,Population based,Both,NA,NA,2015,NA,NA,2003,NA,Not adjusted,Sex,Unspecified,Serology,Not significant,NA,FALSE,Unspecified,Unspecified,3,Risk factors,NA,NA,NA,Laos,NA,NA,FALSE,NA,NA,NA,2003,2015,2003 - 2015
f9f9ebff670b1bd3191d78ee4b6712e3,239957e6bab1b6f7f72b828d1c3b423c,1411,Seroprevalence - IgM,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,73,Unspecified,5,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Keith,NA,FALSE,0,0,Argentina,Persons under investigation,NA,104,Other,Unspecified,NA,Mar,2017,NA,Apr,2016,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,Unspecified,Unspecified,13,Seroprevalence,NA,NA,NA,Argentina,NA,NA,FALSE,NA,NA,NA,Apr 2016,Mar 2017,Apr 2016 - Mar 2017
3b89cd7db8a8b34ba4cc09d994e10dbe,418a112e8d5c908d32a8f51f0cbc11c1,1461,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,NA,FALSE,NA,NA,Bolivia,General population,"Beni, Santa Cruz, Tarija, Cochabamba, La Paz",814,Population based,Both,NA,Apr,2017,NA,Dec,2016,NA,Unspecified,Age;Sex,NA,Serology,Not significant,NA,FALSE,NA,NA,4,Risk factors,NA,NA,NA,Bolivia,NA,NA,FALSE,NA,NA,NA,Dec 2016,Apr 2017,Dec 2016 - Apr 2017
3b89cd7db8a8b34ba4cc09d994e10dbe,d964b2db36641d90367dbdf3c7594bf3,1461,Seroprevalence - IgG,Percentage (%),0,61.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed;Other,105,NA,65,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Sex",FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,Bolivia,General population,Beni,105,Population based,Both,NA,Dec,2016,NA,Dec,2016,NA,NA,NA,NA,NA,NA,Adjusted,FALSE,NA,NA,4,Seroprevalence,NA,NA,NA,Bolivia,NA,NA,FALSE,NA,NA,NA,Dec 2016,Dec 2016,Dec 2016
3b89cd7db8a8b34ba4cc09d994e10dbe,664d2e9f1979c1b422cdb2d3ecee423f,1461,Seroprevalence - IgG,Percentage (%),0,61,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed;Other,200,NA,122,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Sex",FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,Bolivia,General population,Santa Cruz,200,Population based,Both,NA,Apr,2017,NA,Mar,2017,NA,NA,NA,NA,NA,NA,Adjusted,FALSE,NA,NA,4,Seroprevalence,NA,NA,NA,Bolivia,NA,NA,FALSE,NA,NA,NA,Mar 2017,Apr 2017,Mar 2017 - Apr 2017
3b89cd7db8a8b34ba4cc09d994e10dbe,de63e175e7fa5b6e8106cdf7543ed51d,1461,Seroprevalence - IgG,Percentage (%),0,9.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed;Other,196,NA,19,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Sex",FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,Bolivia,General population,Tarija,196,Population based,Both,NA,Apr,2017,NA,Mar,2017,NA,NA,NA,NA,NA,NA,Adjusted,FALSE,NA,NA,4,Seroprevalence,NA,NA,NA,Bolivia,NA,NA,FALSE,NA,NA,NA,Mar 2017,Apr 2017,Mar 2017 - Apr 2017
3b89cd7db8a8b34ba4cc09d994e10dbe,422686a50ad9063269eb81a102e8d6d5,1461,Seroprevalence - IgG,Percentage (%),0,1.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed;Other,162,NA,3,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Sex",FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,Bolivia,General population,La Paz,162,Population based,Both,NA,Apr,2017,NA,Mar,2017,NA,NA,NA,NA,NA,NA,Adjusted,FALSE,NA,NA,4,Seroprevalence,NA,NA,NA,Bolivia,NA,NA,FALSE,NA,NA,NA,Mar 2017,Apr 2017,Mar 2017 - Apr 2017
3b89cd7db8a8b34ba4cc09d994e10dbe,520b6e8eb8a6438509111cca0aa08b42,1461,Seroprevalence - IgG,Percentage (%),0,2.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed;Other,152,NA,4,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Sex",FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,Bolivia,General population,Cochabamba,152,Population based,Both,NA,Apr,2017,NA,Mar,2017,NA,NA,NA,NA,NA,NA,Adjusted,FALSE,NA,NA,4,Seroprevalence,NA,NA,NA,Bolivia,NA,NA,FALSE,NA,NA,NA,Mar 2017,Apr 2017,Mar 2017 - Apr 2017
3b89cd7db8a8b34ba4cc09d994e10dbe,9350bbaea12cf168e5f0cc3735054936,1461,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,39,NA,30,48,95% CI,NA,NA,NA,NA,NA,Lab confirmed;Other,70,NA,41,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Sex",FALSE,FALSE,Unspecified,NA,Anna-Maria Hartner,Observed sample statistic,FALSE,NA,NA,Bolivia,General population,Beni,70,Population based,Both,NA,Apr,2017,NA,Mar,2017,NA,NA,NA,NA,NA,NA,Adjusted,FALSE,NA,NA,4,Seroprevalence,NA,95% CI,30 - 48,Bolivia,NA,NA,FALSE,NA,NA,NA,Mar 2017,Apr 2017,Mar 2017 - Apr 2017
3b89cd7db8a8b34ba4cc09d994e10dbe,a3d12e91511dfafa727a860cfbade008,1461,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,21.5,NA,16,27,95% CI,NA,NA,NA,NA,NA,Lab confirmed;Other,134,NA,43,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Sex",FALSE,FALSE,Unspecified,NA,Anna-Maria Hartner,Observed sample statistic,FALSE,NA,NA,Bolivia,General population,Santa Cruz,134,Population based,Both,NA,Apr,2017,NA,Mar,2017,NA,NA,NA,NA,NA,NA,Adjusted,FALSE,NA,NA,4,Seroprevalence,NA,95% CI,16 - 27,Bolivia,NA,NA,FALSE,NA,NA,NA,Mar 2017,Apr 2017,Mar 2017 - Apr 2017
3b89cd7db8a8b34ba4cc09d994e10dbe,99bb0c37989efb5e0a144e756ed3e630,1461,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,0.5,NA,0,1.5,95% CI,NA,NA,NA,NA,NA,Lab confirmed;Other,22,NA,1,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Sex",FALSE,FALSE,Unspecified,NA,Anna-Maria Hartner,Observed sample statistic,FALSE,NA,NA,Bolivia,General population,Tarija,22,Population based,Both,NA,Apr,2017,NA,Mar,2017,NA,NA,NA,NA,NA,NA,Adjusted,FALSE,NA,NA,4,Seroprevalence,NA,95% CI,0 - 1.5,Bolivia,NA,NA,FALSE,NA,NA,NA,Mar 2017,Apr 2017,Mar 2017 - Apr 2017
3b89cd7db8a8b34ba4cc09d994e10dbe,3c4bef2a2b38500d1ce44e440fe802b6,1461,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,0,NA,0,0,95% CI,NA,NA,NA,NA,NA,Lab confirmed;Other,4,NA,0,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Sex",FALSE,FALSE,Unspecified,NA,Anna-Maria Hartner,Observed sample statistic,FALSE,NA,NA,Bolivia,General population,La Paz,4,Population based,Both,NA,Apr,2017,NA,Mar,2017,NA,NA,NA,NA,NA,NA,Adjusted,FALSE,NA,NA,4,Seroprevalence,NA,95% CI,0 - 0,Bolivia,NA,NA,FALSE,NA,NA,NA,Mar 2017,Apr 2017,Mar 2017 - Apr 2017
3b89cd7db8a8b34ba4cc09d994e10dbe,1a2b67922f9537e0e77ad5fcead8274f,1461,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,0,NA,0,0,95% CI,NA,NA,NA,NA,NA,Lab confirmed;Other,7,NA,0,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Sex",FALSE,FALSE,Unspecified,NA,Anna-Maria Hartner,Observed sample statistic,FALSE,NA,NA,Bolivia,General population,Cochabamba,7,Population based,Both,NA,Apr,2017,NA,Mar,2017,NA,NA,NA,NA,NA,NA,Adjusted,FALSE,NA,NA,4,Seroprevalence,NA,95% CI,0 - 0,Bolivia,NA,NA,FALSE,NA,NA,NA,Mar 2017,Apr 2017,Mar 2017 - Apr 2017
9e3a32f583820313a4b6205dfb56c762,bc3c222813b0075a59236ff1f1f6a65c,1473,Mosquito delay - extrinsic incubation period,Days,0,NA,NA,NA,NA,NA,NA,NA,10,14,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,52,Mosquito,10 - 14,NA,NA,NA,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
5ac6eec005717425a5d54755ed6e6fec,fed2e42fa61b9b1a4bf8a2bb67b1cfc7,1496,Reproduction number (Basic R0),No units,0,1.12,Median,NA,NA,NA,NA,NA,0.98,56.38,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Region,FALSE,FALSE,Mid outbreak,Compartmental model,Shazia Ruybal-Pesantez,Estimated model parameter,FALSE,NA,NA,Colombia,Persons under investigation,Antioquia,1841,Population based,Both,11,Apr,2016,1,Jan,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Both urban and rural areas,1,Reproduction number,0.98 - 56.38,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,11 Apr 2016,1 Jan 2016 - 11 Apr 2016
5ac6eec005717425a5d54755ed6e6fec,fed2e42fa61b9b1a4bf8a2bb67b1cfc7av1,1496,Reproduction number (Basic R0),No units,0,56.38,Median,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,NA,FALSE,FALSE,Mid outbreak,Compartmental model,Anna Vicco,Estimated model parameter,FALSE,NA,NA,Colombia,Persons under investigation,Cáceres,1841,Population based,Both,11,Apr,2016,1,Jan,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Both urban and rural areas,1,Reproduction number,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,11 Apr 2016,1 Jan 2016 - 11 Apr 2016
5ac6eec005717425a5d54755ed6e6fec,fed2e42fa61b9b1a4bf8a2bb67b1cfc7av2,1496,Reproduction number (Basic R0),No units,0,1.009,Median,0.99,1.02,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,NA,FALSE,FALSE,Mid outbreak,Compartmental model,Anna Vicco,Estimated model parameter,FALSE,NA,NA,Colombia,Persons under investigation,Caucasia,1841,Population based,Both,11,Apr,2016,1,Jan,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Both urban and rural areas,1,Reproduction number,NA,95% CI,0.99 - 1.02,Colombia,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,11 Apr 2016,1 Jan 2016 - 11 Apr 2016
5ac6eec005717425a5d54755ed6e6fec,fed2e42fa61b9b1a4bf8a2bb67b1cfc7av3,1496,Reproduction number (Basic R0),No units,0,2.2,Median,1.54,2.86,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,NA,FALSE,FALSE,Mid outbreak,Compartmental model,Anna Vicco,Estimated model parameter,FALSE,NA,NA,Colombia,Persons under investigation,Nechí,1841,Population based,Both,11,Apr,2016,1,Jan,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Both urban and rural areas,1,Reproduction number,NA,95% CI,1.54 - 2.86,Colombia,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,11 Apr 2016,1 Jan 2016 - 11 Apr 2016
5ac6eec005717425a5d54755ed6e6fec,fed2e42fa61b9b1a4bf8a2bb67b1cfc7av4,1496,Reproduction number (Basic R0),No units,0,1.13,Median,0.84,1.42,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,NA,FALSE,FALSE,Mid outbreak,Compartmental model,Anna Vicco,Estimated model parameter,FALSE,NA,NA,Colombia,Persons under investigation,Remedios,1841,Population based,Both,11,Apr,2016,1,Jan,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Both urban and rural areas,1,Reproduction number,NA,95% CI,0.84 - 1.42,Colombia,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,11 Apr 2016,1 Jan 2016 - 11 Apr 2016
5ac6eec005717425a5d54755ed6e6fec,fed2e42fa61b9b1a4bf8a2bb67b1cfc7av5,1496,Reproduction number (Basic R0),No units,0,1.11,Median,1.09,1.13,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,NA,FALSE,FALSE,Mid outbreak,Compartmental model,Anna Vicco,Estimated model parameter,FALSE,NA,NA,Colombia,Persons under investigation,Apartadó,1841,Population based,Both,11,Apr,2016,1,Jan,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Both urban and rural areas,1,Reproduction number,NA,95% CI,1.09 - 1.13,Colombia,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,11 Apr 2016,1 Jan 2016 - 11 Apr 2016
5ac6eec005717425a5d54755ed6e6fec,fed2e42fa61b9b1a4bf8a2bb67b1cfc7av6,1496,Reproduction number (Basic R0),No units,0,1.23,Median,1.18,1.28,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,NA,FALSE,FALSE,Mid outbreak,Compartmental model,Anna Vicco,Estimated model parameter,FALSE,NA,NA,Colombia,Persons under investigation,Carepa,1841,Population based,Both,11,Apr,2016,1,Jan,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Both urban and rural areas,1,Reproduction number,NA,95% CI,1.18 - 1.28,Colombia,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,11 Apr 2016,1 Jan 2016 - 11 Apr 2016
5ac6eec005717425a5d54755ed6e6fec,fed2e42fa61b9b1a4bf8a2bb67b1cfc7av7,1496,Reproduction number (Basic R0),No units,0,1.53,Median,1.71,1.89,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,NA,FALSE,FALSE,Mid outbreak,Compartmental model,Anna Vicco,Estimated model parameter,FALSE,NA,NA,Colombia,Persons under investigation,Chigorodó,1841,Population based,Both,11,Apr,2016,1,Jan,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Both urban and rural areas,1,Reproduction number,NA,95% CI,1.71 - 1.89,Colombia,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,11 Apr 2016,1 Jan 2016 - 11 Apr 2016
5ac6eec005717425a5d54755ed6e6fec,fed2e42fa61b9b1a4bf8a2bb67b1cfc7av8,1496,Reproduction number (Basic R0),No units,0,1.12,Median,0.99,1.24,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,NA,FALSE,FALSE,Mid outbreak,Compartmental model,Anna Vicco,Estimated model parameter,FALSE,NA,NA,Colombia,Persons under investigation,Necoclí,1841,Population based,Both,11,Apr,2016,1,Jan,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Both urban and rural areas,1,Reproduction number,NA,95% CI,0.99 - 1.24,Colombia,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,11 Apr 2016,1 Jan 2016 - 11 Apr 2016
5ac6eec005717425a5d54755ed6e6fec,fed2e42fa61b9b1a4bf8a2bb67b1cfc7av9,1496,Reproduction number (Basic R0),No units,0,1.31,Median,1.1,1.52,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,NA,FALSE,FALSE,Mid outbreak,Compartmental model,Anna Vicco,Estimated model parameter,FALSE,NA,NA,Colombia,Persons under investigation,San Pedro de Urabá,1841,Population based,Both,11,Apr,2016,1,Jan,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Both urban and rural areas,1,Reproduction number,NA,95% CI,1.1 - 1.52,Colombia,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,11 Apr 2016,1 Jan 2016 - 11 Apr 2016
5ac6eec005717425a5d54755ed6e6fec,fed2e42fa61b9b1a4bf8a2bb67b1cfc7av10,1496,Reproduction number (Basic R0),No units,0,1.15,Median,1.12,1.17,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,NA,FALSE,FALSE,Mid outbreak,Compartmental model,Anna Vicco,Estimated model parameter,FALSE,NA,NA,Colombia,Persons under investigation,Turbo,1841,Population based,Both,11,Apr,2016,1,Jan,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Both urban and rural areas,1,Reproduction number,NA,95% CI,1.12 - 1.17,Colombia,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,11 Apr 2016,1 Jan 2016 - 11 Apr 2016
5ac6eec005717425a5d54755ed6e6fec,fed2e42fa61b9b1a4bf8a2bb67b1cfc7av11,1496,Reproduction number (Basic R0),No units,0,1.08,Median,1.02,1.15,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,NA,FALSE,FALSE,Mid outbreak,Compartmental model,Anna Vicco,Estimated model parameter,FALSE,NA,NA,Colombia,Persons under investigation,Puerto Berrío,1841,Population based,Both,11,Apr,2016,1,Jan,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Both urban and rural areas,1,Reproduction number,NA,95% CI,1.02 - 1.15,Colombia,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,11 Apr 2016,1 Jan 2016 - 11 Apr 2016
5ac6eec005717425a5d54755ed6e6fec,fed2e42fa61b9b1a4bf8a2bb67b1cfc7av12,1496,Reproduction number (Basic R0),No units,0,1.03,Median,0.97,1.09,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,NA,FALSE,FALSE,Mid outbreak,Compartmental model,Anna Vicco,Estimated model parameter,FALSE,NA,NA,Colombia,Persons under investigation,Puerto Triunfo,1841,Population based,Both,11,Apr,2016,1,Jan,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Both urban and rural areas,1,Reproduction number,NA,95% CI,0.97 - 1.09,Colombia,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,11 Apr 2016,1 Jan 2016 - 11 Apr 2016
5ac6eec005717425a5d54755ed6e6fec,fed2e42fa61b9b1a4bf8a2bb67b1cfc7av13,1496,Reproduction number (Basic R0),No units,0,1.07,Median,0.8,1.26,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,NA,FALSE,FALSE,Mid outbreak,Compartmental model,Anna Vicco,Estimated model parameter,FALSE,NA,NA,Colombia,Persons under investigation,Sopetrán,1841,Population based,Both,11,Apr,2016,1,Jan,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Both urban and rural areas,1,Reproduction number,NA,95% CI,0.8 - 1.26,Colombia,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,11 Apr 2016,1 Jan 2016 - 11 Apr 2016
5ac6eec005717425a5d54755ed6e6fec,fed2e42fa61b9b1a4bf8a2bb67b1cfc7av14,1496,Reproduction number (Basic R0),No units,0,1.18,Median,1.06,1.3,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,NA,FALSE,FALSE,Mid outbreak,Compartmental model,Anna Vicco,Estimated model parameter,FALSE,NA,NA,Colombia,Persons under investigation,BeIlo,1841,Population based,Both,11,Apr,2016,1,Jan,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Both urban and rural areas,1,Reproduction number,NA,95% CI,1.06 - 1.3,Colombia,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,11 Apr 2016,1 Jan 2016 - 11 Apr 2016
5ac6eec005717425a5d54755ed6e6fec,fed2e42fa61b9b1a4bf8a2bb67b1cfc7av15,1496,Reproduction number (Basic R0),No units,0,22.2,Median,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,NA,FALSE,FALSE,Mid outbreak,Compartmental model,Anna Vicco,Estimated model parameter,FALSE,NA,NA,Colombia,Persons under investigation,Medellín,1841,Population based,Both,11,Apr,2016,1,Jan,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Both urban and rural areas,1,Reproduction number,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,11 Apr 2016,1 Jan 2016 - 11 Apr 2016
5ac6eec005717425a5d54755ed6e6fec,fed2e42fa61b9b1a4bf8a2bb67b1cfc7av16,1496,Reproduction number (Basic R0),No units,0,0.98,Median,0.93,1.02,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,NA,FALSE,FALSE,Mid outbreak,Compartmental model,Anna Vicco,Estimated model parameter,FALSE,NA,NA,Colombia,Persons under investigation,Envigado,1841,Population based,Both,11,Apr,2016,1,Jan,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Both urban and rural areas,1,Reproduction number,NA,95% CI,0.93 - 1.02,Colombia,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,11 Apr 2016,1 Jan 2016 - 11 Apr 2016
5ac6eec005717425a5d54755ed6e6fec,fed2e42fa61b9b1a4bf8a2bb67b1cfc7av17,1496,Reproduction number (Basic R0),No units,0,0.98,Median,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,NA,FALSE,FALSE,Mid outbreak,Compartmental model,Anna Vicco,Estimated model parameter,FALSE,NA,NA,Colombia,Persons under investigation,Itagüí,1841,Population based,Both,11,Apr,2016,1,Jan,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Both urban and rural areas,1,Reproduction number,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,11 Apr 2016,1 Jan 2016 - 11 Apr 2016
5ac6eec005717425a5d54755ed6e6fec,fed2e42fa61b9b1a4bf8a2bb67b1cfc7av18,1496,Reproduction number (Basic R0),No units,0,0.98,Median,0.88,1.08,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,NA,FALSE,FALSE,Mid outbreak,Compartmental model,Anna Vicco,Estimated model parameter,FALSE,NA,NA,Colombia,Persons under investigation,Mutatá,1841,Population based,Both,11,Apr,2016,1,Jan,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Both urban and rural areas,1,Reproduction number,NA,95% CI,0.88 - 1.08,Colombia,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,11 Apr 2016,1 Jan 2016 - 11 Apr 2016
5ac6eec005717425a5d54755ed6e6fec,fed2e42fa61b9b1a4bf8a2bb67b1cfc7av19,1496,Reproduction number (Basic R0),No units,0,0.98,Median,0.92,1.03,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,NA,FALSE,FALSE,Mid outbreak,Compartmental model,Anna Vicco,Estimated model parameter,FALSE,NA,NA,Colombia,Persons under investigation,Rionegro,1841,Population based,Both,11,Apr,2016,1,Jan,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Both urban and rural areas,1,Reproduction number,NA,95% CI,0.92 - 1.03,Colombia,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,11 Apr 2016,1 Jan 2016 - 11 Apr 2016
5ac6eec005717425a5d54755ed6e6fec,fed2e42fa61b9b1a4bf8a2bb67b1cfc7av20,1496,Reproduction number (Basic R0),No units,0,0.98,Median,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,NA,FALSE,FALSE,Mid outbreak,Compartmental model,Anna Vicco,Estimated model parameter,FALSE,NA,NA,Colombia,Persons under investigation,Zaragoza,1841,Population based,Both,11,Apr,2016,1,Jan,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Both urban and rural areas,1,Reproduction number,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,11 Apr 2016,1 Jan 2016 - 11 Apr 2016
ba5191dade90f2489e694a6db6bee7b2,5ccc278c8b6b48554ec5a881b08bf5c7,1508,Reproduction number (Basic R0),No units,0,1.81,Mean,1.74,1.87,95% CrI,NA,NA,0.76,2.51,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Other, Region",FALSE,FALSE,Unspecified,Compartmental model,Ettie Unwin,Estimated model parameter,FALSE,NA,NA,Multi-country: Americas (n = 32),General population,90 major cities across LAC,NA,Population based,NA,NA,NA,2017,NA,NA,2015,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,2,Reproduction number,0.76 - 2.51,95% CrI,1.74 - 1.87,"Antigua and Barbuda, Argentina, Aruba, Bahamas,  The, Barbados, Belize, Bolivia, Brazil, Colombia, Costa Rica, Cuba, CuraÃ§ao, Dominican Republic, Ecuador, El Salvador, Grenada, Guatemala, Guyana, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Puerto Rico, St. Vincent and the Grenadines, Suriname, Trinidad and Tobago, Venezuela, Virgin Islands (U.S.)",NA,NA,FALSE,NA,NA,NA,2015,2017,2015 - 2017
94b5484c2f17ebf58b1db406635e3701,bbf11bce1e535f9ca996a8a00e9cdf4b,1628,Severity - proportion of symptomatic cases,Percentage (%),0,44,Median,26,66,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,FALSE,FALSE,Unspecified,NA,Rob Johnson,Estimated model parameter,FALSE,NA,NA,France,Unspecified,French Polynesia,NA,Unspecified,Unspecified,NA,NA,2014,NA,NA,2013,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,4,Severity,NA,95% CrI,26 - 66,France,NA,NA,FALSE,NA,NA,NA,2013,2014,2013 - 2014
94b5484c2f17ebf58b1db406635e3701,2c9d2582374cc1e36ccf7e8db48f8942,1628,Severity - proportion of symptomatic cases,Percentage (%),0,27,Median,15,37,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,FALSE,FALSE,Unspecified,NA,Rob Johnson,Estimated model parameter,FALSE,NA,NA,Federated States of Micronesia,Unspecified,Yap Island,NA,Unspecified,Unspecified,NA,NA,2007,NA,NA,2007,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,4,Severity,NA,95% CrI,15 - 37,Federated States of Micronesia,NA,NA,FALSE,NA,NA,NA,2007,2007,2007
94b5484c2f17ebf58b1db406635e3701,9ba2d6a710f29016d6e74e6928728d03,1628,Severity - proportion of symptomatic cases,Percentage (%),0,50,Median,34,92,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,FALSE,FALSE,Unspecified,NA,Rob Johnson,Estimated model parameter,FALSE,NA,NA,United States,Unspecified,Puerto Rico,NA,Unspecified,Unspecified,NA,NA,2016,NA,NA,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,4,Severity,NA,95% CrI,34 - 92,United States,NA,NA,FALSE,NA,NA,NA,2016,2016,2016
160b479aef11cf74f29343c47944c671,e0cf2b5f0185adc92789b851d732def3,1674,Seroprevalence - IgG,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,1645,Naive,65,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Sequoia,NA,FALSE,NA,5,Ethiopia,General population,NA,1645,Community based,Both,NA,Jul,2014,NA,May,2014,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,10,Seroprevalence,NA,NA,NA,Ethiopia,NA,NA,FALSE,NA,NA,NA,May 2014,Jul 2014,May 2014 - Jul 2014
160b479aef11cf74f29343c47944c671,505d3106e8a219b847579f96db913bbc,1674,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,0.4,Mean,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,65,Naive,7,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Region,FALSE,FALSE,Unspecified,NA,Sequoia,Observed sample statistic,FALSE,NA,5,Ethiopia,General population,NA,1645,Community based,Both,NA,Jul,2014,NA,May,2014,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,10,Seroprevalence,NA,NA,NA,Ethiopia,NA,NA,TRUE,NA,NA,NA,May 2014,Jul 2014,May 2014 - Jul 2014
0d8b5564a7742b227124ca04b24da9c8,a000bfc5922115b213156977bf59ffca,1679,Attack rate,"Per 100,000 population",0,20,Unspecified,NA,NA,NA,NA,NA,0,11391,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Method, Other, Region, Sex",TRUE,FALSE,Endemic,NA,Richard Sheppard,Observed sample statistic,FALSE,NA,NA,Colombia,General population,NA,48747574,Population based,Both,24,Jun,2017,10,Oct,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,5,Attack rate,0 - 11391,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,10 Oct 2015,24 Jun 2017,10 Oct 2015 - 24 Jun 2017
ed2e15ef94a2a9d4d4b90d9186a7777e,9261b062c252caf204a10d8f6097c632,1821,Reproduction number (Basic R0),No units,0,NA,NA,NA,NA,NA,NA,NA,0.4,2.73,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Compartmental model,Anna-Maria Hartner,NA,FALSE,NA,NA,United States,General population,"Wynwood Neighborhood, Miami-Dade County, Florida",NA,Population based,NA,5,Aug,2016,26,Jan,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,6,Reproduction number,0.4 - 2.73,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,26 Jan 2016,5 Aug 2016,26 Jan 2016 - 5 Aug 2016
ed2e15ef94a2a9d4d4b90d9186a7777e,438bdc2bd7b7b6144be3650ee4ee36ab,1821,Attack rate,Percentage (%),0,14.4,Unspecified,5.6,27.4,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna-Maria Hartner,Estimated model parameter,FALSE,NA,NA,United States,General population,"Wynwood Neighborhood, Miami-Dade County, Florida",NA,Population based,NA,5,Aug,2016,1,Jun,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,6,Attack rate,NA,95% CI,5.6 - 27.4,United States,NA,NA,FALSE,NA,NA,NA,1 Jun 2016,5 Aug 2016,1 Jun 2016 - 5 Aug 2016
ff9ef743561a3c7392b0f0963841ad1c,0cd853d8843d84c6bcccc0c045c2cf15,1860,Reproduction number (Basic R0),No units,0,3.26,Mean,2,5,Range,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Other,Kelly M,Estimated model parameter,FALSE,NA,NA,Colombia,Persons under investigation,NA,NA,Population based,Unspecified,16,Apr,2016,31,May,2015,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,14,Reproduction number,NA,Range,2 - 5,Colombia,NA,NA,FALSE,NA,NA,NA,31 May 2015,16 Apr 2016,31 May 2015 - 16 Apr 2016
ff9ef743561a3c7392b0f0963841ad1c,acbc5a01ac81c7a4dcf8fc5f1b961592,1860,"Reproduction number (Effective, Re)",No units,0,1.63,Mean,1,2,Range,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Other,Kelly M,Estimated model parameter,FALSE,NA,NA,Colombia,Persons under investigation,NA,NA,Population based,Unspecified,16,Apr,2016,31,May,2015,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,14,Reproduction number,NA,Range,1 - 2,Colombia,NA,NA,FALSE,NA,NA,NA,31 May 2015,16 Apr 2016,31 May 2015 - 16 Apr 2016
ff9ef743561a3c7392b0f0963841ad1c,c8d7a1a726904d3865d865fd709d3976,1860,Reproduction number (Basic R0),No units,0,5.36,Mean,3,10,Range,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Other,Kelly M,Estimated model parameter,FALSE,NA,NA,Colombia,Persons under investigation,NA,NA,Population based,Unspecified,16,Apr,2016,22,Aug,2015,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,14,Reproduction number,NA,Range,3 - 10,Colombia,NA,NA,FALSE,NA,NA,NA,22 Aug 2015,16 Apr 2016,22 Aug 2015 - 16 Apr 2016
ff9ef743561a3c7392b0f0963841ad1c,e714b8405d041d0916ec46fc7e6fb88e,1860,"Reproduction number (Effective, Re)",No units,0,1.96,Mean,1,3,Range,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Other,Kelly M,Estimated model parameter,FALSE,NA,NA,Colombia,Persons under investigation,NA,NA,Population based,Unspecified,16,Apr,2016,22,Aug,2015,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,14,Reproduction number,NA,Range,1 - 3,Colombia,NA,NA,FALSE,NA,NA,NA,22 Aug 2015,16 Apr 2016,22 Aug 2015 - 16 Apr 2016
c6eda3ae2c93a150cc1bc378beb97885,9992d9a4a9dbf2b9775b0e39062af343,1927,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Dominic Dee,NA,FALSE,NA,NA,United States,Other,"San Juan, Puerto Rico",367,Contact based,Both,27,Oct,2016,16,Sep,2016,NA,Not adjusted,Age;Comorbidity;Other;Sex,NA,Infection,Not significant,NA,FALSE,NA,Both urban and rural areas,1,Risk factors,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,16 Sep 2016,27 Oct 2016,16 Sep 2016 - 27 Oct 2016
c6eda3ae2c93a150cc1bc378beb97885,36eb145116d623f2a49b6d3c87682e08,1927,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Dominic Dee,NA,FALSE,NA,NA,United States,Other,"San Juan, Puerto Rico",367,Contact based,Both,27,Oct,2016,16,Sep,2016,NA,Not adjusted,Other,NA,Infection,Significant,NA,FALSE,NA,Both urban and rural areas,1,Risk factors,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,16 Sep 2016,27 Oct 2016,16 Sep 2016 - 27 Oct 2016
c6eda3ae2c93a150cc1bc378beb97885,a2afe615e59a74dbd5c0a67611d2e1f6,1927,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Dominic Dee,NA,FALSE,NA,NA,United States,Other,"San Juan, Puerto Rico",367,Contact based,Both,27,Oct,2016,16,Sep,2016,NA,Adjusted,Other,NA,Infection,Significant,NA,FALSE,NA,Both urban and rural areas,1,Risk factors,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,16 Sep 2016,27 Oct 2016,16 Sep 2016 - 27 Oct 2016
c6eda3ae2c93a150cc1bc378beb97885,08dbdff20a396198c69d0a9c8df82011,1927,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Dominic Dee,NA,FALSE,NA,NA,United States,Other,"San Juan, Puerto Rico",367,Contact based,Both,27,Oct,2016,16,Sep,2016,NA,Adjusted,Age;Comorbidity;Other;Sex,NA,Infection,Not significant,NA,FALSE,NA,Both urban and rural areas,1,Risk factors,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,16 Sep 2016,27 Oct 2016,16 Sep 2016 - 27 Oct 2016
c6eda3ae2c93a150cc1bc378beb97885,740f648d4c86452b25fbce7259850313,1927,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Dominic Dee,NA,FALSE,NA,NA,United States,Other,"San Juan, Puerto Rico",114,Contact based,Both,27,Oct,2016,16,Sep,2016,NA,Not adjusted,Age;Comorbidity;Sex,NA,Symptomatic infection,Significant,NA,FALSE,NA,Both urban and rural areas,1,Risk factors,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,16 Sep 2016,27 Oct 2016,16 Sep 2016 - 27 Oct 2016
c6eda3ae2c93a150cc1bc378beb97885,c46978c54bce9d548337b6824a46c47d,1927,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Dominic Dee,NA,FALSE,NA,NA,United States,Other,"San Juan, Puerto Rico",114,Contact based,Both,27,Oct,2016,16,Sep,2016,NA,Not adjusted,Other,NA,Symptomatic infection,Not significant,NA,FALSE,NA,Both urban and rural areas,1,Risk factors,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,16 Sep 2016,27 Oct 2016,16 Sep 2016 - 27 Oct 2016
c6eda3ae2c93a150cc1bc378beb97885,c81c34959eec8adc82676df6acb677b5,1927,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Dominic Dee,NA,FALSE,NA,NA,United States,Other,"San Juan, Puerto Rico",114,Contact based,Both,27,Oct,2016,16,Sep,2016,NA,Adjusted,Age;Comorbidity;Sex,NA,Symptomatic infection,Significant,NA,FALSE,NA,Both urban and rural areas,1,Risk factors,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,16 Sep 2016,27 Oct 2016,16 Sep 2016 - 27 Oct 2016
c6eda3ae2c93a150cc1bc378beb97885,5dd1a51019be4a6c831ef71081be71f0,1927,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Dominic Dee,NA,FALSE,NA,NA,United States,Other,"San Juan, Puerto Rico",114,Contact based,Both,27,Oct,2016,16,Sep,2016,NA,Adjusted,Other,NA,Symptomatic infection,Not significant,NA,FALSE,NA,Both urban and rural areas,1,Risk factors,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,16 Sep 2016,27 Oct 2016,16 Sep 2016 - 27 Oct 2016
c6eda3ae2c93a150cc1bc378beb97885,4192f1dcd3df6103c4afdf3244d73956,1927,Seroprevalence - IgM,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,367,NA,79,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Dominic Dee,NA,FALSE,NA,NA,United States,Other,"San Juan, Puerto Rico",367,Contact based,Both,27,Oct,2016,16,Sep,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Both urban and rural areas,1,Seroprevalence,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,16 Sep 2016,27 Oct 2016,16 Sep 2016 - 27 Oct 2016
ffed0ba2a0676aadae74a55fdc3b26cc,0ea671d91cf038a9c748f240be0a12b5,1940,Reproduction number (Basic R0),No units,0,2.7,Median,1,4.3,Range,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,Unspecified,Thomas Rawson,Estimated model parameter,FALSE,NA,0,Brazil,General population,Feira de Santana,1946,Population based,Both,30,Apr,2017,1,Feb,2015,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Urban area,2,Reproduction number,NA,Range,1 - 4.3,Brazil,NA,NA,FALSE,NA,NA,NA,1 Feb 2015,30 Apr 2017,1 Feb 2015 - 30 Apr 2017
ffed0ba2a0676aadae74a55fdc3b26cc,e55240b0f42c82512dfc7621ca8bc723,1940,Human delay - infectious period,Days,0,5.9,Median,5.47,6.14,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Thomas Rawson,Estimated model parameter,FALSE,NA,0,Brazil,General population,Feira de Santana,1946,Population based,Both,30,Apr,2017,1,Feb,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Urban area,2,Human delay,NA,95% CI,5.47 - 6.14,Brazil,Infectious period,NA,FALSE,NA,NA,NA,1 Feb 2015,30 Apr 2017,1 Feb 2015 - 30 Apr 2017
ffed0ba2a0676aadae74a55fdc3b26cc,961a6929b9eb560252f25c23d14088eb,1940,Human delay - incubation period,Days,0,5.8,Median,5.6,6.15,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Thomas Rawson,Estimated model parameter,FALSE,NA,0,Brazil,General population,Feira de Santana,1946,Population based,Both,30,Apr,2017,1,Feb,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Urban area,2,Human delay,NA,95% CI,5.6 - 6.15,Brazil,Incubation period,NA,FALSE,NA,NA,NA,1 Feb 2015,30 Apr 2017,1 Feb 2015 - 30 Apr 2017
ffed0ba2a0676aadae74a55fdc3b26cc,f0f18a05121b2d759d1fc45c7fab3e6c,1940,Attack rate,Percentage (%),0,65,Unspecified,57,72.9,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Thomas Rawson,Estimated model parameter,FALSE,NA,NA,Brazil,General population,Feira de Santana,NA,Population based,Both,30,Apr,2017,1,Feb,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Urban area,2,Attack rate,NA,95% CI,57 - 72.9,Brazil,NA,NA,FALSE,NA,NA,NA,1 Feb 2015,30 Apr 2017,1 Feb 2015 - 30 Apr 2017
ffed0ba2a0676aadae74a55fdc3b26cc,471e2e2d7a14fa94cabec1410557c0c0,1940,"Reproduction number (Effective, Re)",No units,0,0.62,Mean,0.25,1.06,Range,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,Unspecified,Thomas Rawson,Estimated model parameter,FALSE,NA,NA,Brazil,General population,Feira de Santana,NA,Population based,Both,30,Apr,2017,NA,NA,2017,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Urban area,2,Reproduction number,NA,Range,0.25 - 1.06,Brazil,NA,NA,FALSE,NA,NA,NA,2017,30 Apr 2017,2017 - 30 Apr 2017
2fa3fe874508d86d9bf45299d293eb06,0aca7417a90da2df378b498523ae9939,1941,Reproduction number (Basic R0),No units,0,1.85,Mean,1.5,2.2,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,Growth rate,Kelly M,Estimated model parameter,FALSE,NA,NA,Cabo Verde,Persons under investigation,"Santiago, Fogo, Maio, Boavista",7580,Population based,NA,29,May,2016,5,Oct,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,1,Reproduction number,NA,95% CI,1.5 - 2.2,Cabo Verde,NA,NA,FALSE,NA,NA,NA,5 Oct 2015,29 May 2016,5 Oct 2015 - 29 May 2016
2fa3fe874508d86d9bf45299d293eb06,70d42b350cf15526c0096ba05474d0e7,1941,Attack rate,Unspecified,0,51.1,Mean,42.1,61.1,Other,NA,Standard Error,33.6,83,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,FALSE,FALSE,Mid outbreak,NA,Kelly M,Estimated model parameter,FALSE,NA,NA,Cabo Verde,Children,"Santiago, Fogo, Maio, Boavista",7580,Population based,NA,29,May,2016,5,Oct,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,1,Attack rate,33.6 - 83,Other,42.1 - 61.1,Cabo Verde,NA,NA,FALSE,NA,NA,NA,5 Oct 2015,29 May 2016,5 Oct 2015 - 29 May 2016
2fa3fe874508d86d9bf45299d293eb06,5d2a8c79e8352c3682edcb980e356d09,1941,Zika congenital syndrome (microcephaly) probability,"Per 1,000 births",0,NA,Unspecified,NA,NA,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,NA,TRUE,NA,NA,Multi-country: Brazil and French Polynesia,Persons under investigation,NA,NA,Population based,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,1,Other transmission parameters,NA,NA,NA,"Brazil, French Polynesia",NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
414c20acacc92f631677053a0058584a,c808ab0d28eb9b614a999b6c1e1832d5,1941,Seroprevalence - IgM,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Suspected,64,Unspecified,15,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Kelly M,NA,FALSE,NA,NA,Cabo Verde,Persons under investigation,NA,64,Population based,Unspecified,29,May,2016,5,Oct,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,1,Seroprevalence,NA,NA,NA,Cabo Verde,NA,NA,FALSE,NA,NA,NA,5 Oct 2015,29 May 2016,5 Oct 2015 - 29 May 2016
045ff0d545b643e56e399cccb46bffcd,8ff8d478af8c68a132529a158df4cd57,1954,Mutations - substitution rate,Mutations/year,0,NA,NA,NA,NA,NA,NA,NA,12,25,NA,NA,10272,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid-outbreak,NA,Rob,NA,FALSE,NA,NA,"Multi-country: South and Central America (n = 7), Asia (n = 6), Oceania (n = 1), Africa (n = 4)",Unspecified,Martinique,33,Unspecified,Unspecified,6,Feb,2016,NA,NA,1947,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,4,Mutations,0.12 - 0.25,NA,NA,"Brazil, Cambodia, Central African Republic, China, French Polynesia, Guatemala, Haiti, Malaysia, Federated States of Micronesia, Nigeria, Philippines, Puerto Rico, Senegal, Suriname, Thailand, Uganda, Venezuela",NA,NA,FALSE,NA,NA,NA,1947,6 Feb 2016,1947 - 6 Feb 2016
a18450ee3d7621475fb715d73169dd9c,14a40fdc3c728bb4db76d2d1e5848482,1955,Seroprevalence - IgM,Percentage (%),0,1.3,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,156,Unspecified,2,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Keith,Unspecified,FALSE,NA,NA,Italy,Persons under investigation,Bari,156,Travel based,Both,NA,Jun,2017,NA,Mar,2015,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,NA,Urban area,18,Seroprevalence,NA,NA,NA,Italy,NA,NA,FALSE,NA,NA,NA,Mar 2015,Jun 2017,Mar 2015 - Jun 2017
80698c45218ce4bf21553f4cf4ec5e87,42760fae024fcc40fa5644f1dc6c2252,1993,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,13,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,71,Naive,9,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Sex,FALSE,FALSE,Unspecified,NA,Patrick,Observed sample statistic,FALSE,NA,NA,Indonesia,Other,"Dasan Geres and Kelayu, Lombok",71,Community based,Both,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Rural area,1,Seroprevalence,NA,NA,NA,Indonesia,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
deb1fef9b7389a2583479655837e5720,8b2954ec9394080f165c725235b2b095,2024,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,NA,FALSE,NA,NA,Multi-country: Americas (n = 21),Persons under investigation,NA,4533,Population based,NA,11,Jun,2016,15,Aug,2015,NA,Not adjusted,Other,NA,Infection,Significant,NA,FALSE,NA,Unspecified,2,Risk factors,NA,NA,NA,"Argentina, Barbados, Bolivia, Colombia, Costa Rica, CuraÃ§ao, Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Sint Maarten (Dutch part), Suriname, Trinidad and Tobago, Venezuela, Virgin Islands (U.S.)",NA,NA,FALSE,NA,NA,NA,15 Aug 2015,11 Jun 2016,15 Aug 2015 - 11 Jun 2016
3b7d08ac3817818050d283edeb09315c,5896234d0dde8e672424c25dc8e4241b,2024,Reproduction number (Basic R0) - Sexual,No units,0,NA,Central,NA,NA,NA,NA,NA,0,8.31,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Region,FALSE,FALSE,Unspecified,Other,sangeeta,Estimated model parameter,FALSE,NA,NA,Multi-country: Americas (n = 21),Persons under investigation,NA,377525,Population based,NA,11,Jun,2016,15,Aug,2015,Human-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,1,Reproduction number,0 - 8.31,NA,NA,"Argentina, Barbados, Bolivia, Colombia, Costa Rica, CuraÃ§ao, Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Sint Maarten (Dutch part), Suriname, Trinidad and Tobago, Venezuela, Virgin Islands (U.S.)",NA,NA,FALSE,NA,NA,NA,15 Aug 2015,11 Jun 2016,15 Aug 2015 - 11 Jun 2016
594f54bcdb7db1566a64627e725cb019,4577dfd86657c514789a0fc3d199c5cb,2061,Reproduction number (Basic R0),No units,0,NA,Maximum likelihood,NA,NA,NA,NA,NA,2.8,12.5,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Other,FALSE,FALSE,Start outbreak,Growth rate,Rob,Estimated model parameter,FALSE,NA,NA,Federated States of Micronesia,Unspecified,Yap Island,108,Unspecified,Unspecified,NA,NA,2007,NA,NA,2007,Human-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,2,Reproduction number,2.8 - 12.5,NA,NA,Federated States of Micronesia,NA,NA,FALSE,NA,NA,NA,2007,2007,2007
594f54bcdb7db1566a64627e725cb019,d0907aa2321346350730b37471324a6c,2061,Reproduction number (Basic R0),No units,0,NA,Maximum likelihood,NA,NA,NA,NA,NA,1.5,3.1,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Other,FALSE,FALSE,Start outbreak,Growth rate,Rob,Estimated model parameter,FALSE,NA,NA,France,Unspecified,French Polynesia,8581,Unspecified,Unspecified,NA,NA,2014,NA,NA,2013,Human-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,2,Reproduction number,1.5 - 3.1,NA,NA,France,NA,NA,FALSE,NA,NA,NA,2013,2014,2013 - 2014
604bcb4a5d6378c04f00e71ce805c682,0195e150778d707707480c3fcda42364,2091,Seroprevalence - IgG,Percentage (%),0,63.3,Central,59.4,66.8,95% CI,NA,NA,NA,NA,NA,Lab confirmed,633,Naive,401,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Other, Time",FALSE,FALSE,Unspecified,NA,Anna Vicco,Observed sample statistic,FALSE,84,NA,Brazil,Mixed groups,"Salvador, Bahia",633,Mixed settings,Both,28,May,2016,25,Nov,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Urban area,1,Seroprevalence,NA,95% CI,59.4 - 66.8,Brazil,NA,NA,FALSE,NA,NA,NA,25 Nov 2015,28 May 2016,25 Nov 2015 - 28 May 2016
604bcb4a5d6378c04f00e71ce805c682,8ae4bb7618f818fda4e7d6cf8f16d8eb,2091,Seroprevalence - IgM,Percentage (%),0,1.3,Central,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,633,Naive,8,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Other, Time",FALSE,FALSE,Unspecified,NA,Anna Vicco,Observed sample statistic,FALSE,84,NA,Brazil,Mixed groups,"Salvador, Bahia",633,Mixed settings,Both,28,May,2016,25,Nov,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Urban area,1,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,25 Nov 2015,28 May 2016,25 Nov 2015 - 28 May 2016
604bcb4a5d6378c04f00e71ce805c682,300b148b4e1bd0c59e3089eac1431a58,2091,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,62.5,Central,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,299,Naive,187,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Other, Time",FALSE,FALSE,Unspecified,NA,Anna Vicco,Observed sample statistic,FALSE,84,NA,Brazil,Mixed groups,"Salvador, Bahia",299,Mixed settings,Both,28,May,2016,25,Nov,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Urban area,1,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,25 Nov 2015,28 May 2016,25 Nov 2015 - 28 May 2016
604bcb4a5d6378c04f00e71ce805c682,04a92a9f20a8ec5bf8376f889e27a692,2091,Reproduction number (Basic R0) - Sexual,No units,0,2.1,Unspecified,1.8,2.5,95% CI,NA,NA,NA,NA,NA,Lab confirmed,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Unspecified,Anna Vicco,Estimated model parameter,FALSE,84,NA,Brazil,General population,"Salvador, Bahia",NA,Population based,Unspecified,28,May,2016,NA,Jan,2015,Other,NA,NA,NA,NA,NA,NA,FALSE,NA,Urban area,1,Reproduction number,NA,95% CI,1.8 - 2.5,Brazil,NA,NA,FALSE,NA,NA,NA,Jan 2015,28 May 2016,Jan 2015 - 28 May 2016
7b90ef303fdf0f3af67cb41b4a5111d8,c33429fa2930b7731f7d372d4296bb1a,2132,Risk factors,NA,0,22.9,NA,3.3,238.34,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Sequoia,NA,FALSE,NA,NA,"Multi-country: Americas (n = 19), Europe (n = 8), Asia (n = 1), Oceania (n = 4)",Unspecified,NA,NA,Unspecified,Unspecified,NA,NA,2016,NA,NA,2015,NA,Adjusted,Other,Unspecified,Infection,Significant,NA,FALSE,NA,NA,1,Risk factors,NA,95% CI,3.3 - 238.34,"Argentina, Austria, Barbados, Bolivia, Cabo Verde, Costa Rica, Denmark, Dominican Republic, Ecuador, El Salvador, Fiji, Finland, Guatemala, Haiti, Honduras, Jamaica, Mexico, Netherlands, Nicaragua, Panama, Paraguay, Peru, Portugal, Puerto Rico, Samoa, Spain, Suriname, Switzerland, Taiwan, China, Tonga, United Kingdom, Vanuatu, Venezuela, RB, Virgin Islands (U.S.)",NA,NA,FALSE,NA,NA,NA,2015,2016,2015 - 2016
7b90ef303fdf0f3af67cb41b4a5111d8,b50933ecd33dc75db9fc5984e7ac9196,2132,Risk factors,NA,0,7.68,NA,0.98,73.64,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Sequoia,NA,FALSE,NA,NA,"Multi-country: Americas (n = 19), Europe (n = 8), Asia (n = 1), Oceania (n = 4)",Unspecified,NA,NA,Unspecified,Unspecified,NA,NA,2016,NA,NA,2015,NA,Adjusted,Other,Unspecified,Infection,Not significant,NA,FALSE,NA,NA,1,Risk factors,NA,95% CI,0.98 - 73.64,"Argentina, Austria, Barbados, Bolivia, Cabo Verde, Costa Rica, Denmark, Dominican Republic, Ecuador, El Salvador, Fiji, Finland, Guatemala, Haiti, Honduras, Jamaica, Mexico, Netherlands, Nicaragua, Panama, Paraguay, Peru, Portugal, Puerto Rico, Samoa, Spain, Suriname, Switzerland, Taiwan, China, Tonga, United Kingdom, Vanuatu, Venezuela, RB, Virgin Islands (U.S.)",NA,NA,FALSE,NA,NA,NA,2015,2016,2015 - 2016
f0b43c79e284137798b257e78b4f8fb5,4948a96fbe454f7a0bb31541f57488ab,2302,Seroprevalence - IgG,Percentage (%),0,68.4,NA,63.8,72.6,95% CI,NA,NA,NA,NA,NA,Unspecified,424,Unspecified,290,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Other, Sex, Symptoms",FALSE,FALSE,Post outbreak,NA,Shazia Ruybal-Pesantez,Observed sample statistic,FALSE,NA,NA,Suriname,Persons under investigation,Paramaribo,424,Hospital based,Both,NA,Feb,2017,NA,Jan,2017,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,Unspecified,Urban area,2,Seroprevalence,NA,95% CI,63.8 - 72.6,Suriname,NA,NA,FALSE,NA,NA,NA,Jan 2017,Feb 2017,Jan 2017 - Feb 2017
f0b43c79e284137798b257e78b4f8fb5,76ff4bf340a9386f0e3af93f17f991a2,2302,Seroprevalence - IgG,Percentage (%),0,83.2,NA,77.3,87.9,95% CI,NA,NA,NA,NA,NA,Unspecified,191,Unspecified,159,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Other, Sex, Symptoms",FALSE,FALSE,Post outbreak,NA,Shazia Ruybal-Pesantez,Observed sample statistic,FALSE,NA,NA,Suriname,Persons under investigation,Laduani,191,Hospital based,Both,NA,Feb,2017,NA,Jan,2017,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,Unspecified,Rural area,2,Seroprevalence,NA,95% CI,77.3 - 87.9,Suriname,NA,NA,FALSE,NA,NA,NA,Jan 2017,Feb 2017,Jan 2017 - Feb 2017
f0b43c79e284137798b257e78b4f8fb5,d7d6c0acb58175ca520a8a8b8b625682,2302,Seroprevalence - IgG,Percentage (%),0,49.7,NA,41.9,57.5,95% CI,NA,NA,NA,NA,NA,Unspecified,155,Unspecified,77,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Other, Sex, Symptoms",FALSE,FALSE,Post outbreak,NA,Shazia Ruybal-Pesantez,Observed sample statistic,FALSE,NA,NA,Suriname,General population,Kwamalasamutu,155,Household based,Both,NA,Feb,2017,NA,Jan,2017,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,Unspecified,Rural area,2,Seroprevalence,NA,95% CI,41.9 - 57.5,Suriname,NA,NA,FALSE,NA,NA,NA,Jan 2017,Feb 2017,Jan 2017 - Feb 2017
f0b43c79e284137798b257e78b4f8fb5,fffb4c16c9fce31939c1574e01b90b62,2302,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,38.2,NA,33.7,42.9,95% CI,NA,NA,NA,NA,NA,Unspecified,424,Unspecified,162,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Other, Sex, Symptoms",FALSE,FALSE,Post outbreak,NA,Shazia Ruybal-Pesantez,Observed sample statistic,FALSE,NA,NA,Suriname,Persons under investigation,Paramaribo,424,Hospital based,Both,NA,Feb,2017,NA,Jan,2017,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,Unspecified,Urban area,2,Seroprevalence,NA,95% CI,33.7 - 42.9,Suriname,NA,NA,FALSE,NA,NA,NA,Jan 2017,Feb 2017,Jan 2017 - Feb 2017
f0b43c79e284137798b257e78b4f8fb5,eb43f9fd5acffc885faf5bd50c2342ba,2302,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,36.7,NA,30.1,43.7,95% CI,NA,NA,NA,NA,NA,Unspecified,191,Unspecified,70,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Other, Sex, Symptoms",FALSE,FALSE,Post outbreak,NA,Shazia Ruybal-Pesantez,Observed sample statistic,FALSE,NA,NA,Suriname,Persons under investigation,Laduani,191,Hospital based,Both,NA,Feb,2017,NA,Jan,2017,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,Unspecified,Rural area,2,Seroprevalence,NA,95% CI,30.1 - 43.7,Suriname,NA,NA,FALSE,NA,NA,NA,Jan 2017,Feb 2017,Jan 2017 - Feb 2017
f0b43c79e284137798b257e78b4f8fb5,4e9ea7e76c0eecb164c5fac38ea80949,2302,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,24.5,NA,18.4,31.9,95% CI,NA,NA,NA,NA,NA,Unspecified,155,Unspecified,38,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Other, Sex, Symptoms",FALSE,FALSE,Post outbreak,NA,Shazia Ruybal-Pesantez,Observed sample statistic,FALSE,NA,NA,Suriname,General population,Kwamalasamutu,155,Household based,Both,NA,Feb,2017,NA,Jan,2017,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,Unspecified,Rural area,2,Seroprevalence,NA,95% CI,18.4 - 31.9,Suriname,NA,NA,FALSE,NA,NA,NA,Jan 2017,Feb 2017,Jan 2017 - Feb 2017
a18b9c78fd8f30eb59932dcbd71f2832,2954db76e6fb38459af17484fa668306,2340,Seroprevalence - IgM,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,18,NA,1,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Keith,NA,FALSE,NA,NA,United States,Persons under investigation,Hawaii,18,Other,Female,NA,NA,2012,NA,NA,2009,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,19,Seroprevalence,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,2009,2012,2009 - 2012
a18b9c78fd8f30eb59932dcbd71f2832,9d0295460034a0cbc772208b97ac9ae5,2340,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Keith,NA,FALSE,NA,NA,United States,Persons under investigation,Hawaii,18,Other,Female,NA,NA,2012,NA,NA,2009,NA,Unspecified,Infection during pregnancy,NA,Microcephaly,Not significant,NA,FALSE,Unspecified,Unspecified,19,Risk factors,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,2009,2012,2009 - 2012
a18b9c78fd8f30eb59932dcbd71f2832,e85d4e1fb6feafd8b1c7e3eb897de38b,2340,Seroprevalence - IgG,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,18,NA,4,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Keith,NA,FALSE,NA,NA,United States,Persons under investigation,Hawaii,18,Other,Female,NA,NA,2012,NA,NA,2009,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,19,Seroprevalence,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,2009,2012,2009 - 2012
1d766b4a3d66aadf9e1f721204d3cd9e,95be1b529e77eaa419eeeb9293846457,2353,Attack rate,Percentage (%),0,94,Median,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,Compartmental model,Anna Vicco,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,French Polynesia,NA,Population based,NA,28,Mar,2014,11,Oct,2013,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,3,Attack rate,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,11 Oct 2013,28 Mar 2014,11 Oct 2013 - 28 Mar 2014
27c21cc83210d0ff7c6aa3688e66ee12,3bb1812fe414f84097652ba4f08ec54c,2353,Reproduction number (Basic R0),No units,0,3.5,Median,2.6,5.3,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,Compartmental model,sangeeta,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,"Tahiti, French Polynesia",NA,Population based,NA,28,Mar,2014,11,Oct,2013,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,2,Reproduction number,NA,95% CrI,2.6 - 5.3,France,NA,NA,FALSE,NA,NA,NA,11 Oct 2013,28 Mar 2014,11 Oct 2013 - 28 Mar 2014
27c21cc83210d0ff7c6aa3688e66ee12,77fd0a75da977044bcf4e1c94946b3a4,2353,Reproduction number (Basic R0),No units,0,4.1,Median,3.1,5.7,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,Compartmental model,sangeeta,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,"Sous-le-vent Islands, French Polynesia",NA,Population based,NA,28,Mar,2014,11,Oct,2013,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,2,Reproduction number,NA,95% CrI,3.1 - 5.7,France,NA,NA,FALSE,NA,NA,NA,11 Oct 2013,28 Mar 2014,11 Oct 2013 - 28 Mar 2014
27c21cc83210d0ff7c6aa3688e66ee12,70513e12153e3b99572ed57b3cdecf67,2353,Reproduction number (Basic R0),No units,0,4.8,Median,3.2,8.4,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,Compartmental model,sangeeta,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,"Mo'orea, French Polynesia",NA,Population based,NA,28,Mar,2014,11,Oct,2013,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,2,Reproduction number,NA,95% CrI,3.2 - 8.4,France,NA,NA,FALSE,NA,NA,NA,11 Oct 2013,28 Mar 2014,11 Oct 2013 - 28 Mar 2014
27c21cc83210d0ff7c6aa3688e66ee12,e80eaf7c50e3a8b26cdcb4c83c9bc3dd,2353,Reproduction number (Basic R0),No units,0,3,Median,2.2,6.1,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,Compartmental model,sangeeta,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,"Tuamotu-Gambier, French Polynesia",NA,Population based,NA,28,Mar,2014,11,Oct,2013,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,2,Reproduction number,NA,95% CrI,2.2 - 6.1,France,NA,NA,FALSE,NA,NA,NA,11 Oct 2013,28 Mar 2014,11 Oct 2013 - 28 Mar 2014
27c21cc83210d0ff7c6aa3688e66ee12,f5f8c67a440afd73438eac22a0ba98bb,2353,Reproduction number (Basic R0),No units,0,2.6,Median,1.7,5.3,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,Compartmental model,sangeeta,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,"Marquesas Islands, French Polynesia",NA,Population based,NA,28,Mar,2014,11,Oct,2013,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,2,Reproduction number,NA,95% CrI,1.7 - 5.3,France,NA,NA,FALSE,NA,NA,NA,11 Oct 2013,28 Mar 2014,11 Oct 2013 - 28 Mar 2014
27c21cc83210d0ff7c6aa3688e66ee12,d81847175e910b62240793ecdf02cfed,2353,Reproduction number (Basic R0),No units,0,3.1,Median,2.2,4.6,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,Compartmental model,sangeeta,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,"Australes, French Polynesia",NA,Population based,NA,28,Mar,2014,11,Oct,2013,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,2,Reproduction number,NA,95% CrI,2.2 - 4.6,France,NA,NA,FALSE,NA,NA,NA,11 Oct 2013,28 Mar 2014,11 Oct 2013 - 28 Mar 2014
27c21cc83210d0ff7c6aa3688e66ee12,6a4f497b09046d2a0fe82341dd098343,2353,Mosquito delay - extrinsic incubation period,Days,0,10,Median,6.3,14,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,TRUE,Post outbreak,NA,sangeeta,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,French Polynesia,NA,Population based,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,2,Mosquito,NA,95% CrI,6.3 - 14,France,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
27c21cc83210d0ff7c6aa3688e66ee12,ca3583e034c5f36d24a71b7145530c44,2353,Human delay - incubation period,Days,0,6.6,Median,4.2,11,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,TRUE,Post outbreak,NA,sangeeta,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,French Polynesia,NA,Population based,NA,28,Mar,2014,11,Oct,2013,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,2,Human delay,NA,95% CrI,4.2 - 11,France,Incubation period,NA,FALSE,NA,NA,NA,11 Oct 2013,28 Mar 2014,11 Oct 2013 - 28 Mar 2014
27c21cc83210d0ff7c6aa3688e66ee12,8942bfeb2f9a48fb60e0e2e8df5fd182,2353,Human delay - infectious period,Days,0,5.6,Median,4,10,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,TRUE,Post outbreak,NA,sangeeta,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,French Polynesia,NA,Population based,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,2,Human delay,NA,95% CrI,4 - 10,France,Infectious period,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
12322eff79b18b78c77a02e827fc7b9e,d483a99f3d648d7d43c97f50544ddcd0,2361,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Keith,NA,FALSE,0,0,Brazil,Persons under investigation,Paraíba,157,Other,Unspecified,NA,NA,NA,NA,NA,NA,NA,Unspecified,Infection;Infection during pregnancy;Other,NA,Zika congenital syndrome/other birth defects,Not significant,NA,FALSE,NA,Unspecified,20,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
12322eff79b18b78c77a02e827fc7b9e,70697dd59e6271a6061bdb81d7bd6254,2361,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Keith,NA,FALSE,0,0,Brazil,Persons under investigation,Paraíba,157,Other,Unspecified,NA,NA,NA,NA,NA,NA,NA,Unspecified,Infection;Infection during pregnancy;Other,NA,Zika congenital syndrome/other birth defects,Significant,NA,FALSE,NA,Unspecified,20,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
3491ab9dfacc2c53b17edf810da3471a,cebe7e828509e359f67dc685841166ed,2362,Human delay - incubation period,Days,0,6.4,Mean,5.7,7,95% CI,NA,NA,NA,NA,NA,Clinically diagnosed/symptomatic;Confirmed,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,Weibull,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Dominic Dee,Estimated model parameter,FALSE,81,1,United States,Persons under investigation,All Travellers,197,Travel based,Both,23,Jun,2016,1,Jan,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,2,Human delay,NA,95% CI,5.7 - 7,United States,Incubation period,NA,FALSE,NA,NA,NA,1 Jan 2015,23 Jun 2016,1 Jan 2015 - 23 Jun 2016
3491ab9dfacc2c53b17edf810da3471a,2071c3c51c1cdf44f2da2b52e1123ec4,2362,Human delay - incubation period,Days,0,6,Mean,5.2,6.8,95% CI,NA,NA,NA,NA,NA,Clinically diagnosed/symptomatic;Lab confirmed,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,Weibull,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Dominic Dee,Estimated model parameter,FALSE,NA,NA,United States,Persons under investigation,Travellers <2 weeks travel,79,Travel based,Both,23,Jun,2016,1,Jan,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,2,Human delay,NA,95% CI,5.2 - 6.8,United States,Incubation period,NA,FALSE,NA,NA,NA,1 Jan 2015,23 Jun 2016,1 Jan 2015 - 23 Jun 2016
2b1dd66e1213620b9938a41e1379c1db,c8e13ee4a698fa47cc47281ed1cd3332,2419,Seroprevalence - IgM,Percentage (%),0,6.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,468,Naive,29,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Sex, Symptoms",FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,NA,Nigeria,General population,"Plateau, Nasarawa",468,Community based,Both,NA,Dec,2016,NA,Jan,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,4,Seroprevalence,NA,NA,NA,Nigeria,NA,NA,FALSE,NA,NA,NA,Jan 2016,Dec 2016,Jan 2016 - Dec 2016
2b1dd66e1213620b9938a41e1379c1db,55f77fba072fd1b41cf552a328ea2771,2419,Seroprevalence - IgG,Percentage (%),0,3.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,468,Naive,17,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Sex, Symptoms",FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,NA,Nigeria,General population,"Plateau, Nasarawa",468,Community based,Both,NA,Dec,2016,NA,Jan,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,4,Seroprevalence,NA,NA,NA,Nigeria,NA,NA,FALSE,NA,NA,NA,Jan 2016,Dec 2016,Jan 2016 - Dec 2016
2b1dd66e1213620b9938a41e1379c1db,9b9930b1d5ffbdc7224f5000450482ff,2419,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,NA,FALSE,NA,NA,Nigeria,General population,"Plateau, Nasarawa",468,Community based,Both,NA,Dec,2016,NA,Jan,2016,NA,Not adjusted,Other;Sex,NA,Serology,Significant,NA,FALSE,Unspecified,Unspecified,4,Risk factors,NA,NA,NA,Nigeria,NA,NA,FALSE,NA,NA,NA,Jan 2016,Dec 2016,Jan 2016 - Dec 2016
2b1dd66e1213620b9938a41e1379c1db,5cbe92fbb77be5331ceaac30519cfe9f,2419,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,NA,FALSE,NA,NA,Nigeria,General population,"Plateau, Nasarawa",468,Community based,Both,NA,Dec,2016,NA,Jan,2016,NA,Not adjusted,Comorbidity;Prior immunity to arboviruses;Sex,NA,Serology,Not significant,NA,FALSE,Unspecified,Unspecified,4,Risk factors,NA,NA,NA,Nigeria,NA,NA,FALSE,NA,NA,NA,Jan 2016,Dec 2016,Jan 2016 - Dec 2016
250613eb695fcc327787def8b4bd21ec,46f92eb8c0ab06e8abd3ed8f1f202de1,2578,Seroprevalence - IgG and IgM,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,214,Unspecified,54,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Keith,NA,FALSE,NA,NA,Brazil,Pregnant women,Rio de Janeiro,219,Hospital based,Female,NA,Aug,2016,NA,Jan,2015,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,Unspecified,Urban area,21,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Jan 2015,Aug 2016,Jan 2015 - Aug 2016
250613eb695fcc327787def8b4bd21ec,c6fc805d13dddfdead4ab992bce68bfa,2578,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Keith,NA,FALSE,NA,NA,Brazil,Pregnant women,Rio de Janeiro,219,Hospital based,Female,NA,Aug,2016,NA,Jan,2015,NA,Adjusted,Infection during pregnancy,Unspecified,Zika congenital syndrome/other birth defects,Significant,NA,FALSE,Unspecified,Urban area,21,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Jan 2015,Aug 2016,Jan 2015 - Aug 2016
35ea1f7c974419f0d511e9d2515348b2,a1cb61c6c8d5d4832e8c6a412478be5b,2688,Reproduction number (Basic R0),No units,0,6,Mean,0.06,11.95,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Region,FALSE,FALSE,Unspecified,Other,Keith,Estimated model parameter,FALSE,NA,NA,France,NA,French Polynesia,NA,NA,NA,NA,NA,2014,NA,NA,2013,Other,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,3,Reproduction number,NA,95% CI,0.06 - 11.95,France,NA,NA,FALSE,NA,NA,NA,2013,2014,2013 - 2014
35ea1f7c974419f0d511e9d2515348b2,d28bb5762a5bf33cbc0611e5e403d9f4,2688,Reproduction number (Basic R0),No units,0,1.75,Mean,1.34,2.16,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Time,TRUE,FALSE,Unspecified,Other,Keith,Estimated model parameter,FALSE,NA,NA,Colombia,NA,NA,NA,NA,NA,NA,NA,2016,NA,NA,2015,Other,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,3,Reproduction number,NA,95% CI,1.34 - 2.16,Colombia,NA,NA,FALSE,NA,NA,NA,2015,2016,2015 - 2016
35ea1f7c974419f0d511e9d2515348b2,7896eae7994ed2f5aa7d0f1e6f53e5c1,2688,Reproduction number (Basic R0),No units,0,1.68,Mean,1.32,2.04,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Other,Keith,Estimated model parameter,FALSE,NA,NA,Suriname,NA,NA,NA,NA,NA,NA,NA,2016,NA,NA,2015,Other,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,3,Reproduction number,NA,95% CI,1.32 - 2.04,Suriname,NA,NA,FALSE,NA,NA,NA,2015,2016,2015 - 2016
35ea1f7c974419f0d511e9d2515348b2,8f468cf1181f9acf5f40637040858b7f,2688,Reproduction number (Basic R0),No units,0,1.59,Mean,1.28,1.9,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Time,TRUE,FALSE,Unspecified,Other,Keith,Estimated model parameter,FALSE,NA,NA,Guatemala,NA,NA,NA,NA,NA,NA,NA,2016,NA,NA,2015,Other,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,3,Reproduction number,NA,95% CI,1.28 - 1.9,Guatemala,NA,NA,FALSE,NA,NA,NA,2015,2016,2015 - 2016
35ea1f7c974419f0d511e9d2515348b2,9dddaa5a7bff7afef740c016d614059a,2688,Reproduction number (Basic R0),No units,0,5.7,Mean,0,11.75,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Other,Keith,Estimated model parameter,FALSE,NA,NA,Multi-country: France and Netherlands,NA,Saint Martin,NA,NA,NA,NA,NA,2016,NA,NA,2015,Other,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,3,Reproduction number,NA,95% CI,0 - 11.75,"France, Netherlands",NA,NA,FALSE,NA,NA,NA,2015,2016,2015 - 2016
35ea1f7c974419f0d511e9d2515348b2,292faa7975b542570bdbe004ba14e840,2688,Reproduction number (Basic R0),No units,0,6.89,Mean,0,16.24,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Other,Keith,Estimated model parameter,FALSE,NA,NA,United States,NA,Puerto Rico,NA,NA,NA,NA,NA,2016,NA,NA,2015,Other,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,3,Reproduction number,NA,95% CI,0 - 16.24,United States,NA,NA,FALSE,NA,NA,NA,2015,2016,2015 - 2016
35ea1f7c974419f0d511e9d2515348b2,13e119f91d25b9321471152f01f365eb,2688,Reproduction number (Basic R0),No units,0,1.79,Mean,1.29,2.3,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Other,Keith,Estimated model parameter,FALSE,NA,NA,Colombia,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Other,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,3,Reproduction number,NA,95% CI,1.29 - 2.3,Colombia,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
35ea1f7c974419f0d511e9d2515348b2,d68ed5e86a40403109338d0d8e59b9f7,2688,Reproduction number (Basic R0),No units,0,1.05,Mean,1.03,1.08,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Other,Keith,Estimated model parameter,FALSE,NA,NA,Guatemala,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Other,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,3,Reproduction number,NA,95% CI,1.03 - 1.08,Guatemala,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
f5ba13da9154aabfb7e590e71adec589,c473c540a0f7da02398b1400beee7ab1,2713,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,NA,FALSE,46,18,France,Pregnant women,"Martinique, Guadeloupe, French Guiana",555,Population based,Female,27,Apr,2017,NA,Mar,2016,NA,Not adjusted,Other,NA,Zika congenital syndrome/other birth defects,Significant,NA,FALSE,NA,Unspecified,41,Risk factors,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,Mar 2016,27 Apr 2017,Mar 2016 - 27 Apr 2017
f5ba13da9154aabfb7e590e71adec589,0ab67aa67d085f907d232151d8fc0994,2713,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,NA,FALSE,46,18,France,Pregnant women,"Martinique, Guadeloupe, French Guiana",555,Population based,Female,27,Apr,2017,NA,Mar,2016,NA,Not adjusted,Other,NA,Microcephaly,Significant,NA,FALSE,NA,Unspecified,41,Risk factors,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,Mar 2016,27 Apr 2017,Mar 2016 - 27 Apr 2017
f395586183a6abb67d89f68a3e7d3326,92af8ac355ef651c3ba68ed30fa162da,2804,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,62.1,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,119,NA,74,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,Observed sample statistic,FALSE,80,4,Mexico,General population,Chiapas State,119,Population based,Both,18,Dec,2015,30,Nov,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,42,Seroprevalence,NA,NA,NA,Mexico,NA,NA,FALSE,NA,NA,NA,30 Nov 2015,18 Dec 2015,30 Nov 2015 - 18 Dec 2015
9a2a29e0617a3eced13442330b08c80f,117be9239dd2bbe6d27cb62fdc92c4aa,2876,Reproduction number (Effective; Re) - Sexual,No units,0,3.3,Unspecified,1.3,5.3,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Growth rate,Christian,Estimated model parameter,FALSE,NA,NA,Nicaragua,Children,Managua,NA,Community based,Unspecified,NA,Jun,2016,NA,Jun,2016,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,NA,Urban area,5,Reproduction number,NA,95% CI,1.3 - 5.3,Nicaragua,NA,NA,FALSE,NA,NA,NA,Jun 2016,Jun 2016,Jun 2016
9a2a29e0617a3eced13442330b08c80f,7743ac10b6ece2423f28cb6eb34a8ebb,2876,Reproduction number (Effective; Re) - Sexual,No units,0,3.4,Unspecified,2.4,4.7,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Growth rate,Christian,Estimated model parameter,FALSE,NA,NA,Nicaragua,Children,Managua,NA,Community based,Unspecified,NA,Jul,2016,NA,Jun,2016,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,NA,Urban area,5,Reproduction number,NA,95% CI,2.4 - 4.7,Nicaragua,NA,NA,FALSE,NA,NA,NA,Jun 2016,Jul 2016,Jun 2016 - Jul 2016
9a2a29e0617a3eced13442330b08c80f,f1a0425ed3e97c33da8f297e96999420,2876,Growth rate (r),Unspecified,0,0.2,Unspecified,0.1,0.4,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Estimated model parameter,FALSE,NA,NA,Nicaragua,Children,Managua,NA,Community based,Unspecified,NA,Jul,2016,NA,Jun,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Urban area,5,Growth rate,NA,95% CI,0.1 - 0.4,Nicaragua,NA,NA,FALSE,NA,NA,NA,Jun 2016,Jul 2016,Jun 2016 - Jul 2016
9a2a29e0617a3eced13442330b08c80f,4abd2a9098f43247d63bff7b276e05cc,2876,Growth rate (r),Unspecified,0,0.1,Unspecified,0.1,0.2,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Estimated model parameter,FALSE,NA,NA,Nicaragua,Children,Managua,NA,Community based,Unspecified,NA,Jul,2016,NA,Jun,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Urban area,5,Growth rate,NA,95% CI,0.1 - 0.2,Nicaragua,NA,NA,FALSE,NA,NA,NA,Jun 2016,Jul 2016,Jun 2016 - Jul 2016
1b5e8a4b9bfc09d4e2a5221ccdfa16c2,ebcba612c85ecd5b00e60fc714ad3e35,2876,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Rob,NA,FALSE,NA,NA,Nicaragua,Children,Managua,3296,Community based,Both,28,Feb,2017,1,Jan,2016,NA,Adjusted,Age;Sex,NA,Infection,Significant,NA,FALSE,NA,Urban area,3,Risk factors,NA,NA,NA,Nicaragua,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,28 Feb 2017,1 Jan 2016 - 28 Feb 2017
1b5e8a4b9bfc09d4e2a5221ccdfa16c2,2782ae8eb1dc3ded0f0a39e27b9e880b,2876,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Rob,NA,FALSE,NA,NA,Nicaragua,Children,Managua,3296,Community based,Both,28,Feb,2017,1,Jan,2016,NA,Not adjusted,Age;Prior immunity to arboviruses;Sex,NA,Infection,Significant,NA,FALSE,NA,Urban area,3,Risk factors,NA,NA,NA,Nicaragua,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,28 Feb 2017,1 Jan 2016 - 28 Feb 2017
1b5e8a4b9bfc09d4e2a5221ccdfa16c2,0a1a28f74c12385e2f3e7d3fbaa56430,2876,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Rob,NA,FALSE,NA,NA,Nicaragua,Children,Managua,2659,Community based,Both,28,Feb,2017,1,Jan,2016,NA,Adjusted,Other;Prior immunity to arboviruses,NA,Infection,Not significant,NA,FALSE,NA,Urban area,3,Risk factors,NA,NA,NA,Nicaragua,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,28 Feb 2017,1 Jan 2016 - 28 Feb 2017
1b5e8a4b9bfc09d4e2a5221ccdfa16c2,4851ee0499e1d4807a213687466ed5ad,2876,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Rob,NA,FALSE,NA,NA,Nicaragua,Children,Managua,2659,Community based,Both,28,Feb,2017,1,Jan,2016,NA,Not adjusted,Other,NA,Infection,Not significant,NA,FALSE,NA,Urban area,3,Risk factors,NA,NA,NA,Nicaragua,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,28 Feb 2017,1 Jan 2016 - 28 Feb 2017
1b5e8a4b9bfc09d4e2a5221ccdfa16c2,33752a7df9d04f3d95df196e4ddbfab9,2876,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Rob,NA,FALSE,NA,NA,Nicaragua,Children,Managua,3893,Community based,Both,28,Feb,2017,1,Jan,2016,NA,Adjusted,Age;Other;Prior immunity to arboviruses;Sex,NA,Other,Significant,NA,FALSE,NA,Urban area,3,Risk factors,NA,NA,NA,Nicaragua,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,28 Feb 2017,1 Jan 2016 - 28 Feb 2017
1b5e8a4b9bfc09d4e2a5221ccdfa16c2,b69a81a1cad5f81f57e2a7a4b3f33183,2876,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Rob,NA,FALSE,NA,NA,Nicaragua,Children,Managua,3893,Community based,Both,28,Feb,2017,1,Jan,2016,NA,Not adjusted,Age;Other;Prior immunity to arboviruses,NA,Other,Significant,NA,FALSE,NA,Urban area,3,Risk factors,NA,NA,NA,Nicaragua,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,28 Feb 2017,1 Jan 2016 - 28 Feb 2017
1b5e8a4b9bfc09d4e2a5221ccdfa16c2,da983a8bab650efc8590e2eb056bf173,2876,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Rob,NA,FALSE,NA,NA,Nicaragua,Children,Managua,3893,Community based,Both,28,Feb,2017,1,Jan,2016,NA,Adjusted,Age;Other;Sex,NA,Other,Not significant,NA,FALSE,NA,Urban area,3,Risk factors,NA,NA,NA,Nicaragua,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,28 Feb 2017,1 Jan 2016 - 28 Feb 2017
1b5e8a4b9bfc09d4e2a5221ccdfa16c2,3f001c5ea92672cf5b8042592e0710a4,2876,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Rob,NA,FALSE,NA,NA,Nicaragua,Children,Managua,3893,Community based,Both,28,Feb,2017,1,Jan,2016,NA,Not adjusted,Sex,NA,Other,Not significant,NA,FALSE,NA,Urban area,3,Risk factors,NA,NA,NA,Nicaragua,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,28 Feb 2017,1 Jan 2016 - 28 Feb 2017
04ebe9a7fdfe979389ca091f904656a5,87da627452b7d38dc79b302d33b186be,3017,Reproduction number (Basic R0),No units,0,2.055,Median,0.523,6.3,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Compartmental model,Keith,Estimated model parameter,FALSE,NA,NA,"Multi-country: Brazil, Colombia, El Salvador",General population,NA,NA,Population based,Unspecified,27,Feb,2016,NA,Apr,2015,Other,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,4,Reproduction number,NA,95% CI,0.523 - 6.3,"Brazil, Colombia, El Salvador",NA,NA,FALSE,NA,NA,NA,Apr 2015,27 Feb 2016,Apr 2015 - 27 Feb 2016
04ebe9a7fdfe979389ca091f904656a5,4cbf03c3845084dd5627960a69b4e1bc,3017,Reproduction number (Basic R0) - Vector-borne,No units,0,1.96,Median,0.45,6.227,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Compartmental model,Keith,Estimated model parameter,FALSE,NA,NA,"Multi-country: Brazil, Colombia, El Salvador",General population,NA,NA,Population based,Unspecified,27,Feb,2016,NA,Apr,2015,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,4,Reproduction number,NA,95% CI,0.45 - 6.227,"Brazil, Colombia, El Salvador",NA,NA,FALSE,NA,NA,NA,Apr 2015,27 Feb 2016,Apr 2015 - 27 Feb 2016
04ebe9a7fdfe979389ca091f904656a5,117e19a9609cd2e4e8fcac26333289db,3017,Reproduction number (Basic R0) - Sexual,No units,0,0.136,Median,0.009,0.521,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Compartmental model,Keith,Estimated model parameter,FALSE,NA,NA,"Multi-country: Brazil, Colombia, El Salvador",General population,NA,NA,Population based,Unspecified,27,Feb,2016,NA,Apr,2015,Human-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,4,Reproduction number,NA,95% CI,0.009 - 0.521,"Brazil, Colombia, El Salvador",NA,NA,FALSE,NA,NA,NA,Apr 2015,27 Feb 2016,Apr 2015 - 27 Feb 2016
04ebe9a7fdfe979389ca091f904656a5,6ef0c3862f88f9441ab82eafcc343039,3017,Reproduction number (Basic R0),No units,0,1.79,Unspecified,1.68,1.91,Other,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Other,Keith,NA,FALSE,NA,NA,France,General population,"Yap Island, French Polynesia",NA,Population based,Unspecified,NA,NA,2007,NA,NA,2007,Other,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,4,Reproduction number,NA,Other,1.68 - 1.91,France,NA,NA,FALSE,NA,NA,NA,2007,2007,2007
2b8ecdddd1cd001a23abeccc35f2016f,e8c2a85a7043fd49415b258c1cdcd508,3030,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,2,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,150,NA,3,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,Observed sample statistic,FALSE,NA,NA,Cameroon,Blood donors,Maroua,150,Other,Unspecified,NA,Oct,2015,NA,Aug,2015,NA,NA,NA,NA,NA,NA,Adjusted,FALSE,NA,NA,2,Seroprevalence,NA,NA,NA,Cameroon,NA,NA,FALSE,NA,NA,NA,Aug 2015,Oct 2015,Aug 2015 - Oct 2015
2b8ecdddd1cd001a23abeccc35f2016f,4ef5963f764d5297c806fa0dba8df6f4,3030,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,4.8,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,186,NA,9,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,Observed sample statistic,FALSE,NA,NA,Cameroon,Blood donors,Garoua,186,Other,Unspecified,NA,Oct,2015,NA,Aug,2015,NA,NA,NA,NA,NA,NA,Adjusted,FALSE,NA,NA,2,Seroprevalence,NA,NA,NA,Cameroon,NA,NA,FALSE,NA,NA,NA,Aug 2015,Oct 2015,Aug 2015 - Oct 2015
2b8ecdddd1cd001a23abeccc35f2016f,38a6ea605b650e63a6153f721f40b852,3030,Seroprevalence - Neutralisation/PRNT,NA,0,2,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,149,NA,3,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,Observed sample statistic,FALSE,NA,NA,Cameroon,Blood donors,Ngaoundere,149,Other,Unspecified,NA,Oct,2015,NA,Aug,2015,NA,NA,NA,NA,NA,NA,Adjusted,FALSE,NA,NA,2,Seroprevalence,NA,NA,NA,Cameroon,NA,NA,FALSE,NA,NA,NA,Aug 2015,Oct 2015,Aug 2015 - Oct 2015
2b8ecdddd1cd001a23abeccc35f2016f,3daa569287c4f7b029c6ec30debba4e6,3030,Seroprevalence - Neutralisation/PRNT,NA,0,10,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,170,NA,17,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,Observed sample statistic,FALSE,NA,NA,Cameroon,Blood donors,Douala,170,Other,Unspecified,NA,Oct,2015,NA,Aug,2015,NA,NA,NA,NA,NA,NA,Adjusted,FALSE,NA,NA,2,Seroprevalence,NA,NA,NA,Cameroon,NA,NA,FALSE,NA,NA,NA,Aug 2015,Oct 2015,Aug 2015 - Oct 2015
2b8ecdddd1cd001a23abeccc35f2016f,ad1beb6d44178baa3b23fe01fc76a1fc,3030,Seroprevalence - Neutralisation/PRNT,NA,0,3.3,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,272,NA,9,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,Observed sample statistic,FALSE,NA,NA,Cameroon,Blood donors,Yaounde,272,Other,Unspecified,NA,Oct,2015,NA,Aug,2015,NA,NA,NA,NA,NA,NA,Adjusted,FALSE,NA,NA,2,Seroprevalence,NA,NA,NA,Cameroon,NA,NA,FALSE,NA,NA,NA,Aug 2015,Oct 2015,Aug 2015 - Oct 2015
2b8ecdddd1cd001a23abeccc35f2016f,50c7f9dce3f70955800990fd34e8de91,3030,Seroprevalence - Neutralisation/PRNT,NA,0,7.6,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,157,NA,12,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,Observed sample statistic,FALSE,NA,NA,Cameroon,Blood donors,Bertoua,157,Other,Unspecified,NA,Oct,2015,NA,Aug,2015,NA,NA,NA,NA,NA,NA,Adjusted,FALSE,NA,NA,2,Seroprevalence,NA,NA,NA,Cameroon,NA,NA,FALSE,NA,NA,NA,Aug 2015,Oct 2015,Aug 2015 - Oct 2015
2b8ecdddd1cd001a23abeccc35f2016f,ad8b87a1c2c046773bef975bfbc3159a,3030,Risk factors,NA,0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,Observed sample statistic,FALSE,NA,NA,Cameroon,Blood donors,"Maroua, Garoua, Ngaoundere, Douala, Yaounde, Bertoua",1084,Other,Unspecified,NA,Oct,2015,NA,Aug,2015,NA,Adjusted,Occupation;Other,Other,Serology,Significant,NA,FALSE,NA,NA,2,Risk factors,NA,NA,NA,Cameroon,NA,NA,FALSE,NA,NA,NA,Aug 2015,Oct 2015,Aug 2015 - Oct 2015
85fa0e8b372a7f499bfb4f3627aa2627,b2bc871fa5c5b7f8b05c8840d5fab377,3039,Reproduction number (Basic R0) - Sexual,No units,0,7.6,Median,4.8,14,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,FALSE,FALSE,Post outbreak,Next generation matrix,Kelly M,Estimated model parameter,FALSE,NA,NA,Federated States of Micronesia,Persons under investigation,Yap Main Islands,108,Population based,NA,NA,Jul,2007,NA,Apr,2007,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Rural,6,Reproduction number,NA,95% CI,4.8 - 14,Federated States of Micronesia,NA,NA,FALSE,NA,NA,NA,Apr 2007,Jul 2007,Apr 2007 - Jul 2007
19a4f2af2f3e38e7159698fb7922342c,2b1d8ff2cef6f01f68a2590c545c8e74,3042,Risk factors,NA,0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,Observed sample statistic,FALSE,NA,NA,Brazil,Persons under investigation,Rio de Janeiro,NA,Population based,NA,NA,May,2016,NA,Feb,2015,NA,Unspecified,Other,Unspecified,Infection,Significant,NA,FALSE,NA,NA,4,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Feb 2015,May 2016,Feb 2015 - May 2016
b706d8e6b994cdce0e86244457393f78,f14efa464562a0f478541e49a89abc4d,3071,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,NA,FALSE,NA,NA,Brazil,Pregnant women,NA,523,Population based,Female,27,Feb,2016,19,Nov,2015,NA,Not adjusted,Other,NA,Other,Significant,NA,FALSE,NA,Unspecified,43,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,19 Nov 2015,27 Feb 2016,19 Nov 2015 - 27 Feb 2016
b706d8e6b994cdce0e86244457393f78,d1592274804eed603ccd57f56bad5a4a,3071,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,NA,FALSE,NA,NA,Brazil,Pregnant women,NA,602,Population based,Female,27,Feb,2016,19,Nov,2015,NA,Not adjusted,Other,NA,Other,Significant,NA,FALSE,NA,Unspecified,43,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,19 Nov 2015,27 Feb 2016,19 Nov 2015 - 27 Feb 2016
a9a2fc310bc8c7cb565699d7d7c4cbbd,fce350b533346c0d9f826b60ff383996,3098,Severity - proportion of symptomatic cases,Percentage (%),0,23.2,Mean,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,573,NA,133,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,France,Pregnant women,French Guiana,573,Population based,Female,1,Jun,2016,1,Feb,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,68,Severity,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,1 Feb 2016,1 Jun 2016,1 Feb 2016 - 1 Jun 2016
52d1b294c5a2ae5543b0d2b08356a557,dbdb92a7dcca558bfe4a0c8c6fed2124,3152,Reproduction number (Basic R0),No units,0,NA,Mean,NA,NA,NA,NA,NA,1.29,1.71,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,TRUE,TRUE,Unspecified,Branching process,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,Brazil,Persons under investigation,Centre-West Brazil,44825,Population based,Unspecified,19,Nov,2016,1,Jan,2015,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,1,Reproduction number,1.29 - 1.71,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,1 Jan 2015,19 Nov 2016,1 Jan 2015 - 19 Nov 2016
52d1b294c5a2ae5543b0d2b08356a557,74365a9b5c2b0e72a89b9042d2f22413,3152,Reproduction number (Basic R0),No units,0,NA,Mean,NA,NA,NA,NA,NA,1.58,2.48,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,TRUE,TRUE,Unspecified,Branching process,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,Brazil,Persons under investigation,North Brazil,22373,Population based,Unspecified,19,Nov,2016,1,Jan,2015,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,1,Reproduction number,1.58 - 2.48,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,1 Jan 2015,19 Nov 2016,1 Jan 2015 - 19 Nov 2016
52d1b294c5a2ae5543b0d2b08356a557,5dc997add30c7fb68f77b27844fbacd4,3152,Reproduction number (Basic R0),No units,0,NA,Mean,NA,NA,NA,NA,NA,1.75,3.12,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Method, Time",TRUE,TRUE,Unspecified,Branching process,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,Brazil,Persons under investigation,Northeast Brazil,122779,Population based,Unspecified,19,Nov,2016,1,Jan,2015,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,1,Reproduction number,1.75 - 3.12,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,1 Jan 2015,19 Nov 2016,1 Jan 2015 - 19 Nov 2016
52d1b294c5a2ae5543b0d2b08356a557,8333c4c2980f27172c31f6903329ce1a,3152,Reproduction number (Basic R0),No units,0,NA,Mean,NA,NA,NA,NA,NA,1.98,3.85,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,TRUE,TRUE,Unspecified,Branching process,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,Brazil,Persons under investigation,South-East Brazil,112689,Population based,Unspecified,19,Nov,2016,1,Jan,2015,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,1,Reproduction number,1.98 - 3.85,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,1 Jan 2015,19 Nov 2016,1 Jan 2015 - 19 Nov 2016
52d1b294c5a2ae5543b0d2b08356a557,6815ddc3e3cd7e79ece3177728e89adf,3152,Reproduction number (Basic R0),No units,0,NA,Mean,NA,NA,NA,NA,NA,1.61,2.57,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,TRUE,TRUE,Unspecified,Branching process,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,Brazil,Persons under investigation,South Brazil,4944,Population based,Unspecified,19,Nov,2016,1,Jan,2015,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,1,Reproduction number,1.61 - 2.57,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,1 Jan 2015,19 Nov 2016,1 Jan 2015 - 19 Nov 2016
52d1b294c5a2ae5543b0d2b08356a557,5172aaf569757afa37f155633e8a1609,3152,Mutations - evolutionary rate,Substitutions/site/year,-3,1.12,Unspecified,0.97,1.27,95% CrI,NA,NA,NA,NA,Whole genome sequence,NA,NA,NA,NA,Yes - on Github,NA,FALSE,NA,NA,FALSE,NA,NA,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,"Multi-country: Americas, Asia, Oceania",Persons under investigation,NA,254,Unspecified,Unspecified,1,Mar,2016,NA,NA,1966,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,1,Mutations,NA,95% CrI,0.97 - 1.27,"Brazil, Polynesia, Caribbean, Central America, South America",NA,Asian; AmZIKV lineage,FALSE,NA,NA,NA,1966,1 Mar 2016,1966 - 1 Mar 2016
294eb0700d89a1b72f4d9c8d48c675df,68c916d33eb4189f4ebbdfe00c04771b,3154,Mutations - evolutionary rate,Substitutions/site/year,-3,NA,Mean,NA,NA,NA,NA,NA,0.98,1.06,near-complete genome,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,TRUE,FALSE,FALSE,TRUE,Method,FALSE,FALSE,Unspecified,NA,Dominic Dee,Estimated model parameter,FALSE,NA,NA,"Multi-country: Africa (n = 4), Americas (n = 9), Asia (n = 7), Oceania (n = 4), Europe (n = 2)",NA,NA,NA,NA,Unspecified,NA,Dec,2015,NA,NA,1947,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,3,Mutations,0.98 - 1.06,NA,NA,"Russia, Colombia, Brazil, China, Thailand, Indonesia, Mexico, Philippines, Haiti, Martinique, Puerto Rico, Guatemala, Suriname, Cook Islands, New Caledonia, Easter Island, French Polynesia, Indonesia, Malaysia, Cambodia, Micronesia, Senegal, Central African Republic, Nigeria, Uganda, Norway",NA,Asian lineage,FALSE,NA,NA,NA,1947,Dec 2015,1947 - Dec 2015
910ffd40e130e748afbc689213016c99,ad1c40fa5150092e9fd95bc44bb1e3e9,3163,Mutations - evolutionary rate,Substitutions/site/year,-3,1.2,Mean,0.951,1.41,HPDI 95%,NA,NA,NA,NA,Whole genome sequence,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Rob,Estimated model parameter,FALSE,NA,NA,"Multi-country: South and Central America (n = 8), Asia (n = 5), Oceania (n = 1)",Unspecified,Martinique,39,Unspecified,Unspecified,NA,NA,2016,NA,NA,2007,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,5,Mutations,NA,HPDI 95%,0.951 - 1.41,"Brazil, Cambodia, China, Colombia, Dominican Republic, French Polynesia, Guatemala, Haiti, Mexico, Federated States of Micronesia, Philippines, Puerto Rico, Suriname, Thailand",NA,NA,FALSE,NA,NA,NA,2007,2016,2007 - 2016
6fe6159b6cc19850b2e73dc98bbc5325,b3785d4a782c8148053489dbe24547d3,3221,Attack rate,Percentage (%),0,78,Central,63.5,86.3,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Region,FALSE,FALSE,Post outbreak,NA,sangeeta,Estimated model parameter,FALSE,NA,NA,France,General population,French Polynesia,NA,Population based,Unspecified,NA,May,2014,NA,Aug,2013,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,4,Attack rate,NA,95% CI,63.5 - 86.3,France,NA,NA,FALSE,NA,NA,NA,Aug 2013,May 2014,Aug 2013 - May 2014
6fe6159b6cc19850b2e73dc98bbc5325,123e2ffc04835ea8ce841e6ea00a0f0e,3221,Attack rate,Percentage (%),0,20.8,Central,1.1,50.3,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,sangeeta,Estimated model parameter,FALSE,NA,NA,Colombia,General population,NA,NA,Population based,Unspecified,NA,May,2016,NA,Aug,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,4,Attack rate,NA,95% CI,1.1 - 50.3,Colombia,NA,NA,FALSE,NA,NA,NA,Aug 2015,May 2016,Aug 2015 - May 2016
6fe6159b6cc19850b2e73dc98bbc5325,7834538afb582910a5762310737969af,3221,Attack rate,Percentage (%),0,32.4,Central,2.5,94.2,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,sangeeta,Estimated model parameter,FALSE,NA,NA,Brazil,General population,Bahia,NA,Population based,Unspecified,NA,Feb,2016,NA,Feb,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,4,Attack rate,NA,95% CI,2.5 - 94.2,Brazil,NA,NA,FALSE,NA,NA,NA,Feb 2015,Feb 2016,Feb 2015 - Feb 2016
6fe6159b6cc19850b2e73dc98bbc5325,514110af4f870f049c0638fedb80c446,3221,Attack rate,Percentage (%),0,71.3,Central,67.4,94.1,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,sangeeta,Estimated model parameter,FALSE,NA,NA,France,General population,"Tahiti, French Polynesia",NA,Population based,Unspecified,NA,May,2014,NA,Aug,2013,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,4,Attack rate,NA,95% CI,67.4 - 94.1,France,NA,NA,FALSE,NA,NA,NA,Aug 2013,May 2014,Aug 2013 - May 2014
6fe6159b6cc19850b2e73dc98bbc5325,eabca1971d3db32d0a59be24d92fe4c9,3221,Attack rate,Percentage (%),0,70.1,Central,66.3,92.5,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,sangeeta,Estimated model parameter,FALSE,NA,NA,France,General population,"Sous-le-vent Islands, French Polynesia",NA,Population based,Unspecified,NA,May,2014,NA,Aug,2013,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,4,Attack rate,NA,95% CI,66.3 - 92.5,France,NA,NA,FALSE,NA,NA,NA,Aug 2013,May 2014,Aug 2013 - May 2014
6fe6159b6cc19850b2e73dc98bbc5325,a081e2954bf3ec245d95b44d6162ed34,3221,Attack rate,Percentage (%),0,62.5,Unspecified,59.2,82.5,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,sangeeta,NA,FALSE,NA,NA,France,General population,"""Other four archipelagos"", French Polynesia",NA,Population based,Unspecified,NA,May,2014,NA,Aug,2013,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,4,Attack rate,NA,95% CI,59.2 - 82.5,France,NA,NA,FALSE,NA,NA,NA,Aug 2013,May 2014,Aug 2013 - May 2014
9135e327db41a954cc5ec7640fe69d8a,14d04ae15e72d20fd45d0f13101fe56c,3221,Reproduction number (Basic R0) - Sexual,No units,0,NA,Central,NA,NA,NA,NA,NA,0.5,2.5,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,Unspecified,Thomas Rawson,Unspecified,TRUE,NA,NA,"Multi-country: Brazil, Colombia, French Polynesia",General population,NA,NA,Population based,Unspecified,NA,Jun,2016,NA,Aug,2013,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,6,Reproduction number,0.5 - 2.5,NA,NA,"Brazil, Colombia, French Polynesia",NA,NA,FALSE,NA,NA,NA,Aug 2013,Jun 2016,Aug 2013 - Jun 2016
d7ad85cf1607a27c587c0f5327f9ff27,4bc5b7832ed428fe047a3da39c4320c5,3337,Attack rate,"Per 10,000 population",0,14.6,Unspecified,NA,NA,NA,NA,NA,3.6,21.5,NA,Confirmed;Probable,7391,NA,108,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Region, Sex",FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,Federated States of Micronesia,Persons under investigation,Yap Island,185,Hospital based,Both,31,Jul,2007,1,Apr,2007,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,4,Attack rate,3.6 - 21.5,NA,NA,Federated States of Micronesia,NA,NA,FALSE,NA,NA,NA,1 Apr 2007,31 Jul 2007,1 Apr 2007 - 31 Jul 2007
a1879211358efb83d2783836a84b5163,654613fbdca95e43dbcaa7e70900111b,3337,Seroprevalence - IgM,Percentage (%),0,74,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,557,NA,414,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Sex,FALSE,FALSE,Unspecified,NA,Richard Sheppard,Observed sample statistic,FALSE,NA,3,Federated States of Micronesia,General population,Yap Island,557,Household based,Both,31,Jul,2007,1,Apr,2007,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,2,Seroprevalence,NA,NA,NA,Federated States of Micronesia,NA,NA,FALSE,NA,NA,NA,1 Apr 2007,31 Jul 2007,1 Apr 2007 - 31 Jul 2007
a1879211358efb83d2783836a84b5163,aef82a0d28b1e9b41f2d5522333444f9,3337,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Richard Sheppard,NA,FALSE,NA,3,Federated States of Micronesia,General population,Yap Island,557,Household based,Both,31,Jul,2007,1,Apr,2007,NA,Unspecified,Other;Sex,Unspecified,Serology,Significant,NA,FALSE,Unspecified,Unspecified,2,Risk factors,NA,NA,NA,Federated States of Micronesia,NA,NA,FALSE,NA,NA,NA,1 Apr 2007,31 Jul 2007,1 Apr 2007 - 31 Jul 2007
a1879211358efb83d2783836a84b5163,48cc7b95a10e2b105797c6d9966df7f5,3337,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Richard Sheppard,NA,FALSE,NA,3,Federated States of Micronesia,General population,Yap Island,557,Household based,Both,31,Jul,2007,1,Apr,2007,NA,Unspecified,Age;Other,Unspecified,Serology,Not significant,NA,FALSE,Unspecified,Unspecified,2,Risk factors,NA,NA,NA,Federated States of Micronesia,NA,NA,FALSE,NA,NA,NA,1 Apr 2007,31 Jul 2007,1 Apr 2007 - 31 Jul 2007
4c2f7b4eaab6bd2ae13428909c823539,b3c6597fec5099b8dd076a724a3d04d3,3403,"Reproduction number (Effective, Re)",No units,0,0.16,NA,0.13,0.19,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Branching process,Christian,Estimated model parameter,FALSE,NA,NA,United States,General population,Florida,NA,Population based,Unspecified,23,Sep,2016,1,May,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,3,Reproduction number,NA,95% CI,0.13 - 0.19,United States,NA,NA,FALSE,NA,NA,NA,1 May 2016,23 Sep 2016,1 May 2016 - 23 Sep 2016
9e7490762ff2c863e9c40bf0a28abe91,bc03f0ae154d7c72d28711e405e72078,3451,Seroprevalence - IgG,Percentage (%),0,17,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,92,NA,17,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Tristan Naidoo,Observed sample statistic,FALSE,NA,NA,Bangladesh,Persons under investigation,NA,92,Population based,Unspecified,NA,NA,2014,NA,NA,2014,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,44,Seroprevalence,NA,NA,NA,Bangladesh,NA,NA,FALSE,NA,NA,NA,2014,2014,2014
9e7490762ff2c863e9c40bf0a28abe91,8f93cb4761873843ba029b64ccd0af45,3451,Seroprevalence - IgG,Percentage (%),0,28,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,52,NA,15,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Tristan Naidoo,Observed sample statistic,FALSE,NA,NA,Bangladesh,Persons under investigation,NA,52,Population based,Unspecified,NA,NA,2015,NA,NA,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,44,Seroprevalence,NA,NA,NA,Bangladesh,NA,NA,FALSE,NA,NA,NA,2015,2015,2015
9e7490762ff2c863e9c40bf0a28abe91,b31daf096b729ab5c121e5e2bf4f782f,3451,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,3.1,Unspecified,NA,NA,NA,NA,NA,0,11.5,NA,NA,16,NA,12,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Time,FALSE,FALSE,Endemic,NA,Tristan Naidoo,Observed sample statistic,FALSE,NA,16,Bangladesh,General population,NA,418,Population based,Both,NA,NA,2015,NA,NA,2011,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,44,Seroprevalence,0 - 11.5,NA,NA,Bangladesh,NA,NA,TRUE,NA,NA,NA,2011,2015,2011 - 2015
9e7490762ff2c863e9c40bf0a28abe91,415be3076d202611c101d7ba57c4b598,3451,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,4.3,Unspecified,NA,NA,NA,NA,NA,0,13.2,NA,NA,15,NA,5,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Time,FALSE,FALSE,Endemic,NA,Tristan Naidoo,Observed sample statistic,FALSE,NA,NA,Bangladesh,Persons under investigation,NA,418,Population based,Both,NA,NA,2015,NA,NA,2011,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,44,Seroprevalence,0 - 13.2,NA,NA,Bangladesh,NA,NA,TRUE,NA,NA,NA,2011,2015,2011 - 2015
9e7490762ff2c863e9c40bf0a28abe91,a4b7c25e3a205a6ec92e7f82182e8b2e,3451,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Tristan Naidoo,NA,FALSE,NA,NA,Bangladesh,Mixed groups,NA,NA,Population based,Both,NA,NA,2015,NA,NA,2011,NA,Not adjusted,Other,NA,Guillain Barre syndrome,Not significant,NA,FALSE,NA,Unspecified,44,Risk factors,NA,NA,NA,Bangladesh,NA,NA,FALSE,NA,NA,NA,2011,2015,2011 - 2015
9e7490762ff2c863e9c40bf0a28abe91,f813d51af6cf313804b06285992a3c85,3451,Seroprevalence - IgM,Percentage (%),0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,418,NA,3,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Tristan Naidoo,Observed sample statistic,FALSE,NA,16,Bangladesh,General population,NA,418,Population based,Both,NA,NA,2015,NA,NA,2011,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,44,Seroprevalence,NA,NA,NA,Bangladesh,NA,NA,FALSE,NA,NA,NA,2011,2015,2011 - 2015
9e7490762ff2c863e9c40bf0a28abe91,6208ad4de820229ff55e0dd58770686d,3451,Seroprevalence - IgM,Percentage (%),0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,418,NA,1,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Tristan Naidoo,Observed sample statistic,FALSE,NA,NA,Bangladesh,Persons under investigation,NA,418,Population based,Both,NA,NA,2015,NA,NA,2011,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,44,Seroprevalence,NA,NA,NA,Bangladesh,NA,NA,FALSE,NA,NA,NA,2011,2015,2011 - 2015
dbb95a8a182d2575d38c35a4a50a9b9c,221459cc2713a639d1a8e5c3d61c2120,3452,Seroprevalence - HAI/HI,Percentage (%),0,3.3,Mean,NA,NA,NA,NA,NA,0,20,NA,NA,822,NA,27,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Other",FALSE,FALSE,Endemic,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Kenya,General population,Central Nyanza,822,Population based,NA,NA,Apr,1968,NA,Nov,1966,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,3,Seroprevalence,0 - 20,NA,NA,Kenya,NA,NA,FALSE,NA,NA,NA,Nov 1966,Apr 1968,Nov 1966 - Apr 1968
dbb95a8a182d2575d38c35a4a50a9b9c,6967991b530f85a9e2c8847c90d1b13c,3452,Seroprevalence - HAI/HI,Percentage (%),0,1.3,Mean,NA,NA,NA,NA,NA,0,7.7,NA,NA,1042,NA,14,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Other",FALSE,FALSE,Endemic,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Kenya,General population,Kitui District,1042,Population based,NA,NA,Apr,1968,NA,Nov,1966,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,3,Seroprevalence,0 - 7.7,NA,NA,Kenya,NA,NA,FALSE,NA,NA,NA,Nov 1966,Apr 1968,Nov 1966 - Apr 1968
dbb95a8a182d2575d38c35a4a50a9b9c,368311ceab42c6a80a47322de6470b6e,3452,Seroprevalence - HAI/HI,Percentage (%),0,52,Mean,NA,NA,NA,NA,NA,7.2,89.6,NA,NA,834,NA,434,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Other",FALSE,FALSE,Endemic,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Kenya,General population,Malindi District,834,Population based,NA,NA,Apr,1968,NA,Nov,1966,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,3,Seroprevalence,7.2 - 89.6,NA,NA,Kenya,NA,NA,FALSE,NA,NA,NA,Nov 1966,Apr 1968,Nov 1966 - Apr 1968
f7ab2533f46aa0fafc3df9f8cc2fcde5,e9ed39d93da42144db80398bd2c36160,3490,Mutations - evolutionary rate,Substitutions/site/year,-4,9.2,Mean,7.1,12,95% CrI,NA,NA,NA,NA,Whole genome sequence,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,TRUE,Unspecified,NA,Christian,Estimated model parameter,FALSE,NA,NA,"Multi-country: Americas, Asia, Oceania",NA,NA,65,NA,NA,NA,Aug,2017,NA,NA,1966,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,3,Mutations,NA,95% CrI,7.1 - 12,"Southeastern Asia (n = 20, 1966-2016), Pacific (n = 23, 2007-2016) and the Americas (n = 22, 2014-2015)",NA,NA,FALSE,NA,NA,NA,1966,Aug 2017,1966 - Aug 2017
157643dbdda6fafd389a7219a560c1a9,193ef75328dea7c64f2e5fc234c547b8,3528,Severity - case fatality rate (CFR),Percentage (%),0,8.3,Unspecified,7.2,9.6,95% CI,NA,NA,3.4,19,NA,Confirmed,2063,Naive,171,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,Brazil,Other,NA,2063,Hospital based,Both,15,Oct,2016,10,Nov,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,2,Severity,3.4 - 19,95% CI,7.2 - 9.6,Brazil,NA,NA,FALSE,NA,NA,NA,10 Nov 2015,15 Oct 2016,10 Nov 2015 - 15 Oct 2016
157643dbdda6fafd389a7219a560c1a9,b4a8869c5ba05f4c0ce9bb863ad86650,3528,Severity - case fatality rate (CFR),Percentage (%),0,10.5,Unspecified,9.5,11.7,95% CI,NA,NA,3.4,19,NA,Confirmed;Probable,2974,Unspecified,313,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Estimated model parameter,FALSE,NA,NA,Brazil,Other,NA,2974,Hospital based,Both,15,Oct,2016,10,Nov,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,2,Severity,3.4 - 19,95% CI,9.5 - 11.7,Brazil,NA,NA,FALSE,NA,NA,NA,10 Nov 2015,15 Oct 2016,10 Nov 2015 - 15 Oct 2016
580150f2a57adf8d4cffe239b66e7961,7643bb6e6ef662a3e0009c2daaf8de9c,3589,Seroprevalence - IgM,Percentage (%),0,7,Central,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,295,Naive,22,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,0,0,United States,Persons under investigation,New York,295,Hospital based,Both,30,Jun,2017,1,Jan,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Urban area,53,Seroprevalence,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,30 Jun 2017,1 Jan 2016 - 30 Jun 2017
79588738d1cff05fb9eb5555e612e89b,2d329f8b0acc72ef4e1acc416771214f,3614,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,NA,FALSE,NA,NA,Australia,Blood donors,NA,10595,Other,Unspecified,NA,Jun,2014,NA,Jul,2013,NA,Unspecified,Other,NA,Infection,Unspecified,NA,FALSE,NA,NA,6,Risk factors,NA,NA,NA,Australia,NA,NA,FALSE,NA,NA,NA,Jul 2013,Jun 2014,Jul 2013 - Jun 2014
08fcdd723879698c5389f895062ff097,5907dfb1122f07d18ff2db3e740164dd,3650,Reproduction number (Effective; Re) - Sexual,No units,0,NA,Unspecified,NA,NA,NA,NA,NA,1.6,10.3,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Method, Time",TRUE,FALSE,Start outbreak,Other,Christian,Estimated model parameter,FALSE,NA,NA,Colombia,General population,Antioquia,NA,Population based,Unspecified,10,Apr,2016,14,Oct,2015,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,5,Reproduction number,1.6 - 10.3,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,14 Oct 2015,10 Apr 2016,14 Oct 2015 - 10 Apr 2016
5cbcf65709671f8c13f9e50bc00f1f85,6ff5f43458149d05cc34d56e0cae17fa,3678,Risk factors,NA,-3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,NA,FALSE,NA,NA,United States,Other,Puerto Rico,21468,Community based,Both,12,Aug,2016,3,Apr,2016,NA,Unspecified,Age,NA,Infection,Not significant,NA,FALSE,NA,NA,1,Risk factors,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,3 Apr 2016,12 Aug 2016,3 Apr 2016 - 12 Aug 2016
5cbcf65709671f8c13f9e50bc00f1f85,c9248ad4dea2a6d9098a5a5d2c6f90a5,3678,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,NA,FALSE,NA,NA,United States,Other,Puerto Rico,21468,Community based,Both,12,Aug,2016,3,Apr,2016,NA,Unspecified,Other;Sex,NA,Infection,Significant,NA,FALSE,NA,NA,1,Risk factors,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,3 Apr 2016,12 Aug 2016,3 Apr 2016 - 12 Aug 2016
c7f143f193b3170c29121c52fb9794d9,dbb87738a0abb8c675db2255ff882e84,3738,Human delay - infectious period,Days,0,5.2,Median,4.1,6.7,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,"Tahiti, French Polynesia",NA,Population based,Unspecified,NA,Apr,2014,NA,Oct,2013,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,2,Human delay,NA,95% CrI,4.1 - 6.7,France,Infectious period,NA,FALSE,NA,NA,NA,Oct 2013,Apr 2014,Oct 2013 - Apr 2014
c7f143f193b3170c29121c52fb9794d9,ea136eaabcee913154c24d4d9d51dbf8,3738,Human delay - infectious period,Days,0,5.5,Median,4.2,6.8,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,New Caledonia,NA,Population based,Unspecified,NA,Aug,2014,12,Nov,2013,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,2,Human delay,NA,95% CrI,4.2 - 6.8,France,Infectious period,NA,FALSE,NA,NA,NA,12 Nov 2013,Aug 2014,12 Nov 2013 - Aug 2014
c7f143f193b3170c29121c52fb9794d9,c79e7fb38f1a221838166bb4a2366f8a,3738,Human delay - infectious period,Days,0,5.3,Median,4.1,6.6,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Estimated model parameter,FALSE,NA,NA,Federated States of Micronesia,Persons under investigation,Yap Island,NA,Population based,Unspecified,29,Jul,2007,1,Apr,2007,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,2,Human delay,NA,95% CrI,4.1 - 6.6,Federated States of Micronesia,Infectious period,NA,FALSE,NA,NA,NA,1 Apr 2007,29 Jul 2007,1 Apr 2007 - 29 Jul 2007
c7f143f193b3170c29121c52fb9794d9,7eba5d2d971edfa1522fa906ec057311,3738,Human delay - infectious period,Days,0,5.3,Median,4.1,6.7,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,"Mo'orea, French Polynesia",NA,Population based,Unspecified,NA,Apr,2014,NA,Oct,2013,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,2,Human delay,NA,95% CrI,4.1 - 6.7,France,Infectious period,NA,FALSE,NA,NA,NA,Oct 2013,Apr 2014,Oct 2013 - Apr 2014
c7f143f193b3170c29121c52fb9794d9,33fd073844d123d8a8fa9a061113d6bd,3738,Human delay - infectious period,Days,0,5.2,Median,4.1,6.7,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,"Tahiti, French Polynesia",NA,Population based,Unspecified,NA,Apr,2014,NA,Oct,2013,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,2,Human delay,NA,95% CrI,4.1 - 6.7,France,Infectious period,NA,FALSE,NA,NA,NA,Oct 2013,Apr 2014,Oct 2013 - Apr 2014
c7f143f193b3170c29121c52fb9794d9,bbc01dee3434a8dbc3440480c4aa0337,3738,Human delay - infectious period,Days,0,5.4,Median,4.1,6.8,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,New Caledonia,NA,Population based,Unspecified,NA,Aug,2014,12,Nov,2013,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,2,Human delay,NA,95% CrI,4.1 - 6.8,France,Infectious period,NA,FALSE,NA,NA,NA,12 Nov 2013,Aug 2014,12 Nov 2013 - Aug 2014
c7f143f193b3170c29121c52fb9794d9,b7ed7eeae782872bd8c71a7efc2c9740,3738,Mosquito delay - extrinsic incubation period,Days,0,10.6,Median,8.7,12.5,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Estimated model parameter,FALSE,NA,NA,Federated States of Micronesia,Persons under investigation,Yap Island,NA,Population based,Unspecified,29,Jul,2007,1,Apr,2007,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,2,Mosquito,NA,95% CrI,8.7 - 12.5,Federated States of Micronesia,NA,NA,FALSE,NA,NA,NA,1 Apr 2007,29 Jul 2007,1 Apr 2007 - 29 Jul 2007
c7f143f193b3170c29121c52fb9794d9,18aead6a072690144d6b134010e3c347,3738,Mosquito delay - extrinsic incubation period,Days,0,10.5,Median,8.6,12.4,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,"Mo'orea, French Polynesia",NA,Population based,Unspecified,NA,Apr,2014,NA,Oct,2013,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,2,Mosquito,NA,95% CrI,8.6 - 12.4,France,NA,NA,FALSE,NA,NA,NA,Oct 2013,Apr 2014,Oct 2013 - Apr 2014
c7f143f193b3170c29121c52fb9794d9,afe3feaf43a97db5cc1f019cd0f12594,3738,Mosquito delay - extrinsic incubation period,Days,0,10.5,Median,8.6,12.6,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,"Tahiti, French Polynesia",NA,Population based,Unspecified,NA,Apr,2014,NA,Oct,2013,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,2,Mosquito,NA,95% CrI,8.6 - 12.6,France,NA,NA,FALSE,NA,NA,NA,Oct 2013,Apr 2014,Oct 2013 - Apr 2014
c7f143f193b3170c29121c52fb9794d9,30daead3ffe757055ba0d75b6b09a2fe,3738,Mosquito delay - extrinsic incubation period,Days,0,10.7,Median,8.9,12.5,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,New Caledonia,NA,Population based,Unspecified,NA,Aug,2014,12,Nov,2013,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,2,Mosquito,NA,95% CrI,8.9 - 12.5,France,NA,NA,FALSE,NA,NA,NA,12 Nov 2013,Aug 2014,12 Nov 2013 - Aug 2014
c7f143f193b3170c29121c52fb9794d9,856d43503cb8294e24fb76c1f7189929,3738,Mosquito delay - extrinsic incubation period,Days,0,10.7,Median,8.8,12.7,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Estimated model parameter,FALSE,NA,NA,Federated States of Micronesia,Persons under investigation,Yap Island,NA,Population based,Unspecified,29,Jul,2007,1,Apr,2007,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,2,Mosquito,NA,95% CrI,8.8 - 12.7,Federated States of Micronesia,NA,NA,FALSE,NA,NA,NA,1 Apr 2007,29 Jul 2007,1 Apr 2007 - 29 Jul 2007
c7f143f193b3170c29121c52fb9794d9,99ae8f5224280d208327dc2b2a0ed0cd,3738,Mosquito delay - extrinsic incubation period,Days,0,10.6,Median,8.6,12.6,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,"Mo'orea, French Polynesia",NA,Population based,Unspecified,NA,Apr,2014,NA,Oct,2013,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,2,Mosquito,NA,95% CrI,8.6 - 12.6,France,NA,NA,FALSE,NA,NA,NA,Oct 2013,Apr 2014,Oct 2013 - Apr 2014
c7f143f193b3170c29121c52fb9794d9,2f01c6a8620a82a42732e70dccbcbbb8,3738,Mosquito delay - extrinsic incubation period,Days,0,10.5,Median,8.5,12.5,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,"Tahiti, French Polynesia",NA,Population based,Unspecified,NA,Apr,2014,NA,Oct,2013,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,2,Mosquito,NA,95% CrI,8.5 - 12.5,France,NA,NA,FALSE,NA,NA,NA,Oct 2013,Apr 2014,Oct 2013 - Apr 2014
c7f143f193b3170c29121c52fb9794d9,0b2d9069c5735f8422765be8ba39f0fc,3738,Mosquito delay - extrinsic incubation period,Days,0,10.8,Median,8.9,12.8,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,New Caledonia,NA,Population based,Unspecified,NA,Aug,2014,12,Nov,2013,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,2,Mosquito,NA,95% CrI,8.9 - 12.8,France,NA,NA,FALSE,NA,NA,NA,12 Nov 2013,Aug 2014,12 Nov 2013 - Aug 2014
c7f143f193b3170c29121c52fb9794d9,dc0bcd78a6ed15c0e57f107019e3567e,3738,Reproduction number (Basic R0),No units,0,2.6,Median,2.2,3.3,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Next generation matrix,Kelly M,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,"Mo'orea, French Polynesia",NA,Population based,Unspecified,NA,Apr,2014,NA,Oct,2013,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,2,Reproduction number,NA,95% CrI,2.2 - 3.3,France,NA,NA,FALSE,NA,NA,NA,Oct 2013,Apr 2014,Oct 2013 - Apr 2014
c7f143f193b3170c29121c52fb9794d9,d06753a01ce331647c83f0333c2c0e55,3738,Reproduction number (Basic R0),No units,0,2.4,Median,2,3.2,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Next generation matrix,Kelly M,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,"Tahiti, French Polynesia",NA,Population based,Unspecified,NA,Apr,2014,NA,Oct,2013,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,2,Reproduction number,NA,95% CrI,2 - 3.2,France,NA,NA,FALSE,NA,NA,NA,Oct 2013,Apr 2014,Oct 2013 - Apr 2014
c7f143f193b3170c29121c52fb9794d9,1a50b6c9b68e560958180044adb5124c,3738,Reproduction number (Basic R0),No units,0,2,Median,1.8,2.2,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Next generation matrix,Kelly M,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,New Caledonia,NA,Population based,Unspecified,NA,Aug,2014,12,Nov,2013,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,2,Reproduction number,NA,95% CrI,1.8 - 2.2,France,NA,NA,FALSE,NA,NA,NA,12 Nov 2013,Aug 2014,12 Nov 2013 - Aug 2014
c7f143f193b3170c29121c52fb9794d9,052b50a621c69f59179286930442aae0,3738,Reproduction number (Basic R0),No units,0,2.2,Median,1.9,2.6,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Next generation matrix,Kelly M,Estimated model parameter,FALSE,NA,NA,Federated States of Micronesia,Persons under investigation,Yap Island,NA,Population based,Unspecified,29,Jul,2007,1,Apr,2007,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,2,Reproduction number,NA,95% CrI,1.9 - 2.6,Federated States of Micronesia,NA,NA,FALSE,NA,NA,NA,1 Apr 2007,29 Jul 2007,1 Apr 2007 - 29 Jul 2007
c7f143f193b3170c29121c52fb9794d9,3872bc0531d74828f1b1b10df8575bae,3738,Reproduction number (Basic R0),No units,0,3.2,Median,2.4,4.1,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Next generation matrix,Kelly M,Estimated model parameter,FALSE,NA,NA,Federated States of Micronesia,Persons under investigation,Yap Island,NA,Population based,Unspecified,29,Jul,2007,1,Apr,2007,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,2,Reproduction number,NA,95% CrI,2.4 - 4.1,Federated States of Micronesia,NA,NA,FALSE,NA,NA,NA,1 Apr 2007,29 Jul 2007,1 Apr 2007 - 29 Jul 2007
c7f143f193b3170c29121c52fb9794d9,8ca6422c882f2d292ae76676e316276c,3738,Reproduction number (Basic R0),No units,0,1.8,Median,1.6,2,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Next generation matrix,Kelly M,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,"Mo'orea, French Polynesia",NA,Population based,Unspecified,NA,Apr,2014,NA,Oct,2013,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,2,Reproduction number,NA,95% CrI,1.6 - 2,France,NA,NA,FALSE,NA,NA,NA,Oct 2013,Apr 2014,Oct 2013 - Apr 2014
c7f143f193b3170c29121c52fb9794d9,f1dbde96fba86a5d575b12f00048ab89,3738,Reproduction number (Basic R0),No units,0,1.6,Median,1.5,1.7,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Next generation matrix,Kelly M,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,"Tahiti, French Polynesia",NA,Population based,Unspecified,NA,Apr,2014,NA,Oct,2013,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,2,Reproduction number,NA,95% CrI,1.5 - 1.7,France,NA,NA,FALSE,NA,NA,NA,Oct 2013,Apr 2014,Oct 2013 - Apr 2014
c7f143f193b3170c29121c52fb9794d9,f092742488e25686b7f6898b3a0a5cb9,3738,Reproduction number (Basic R0),No units,0,1.6,Median,1.5,1.7,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Next generation matrix,Kelly M,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,New Caledonia,NA,Population based,Unspecified,NA,Aug,2014,12,Nov,2013,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,2,Reproduction number,NA,95% CrI,1.5 - 1.7,France,NA,NA,FALSE,NA,NA,NA,12 Nov 2013,Aug 2014,12 Nov 2013 - Aug 2014
c7f143f193b3170c29121c52fb9794d9,248a3d9e6cde97fb24fad709315e3ae9,3738,Human delay - infectious period,Days,0,5.2,Median,4.1,6.7,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Estimated model parameter,FALSE,NA,NA,Federated States of Micronesia,Persons under investigation,Yap Island,NA,Population based,Unspecified,29,Jul,2007,1,Apr,2007,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,2,Human delay,NA,95% CrI,4.1 - 6.7,Federated States of Micronesia,Infectious period,NA,FALSE,NA,NA,NA,1 Apr 2007,29 Jul 2007,1 Apr 2007 - 29 Jul 2007
c7f143f193b3170c29121c52fb9794d9,aaf7f3ed5eb83970bb9eb1ce1c294d31,3738,Human delay - infectious period,Days,0,5.2,Median,4.1,6.8,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,"Mo'orea, French Polynesia",NA,Population based,Unspecified,NA,Apr,2014,NA,Oct,2013,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,2,Human delay,NA,95% CrI,4.1 - 6.8,France,Infectious period,NA,FALSE,NA,NA,NA,Oct 2013,Apr 2014,Oct 2013 - Apr 2014
27d234382426455d701c5d81c9df92ed,efc9673b3d7370825fac7283074e10e4,3747,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Thomas Rawson,NA,FALSE,NA,NA,France,Pregnant women,French Polynesia,NA,Population based,Female,NA,Jul,2015,NA,Sep,2013,NA,Not adjusted,Infection during pregnancy,NA,Microcephaly,Significant,NA,FALSE,First trimester,Unspecified,56,Risk factors,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,Sep 2013,Jul 2015,Sep 2013 - Jul 2015
764c1f539ff36d56df1ede490b5e03d1,97d19b3d0b2b4cca888f4e842bf954f4,3808,Seroprevalence - IgM,Percentage (%),0,17,Central,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,98,Naive,17,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,NA,France,General population,"Papeete, Tahiti, French Polynesia",98,Hospital based,Both,NA,Feb,2014,NA,Nov,2013,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,57,Seroprevalence,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,Nov 2013,Feb 2014,Nov 2013 - Feb 2014
764c1f539ff36d56df1ede490b5e03d1,4b89227c771fdc3afb1ad28ae1329016,3808,Seroprevalence - IgG,Percentage (%),0,26,Central,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,98,Naive,25,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,NA,France,General population,"Papeete, Tahiti, French Polynesia",98,Hospital based,Both,NA,Feb,2014,NA,Nov,2013,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,57,Seroprevalence,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,Nov 2013,Feb 2014,Nov 2013 - Feb 2014
764c1f539ff36d56df1ede490b5e03d1,96cda0567cc5edaa70fcbc1268d13286,3808,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,56,Central,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,98,Naive,54,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,NA,France,General population,"Papeete, Tahiti, French Polynesia",98,Hospital based,Both,NA,Feb,2014,NA,Nov,2013,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,57,Seroprevalence,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,Nov 2013,Feb 2014,Nov 2013 - Feb 2014
5dd0cee8d81acc040993224a11df18dd,9cbfb62d8a090d70b406cad4ef496d37,3881,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Nicaragua,Household contacts of survivors,Managua,142,Household based,Both,21,Oct,2016,31,Aug,2016,NA,Adjusted,Age;Household contact;Other;Sex,NA,Infection,Not significant,NA,FALSE,NA,Unspecified,10,Risk factors,NA,NA,NA,Nicaragua,NA,NA,FALSE,NA,NA,NA,31 Aug 2016,21 Oct 2016,31 Aug 2016 - 21 Oct 2016
5dd0cee8d81acc040993224a11df18dd,8c7aad51a73a40427f70e6eaac287de0,3881,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Nicaragua,Household contacts of survivors,Managua,142,Household based,Both,21,Oct,2016,31,Aug,2016,NA,Adjusted,Other,NA,Infection,Significant,NA,FALSE,NA,Unspecified,10,Risk factors,NA,NA,NA,Nicaragua,NA,NA,FALSE,NA,NA,NA,31 Aug 2016,21 Oct 2016,31 Aug 2016 - 21 Oct 2016
5dd0cee8d81acc040993224a11df18dd,ac9098843b491422125871fd0d087fa7,3881,Human delay - Onset to Negative PCR test in serum/plasma,Days,0,2.56,Mean,NA,NA,NA,1.53,Standard Deviation,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Nicaragua,Household contacts of survivors,Managua,25,Household based,Both,21,Oct,2016,31,Aug,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,10,Human delay,NA,Standard Deviation,1.53,Nicaragua,Onset to negative pcr test in serum/plasma,NA,FALSE,NA,NA,NA,31 Aug 2016,21 Oct 2016,31 Aug 2016 - 21 Oct 2016
5dd0cee8d81acc040993224a11df18dd,eb43a272f4674c79d718c6739614fac9,3881,Human delay - Onset to Negative PCR test in saliva,Days,0,3.1,Mean,NA,NA,NA,1.5,Standard Deviation,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Nicaragua,Household contacts of survivors,Managua,51,Household based,Both,21,Oct,2016,31,Aug,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,10,Human delay,NA,Standard Deviation,1.5,Nicaragua,Onset to negative pcr test in saliva,NA,FALSE,NA,NA,NA,31 Aug 2016,21 Oct 2016,31 Aug 2016 - 21 Oct 2016
5dd0cee8d81acc040993224a11df18dd,48e95ec45dcb6fd9bcfd1c313185e16f,3881,Human delay - Onset to Negative PCR test in urine,Days,0,5.94,Mean,NA,NA,NA,3.8,Standard Deviation,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Nicaragua,Household contacts of survivors,Managua,86,Household based,Both,21,Oct,2016,31,Aug,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,10,Human delay,NA,Standard Deviation,3.8,Nicaragua,Onset to negative pcr test in urine,NA,FALSE,NA,NA,NA,31 Aug 2016,21 Oct 2016,31 Aug 2016 - 21 Oct 2016
5dd0cee8d81acc040993224a11df18dd,8904fbf792df06453fe1f7d3996d7a1d,3881,Seroprevalence - IgM,No units,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,142,NA,23,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Sex, Symptoms",FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Nicaragua,Household contacts of survivors,Managua,142,Household based,Both,21,Oct,2016,31,Aug,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,10,Seroprevalence,NA,NA,NA,Nicaragua,NA,NA,FALSE,NA,NA,NA,31 Aug 2016,21 Oct 2016,31 Aug 2016 - 21 Oct 2016
1f0ebbfd65f2c7c1c38cb94148d8dfe7,07422cede01505bdf414909329786e07,3958,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,NA,FALSE,0,0,Brazil,Children,Recife,264,Hospital based,Both,30,Nov,2016,15,Jan,2016,NA,Not adjusted,Infection;Other;Sex,NA,Microcephaly,Significant,NA,FALSE,Unspecified,Unspecified,58,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,15 Jan 2016,30 Nov 2016,15 Jan 2016 - 30 Nov 2016
26bb48e1d0b2817855acd05eb8f788f9,475892227e0ad83e720a861b45ed69cf,4021,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,NA,FALSE,NA,NA,Brazil,Children,NA,3603823,Population based,Both,23,May,2017,1,Jan,2015,NA,Adjusted,Infection during pregnancy;Other,NA,Microcephaly,Significant,NA,FALSE,NA,Unspecified,59,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,1 Jan 2015,23 May 2017,1 Jan 2015 - 23 May 2017
26bb48e1d0b2817855acd05eb8f788f9,77ea6891b10021fe7e5512e106d91d86,4021,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,NA,FALSE,NA,NA,Brazil,Children,NA,3603828,Population based,Both,23,May,2017,1,Jan,2015,NA,Adjusted,Infection during pregnancy;Other,NA,Zika congenital syndrome/other birth defects,Significant,NA,FALSE,NA,Unspecified,59,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,1 Jan 2015,23 May 2017,1 Jan 2015 - 23 May 2017
26bb48e1d0b2817855acd05eb8f788f9,8bfd88cd472121a7b13e18f23476bae5,4021,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,TRUE,Unspecified,NA,Kelly M,NA,FALSE,NA,NA,Brazil,Children,NA,3603828,Population based,Both,23,May,2017,1,Jan,2015,NA,Adjusted,Other,NA,Microcephaly,Not significant,NA,FALSE,NA,Unspecified,59,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,1 Jan 2015,23 May 2017,1 Jan 2015 - 23 May 2017
5cd0575bbd3886b8fced2ce9bf7e36b0,0fe8f43fcc03554dcc70a74af315f5af,4032,Attack rate,"Per 10,000 population",0,5.2,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Dominican Republic,General population,NA,5235,Population based,Both,NA,Dec,2016,NA,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Both urban and rural areas,17,Attack rate,NA,NA,NA,Dominican Republic,NA,NA,FALSE,NA,NA,NA,Jan 2016,Dec 2016,Jan 2016 - Dec 2016
5cd0575bbd3886b8fced2ce9bf7e36b0,4853707fc181409beb055a772aa8872a,4032,Attack rate,"Per 10,000 population",0,2.7,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Age,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Dominican Republic,General population,NA,NA,Population based,Male,NA,Dec,2016,NA,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Both urban and rural areas,17,Attack rate,NA,NA,NA,Dominican Republic,NA,NA,FALSE,NA,NA,NA,Jan 2016,Dec 2016,Jan 2016 - Dec 2016
5cd0575bbd3886b8fced2ce9bf7e36b0,1b0007dc951da816e4bfac9c48fa4c09,4032,Attack rate,"Per 10,000 population",0,7.6,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Age,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Dominican Republic,General population,NA,NA,Population based,Female,NA,Dec,2016,NA,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Both urban and rural areas,17,Attack rate,NA,NA,NA,Dominican Republic,NA,NA,FALSE,NA,NA,NA,Jan 2016,Dec 2016,Jan 2016 - Dec 2016
5cd0575bbd3886b8fced2ce9bf7e36b0,77a9b9639639220485f3367cbd163ab8,4032,Reproduction number (Basic R0),No units,0,1.8,Central,1.78,1.82,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Growth rate,Kelly M,Observed sample statistic,FALSE,NA,NA,Dominican Republic,General population,NA,5235,Population based,Both,NA,Dec,2016,NA,Jan,2016,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,NA,Both urban and rural areas,17,Reproduction number,NA,95% CI,1.78 - 1.82,Dominican Republic,NA,NA,FALSE,NA,NA,NA,Jan 2016,Dec 2016,Jan 2016 - Dec 2016
5cd0575bbd3886b8fced2ce9bf7e36b0,22167f39ee370d5586febb10dede9ba5,4032,Reproduction number (Basic R0),No units,0,1.84,Central,1.82,1.87,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Age,FALSE,FALSE,Unspecified,Growth rate,Kelly M,Observed sample statistic,FALSE,NA,NA,Dominican Republic,General population,NA,NA,Population based,Female,NA,Dec,2016,NA,Jan,2016,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,NA,Both urban and rural areas,17,Reproduction number,NA,95% CI,1.82 - 1.87,Dominican Republic,NA,NA,FALSE,NA,NA,NA,Jan 2016,Dec 2016,Jan 2016 - Dec 2016
5cd0575bbd3886b8fced2ce9bf7e36b0,c3ffb2b87c7ab32584928ca4b707d469,4032,Reproduction number (Basic R0),No units,0,1.72,Central,1.69,1.75,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Age,FALSE,FALSE,Unspecified,Growth rate,Kelly M,Observed sample statistic,FALSE,NA,NA,Dominican Republic,General population,NA,NA,Population based,Male,NA,Dec,2016,NA,Jan,2016,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,NA,Both urban and rural areas,17,Reproduction number,NA,95% CI,1.69 - 1.75,Dominican Republic,NA,NA,FALSE,NA,NA,NA,Jan 2016,Dec 2016,Jan 2016 - Dec 2016
edbdd1cb5ae03032e242068da8e13186,c5927081ba0c7fd161c1503b700dca26,4074,Attack rate,Percentage (%),0,0.05,Mean,0.01,0.29,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,NA,Brazil,Blood donors,Campinas,1962,Population based,Both,NA,Mar,2015,NA,Mar,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Urban area,1,Attack rate,NA,95% CI,0.01 - 0.29,Brazil,NA,NA,FALSE,NA,NA,NA,Mar 2015,Mar 2015,Mar 2015
edbdd1cb5ae03032e242068da8e13186,03a32025cea2014ea9097f9606473ceb,4074,Attack rate,Percentage (%),0,0.17,Mean,0.06,0.5,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,NA,Brazil,Blood donors,Campinas,1775,Population based,Both,NA,Mar,2016,NA,Mar,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Urban area,1,Attack rate,NA,95% CI,0.06 - 0.5,Brazil,NA,NA,FALSE,NA,NA,NA,Mar 2016,Mar 2016,Mar 2016
20e93aa2aca63443778478a772fab752,971021f94303455b4ba5de040111c0ab,4110,Reproduction number (Basic R0),No units,0,2.53,Mean,1.59,3.45,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,Compartmental model,Thomas Rawson,Estimated model parameter,FALSE,NA,NA,Brazil,General population,Rio de Janeiro,NA,Population based,Both,NA,NA,2016,NA,NA,2015,Human-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Urban area,2,Reproduction number,NA,95% CI,1.59 - 3.45,Brazil,NA,NA,FALSE,NA,NA,NA,2015,2016,2015 - 2016
20e93aa2aca63443778478a772fab752,3447898735abb2c671c16de572b6d9c5,4110,Human delay - infectious period,Days,0,9.599,Mean,7.673,11.701,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Sex,FALSE,FALSE,Post outbreak,NA,Thomas Rawson,Estimated model parameter,FALSE,NA,NA,Brazil,General population,Rio de Janeiro,NA,Population based,Both,NA,NA,2016,NA,NA,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Urban area,2,Human delay,NA,95% CI,7.673 - 11.701,Brazil,Infectious period,NA,FALSE,NA,NA,NA,2015,2016,2015 - 2016
20e93aa2aca63443778478a772fab752,3f4b380d26fb8a09e9766330de2becdc,4110,Human delay - infectious period,Days,0,11.568,Mean,9.246,13.963,HPDI 95%,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Thomas Rawson,Estimated model parameter,TRUE,NA,NA,Brazil,General population,Rio de Janeiro,NA,Population based,Male,NA,NA,2016,NA,NA,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Urban area,2,Human delay,NA,HPDI 95%,9.246 - 13.963,Brazil,Infectious period,NA,FALSE,NA,NA,NA,2015,2016,2015 - 2016
20e93aa2aca63443778478a772fab752,4e3d39ae577b5732d1c0471c200450b7,4110,Human delay - infectious period,Days,0,9.207,Mean,7.283,11.134,HPDI 95%,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Thomas Rawson,Estimated model parameter,TRUE,NA,NA,Brazil,General population,Rio de Janeiro,NA,Population based,Female,NA,NA,2016,NA,NA,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Urban area,2,Human delay,NA,HPDI 95%,7.283 - 11.134,Brazil,Infectious period,NA,FALSE,NA,NA,NA,2015,2016,2015 - 2016
20e93aa2aca63443778478a772fab752,b737263763a591d46b3865ddd05afd9e,4110,Human delay - infectious period,Days,0,9.073,Mean,5.956,12.232,HPDI 95%,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Thomas Rawson,Estimated model parameter,TRUE,48,14,Brazil,Other,Rio de Janeiro,NA,Population based,Female,NA,NA,2016,NA,NA,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Urban area,2,Human delay,NA,HPDI 95%,5.956 - 12.232,Brazil,Infectious period,NA,FALSE,NA,NA,NA,2015,2016,2015 - 2016
9473db04f5965b3f8e52a76941b9b465,f38688a7317fd3e9f72c05d957fac2aa,4119,Human delay - Onset to ZIKV RNA clearance from plasma,Days,0,11.5,Median,6,64,IQR,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Estimated model parameter,FALSE,63,18,Italy,Persons under investigation,"Padova and Pavia, travel-related",30,Hospital based,Both,NA,Jan,2017,NA,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,60,Human delay,NA,IQR,6 - 64,Italy,Onset to zikv rna clearance from plasma,NA,FALSE,NA,NA,NA,Jan 2016,Jan 2017,Jan 2016 - Jan 2017
9473db04f5965b3f8e52a76941b9b465,59b934fbd7c82851c583f09afad49045,4119,Human delay - Onset to ZIKV RNA clearance from urine,Days,0,24,Median,17,34,IQR,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Estimated model parameter,FALSE,63,18,Italy,Persons under investigation,"Padova and Pavia, travel-related",29,Hospital based,Both,NA,Jan,2017,NA,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,60,Human delay,NA,IQR,17 - 34,Italy,Onset to zikv rna clearance from urine,NA,FALSE,NA,NA,NA,Jan 2016,Jan 2017,Jan 2016 - Jan 2017
9473db04f5965b3f8e52a76941b9b465,1cab3c40dc70b9028b72a0f1d4582713,4119,Human delay - Onset to ZIKV RNA clearance from saliva,Days,0,14,Median,8,31,IQR,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Estimated model parameter,FALSE,63,18,Italy,Persons under investigation,"Padova and Pavia, travel-related",26,Hospital based,Both,NA,Jan,2017,NA,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,60,Human delay,NA,IQR,8 - 31,Italy,Onset to zikv rna clearance from saliva,NA,FALSE,NA,NA,NA,Jan 2016,Jan 2017,Jan 2016 - Jan 2017
9473db04f5965b3f8e52a76941b9b465,511afd947be226f6797608e382003771,4119,Human delay - Onset to ZIKV RNA clearance from semen,Days,0,25,Median,14,29,IQR,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Estimated model parameter,FALSE,63,18,Italy,Persons under investigation,"Padova and Pavia, travel-related",10,Hospital based,Male,NA,Jan,2017,NA,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,60,Human delay,NA,IQR,14 - 29,Italy,Onset to zikv rna clearance from semen,NA,FALSE,NA,NA,NA,Jan 2016,Jan 2017,Jan 2016 - Jan 2017
9473db04f5965b3f8e52a76941b9b465,67c949b334c3a1004235a6ca73f0e416,4119,Human delay - Onset to ZIKV IgM detection,Days,0,8,Median,5,15,IQR,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Estimated model parameter,FALSE,63,18,Italy,Persons under investigation,"Padova and Pavia, travel-related",30,Hospital based,Both,NA,Jan,2017,NA,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,60,Human delay,NA,IQR,5 - 15,Italy,Onset to zikv igm detection,NA,FALSE,NA,NA,NA,Jan 2016,Jan 2017,Jan 2016 - Jan 2017
9473db04f5965b3f8e52a76941b9b465,11a370ec54359981294fbf20246244da,4119,Human delay - Onset to ZIKV IgG detection,Days,0,17,Median,12,26,IQR,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Estimated model parameter,FALSE,63,18,Italy,Persons under investigation,"Padova and Pavia, travel-related",30,Hospital based,Both,NA,Jan,2017,NA,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,60,Human delay,NA,IQR,12 - 26,Italy,Onset to zikv igg detection,NA,FALSE,NA,NA,NA,Jan 2016,Jan 2017,Jan 2016 - Jan 2017
4ba7a70af7fb93be4011182fd020b50b,3fb0ea8a63db25c5849adb70a92c37e4,4200,Seroprevalence - IgG,Percentage (%),0,37,Central,26,47,95% CI,NA,NA,NA,NA,NA,NA,49,Naive,18,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,End outbreak,NA,Thomas Rawson,Observed sample statistic,FALSE,77,13,France,General population,"Society Islands, French Polynesia",49,Population based,Unspecified,NA,Mar,2014,NA,Feb,2014,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,4,Seroprevalence,NA,95% CI,26 - 47,France,NA,NA,FALSE,NA,NA,NA,Feb 2014,Mar 2014,Feb 2014 - Mar 2014
4ba7a70af7fb93be4011182fd020b50b,fe36a451c231530ad148a6e5a1ee4165,4200,Severity - proportion of symptomatic cases,Percentage (%),0,44,Central,26,69,95% CI,NA,NA,NA,NA,NA,Other,18,Naive,8,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,End outbreak,NA,Thomas Rawson,Observed sample statistic,FALSE,77,13,France,General population,"Society Islands, French Polynesia",18,Population based,Unspecified,NA,Mar,2014,NA,Feb,2014,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,4,Severity,NA,95% CI,26 - 69,France,NA,NA,FALSE,NA,NA,NA,Feb 2014,Mar 2014,Feb 2014 - Mar 2014
4ba7a70af7fb93be4011182fd020b50b,643dd30630d7424447cbd0a42899078f,4200,Seroprevalence - IgG,Percentage (%),0,45,Central,38,52,95% CI,NA,NA,NA,NA,NA,NA,49,Naive,22,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,End outbreak,NA,Thomas Rawson,Observed sample statistic,FALSE,86,7,France,General population,"Tuamotu Islands, French Polynesia",49,Population based,Unspecified,NA,Mar,2014,NA,Feb,2014,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,4,Seroprevalence,NA,95% CI,38 - 52,France,NA,NA,FALSE,NA,NA,NA,Feb 2014,Mar 2014,Feb 2014 - Mar 2014
4ba7a70af7fb93be4011182fd020b50b,a30bc2b17840c0735488a9af164f988c,4200,Severity - proportion of symptomatic cases,Percentage (%),0,55,Central,34,75,95% CI,NA,NA,NA,NA,NA,Other,22,Naive,12,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,End outbreak,NA,Thomas Rawson,Observed sample statistic,FALSE,86,7,France,General population,"Tuamotu Islands, French Polynesia",22,Population based,Unspecified,NA,Mar,2014,NA,Feb,2014,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,4,Severity,NA,95% CI,34 - 75,France,NA,NA,FALSE,NA,NA,NA,Feb 2014,Mar 2014,Feb 2014 - Mar 2014
4ba7a70af7fb93be4011182fd020b50b,8228fb1f6347210e92ad7a04878d0ecb,4200,Seroprevalence - IgG,Percentage (%),0,57,Central,47,68,95% CI,NA,NA,NA,NA,NA,NA,49,Naive,28,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,End outbreak,NA,Thomas Rawson,Observed sample statistic,FALSE,82,10,France,General population,"Marquesas Islands, French Polynesia",49,Population based,Unspecified,NA,Mar,2014,NA,Feb,2014,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,4,Seroprevalence,NA,95% CI,47 - 68,France,NA,NA,FALSE,NA,NA,NA,Feb 2014,Mar 2014,Feb 2014 - Mar 2014
4ba7a70af7fb93be4011182fd020b50b,a1f084b75705cb2255958e257dfadf00,4200,Severity - proportion of symptomatic cases,Percentage (%),0,57,Central,39,75,95% CI,NA,NA,NA,NA,NA,Other,28,Naive,16,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,End outbreak,NA,Thomas Rawson,Observed sample statistic,FALSE,82,10,France,General population,"Marquesas Islands, French Polynesia",28,Population based,Unspecified,NA,Mar,2014,NA,Feb,2014,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,4,Severity,NA,95% CI,39 - 75,France,NA,NA,FALSE,NA,NA,NA,Feb 2014,Mar 2014,Feb 2014 - Mar 2014
4ba7a70af7fb93be4011182fd020b50b,58bd9c769a78d0049ca0ec73de11f612,4200,Seroprevalence - IgG,Percentage (%),0,59,Central,39,80,95% CI,NA,NA,NA,NA,NA,NA,49,Naive,29,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,End outbreak,NA,Thomas Rawson,Observed sample statistic,FALSE,84,7,France,General population,"Austral–Gambier Islands, French Polynesia",49,Population based,Unspecified,NA,Mar,2014,NA,Feb,2014,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,4,Seroprevalence,NA,95% CI,39 - 80,France,NA,NA,FALSE,NA,NA,NA,Feb 2014,Mar 2014,Feb 2014 - Mar 2014
4ba7a70af7fb93be4011182fd020b50b,f93a87929141e570957ee52767f22ee0,4200,Severity - proportion of symptomatic cases,Percentage (%),0,66,Central,48,83,95% CI,NA,NA,NA,NA,NA,Other,29,Naive,19,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,End outbreak,NA,Thomas Rawson,Observed sample statistic,FALSE,84,7,France,General population,"Austral–Gambier Islands, French Polynesia",29,Population based,Unspecified,NA,Mar,2014,NA,Feb,2014,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,4,Severity,NA,95% CI,48 - 83,France,NA,NA,FALSE,NA,NA,NA,Feb 2014,Mar 2014,Feb 2014 - Mar 2014
4ba7a70af7fb93be4011182fd020b50b,a5940c5761285bee4381c19bce95178b,4200,Seroprevalence - IgG,Percentage (%),0,66,Central,60,71,95% CI,NA,NA,NA,NA,NA,NA,476,Naive,312,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,TRUE,FALSE,NA,FALSE,FALSE,End outbreak,NA,Thomas Rawson,Observed sample statistic,FALSE,16,6,France,Children,"Society Islands, French Polynesia",476,School based,Both,NA,Jun,2014,NA,May,2014,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,4,Seroprevalence,NA,95% CI,60 - 71,France,NA,NA,FALSE,NA,NA,NA,May 2014,Jun 2014,May 2014 - Jun 2014
4ba7a70af7fb93be4011182fd020b50b,fc088bdf413b051c4f772ce7789323cf,4200,Severity - proportion of symptomatic cases,Percentage (%),0,71,Central,66,76,95% CI,NA,NA,NA,NA,NA,Other,312,Naive,221,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,End outbreak,NA,Thomas Rawson,Observed sample statistic,FALSE,16,6,France,Children,"Society Islands, French Polynesia",312,School based,Both,NA,Jun,2014,NA,May,2014,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,4,Severity,NA,95% CI,66 - 76,France,NA,NA,FALSE,NA,NA,NA,May 2014,Jun 2014,May 2014 - Jun 2014
4ba7a70af7fb93be4011182fd020b50b,aa34166c6cc8a84f5f2844052190efc5,4200,Seroprevalence - IgG,Percentage (%),0,22,Central,16,28,95% CI,NA,NA,NA,NA,NA,NA,700,Naive,154,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Thomas Rawson,Observed sample statistic,FALSE,88,4,France,General population,"Society Islands, French Polynesia",700,Population based,Both,NA,Nov,2015,NA,Sep,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,4,Seroprevalence,NA,95% CI,16 - 28,France,NA,NA,FALSE,NA,NA,NA,Sep 2015,Nov 2015,Sep 2015 - Nov 2015
4ba7a70af7fb93be4011182fd020b50b,1cc103f0ce00e12a4714ad8fa3650217,4200,Severity - proportion of symptomatic cases,Percentage (%),0,47,Central,40,55,95% CI,NA,NA,NA,NA,NA,Other,154,Naive,73,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Thomas Rawson,Observed sample statistic,FALSE,88,4,France,General population,"Society Islands, French Polynesia",154,Population based,Both,NA,Nov,2015,NA,Sep,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,4,Severity,NA,95% CI,40 - 55,France,NA,NA,FALSE,NA,NA,NA,Sep 2015,Nov 2015,Sep 2015 - Nov 2015
3612e1ca90f295b2c8bf6e4247252e4d,f8d464c5c973d0b5e6312035d8e659f3,4204,Seroprevalence - IgG,Percentage (%),0,0.8,Central,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,593,Naive,5,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Level of exposure,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,75,18,France,Mixed groups,French Polynesia,593,Population based,Both,NA,Oct,2013,NA,Jul,2011,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,5,Seroprevalence,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,Jul 2011,Oct 2013,Jul 2011 - Oct 2013
ca4d45034725c8d34007baf39aecddab,93b5be2ca53eda4ce067e507618eefed,4268,Human delay - Admission to care to Discharge from care,Days,0,23,Median,9.5,36,IQR,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Colombia,Persons under investigation,Cucuta,6117,Hospital based,Both,30,Jul,2016,29,Jun,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,61,Human delay,NA,IQR,9.5 - 36,Colombia,Admission to care to discharge from care,NA,FALSE,NA,NA,NA,29 Jun 2015,30 Jul 2016,29 Jun 2015 - 30 Jul 2016
ca4d45034725c8d34007baf39aecddab,a80305994771ad3c6382df8049950c6b,4268,Seroprevalence - IgG,Percentage (%),0,100,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,29,NA,29,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Colombia,Other,Cucuta,29,Hospital based,Both,30,Jul,2016,29,Jun,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,61,Seroprevalence,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,29 Jun 2015,30 Jul 2016,29 Jun 2015 - 30 Jul 2016
ca4d45034725c8d34007baf39aecddab,6fbdc58d30cf1f5f385928876f95ef20,4268,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Kelly M,NA,FALSE,NA,NA,Colombia,Other,Cucuta,29,Hospital based,Both,30,Jul,2016,29,Jun,2015,NA,Not adjusted,Comorbidity;Occupation;Other;Sex,Other,Guillain Barre syndrome,Not significant,NA,FALSE,NA,Unspecified,61,Risk factors,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,29 Jun 2015,30 Jul 2016,29 Jun 2015 - 30 Jul 2016
ca4d45034725c8d34007baf39aecddab,dc639311388513c44f55853352306eef,4268,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Kelly M,NA,FALSE,NA,NA,Colombia,Other,Cucuta,29,Hospital based,Both,30,Jul,2016,29,Jun,2015,NA,Not adjusted,Occupation;Other,Other,Guillain Barre syndrome,Significant,NA,FALSE,NA,Unspecified,61,Risk factors,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,29 Jun 2015,30 Jul 2016,29 Jun 2015 - 30 Jul 2016
ca4d45034725c8d34007baf39aecddab,ef4d8f9395be886bf62eb24826247d92,4268,Reproduction number (Basic R0),No units,0,NA,Central,NA,NA,NA,NA,NA,2.68,4.57,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,Method,TRUE,FALSE,Endemic,Growth rate,Kelly M,Estimated model parameter,FALSE,NA,NA,Colombia,Persons under investigation,Cucuta,6117,Hospital based,Both,30,Jul,2016,29,Jun,2015,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,61,Reproduction number,2.68 - 4.57,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,29 Jun 2015,30 Jul 2016,29 Jun 2015 - 30 Jul 2016
ca4d45034725c8d34007baf39aecddab,189be1a874e2e6c211596514201cb089,4268,Attack rate,"Per 100,000 population",0,1306,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Age,FALSE,FALSE,Endemic,NA,Kelly M,Unspecified,FALSE,NA,NA,Colombia,Persons under investigation,Cucuta,NA,Hospital based,Female,30,Jul,2016,29,Jun,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,61,Attack rate,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,29 Jun 2015,30 Jul 2016,29 Jun 2015 - 30 Jul 2016
ca4d45034725c8d34007baf39aecddab,6e6a5eb193e88e8ac995b88a63e284e3,4268,Attack rate,"Per 100,000 population",0,552,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Age,FALSE,FALSE,Endemic,NA,Kelly M,Unspecified,FALSE,NA,NA,Colombia,Persons under investigation,Cucuta,NA,Hospital based,Male,30,Jul,2016,29,Jun,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,61,Attack rate,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,29 Jun 2015,30 Jul 2016,29 Jun 2015 - 30 Jul 2016
ca4d45034725c8d34007baf39aecddab,15a130186b6051afb66be60ffde6c8ef,4268,Human delay - Diagnosis/test result to Onset of neurologic symptoms,Days,0,7,Median,2,14.5,IQR,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Colombia,Other,Cucuta,29,Hospital based,Both,30,Jul,2016,29,Jun,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,61,Human delay,NA,IQR,2 - 14.5,Colombia,Diagnosis/test result to onset of neurologic symptoms,NA,FALSE,NA,NA,NA,29 Jun 2015,30 Jul 2016,29 Jun 2015 - 30 Jul 2016
8d53cd9332427aef1d6b8dd9919b20ae,19fab79679f2750f5f1787249b8e4251,4328,Mutations - evolutionary rate,Substitutions/site/year,-3,1.55,Mean,1.06,2.05,HPDI 95%,NA,NA,NA,NA,Whole genome sequence,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna-Maria Hartner,Estimated model parameter,FALSE,NA,NA,Multi-country: Americas,NA,Americas,49,NA,NA,NA,Oct,2016,NA,Dec,2014,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,4,Mutations,NA,HPDI 95%,0.00205 - 0.00106,Multi-country: Americas,NA,NA,FALSE,NA,NA,NA,Dec 2014,Oct 2016,Dec 2014 - Oct 2016
a13170e27efb51baebf954896924243c,417aa581ddb7d24acd994eb92a604fd3,4337,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna-Maria Hartner,NA,FALSE,NA,NA,Saudi Arabia,Pregnant women,NA,410,Hospital based,Female,NA,Jul,2017,NA,Nov,2016,NA,Not adjusted,Other,NA,Serology,Significant,NA,FALSE,Unspecified,Unspecified,5,Risk factors,NA,NA,NA,Saudi Arabia,NA,NA,FALSE,NA,NA,NA,Nov 2016,Jul 2017,Nov 2016 - Jul 2017
a13170e27efb51baebf954896924243c,05a2fd07bd710bfd1bed2db347462a76,4337,Seroprevalence - IgM,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,410,Unspecified,24,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna-Maria Hartner,NA,FALSE,NA,NA,Saudi Arabia,Pregnant women,Najran city,410,Hospital based,Female,NA,Jul,2017,NA,Nov,2016,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,Unspecified,Unspecified,5,Seroprevalence,NA,NA,NA,Saudi Arabia,NA,NA,FALSE,NA,NA,NA,Nov 2016,Jul 2017,Nov 2016 - Jul 2017
a13170e27efb51baebf954896924243c,ada8055d54898f613755542750f585f8,4337,Seroprevalence - IgG,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,410,Unspecified,52,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna-Maria Hartner,NA,FALSE,NA,NA,Saudi Arabia,Pregnant women,Najran city,410,Hospital based,Female,NA,Jul,2017,NA,Nov,2016,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,Unspecified,Unspecified,5,Seroprevalence,NA,NA,NA,Saudi Arabia,NA,NA,FALSE,NA,NA,NA,Nov 2016,Jul 2017,Nov 2016 - Jul 2017
a13170e27efb51baebf954896924243c,acebb893d117239cae5bf3fa74be9a0b,4337,Seroprevalence - IgM,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,52,Unspecified,0,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna-Maria Hartner,NA,FALSE,NA,NA,Saudi Arabia,Other,Najran city,52,Hospital based,Unspecified,NA,Jul,2017,NA,Nov,2016,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,Unspecified,Unspecified,5,Seroprevalence,NA,NA,NA,Saudi Arabia,NA,NA,FALSE,NA,NA,NA,Nov 2016,Jul 2017,Nov 2016 - Jul 2017
a13170e27efb51baebf954896924243c,4f790b9dc6efe64fd61473d67d3e356c,4337,Seroprevalence - IgG,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,52,Unspecified,0,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna-Maria Hartner,NA,FALSE,NA,NA,Saudi Arabia,Other,Najran city,52,Hospital based,Unspecified,NA,Jul,2017,NA,Nov,2016,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,Unspecified,Unspecified,5,Seroprevalence,NA,NA,NA,Saudi Arabia,NA,NA,FALSE,NA,NA,NA,Nov 2016,Jul 2017,Nov 2016 - Jul 2017
420fb93399debcccdb2fb1294380e63f,120f075bca3f2b459518be0105bb1508,4352,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Anna-Maria Hartner,NA,FALSE,94,18,United States,General population,"Miami-Dade County, Florida",270,Community based,Both,NA,Dec,2016,NA,Jul,2016,NA,Unspecified,Other,NA,Infection,Significant,NA,FALSE,NA,Unspecified,8,Risk factors,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,Jul 2016,Dec 2016,Jul 2016 - Dec 2016
762d160d6b3f0805d6d40fd3c7cb9339,25250c0b266f9b2414fc2b20e276c8f0,4381,Seroprevalence - IgM,Percentage (%),0,7,Central,NA,NA,NA,NA,NA,NA,NA,NA,Probable,547,Naive,36,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,NA,United States,Pregnant women,"Dallas, Texas",547,Travel based,Female,1,Oct,2016,14,Mar,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,59,Seroprevalence,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,14 Mar 2016,1 Oct 2016,14 Mar 2016 - 1 Oct 2016
762d160d6b3f0805d6d40fd3c7cb9339,13220c65f1f31bcabd145e47d631d618,4381,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,NA,FALSE,NA,NA,United States,Pregnant women,"Dallas, Texas",547,Travel based,Female,1,Oct,2016,14,Mar,2016,NA,Not adjusted,Age;Other,NA,Infection,Not significant,NA,FALSE,Unspecified,Unspecified,59,Risk factors,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,14 Mar 2016,1 Oct 2016,14 Mar 2016 - 1 Oct 2016
762d160d6b3f0805d6d40fd3c7cb9339,49e68ba3db30587070b93ba5d934f232,4381,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,NA,FALSE,0,0,United States,Children,"Dallas, Texas",334,Hospital based,Both,1,Oct,2016,14,Mar,2016,NA,Not adjusted,Infection during pregnancy,NA,Microcephaly,Not significant,NA,FALSE,Unspecified,Unspecified,59,Risk factors,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,14 Mar 2016,1 Oct 2016,14 Mar 2016 - 1 Oct 2016
762d160d6b3f0805d6d40fd3c7cb9339,10fa876b87fb2eb8763dcda7e9e8f663,4381,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,5.3,Central,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,36,NA,29,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,NA,United States,Pregnant women,"Dallas, Texas",547,Travel based,Female,1,Oct,2016,14,Mar,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,59,Seroprevalence,NA,NA,NA,United States,NA,NA,TRUE,NA,NA,NA,14 Mar 2016,1 Oct 2016,14 Mar 2016 - 1 Oct 2016
2545b2b26ee510da031fb36871874bc5,5af7fc9adb128ec8f991d89489cce381,4383,Seroprevalence - HAI/HI,Percentage (%),0,56,Other,NA,NA,NA,NA,NA,NA,NA,NA,NA,267,Naive,150,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Age,FALSE,FALSE,Unspecified,NA,sangeeta,Observed sample statistic,FALSE,NA,NA,Nigeria,NA,Kainji Lake,NA,NA,NA,NA,NA,1980,NA,NA,1980,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,3,Seroprevalence,NA,NA,NA,Nigeria,NA,NA,FALSE,NA,NA,NA,1980,1980,1980
92283c0991bf298e5b92dc7328b1c21b,3fca9fa9d8f176e6321975df473cadad,4413,Reproduction number (Basic R0) - Sexual,No units,0,NA,NA,NA,NA,NA,NA,NA,1.15,2.75,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Other,TRUE,FALSE,Unspecified,Ross-Macdonald formula,sangeeta,Estimated model parameter,TRUE,NA,NA,Brazil,NA,Manacapuru,NA,NA,NA,NA,Feb,2015,NA,Feb,2014,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,4,Reproduction number,1.15 - 2.75,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Feb 2014,Feb 2015,Feb 2014 - Feb 2015
0904ff363fac8a12b3a3ee79a5d078c3,56e94a2f28ae794eb5ff1fba7dcc09cc,4427,Human delay - serial interval,Days,0,7.4,Mean,4.59,10.2,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,sangeeta,Estimated model parameter,FALSE,49,4,Singapore,Persons under investigation,NA,10,Community based,Both,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,5,Human delay,NA,95% CI,4.59 - 10.2,Singapore,Serial interval,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
0904ff363fac8a12b3a3ee79a5d078c3,b901775b756b43c9f88e8e39f630db3a,4427,Reproduction number (Basic R0),No units,0,3.62,Central,3.48,3.77,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Time,TRUE,FALSE,Unspecified,Other,sangeeta,Estimated model parameter,FALSE,NA,NA,Singapore,Persons under investigation,NA,NA,NA,NA,1,Sep,2016,31,Jul,2016,Human-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,5,Reproduction number,NA,95% CI,3.48 - 3.77,Singapore,NA,NA,FALSE,NA,NA,NA,31 Jul 2016,1 Sep 2016,31 Jul 2016 - 1 Sep 2016
0904ff363fac8a12b3a3ee79a5d078c3,16e7a966dcd5ef5190df9fdb016e29ed,4427,"Reproduction number (Effective, Re)",No units,0,1.22,Central,1.19,1.24,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Time,FALSE,FALSE,Unspecified,Other,sangeeta,Estimated model parameter,FALSE,NA,NA,Singapore,Persons under investigation,NA,NA,NA,NA,24,Nov,2016,1,Sep,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,5,Reproduction number,NA,95% CI,1.19 - 1.24,Singapore,NA,NA,FALSE,NA,NA,NA,1 Sep 2016,24 Nov 2016,1 Sep 2016 - 24 Nov 2016
3743b4e8e16bc49684d8b9c60ec85ee0,1382ac9f14fa208c42743bba7ad38d4a,4438,Mutations - evolutionary rate,Substitutions/site/year,-3,1.57,Central,NA,NA,NA,NA,NA,NA,NA,Whole genome sequence,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,sangeeta,Estimated model parameter,FALSE,NA,NA,Multi-country: Americas,NA,NA,139,NA,NA,NA,NA,2016,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,6,Mutations,NA,NA,NA,"Brazil, USA, other Americas",NA,NA,FALSE,NA,NA,NA,Unspecified,2016,Unspecified - 2016
3743b4e8e16bc49684d8b9c60ec85ee0,0fa87956f3af5e3c82e029d156a3f472,4438,Mutations - evolutionary rate,Substitutions/site/year,-3,1.76,Central,NA,NA,NA,NA,NA,NA,NA,Whole genome sequence,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,sangeeta,Estimated model parameter,FALSE,NA,NA,Brazil,NA,NA,67,NA,NA,NA,NA,2016,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,6,Mutations,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Unspecified,2016,Unspecified - 2016
3743b4e8e16bc49684d8b9c60ec85ee0,a65fea52ac5577fd3782f58f710d6c8b,4438,Mutations - evolutionary rate,Substitutions/site/year,-3,6.42,Central,NA,NA,NA,NA,NA,NA,NA,Whole genome sequence,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,sangeeta,Estimated model parameter,FALSE,NA,NA,United States,NA,Florida,23,NA,NA,11,Oct,2016,NA,Jun,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,6,Mutations,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,Jun 2016,11 Oct 2016,Jun 2016 - 11 Oct 2016
484d4670486b778cb3534499110c16d9,e0d9d3a677da082d979488cc2bd7d0a1,4447,Seroprevalence - IgM,Percentage (%),0,0.3,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,1001,Naive,3,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,65,18,Austria,Blood donors,Tyrol,1001,Population based,Both,NA,Nov,2016,NA,Aug,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,60,Seroprevalence,NA,NA,NA,Austria,NA,NA,FALSE,NA,NA,NA,Aug 2016,Nov 2016,Aug 2016 - Nov 2016
484d4670486b778cb3534499110c16d9,71121a2927c5979f57fc25bad749e960,4447,Seroprevalence - IgG,Percentage (%),0,0.1,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,1001,Naive,1,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,65,18,Austria,Blood donors,Tyrol,1001,Population based,Both,NA,Nov,2016,NA,Aug,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,60,Seroprevalence,NA,NA,NA,Austria,NA,NA,FALSE,NA,NA,NA,Aug 2016,Nov 2016,Aug 2016 - Nov 2016
484d4670486b778cb3534499110c16d9,de1ecda5fc888fcd0480f577fcf311c9,4447,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,0,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,Naive,0,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,65,18,Austria,Blood donors,Tyrol,1001,Population based,Both,NA,Nov,2016,NA,Aug,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,60,Seroprevalence,NA,NA,NA,Austria,NA,NA,TRUE,NA,NA,NA,Aug 2016,Nov 2016,Aug 2016 - Nov 2016
9bbc7bc3866e6f7876fa2e66423fb4d4,2f7974932fdd60a9af63a6c73a880528,5530,Mosquito delay - extrinsic incubation period,Days,0,NA,NA,NA,NA,NA,NA,NA,5.1,24.2,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,Other,TRUE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,56,Mosquito,5.1 - 24.2,NA,NA,NA,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
c02d386a290359f8c704cbc743056940,25a8eb97cd1c59155a6a42036c7eac2d,5535,Mosquito delay - extrinsic incubation period (EIP10),E10,0,NA,Central,NA,NA,NA,NA,NA,9.7,25.6,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Other,TRUE,FALSE,Unspecified,NA,Anna Vicco,Estimated model parameter,FALSE,NA,NA,Unspecified,Other,NA,NA,Other,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,9,Mosquito,9.7 - 25.6,NA,NA,NA,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
92ab87412cd5ac7647b176b4872239cf,5b30dd02ac41bfb9de6f4fb9ccf29011,5543,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Brazil,Pregnant women,Maranhao state,108,Contact based,NA,NA,Sep,2018,NA,Mar,2015,NA,Unspecified,Infection during pregnancy,NA,Microcephaly,Significant,NA,FALSE,First trimester,NA,11,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Mar 2015,Sep 2018,Mar 2015 - Sep 2018
92ab87412cd5ac7647b176b4872239cf,386eaff6b1952b5f717d3ed81a7e18ed,5543,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Brazil,Pregnant women,Maranhao state,108,Contact based,NA,NA,Sep,2018,NA,Mar,2015,NA,Unspecified,Infection during pregnancy,NA,Zika congenital syndrome/other birth defects,Significant,NA,FALSE,First trimester,NA,11,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Mar 2015,Sep 2018,Mar 2015 - Sep 2018
07c9c5a032352f185f49431f38647517,71cc828201cfc0468877e507fbf896e3,5551,Seroprevalence - IgM,Percentage (%),0,13,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,141,NA,16,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,Observed sample statistic,FALSE,NA,NA,United States,Children,NA,141,Hospital based,Both,NA,NA,2017,NA,NA,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,50,Seroprevalence,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,2016,2017,2016 - 2017
1923d3cc7ef83ee7bb52a4858a2c67f8,4970b95da15c06dc2b440a2f2b744e5b,5555,Reproduction number (Basic R0),No units,0,0.4942,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Unspecified,Kelly M,Estimated model parameter,FALSE,NA,NA,Colombia,Unspecified,NA,NA,Unspecified,Unspecified,NA,NA,2015,NA,NA,2015,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,21,Reproduction number,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,2015,2015,2015
9afdc166d194c8f3bbfc062247706af3,ee9249af5e8c2d79daf011338dc3325b,5581,"Reproduction number (Effective, Re)",No units,0,NA,Unspecified,NA,NA,NA,NA,NA,0.8822,0.941,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,FALSE,FALSE,Unspecified,Compartmental model,Ruth,Estimated model parameter,FALSE,NA,NA,Brazil,Persons under investigation,NA,NA,Population based,Unspecified,14,Apr,2018,25,Mar,2016,Other,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,1,Reproduction number,0.8822 - 0.941,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,25 Mar 2016,14 Apr 2018,25 Mar 2016 - 14 Apr 2018
9afdc166d194c8f3bbfc062247706af3,6a1d6e94c94a631ebbda4f0e3097b016,5581,Reproduction number (Effective; Re) - Vector-borne,No units,0,0.8568,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Compartmental model,Ruth,Estimated model parameter,FALSE,NA,NA,Brazil,Persons under investigation,NA,NA,Population based,Unspecified,14,Apr,2018,25,Mar,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,1,Reproduction number,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,25 Mar 2016,14 Apr 2018,25 Mar 2016 - 14 Apr 2018
9afdc166d194c8f3bbfc062247706af3,f7777806115c73e4241c453fbe5827ba,5581,Reproduction number (Effective; Re) - Sexual,No units,0,0.05,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Compartmental model,Ruth,Estimated model parameter,FALSE,NA,NA,Brazil,Persons under investigation,NA,NA,Population based,Unspecified,14,Apr,2018,25,Mar,2016,Human-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,1,Reproduction number,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,25 Mar 2016,14 Apr 2018,25 Mar 2016 - 14 Apr 2018
9afdc166d194c8f3bbfc062247706af3,57217b5fc9ceaf0474bf6e4dc0c8ad79,5581,Reproduction number (Basic R0),No units,0,1.8162,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Compartmental model,Ruth,Estimated model parameter,FALSE,NA,NA,Brazil,Persons under investigation,NA,NA,Population based,Unspecified,14,Apr,2018,25,Mar,2016,Other,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,1,Reproduction number,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,25 Mar 2016,14 Apr 2018,25 Mar 2016 - 14 Apr 2018
9afdc166d194c8f3bbfc062247706af3,b8e5f2b0126735e79b213cc381ada726,5581,Reproduction number (Basic R0) - Vector-borne,No units,0,1.7133,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Compartmental model,Ruth,Estimated model parameter,FALSE,NA,NA,Brazil,Persons under investigation,NA,NA,Population based,Unspecified,14,Apr,2018,25,Mar,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,1,Reproduction number,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,25 Mar 2016,14 Apr 2018,25 Mar 2016 - 14 Apr 2018
9afdc166d194c8f3bbfc062247706af3,7b3726426cd1aec39fc30d357d0bc74f,5581,Reproduction number (Basic R0) - Sexual,No units,0,0.1999,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Compartmental model,Ruth,Estimated model parameter,FALSE,NA,NA,Brazil,Persons under investigation,NA,NA,Population based,Unspecified,14,Apr,2018,25,Mar,2016,Human-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,1,Reproduction number,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,25 Mar 2016,14 Apr 2018,25 Mar 2016 - 14 Apr 2018
9d6c49468052bc01065cc59d2a88dade,82a672cdedc4b2959a5fa001a0d7a2ec,5585,Reproduction number (Basic R0) - Sexual,No units,0,0.8812,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Compartmental model,Thom Rawson,Estimated model parameter,FALSE,NA,NA,Colombia,General population,NA,NA,Population based,Unspecified,NA,NA,2016,NA,NA,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,10,Reproduction number,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,2016,2016,2016
768775dd1891ad15ecb15c251063ef20,cf8a1c1391115f4d13165fba78e1406f,5609,Reproduction number (Basic R0) - Sexual,No units,0,1.66,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Next generation matrix,Thom Rawson,Estimated model parameter,FALSE,NA,NA,Brazil,General population,Itabuna,NA,Population based,Unspecified,NA,NA,2016,NA,NA,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,12,Reproduction number,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,2016,2016,2016
768775dd1891ad15ecb15c251063ef20,4d57bea786598d3b38d4f71ded39a21b,5609,Reproduction number (Basic R0) - Sexual,No units,0,1.8,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Next generation matrix,Thom Rawson,Estimated model parameter,FALSE,NA,NA,Brazil,General population,Cuiaba,NA,Population based,Unspecified,NA,NA,2016,NA,NA,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,12,Reproduction number,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,2016,2016,2016
768775dd1891ad15ecb15c251063ef20,de0362ffc82d7a21d100715e1bfa9d9c,5609,Reproduction number (Basic R0) - Sexual,No units,0,2.76,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Next generation matrix,Thom Rawson,Estimated model parameter,FALSE,NA,NA,Brazil,General population,Goiania,NA,Population based,Unspecified,NA,NA,2016,NA,NA,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,12,Reproduction number,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,2016,2016,2016
768775dd1891ad15ecb15c251063ef20,cf63566d132d5db3e7975a6bc6dd5bd1,5609,Reproduction number (Basic R0) - Sexual,No units,0,1.87,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Next generation matrix,Thom Rawson,Estimated model parameter,FALSE,NA,NA,Brazil,General population,Rio de Janeiro,NA,Population based,Unspecified,NA,NA,2016,NA,NA,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,12,Reproduction number,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,2016,2016,2016
56d339cfb42880921d64b0240691abf0,8ba86ab66c06a6c4a13d1b41fb38bf55,5612,Reproduction number (Effective; Re) - Sexual,No units,0,NA,Unspecified,NA,NA,NA,NA,NA,0.85,1.71,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Next generation matrix,Thom Rawson,Unspecified,FALSE,NA,NA,Brazil,Unspecified,"""north-eastern""",NA,Unspecified,Unspecified,NA,Sep,2016,NA,Jan,2015,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,13,Reproduction number,0.85 - 1.71,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Jan 2015,Sep 2016,Jan 2015 - Sep 2016
56d339cfb42880921d64b0240691abf0,0ff586283349cd158e38169e9934d687,5612,Relative contribution - vector-borne,Percentage (%),0,98.6,Median,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thom Rawson,Estimated model parameter,FALSE,NA,NA,Brazil,Unspecified,"""north-eastern""",NA,Unspecified,Unspecified,NA,Sep,2016,NA,Jan,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,13,Relative contribution,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Jan 2015,Sep 2016,Jan 2015 - Sep 2016
56d339cfb42880921d64b0240691abf0,bc122c9f906f13dadb55e39930ebc0a9,5612,Relative contribution - sexual,Percentage (%),0,1.4,Median,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thom Rawson,Estimated model parameter,FALSE,NA,NA,Brazil,Unspecified,"""north-eastern""",NA,Unspecified,Unspecified,NA,Sep,2016,NA,Jan,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,13,Relative contribution,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Jan 2015,Sep 2016,Jan 2015 - Sep 2016
6fdf1a4bb8212ad30e9f7199ace4571a,76efaca1a363708c44f59b0e74a8d2c6,5639,Seroprevalence - IgG,Percentage (%),0,35,NA,26,48,95% CI,NA,NA,15,57,NA,Lab confirmed,5108,Naive,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Region,FALSE,FALSE,Unspecified,NA,Christian,Estimated model parameter,FALSE,59,2,Brazil,Other,"Belo Horizonte, Salvador, Laranjeiras, Fortaleza, Recife, Cuiaba and Campo Grande, Porto Velho",5108,Other,Unspecified,NA,Jun,2019,NA,Jul,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,51,Seroprevalence,15 - 57,95% CI,26 - 48,Brazil,NA,NA,FALSE,NA,NA,NA,Jul 2016,Jun 2019,Jul 2016 - Jun 2019
6fdf1a4bb8212ad30e9f7199ace4571a,392c7a334a66338aae3f574f9796e795,5639,Reproduction number (Basic R0),No units,0,1.54,NA,1.35,1.92,95% CI,NA,NA,1.18,2.33,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Region,FALSE,FALSE,Unspecified,Other,Christian,Estimated model parameter,FALSE,59,2,Brazil,Other,"Belo Horizonte, Salvador, Laranjeiras, Fortaleza, Recife, Cuiaba and Campo Grande, Porto Velho",5108,Other,Unspecified,NA,Jun,2019,NA,Jul,2016,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,51,Reproduction number,1.18 - 2.33,95% CI,1.35 - 1.92,Brazil,NA,NA,FALSE,NA,NA,NA,Jul 2016,Jun 2019,Jul 2016 - Jun 2019
6fdf1a4bb8212ad30e9f7199ace4571a,78032d49af82affa17f67cf4a09eb671,5639,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,NA,FALSE,59,2,Brazil,Other,"Belo Horizonte, Salvador, Laranjeiras, Fortaleza, Recife, Cuiaba and Campo Grande, Porto Velho",5108,Other,Unspecified,NA,Jun,2019,NA,Jul,2016,NA,Not adjusted,Other,NA,Other,Unspecified,NA,FALSE,NA,NA,51,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Jul 2016,Jun 2019,Jul 2016 - Jun 2019
6fdf1a4bb8212ad30e9f7199ace4571a,1db9f94b924366c38939cdef08bfc06e,5639,Seroprevalence - IgG,Percentage (%),0,22,NA,7,41,95% CI,NA,NA,NA,NA,NA,Lab confirmed,817,Naive,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Estimated model parameter,FALSE,59,2,Brazil,Other,Belo Horizonte,817,Other,Unspecified,NA,Jun,2019,NA,Jul,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,51,Seroprevalence,NA,95% CI,7 - 41,Brazil,NA,NA,FALSE,NA,NA,NA,Jul 2016,Jun 2019,Jul 2016 - Jun 2019
6fdf1a4bb8212ad30e9f7199ace4571a,27118fcda5ad6ba76654e03fc641c90e,5639,Seroprevalence - IgG,Percentage (%),0,29,NA,11,52,95% CI,NA,NA,NA,NA,NA,Lab confirmed,494,Naive,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Estimated model parameter,FALSE,59,2,Brazil,Other,"Salvador, Bahia",494,Other,Unspecified,NA,Jun,2019,NA,Jul,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,51,Seroprevalence,NA,95% CI,11 - 52,Brazil,NA,NA,FALSE,NA,NA,NA,Jul 2016,Jun 2019,Jul 2016 - Jun 2019
6fdf1a4bb8212ad30e9f7199ace4571a,0296cdab1225635d258b4d560a37975d,5639,Seroprevalence - IgG,Percentage (%),0,57,NA,35,74,95% CI,NA,NA,NA,NA,NA,Lab confirmed,574,Naive,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Estimated model parameter,FALSE,59,2,Brazil,Other,Laranjeiras,574,Other,Unspecified,NA,Jun,2019,NA,Jul,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,51,Seroprevalence,NA,95% CI,35 - 74,Brazil,NA,NA,FALSE,NA,NA,NA,Jul 2016,Jun 2019,Jul 2016 - Jun 2019
6fdf1a4bb8212ad30e9f7199ace4571a,9720ee90c6e64dd7009b1fe95da8cb3b,5639,Seroprevalence - IgG,Percentage (%),0,30,NA,17,46,95% CI,NA,NA,NA,NA,NA,Lab confirmed,345,Naive,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Estimated model parameter,FALSE,59,2,Brazil,Other,Fortaleza,345,Other,Unspecified,NA,Jun,2019,NA,Jul,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,51,Seroprevalence,NA,95% CI,17 - 46,Brazil,NA,NA,FALSE,NA,NA,NA,Jul 2016,Jun 2019,Jul 2016 - Jun 2019
6fdf1a4bb8212ad30e9f7199ace4571a,0dfa7d15d1c33396daf067cb9adf5ee7,5639,Seroprevalence - IgG,Percentage (%),0,47,NA,25,69,95% CI,NA,NA,NA,NA,NA,Lab confirmed,1110,Naive,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Estimated model parameter,FALSE,59,2,Brazil,Other,Recife,1110,Other,Unspecified,NA,Jun,2019,NA,Jul,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,51,Seroprevalence,NA,95% CI,25 - 69,Brazil,NA,NA,FALSE,NA,NA,NA,Jul 2016,Jun 2019,Jul 2016 - Jun 2019
6fdf1a4bb8212ad30e9f7199ace4571a,f9d0cf9b2c10298fa7d80e30ab443c18,5639,Seroprevalence - IgG,Percentage (%),0,40,NA,30,72,95% CI,NA,NA,NA,NA,NA,Lab confirmed,1017,Naive,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Estimated model parameter,FALSE,59,2,Brazil,Other,Cuiaba and Campo Grande,1017,Other,Unspecified,NA,Jun,2019,NA,Jul,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,51,Seroprevalence,NA,95% CI,30 - 72,Brazil,NA,NA,FALSE,NA,NA,NA,Jul 2016,Jun 2019,Jul 2016 - Jun 2019
6fdf1a4bb8212ad30e9f7199ace4571a,ae1441d7408c10cfbb0778d21d60ef92,5639,Seroprevalence - IgG,Percentage (%),0,15,NA,4,29,95% CI,NA,NA,NA,NA,NA,Lab confirmed,751,Naive,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Estimated model parameter,FALSE,59,2,Brazil,Other,Porto Velho,751,Other,Unspecified,NA,Jun,2019,NA,Jul,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,51,Seroprevalence,NA,95% CI,4 - 29,Brazil,NA,NA,FALSE,NA,NA,NA,Jul 2016,Jun 2019,Jul 2016 - Jun 2019
6fdf1a4bb8212ad30e9f7199ace4571a,300896a79a344245e9d6dbcb3d148422,5639,Reproduction number (Basic R0),No units,0,1.28,NA,1.08,1.69,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Other,Christian,Estimated model parameter,FALSE,59,2,Brazil,Other,Belo Horizonte,817,Other,Unspecified,NA,Jun,2016,NA,Jul,2016,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,51,Reproduction number,NA,95% CI,1.08 - 1.69,Brazil,NA,NA,FALSE,NA,NA,NA,Jul 2016,Jun 2016,Jul 2016 - Jun 2016
6fdf1a4bb8212ad30e9f7199ace4571a,1d4037c1d5f9b91f4d6bf66591a01059,5639,Reproduction number (Basic R0),No units,0,1.41,NA,1.12,2.08,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Other,Christian,Estimated model parameter,FALSE,59,2,Brazil,Other,"Salvador, Bahia",494,Other,Unspecified,NA,Jun,2019,NA,Jul,2016,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,51,Reproduction number,NA,95% CI,1.12 - 2.08,Brazil,NA,NA,FALSE,NA,NA,NA,Jul 2016,Jun 2019,Jul 2016 - Jun 2019
6fdf1a4bb8212ad30e9f7199ace4571a,ed82cb26ad21d9b11ef880e748093b93,5639,Reproduction number (Basic R0),No units,0,2.33,NA,1.54,3.85,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Other,Christian,Estimated model parameter,FALSE,59,2,Brazil,Other,Laranjeiras,574,Other,Unspecified,NA,Jun,2019,NA,Jul,2016,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,51,Reproduction number,NA,95% CI,1.54 - 3.85,Brazil,NA,NA,FALSE,NA,NA,NA,Jul 2016,Jun 2019,Jul 2016 - Jun 2019
6fdf1a4bb8212ad30e9f7199ace4571a,640dcfb4c186726f90f4d16429a82cf4,5639,Reproduction number (Basic R0),No units,0,1.43,NA,1.21,1.85,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Other,Christian,Estimated model parameter,FALSE,59,2,Brazil,Other,Fortaleza,345,Other,Unspecified,NA,Jun,2019,NA,Jul,2016,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,51,Reproduction number,NA,95% CI,1.21 - 1.85,Brazil,NA,NA,FALSE,NA,NA,NA,Jul 2016,Jun 2019,Jul 2016 - Jun 2019
6fdf1a4bb8212ad30e9f7199ace4571a,5045716e75b414b8e721491fada9cac4,5639,Reproduction number (Basic R0),No units,0,1.89,NA,1.33,3.23,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Other,Christian,Estimated model parameter,FALSE,59,2,Brazil,Other,Recife,1110,Other,Unspecified,NA,Jun,2019,NA,Jul,2016,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,51,Reproduction number,NA,95% CI,1.33 - 3.23,Brazil,NA,NA,FALSE,NA,NA,NA,Jul 2016,Jun 2019,Jul 2016 - Jun 2019
6fdf1a4bb8212ad30e9f7199ace4571a,63bb940b7a38171538b7c01d9ea12a6d,5639,Reproduction number (Basic R0),No units,0,1.67,NA,1.43,3.57,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Other,Christian,Estimated model parameter,FALSE,59,2,Brazil,Other,Cuiaba and Campo Grande,1017,Other,Unspecified,NA,Jun,2019,NA,Jul,2016,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,51,Reproduction number,NA,95% CI,1.43 - 3.57,Brazil,NA,NA,FALSE,NA,NA,NA,Jul 2016,Jun 2019,Jul 2016 - Jun 2019
6fdf1a4bb8212ad30e9f7199ace4571a,194ee1d0d581a13410481776f4505e5d,5639,Reproduction number (Basic R0),No units,0,1.18,NA,1.04,1.41,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Other,Christian,Estimated model parameter,FALSE,59,2,Brazil,Other,Porto Velho,751,Other,Unspecified,NA,Jun,2019,NA,Jul,2016,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,51,Reproduction number,NA,95% CI,1.04 - 1.41,Brazil,NA,NA,FALSE,NA,NA,NA,Jul 2016,Jun 2019,Jul 2016 - Jun 2019
6d23039791ea672d02fc84a00d9cf786,83d3cde65645e9a854088699666e7b06,5665,Reproduction number (Basic R0),No units,0,0.5477,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Compartmental model,Joseph,Estimated model parameter,FALSE,NA,NA,Colombia,Unspecified,NA,NA,Unspecified,Unspecified,NA,NA,2016,NA,NA,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,2,Reproduction number,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,2016,2016,2016
6d23039791ea672d02fc84a00d9cf786,1a4e2ba238bea0e5d79b110d77dee79b,5665,Human delay - incubation period (inverse parameter),Per day,0,0.0686,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,TRUE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Joseph,Estimated model parameter,FALSE,NA,NA,Colombia,Unspecified,NA,NA,Unspecified,Unspecified,NA,NA,2016,NA,NA,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,2,Human delay,NA,NA,NA,Colombia,Incubation period,NA,FALSE,NA,NA,NA,2016,2016,2016
6d23039791ea672d02fc84a00d9cf786,de78c6f8dd6ef52b80e78c3caa89444c,5665,Human delay - infectious period (inverse parameter),Per day,0,0.0228,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,TRUE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Joseph,Estimated model parameter,FALSE,NA,NA,Colombia,Unspecified,NA,NA,Unspecified,Unspecified,NA,NA,2016,NA,NA,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,2,Human delay,NA,NA,NA,Colombia,Infectious period,NA,FALSE,NA,NA,NA,2016,2016,2016
6d23039791ea672d02fc84a00d9cf786,9751c49261f6590c76d7147911f6aa2d,5665,Human delay - Recovery/non-Infectiousness to Susceptibility (inverse parameter),Per day,0,0.054,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,TRUE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Joseph,Estimated model parameter,FALSE,NA,NA,Colombia,Unspecified,NA,NA,Unspecified,Unspecified,NA,NA,2016,NA,NA,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,2,Human delay,NA,NA,NA,Colombia,Recovery/non-infectiousness to susceptibility,NA,FALSE,NA,NA,NA,2016,2016,2016
72fc96f50bfafb79b6d630f478063923,aa2ae5a688fba9bbd82708674a53eda1,5667,Seroprevalence - IgM,Percentage (%),0,2.18,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed;Lab confirmed,12374,NA,277,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,NA,United States,Mixed groups,"Hidalgo County, Texas",12374,Hospital based,Unspecified,NA,NA,2018,NA,NA,2016,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,Unspecified,Unspecified,6,Seroprevalence,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,2016,2018,2016 - 2018
72fc96f50bfafb79b6d630f478063923,671da1cd4fc4d2aaa63133c0fccd8126,5667,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,18.8,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed;Lab confirmed,234,NA,44,Not avaialble,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,NA,United States,Mixed groups,"Hidalgo County, Texas",234,Hospital based,Unspecified,NA,NA,2018,NA,NA,2016,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,Unspecified,Unspecified,6,Seroprevalence,NA,NA,NA,United States,NA,NA,TRUE,NA,NA,NA,2016,2018,2016 - 2018
151459a0987acb0369d37fe9ec78d14a,3632d95bc57bf74e696a87ff433ee399,5671,Attack rate,Percentage (%),0,50,Unspecified,43,58,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,NA,Estimated model parameter,FALSE,NA,NA,France,Mixed groups,Martinique,NA,Mixed settings,Both,NA,NA,2016,NA,NA,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,46,Attack rate,NA,95% CrI,43 - 58,France,NA,NA,FALSE,NA,NA,NA,2015,2016,2015 - 2016
ef1bd25df7c12e407262f997d20bd655,d36c7ed5197ce3a69e47082256bf1924,5673,Human delay - incubation period,Days,0,4.9,Mean,4.59,5.21,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Ruth,Observed sample statistic,FALSE,90,4,India,Persons under investigation,"Jaipur, Rajasthan",111,Population based,Both,16,Nov,2018,22,Sep,2018,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Urban area,7,Human delay,NA,95% CI,4.59 - 5.21,India,Incubation period,NA,FALSE,NA,NA,NA,22 Sep 2018,16 Nov 2018,22 Sep 2018 - 16 Nov 2018
ef1bd25df7c12e407262f997d20bd655,378a35e5de8495ecf2563b5ed8281899,5673,Human delay - incubation period,Days,0,6,Median,2,10,Range,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Ruth,Observed sample statistic,FALSE,90,4,India,Persons under investigation,"Jaipur, Rajasthan",111,Population based,Both,16,Nov,2018,22,Sep,2018,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Urban area,7,Human delay,NA,Range,2 - 10,India,Incubation period,NA,FALSE,NA,NA,NA,22 Sep 2018,16 Nov 2018,22 Sep 2018 - 16 Nov 2018
a1978ccf8e1d73ae5cf632eaed6080ed,cb6b51ee30e8c2912277c92539d4580f,5675,Reproduction number (Basic R0),No units,0,2.2798,NA,NA,NA,NA,NA,NA,2.1062,2.4443,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Start outbreak,Compartmental model,Shazia Ruybal-Pesantez,Estimated model parameter,FALSE,NA,NA,United States,General population,Puerto Rico,3681000,Unspecified,Unspecified,NA,Dec,2016,NA,Dec,2015,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,1,Reproduction number,2.1062 - 2.4443,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,Dec 2015,Dec 2016,Dec 2015 - Dec 2016
a1978ccf8e1d73ae5cf632eaed6080ed,aae8ac8c537b1f64fcb3e620ec2d1311,5675,"Reproduction number (Effective, Re)",No units,0,NA,NA,NA,NA,NA,NA,NA,0,3.1,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Time,FALSE,FALSE,Start outbreak,Compartmental model,Shazia Ruybal-Pesantez,Estimated model parameter,FALSE,NA,NA,United States,General population,Puerto Rico,3681000,Unspecified,Unspecified,NA,Dec,2016,NA,Dec,2015,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,1,Reproduction number,0 - 3.1,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,Dec 2015,Dec 2016,Dec 2015 - Dec 2016
a759838849ecad6be577edc471b37a98,edefe35ec830a179749cfde258550798,5681,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,13.7,NA,9.4,19.14,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Sex",FALSE,FALSE,Unspecified,NA,Shazia Ruybal-Pesantez,Observed sample statistic,FALSE,29,2,Senegal,NA,Niakhar,NA,NA,Both,NA,Apr,2012,NA,Nov,2011,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,3,Seroprevalence,NA,95% CI,9.4 - 19.14,Senegal,NA,NA,FALSE,NA,NA,NA,Nov 2011,Apr 2012,Nov 2011 - Apr 2012
a759838849ecad6be577edc471b37a98,393816c312c7da39cf4b1aba47eaa183,5681,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,7.1,NA,4.03,11.45,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Sex",FALSE,FALSE,Unspecified,NA,Shazia Ruybal-Pesantez,Observed sample statistic,FALSE,29,2,The Gambia,NA,Basse Santa Su,NA,NA,Both,NA,Apr,2012,NA,Nov,2011,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,3,Seroprevalence,NA,95% CI,4.03 - 11.45,The Gambia,NA,NA,FALSE,NA,NA,NA,Nov 2011,Apr 2012,Nov 2011 - Apr 2012
a759838849ecad6be577edc471b37a98,be2ac4e82993d5b7f8f9151b6f6d6713,5681,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,0.3,NA,0.01,1.9,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Sex",FALSE,FALSE,Unspecified,NA,Shazia Ruybal-Pesantez,Observed sample statistic,FALSE,29,2,Mali,NA,Bamako,NA,NA,Both,NA,Oct,2007,NA,Aug,2007,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,3,Seroprevalence,NA,95% CI,0.01 - 1.9,Mali,NA,NA,FALSE,NA,NA,NA,Aug 2007,Oct 2007,Aug 2007 - Oct 2007
a759838849ecad6be577edc471b37a98,f360b16b9c86d73ce64ea4df3487b320,5681,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,13.4,NA,9.65,17.9,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Sex",FALSE,FALSE,Unspecified,NA,Shazia Ruybal-Pesantez,Observed sample statistic,FALSE,29,2,Senegal,NA,Niakhar,NA,NA,Both,NA,Oct,2007,NA,Aug,2007,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,3,Seroprevalence,NA,95% CI,9.65 - 17.9,Senegal,NA,NA,FALSE,NA,NA,NA,Aug 2007,Oct 2007,Aug 2007 - Oct 2007
a759838849ecad6be577edc471b37a98,45169d9511e7f73ed09d898fe38aebf6,5681,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,3.7,NA,1.87,6.55,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Sex",FALSE,FALSE,Unspecified,NA,Shazia Ruybal-Pesantez,Observed sample statistic,FALSE,29,2,The Gambia,NA,Basse Santa Su,NA,NA,Both,NA,Oct,2007,NA,Aug,2007,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,3,Seroprevalence,NA,95% CI,1.87 - 6.55,The Gambia,NA,NA,FALSE,NA,NA,NA,Aug 2007,Oct 2007,Aug 2007 - Oct 2007
a759838849ecad6be577edc471b37a98,6c696f63ba48f1e89912ced2fe9cc3ed,5681,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,0.4,NA,0.01,2.42,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Sex",FALSE,FALSE,Unspecified,NA,Shazia Ruybal-Pesantez,Observed sample statistic,FALSE,29,2,Mali,NA,Bamako,NA,NA,Both,NA,Apr,2012,NA,Nov,2011,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,3,Seroprevalence,NA,95% CI,0.01 - 2.42,Mali,NA,NA,FALSE,NA,NA,NA,Nov 2011,Apr 2012,Nov 2011 - Apr 2012
657281539ada7b28441275e4426784e3,cc7b21b7723c8f4f4245d7f5585a34b8,5694,Seroprevalence - IgG,Percentage (%),0,2.3,Mean,NA,NA,NA,NA,NA,NA,NA,NA,NA,176,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,Observed sample statistic,FALSE,NA,NA,Vietnam,Pregnant women,Ho Chi Minh City,176,Hospital based,Female,NA,Dec,2008,NA,Jan,2008,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,11,Seroprevalence,NA,NA,NA,Vietnam,NA,NA,FALSE,NA,NA,NA,Jan 2008,Dec 2008,Jan 2008 - Dec 2008
3405b2b6d041e6d53b8544cdd45b8299,0c9cd6c1165e8da2b4173f79e25e189a,5695,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,NA,FALSE,NA,NA,Colombia,General population,NA,NA,Population based,NA,NA,Jul,2016,NA,Sep,2015,NA,Adjusted,Other,NA,Infection,Significant,NA,FALSE,NA,NA,52,Risk factors,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,Sep 2015,Jul 2016,Sep 2015 - Jul 2016
3405b2b6d041e6d53b8544cdd45b8299,81606336d19fe2eaa30a80162c586c4d,5695,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,NA,FALSE,NA,NA,Colombia,General population,NA,NA,Population based,NA,NA,Jul,2016,NA,Sep,2015,NA,Adjusted,Other,NA,Infection,Not significant,NA,FALSE,NA,NA,52,Risk factors,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,Sep 2015,Jul 2016,Sep 2015 - Jul 2016
05937ffed6d5e65cc672cb3714dd138d,0c74211b1a5a740ed6f95c0c9d849053,5714,Seroprevalence - IgG,Percentage (%),0,5.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Shazia Ruybal-Pesantez,Observed sample statistic,FALSE,63,18,Republic of the Congo,Blood donors,"Brazzaville, Pointe-Noire, Ewo, Gamboma, Oyo, Owando",386,Other,Both,NA,Jul,2011,NA,Mar,2011,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Both urban and rural areas,6,Seroprevalence,NA,NA,NA,Republic of the Congo,NA,NA,FALSE,NA,NA,NA,Mar 2011,Jul 2011,Mar 2011 - Jul 2011
05937ffed6d5e65cc672cb3714dd138d,57bee67ee473739a8a1ff9d6155d85cc,5714,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,1.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Shazia Ruybal-Pesantez,Observed sample statistic,FALSE,63,18,Republic of the Congo,Blood donors,"Brazzaville, Pointe-Noire, Ewo, Gamboma, Oyo, Owando",386,Other,Both,NA,Jul,2011,NA,Mar,2011,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Both urban and rural,6,Seroprevalence,NA,NA,NA,Republic of the Congo,NA,NA,TRUE,NA,NA,NA,Mar 2011,Jul 2011,Mar 2011 - Jul 2011
05937ffed6d5e65cc672cb3714dd138d,3bb18047d04b674afcfc12170f05eeb2,5714,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,1.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Shazia Ruybal-Pesantez,Observed sample statistic,FALSE,NA,NA,Republic of the Congo,Blood donors,Brazzaville,NA,Other,NA,NA,Jul,2011,NA,Mar,2011,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Urban,6,Seroprevalence,NA,NA,NA,Republic of the Congo,NA,NA,TRUE,NA,NA,NA,Mar 2011,Jul 2011,Mar 2011 - Jul 2011
05937ffed6d5e65cc672cb3714dd138d,9d4b74cff026d505908f2e066982874b,5714,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,3.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Shazia Ruybal-Pesantez,Observed sample statistic,FALSE,NA,NA,Republic of the Congo,Blood donors,Pointe-Noir,NA,Other,NA,NA,Jul,2011,NA,Mar,2011,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Urban,6,Seroprevalence,NA,NA,NA,Republic of the Congo,NA,NA,TRUE,NA,NA,NA,Mar 2011,Jul 2011,Mar 2011 - Jul 2011
bc17bac336475b498f1590a7abb93d8b,a1b51b336ba79c387604492a4618108a,5715,Seroprevalence - IgG,Percentage (%),0,94,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,187,Naive,176,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,End outbreak,NA,Christian,Observed sample statistic,FALSE,NA,NA,Nicaragua,Pregnant women,León,187,Hospital based,Female,NA,Jul,2017,NA,Feb,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,53,Seroprevalence,NA,NA,NA,Nicaragua,NA,NA,FALSE,NA,NA,NA,Feb 2017,Jul 2017,Feb 2017 - Jul 2017
bc17bac336475b498f1590a7abb93d8b,d404c25d30e5b5d9a6196e3fc21a49f6,5715,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,61,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,176,Adjusted,107,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,End outbreak,NA,Christian,Observed sample statistic,FALSE,NA,NA,Nicaragua,Pregnant women,León,176,Hospital based,Female,NA,Jul,2017,NA,Feb,2017,NA,NA,NA,NA,NA,NA,Adjusted,FALSE,NA,NA,53,Seroprevalence,NA,NA,NA,Nicaragua,NA,NA,TRUE,NA,NA,NA,Feb 2017,Jul 2017,Feb 2017 - Jul 2017
bc17bac336475b498f1590a7abb93d8b,839d717c0421c3e91e2f8fda73d22fbd,5715,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,End outbreak,NA,Christian,NA,FALSE,0,0,Nicaragua,Children,León,194,Hospital based,Unspecified,NA,Jul,2017,NA,Feb,2017,NA,Unspecified,Infection;Infection during pregnancy;Other,NA,Zika congenital syndrome/other birth defects,Not significant,NA,FALSE,NA,NA,53,Risk factors,NA,NA,NA,Nicaragua,NA,NA,FALSE,NA,NA,NA,Feb 2017,Jul 2017,Feb 2017 - Jul 2017
5dcbd2b935f18dbe020d269c63037a80,d320c903a44d5efc17a6cec52633c46f,5720,Seroprevalence - IFA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,196,Naive,5,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,NA,FALSE,NA,NA,Hungary,General population,NA,196,Travel based,Both,NA,NA,2016,NA,NA,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,17,Seroprevalence,NA,NA,NA,Hungary,NA,NA,FALSE,NA,NA,NA,2016,2016,2016
5dcbd2b935f18dbe020d269c63037a80,aaa731b1e2873c44b4e6684419e5c3b5,5720,Seroprevalence - IFA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,219,Naive,1,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,NA,FALSE,NA,NA,Hungary,General population,NA,219,Travel based,Both,NA,NA,2017,NA,NA,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,17,Seroprevalence,NA,NA,NA,Hungary,NA,NA,FALSE,NA,NA,NA,2017,2017,2017
5dcbd2b935f18dbe020d269c63037a80,5a78c8dbbd26ab7bde9b9757cb2a0929,5720,Seroprevalence - IFA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,188,Naive,1,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,NA,FALSE,NA,NA,Hungary,General population,NA,188,Travel based,Both,NA,NA,2018,NA,NA,2018,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,17,Seroprevalence,NA,NA,NA,Hungary,NA,NA,FALSE,NA,NA,NA,2018,2018,2018
bb1c151a434e6d16c9ab0bc3dab129c2,9378a255028b6b8ce2a2dbfe48ca3d5b,5760,Seroprevalence - IgG,Percentage (%),0,30.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,955,Naive,290,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,12,5,Thailand,Children,"Ratchaburi, Bangkok",955,School based,Both,NA,NA,2009,NA,NA,2006,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Both urban and rural areas,60,Seroprevalence,NA,NA,NA,Thailand,NA,NA,FALSE,NA,NA,NA,2006,2009,2006 - 2009
8d2909971dd3996acf6d4241f8996bae,edec4b837291a7049d966ece6d1ab47e,5775,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Christian,NA,FALSE,39,15,Brazil,Other,Fortaleza,1289,Community based,Female,NA,Dec,2018,NA,Feb,2018,NA,Unspecified,Other,NA,Infection,Significant,NA,FALSE,NA,NA,61,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Feb 2018,Dec 2018,Feb 2018 - Dec 2018
8d2909971dd3996acf6d4241f8996bae,49409c9db297e174911eec4c1873a921,5775,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Christian,NA,FALSE,39,15,Brazil,Other,Fortaleza,1289,Community based,Female,NA,Dec,2018,NA,Feb,2018,NA,Unspecified,Other,NA,Serology,Significant,NA,FALSE,NA,NA,61,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Feb 2018,Dec 2018,Feb 2018 - Dec 2018
8d2909971dd3996acf6d4241f8996bae,3ea90652f32bed2af3f1fb80fd96a5b8,5775,Seroprevalence - IgM,Percentage (%),0,2.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,41,naïve,1,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Christian,Observed sample statistic,FALSE,39,15,Brazil,Other,Fortaleza,1289,Community based,Female,NA,Dec,2018,NA,Feb,2018,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,61,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Feb 2018,Dec 2018,Feb 2018 - Dec 2018
38a8a84ebd4c02fae711f7325941239d,ae6aea4d2dbf0501cf56b3ef6bc0d063,5826,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,NA,FALSE,NA,NA,United States,Mixed groups,NA,NA,Mixed settings,Both,NA,NA,2017,NA,NA,2016,NA,Unspecified,Sex,NA,Infection,Unspecified,NA,FALSE,NA,NA,49,Risk factors,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,2016,2017,2016 - 2017
8b987fff4d8cb1d3ac3fb015b29709ef,423cf241ff12ea3bb9a6677f5562861d,5845,Seroprevalence - Neutralisation/PRNT,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,29,Adjusted,4,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,NA,FALSE,NA,NA,India,Persons under investigation,NA,29,Unspecified,Unspecified,NA,Oct,2021,NA,May,2021,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,NA,NA,35,Seroprevalence,NA,NA,NA,India,NA,NA,FALSE,NA,NA,NA,May 2021,Oct 2021,May 2021 - Oct 2021
2d43e5304527700fb246af5bc46ec7f5,f384c92cbe2576f14ebf68ce7178ed6f,5846,Seroprevalence - NS1 BOB ELISA,Percentage (%),0,7.6,NA,6.1,9.3,95% CI,NA,NA,NA,NA,NA,Lab confirmed,1085,Naive,82,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Other, Sex",FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,Malaysia,Mixed groups,Kuala Lumpur,1085,Mixed settings,Both,NA,NA,2017,NA,NA,2012,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Urban area,48,Seroprevalence,NA,95% CI,6.1 - 9.3,Malaysia,NA,NA,FALSE,NA,NA,NA,2012,2017,2012 - 2017
2d43e5304527700fb246af5bc46ec7f5,1f71b0641d2cb098e22e01282725168d,5846,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,3.3,NA,2.4,4.6,95% CI,NA,NA,NA,NA,NA,Lab confirmed,82,Adjusted,36,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,Malaysia,Mixed groups,Kuala Lumpur,1085,Mixed settings,Both,NA,NA,2017,NA,NA,2012,NA,NA,NA,NA,NA,NA,Adjusted,FALSE,NA,Urban area,48,Seroprevalence,NA,95% CI,2.4 - 4.6,Malaysia,NA,NA,TRUE,NA,NA,NA,2012,2017,2012 - 2017
2d43e5304527700fb246af5bc46ec7f5,2098092f50412417128201585b802865,5846,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,NA,FALSE,NA,NA,Malaysia,Mixed groups,Kuala Lumpur,1085,Mixed settings,Both,NA,NA,2017,NA,NA,2012,NA,Adjusted,Age;Sex,NA,Serology,Significant,NA,FALSE,NA,Urban area,48,Risk factors,NA,NA,NA,Malaysia,NA,NA,FALSE,NA,NA,NA,2012,2017,2012 - 2017
2d43e5304527700fb246af5bc46ec7f5,5488ac6f2a801d78a9159a10fb12d25b,5846,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,NA,FALSE,NA,NA,Malaysia,Mixed groups,Kuala Lumpur,1085,Mixed settings,Both,NA,NA,2017,NA,NA,2012,NA,Adjusted,Other,NA,Serology,Not significant,NA,FALSE,NA,Urban area,48,Risk factors,NA,NA,NA,Malaysia,NA,NA,FALSE,NA,NA,NA,2012,2017,2012 - 2017
873af5932ed20a04856c02b4deeb3cd6,9d23eabd0aa942037ccd4ea800207541,5863,Seroprevalence - IgG,Percentage (%),0,64.9,NA,NA,NA,NA,NA,NA,64.9,82.3,NA,Lab confirmed,328,naïve,213,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,47,16,Colombia,Mixed groups,Santander,328,School based,Both,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,54,Seroprevalence,64.9 - 82.3,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
873af5932ed20a04856c02b4deeb3cd6,61475b50d73bcee3be21c2cc28a17dda,5863,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,NA,FALSE,47,16,Colombia,Mixed groups,Santander,328,School based,Both,NA,NA,NA,NA,NA,NA,NA,Unspecified,Age;Other;Sex,NA,Serology,Not significant,NA,FALSE,NA,NA,54,Risk factors,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
873af5932ed20a04856c02b4deeb3cd6,a4b684dd63e93ea45715f3b1ba7d23d5,5863,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,NA,FALSE,47,16,Colombia,Mixed groups,Santander,328,School based,Both,NA,NA,NA,NA,NA,NA,NA,Unspecified,Infection,NA,Serology,Significant,NA,FALSE,NA,NA,54,Risk factors,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
ef237b3212679a44f6c9184f32f080eb,59584ebbbc9648e48059f4c086018dcc,5870,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,NA,FALSE,NA,NA,Philippines,Persons under investigation,NA,997,Population based,Both,NA,NA,2016,NA,NA,2016,NA,Not adjusted,Prior immunity to arboviruses,NA,Severe disease (in general population),Not significant,NA,FALSE,NA,Both urban and rural areas,19,Risk factors,NA,NA,NA,Philippines,NA,NA,FALSE,NA,NA,NA,2016,2016,2016
ef237b3212679a44f6c9184f32f080eb,c99956e86d93f60740a0630063700044,5870,Seroprevalence - IgG,Percentage (%),0,31.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,997,Adjusted,314,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Estimated model parameter,FALSE,NA,NA,Philippines,Persons under investigation,NA,997,Population based,Both,NA,NA,2016,NA,NA,2016,NA,NA,NA,NA,NA,NA,Adjusted,FALSE,NA,Both urban and rural areas,19,Seroprevalence,NA,NA,NA,Philippines,NA,NA,FALSE,NA,NA,NA,2016,2016,2016
ef237b3212679a44f6c9184f32f080eb,59e477d815710737ccd8f22b7988f0ec,5870,Attack rate,Percentage (%),0,5.5,Mean,3,10.4,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Estimated model parameter,FALSE,NA,NA,Philippines,General population,NA,997,Population based,Both,NA,NA,2016,NA,NA,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Both urban and rural areas,19,Attack rate,NA,95% CI,3 - 10.4,Philippines,NA,NA,FALSE,NA,NA,NA,2016,2016,2016
795ba49714310ecaf978039dddb0eb5f,606c5489e3822b6e23f6e79ace0d9b86,5888,Human delay - latent period (inverse parameter),Per day,0,0.0686,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,TRUE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,Estimated model parameter,FALSE,NA,NA,Colombia,Unspecified,NA,NA,Unspecified,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,1,Human delay,NA,NA,NA,Colombia,Latent period,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
795ba49714310ecaf978039dddb0eb5f,7868953032e896f67d08a19d22ece8e5,5888,Human delay - infectious period (inverse parameter),Per day,0,0.0228,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,TRUE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,Estimated model parameter,FALSE,NA,NA,Unspecified,Unspecified,NA,NA,Unspecified,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,1,Human delay,NA,NA,NA,NA,Infectious period,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
795ba49714310ecaf978039dddb0eb5f,6a0f0ad45ac4af1aaeb27a08b2dcfd4b,5888,Human delay - Recovery/non-Infectiousness to Susceptibility (inverse parameter),Per day,0,0.054,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,TRUE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,Estimated model parameter,FALSE,NA,NA,Unspecified,Unspecified,NA,NA,Unspecified,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,1,Human delay,NA,NA,NA,NA,Recovery/non-infectiousness to susceptibility,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
1fe4329d747a9fdde0313120e049797e,e81e0c169e32c2e7b195202ec81f85c3,5890,Seroprevalence - IgM,Percentage (%),0,10,Mean,3.8,20.1,95% CI,NA,NA,NA,NA,NA,Lab confirmed,100,Naive,10,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,78,1,Nigeria,Persons under investigation,Cross River State,100,Population based,Both,30,May,2017,17,Mar,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Both urban and rural areas,21,Seroprevalence,NA,95% CI,3.8 - 20.1,Nigeria,NA,NA,FALSE,NA,NA,NA,17 Mar 2017,30 May 2017,17 Mar 2017 - 30 May 2017
1fe4329d747a9fdde0313120e049797e,4d59ab68960fd7c71789b3091beade3c,5890,Seroprevalence - IgG,Percentage (%),0,12,Mean,9.9,14.4,95% CI,NA,NA,NA,NA,NA,Lab confirmed,100,Naive,12,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,78,1,Nigeria,Persons under investigation,Cross River State,100,Population based,Both,30,May,2017,17,Mar,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Both urban and rural areas,21,Seroprevalence,NA,95% CI,9.9 - 14.4,Nigeria,NA,NA,FALSE,NA,NA,NA,17 Mar 2017,30 May 2017,17 Mar 2017 - 30 May 2017
1fe4329d747a9fdde0313120e049797e,6e2016b2115d1ac528967787737c3da0,5890,Seroprevalence - IgG and IgM,Percentage (%),0,20,Mean,11.9,30.2,95% CI,NA,NA,NA,NA,NA,Lab confirmed,100,Naive,20,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,78,1,Nigeria,Persons under investigation,Cross River State,100,Population based,Both,30,May,2017,17,Mar,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Both urban and rural areas,21,Seroprevalence,NA,95% CI,11.9 - 30.2,Nigeria,NA,NA,FALSE,NA,NA,NA,17 Mar 2017,30 May 2017,17 Mar 2017 - 30 May 2017
1fe4329d747a9fdde0313120e049797e,8c1153427f368681c00a6b82888daaac,5890,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,NA,FALSE,78,1,Nigeria,Persons under investigation,Cross River State,100,Population based,Both,30,May,2017,17,Mar,2017,NA,Adjusted,Age;Other;Sex,NA,Serology,Not significant,NA,FALSE,NA,Both urban and rural areas,21,Risk factors,NA,NA,NA,Nigeria,NA,NA,FALSE,NA,NA,NA,17 Mar 2017,30 May 2017,17 Mar 2017 - 30 May 2017
1fe4329d747a9fdde0313120e049797e,beb6b7a80c75e9dc05b04483b75ef53e,5890,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,NA,FALSE,78,1,Nigeria,Persons under investigation,Cross River State,100,Population based,Both,30,May,2017,17,Mar,2017,NA,Adjusted,Other,NA,Serology,Significant,NA,FALSE,NA,Both urban and rural areas,21,Risk factors,NA,NA,NA,Nigeria,NA,NA,FALSE,NA,NA,NA,17 Mar 2017,30 May 2017,17 Mar 2017 - 30 May 2017
11e9ced5eb3932dc70ad215e583ecfe9,19367210739c715d1a42352ef8afa729,5892,Mosquito delay - extrinsic incubation period,Days,0,8.88,Mean,8,10,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,TRUE,Unspecified,NA,Tristan Naidoo,Estimated model parameter,FALSE,NA,NA,Unspecified,Other,NA,NA,Unspecified,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,15,Mosquito,NA,95% CrI,8 - 10,NA,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
11e9ced5eb3932dc70ad215e583ecfe9,afc83eb1bd9c75739f0ce7fb50041e16,5892,Mosquito delay - extrinsic incubation period,Days,0,7.33,Mean,6,9,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,TRUE,Unspecified,NA,Tristan Naidoo,Estimated model parameter,FALSE,NA,NA,Unspecified,Other,NA,NA,Unspecified,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,15,Mosquito,NA,95% CrI,6 - 9,NA,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
11e9ced5eb3932dc70ad215e583ecfe9,363ea1edba1761c73c37a5e46dcaded8,5892,Reproduction number (Basic R0) - Vector-borne,No units,0,2.96,Mean,2.58,3.39,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Ross-Macdonald formula,Tristan Naidoo,Estimated model parameter,FALSE,NA,NA,Unspecified,Other,NA,NA,Unspecified,Unspecified,NA,NA,NA,NA,NA,NA,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,15,Reproduction number,NA,95% CrI,2.58 - 3.39,NA,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
11e9ced5eb3932dc70ad215e583ecfe9,704ccfb6f2043c41a781f3e07623bf78,5892,Reproduction number (Basic R0) - Vector-borne,No units,0,4.05,Mean,3.22,5.17,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Ross-Macdonald formula,Tristan Naidoo,Estimated model parameter,FALSE,NA,NA,Unspecified,Other,NA,NA,Unspecified,Unspecified,NA,NA,NA,NA,NA,NA,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,15,Reproduction number,NA,95% CrI,3.22 - 5.17,NA,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
6ff7609e9e650f743446789291db2650,1f54f738f865df56788b472e0191ba61,5895,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,End outbreak,NA,Christian,NA,FALSE,60,NA,Vietnam,Mixed groups,Krong Buk,801,Community based,Both,NA,Jul,2018,NA,Jan,2017,NA,Unspecified,Age,NA,Serology,Significant,NA,FALSE,NA,NA,59,Risk factors,NA,NA,NA,Vietnam,NA,NA,FALSE,NA,NA,NA,Jan 2017,Jul 2018,Jan 2017 - Jul 2018
6ff7609e9e650f743446789291db2650,d19b8788d2763eee465cd7796fe82791,5895,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,End outbreak,NA,Christian,NA,FALSE,60,NA,Vietnam,Mixed groups,Krong Buk,801,Community based,Both,NA,Jul,2018,NA,Jan,2017,NA,Unspecified,Other;Sex,NA,Serology,Not significant,NA,FALSE,NA,NA,59,Risk factors,NA,NA,NA,Vietnam,NA,NA,FALSE,NA,NA,NA,Jan 2017,Jul 2018,Jan 2017 - Jul 2018
6ff7609e9e650f743446789291db2650,1a7e27a131f0cbb91fe7fe543f2d5e97,5895,Seroprevalence - IgM,Percentage (%),0,10.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,801,Naive,83,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Other",FALSE,FALSE,End outbreak,NA,Christian,Observed sample statistic,FALSE,60,NA,Vietnam,Mixed groups,Krong Buk,801,Community based,Both,NA,Jul,2018,NA,Jan,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,59,Seroprevalence,NA,NA,NA,Vietnam,NA,NA,FALSE,NA,NA,NA,Jan 2017,Jul 2018,Jan 2017 - Jul 2018
6ff7609e9e650f743446789291db2650,1670127c71cc94c54ed1b381e7805735,5895,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,1.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,83,Adjusted,9,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Other",FALSE,FALSE,End outbreak,NA,Christian,Observed sample statistic,FALSE,60,NA,Vietnam,Mixed groups,Krong Buk,801,Community based,Both,NA,Jul,2018,NA,Jan,2017,NA,NA,NA,NA,NA,NA,Adjusted,FALSE,NA,NA,59,Seroprevalence,NA,NA,NA,Vietnam,NA,NA,TRUE,NA,NA,NA,Jan 2017,Jul 2018,Jan 2017 - Jul 2018
1cebbd872717c9772e75631db4eae1d2,da7236b5c77b5820473d9951d34059fd,5905,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,FALSE,FALSE,Unspecified,NA,Shazia Ruybal-Pesantez,NA,FALSE,NA,NA,Brazil,Children,Rio de Janeiro,163,Other,Both,NA,Sep,2017,NA,Feb,2016,NA,Adjusted,Other,Other,Microcephaly,Significant,NA,FALSE,NA,NA,8,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Feb 2016,Sep 2017,Feb 2016 - Sep 2017
1cebbd872717c9772e75631db4eae1d2,99c573cadfff39a98bfe9659229cb954,5905,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,FALSE,FALSE,Unspecified,NA,Shazia Ruybal-Pesantez,NA,FALSE,NA,NA,Brazil,Children,Rio de Janeiro,163,Other,Both,NA,Sep,2017,NA,Feb,2016,NA,Not adjusted,Other,NA,Microcephaly,Significant,NA,FALSE,NA,NA,8,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Feb 2016,Sep 2017,Feb 2016 - Sep 2017
1cebbd872717c9772e75631db4eae1d2,15eeb67465c67d81ad73bc81a15f94d4,5905,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,FALSE,FALSE,Unspecified,NA,Shazia Ruybal-Pesantez,NA,FALSE,NA,NA,Brazil,Children,Rio de Janeiro,163,Other,Both,NA,Sep,2017,NA,Feb,2016,NA,Adjusted,Other,NA,Microcephaly,Not significant,NA,FALSE,NA,NA,8,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Feb 2016,Sep 2017,Feb 2016 - Sep 2017
1cebbd872717c9772e75631db4eae1d2,bc408a1b3247ebe7165fa5b573907fe2,5905,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,FALSE,FALSE,Unspecified,NA,Shazia Ruybal-Pesantez,NA,FALSE,NA,NA,Brazil,Children,Rio de Janeiro,163,Other,Both,NA,Sep,2017,NA,Feb,2016,NA,Not adjusted,Occupation;Other,NA,Microcephaly,Not significant,NA,FALSE,NA,NA,8,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Feb 2016,Sep 2017,Feb 2016 - Sep 2017
1cebbd872717c9772e75631db4eae1d2,5825e85232117ab7f66e3aa11ff93499,5905,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,FALSE,FALSE,Unspecified,NA,Shazia Ruybal-Pesantez,NA,FALSE,NA,NA,Brazil,Children,Rio de Janeiro,163,Other,Both,NA,Sep,2017,NA,Feb,2016,NA,Adjusted,Other,NA,Other,Significant,NA,FALSE,NA,NA,8,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Feb 2016,Sep 2017,Feb 2016 - Sep 2017
1cebbd872717c9772e75631db4eae1d2,2245e8ad2682128350d2adf8d48646e1,5905,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,FALSE,FALSE,Unspecified,NA,Shazia Ruybal-Pesantez,NA,FALSE,NA,NA,Brazil,Children,Rio de Janeiro,163,Other,Both,NA,Sep,2017,NA,Feb,2016,NA,Adjusted,Other,NA,Other,Not significant,NA,FALSE,NA,NA,8,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Feb 2016,Sep 2017,Feb 2016 - Sep 2017
d9a73b9d096d5f738f9c28324a82e100,a8e1c1532c8f9d5c7b4f8655be2fb51a,5907,Mutations - evolutionary rate,Substitutions/site/year,-4,8.65,Central,NA,NA,NA,NA,NA,NA,NA,Whole genome sequence,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Estimated model parameter,FALSE,NA,NA,"Multi-country: Americas, Oceania",Unspecified,Americas and Oceania,360,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,22,Mutations,NA,NA,NA,"Multi-country: Americas, Oceania",NA,Asian lineage,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
864fa3a17a8c2d012eeeb1fc67d47229,45ba1a87a6a7e274ae31be59af4d6825,5908,Mutations - substitution rate,Substitutions/site/year,-4,8,Mean,6.4,9.7,HPDI 95%,NA,NA,NA,NA,Whole genome sequence,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Estimated model parameter,FALSE,NA,NA,"Multi-country: Africa (n = 4), Americas (n = 14), Asia (n = 5), Oceania (n = 3)",Unspecified,NA,135,Unspecified,NA,NA,NA,2016,NA,NA,1947,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,23,Mutations,NA,HPDI 95%,6.4 - 9.7,"Central African Republic, Nigeria, Senegal, Uganda, Malaysia, Cambodia, Thailand, Singapore, French Polynesia, Mexico, Honduras, Guatemala, Panama, Venezuela, Colombia, Ecuador, Brazil, Suriname, American Samoa, Tonga, the Philippines, Micronesia, Puerto Rico, Haiti, Dominican Republic, Martinique, Cuba",NA,NA,FALSE,NA,NA,NA,1947,2016,1947 - 2016
d27ef772cae9d3189f9c0cbeef120703,f04494ca35afaa8ca21514b48acf2fcc,5921,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,FALSE,FALSE,Unspecified,NA,Shazia Ruybal-Pesantez,NA,FALSE,NA,NA,Brazil,Children,Rio de Janeiro,143,Other,Both,NA,NA,NA,NA,Dec,2015,NA,Adjusted,Other,NA,Zika congenital syndrome/other birth defects,Significant,NA,FALSE,NA,NA,9,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Dec 2015,Unspecified,Dec 2015 - Unspecified
d27ef772cae9d3189f9c0cbeef120703,36cbd676bec7bbb92604f903b8de43c7,5921,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,FALSE,FALSE,Unspecified,NA,Shazia Ruybal-Pesantez,NA,FALSE,NA,NA,Brazil,Children,Rio de Janeiro,143,Other,Both,NA,NA,NA,NA,Dec,2015,NA,Adjusted,Other,NA,Zika congenital syndrome/other birth defects,Not significant,NA,FALSE,NA,NA,9,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Dec 2015,Unspecified,Dec 2015 - Unspecified
d27ef772cae9d3189f9c0cbeef120703,5b7211d14d23588a35384d0b394bd77a,5921,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,FALSE,FALSE,Unspecified,NA,Shazia Ruybal-Pesantez,NA,FALSE,NA,NA,Brazil,Children,Rio de Janeiro,143,Other,Both,NA,NA,NA,NA,Dec,2015,NA,Not adjusted,Other,NA,Zika congenital syndrome/other birth defects,Not significant,NA,FALSE,NA,NA,9,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Dec 2015,Unspecified,Dec 2015 - Unspecified
b4b63ff7dfd39e4c19599990f44c7051,cbb68172036497c6873d4bc4b96ba4e0,5922,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Shazia Ruybal-Pesantez,NA,FALSE,2,0,Nicaragua,Children,León,129,Other,Both,NA,Jul,2017,NA,Feb,2017,NA,Adjusted,Infection during pregnancy;Other,NA,Other neurological symptoms in general population,Significant,NA,FALSE,Post-partum,NA,10,Risk factors,NA,NA,NA,Nicaragua,NA,NA,FALSE,NA,NA,NA,Feb 2017,Jul 2017,Feb 2017 - Jul 2017
b4b63ff7dfd39e4c19599990f44c7051,9de02f3eae520a2aad75675f1e0d0c5f,5922,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Shazia Ruybal-Pesantez,NA,FALSE,2,0,Nicaragua,Children,León,129,Other,Both,NA,Jul,2017,NA,Feb,2017,NA,Not adjusted,Infection during pregnancy,NA,Other neurological symptoms in general population,Significant,NA,FALSE,Post-partum,NA,10,Risk factors,NA,NA,NA,Nicaragua,NA,NA,FALSE,NA,NA,NA,Feb 2017,Jul 2017,Feb 2017 - Jul 2017
b4b63ff7dfd39e4c19599990f44c7051,85e79995d1589b55c5949230705bfd75,5922,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Shazia Ruybal-Pesantez,NA,FALSE,2,0,Nicaragua,Children,León,129,Other,Both,NA,Jul,2017,NA,Feb,2017,NA,Adjusted,Age;Other;Sex,NA,Other neurological symptoms in general population,Not significant,NA,FALSE,Post-partum,NA,10,Risk factors,NA,NA,NA,Nicaragua,NA,NA,FALSE,NA,NA,NA,Feb 2017,Jul 2017,Feb 2017 - Jul 2017
b4b63ff7dfd39e4c19599990f44c7051,f4efd93aa78098252db044c2959d12e3,5922,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Shazia Ruybal-Pesantez,NA,FALSE,2,0,Nicaragua,Children,León,129,Other,Both,NA,Jul,2017,NA,Feb,2017,NA,Not adjusted,Age;Other,NA,Other neurological symptoms in general population,Not significant,NA,FALSE,Post-partum,NA,10,Risk factors,NA,NA,NA,Nicaragua,NA,NA,FALSE,NA,NA,NA,Feb 2017,Jul 2017,Feb 2017 - Jul 2017
ea3eda49f3caad2eaeb365cb8728e09f,39eceaf1e32c3f68841166377dd17f32,5927,Seroprevalence - IgG,Percentage (%),0,15.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,350,NA,53,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Time",FALSE,FALSE,Post outbreak,NA,Shazia Ruybal-Pesantez,NA,FALSE,50,5,Thailand,General population,Samut Songkhram,350,Population based,Both,NA,Apr,2018,NA,Apr,2017,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,11,Seroprevalence,NA,NA,NA,Thailand,NA,NA,FALSE,NA,NA,NA,Apr 2017,Apr 2018,Apr 2017 - Apr 2018
ea3eda49f3caad2eaeb365cb8728e09f,45d57bbf900936501ddba7705baeaebc,5927,Seroprevalence - IgG,Percentage (%),0,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,73,NA,8,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Shazia Ruybal-Pesantez,NA,FALSE,15,5,Thailand,General population,Samut Songkhram,73,Population based,Both,NA,Apr,2018,NA,Apr,2017,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,11,Seroprevalence,NA,NA,NA,Thailand,NA,NA,FALSE,NA,NA,NA,Apr 2017,Apr 2018,Apr 2017 - Apr 2018
ea3eda49f3caad2eaeb365cb8728e09f,a8bb73b032723583af697fc276f1b237,5927,Seroprevalence - IgG,Percentage (%),0,13.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,97,NA,13,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Shazia Ruybal-Pesantez,NA,FALSE,30,16,Thailand,General population,Samut Songkhram,97,Population based,Both,NA,Apr,2018,NA,Apr,2017,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,11,Seroprevalence,NA,NA,NA,Thailand,NA,NA,FALSE,NA,NA,NA,Apr 2017,Apr 2018,Apr 2017 - Apr 2018
ea3eda49f3caad2eaeb365cb8728e09f,0e13a806b7af3ec19a26d2112e6551e4,5927,Seroprevalence - IgG,Percentage (%),0,17.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,180,NA,32,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Shazia Ruybal-Pesantez,NA,FALSE,50,31,Thailand,General population,Samut Songkhram,180,Population based,Both,NA,Apr,2018,NA,Apr,2017,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,11,Seroprevalence,NA,NA,NA,Thailand,NA,NA,FALSE,NA,NA,NA,Apr 2017,Apr 2018,Apr 2017 - Apr 2018
b107392f571ab6b68b34f8a07a49afb8,41f02fd2b1bdf88dd32b4c06d0179ebf,5949,Attack rate,"Per 10,000 population",0,NA,Unspecified,0.897,21.548,95% CI,NA,NA,0.897,21.16,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Region,TRUE,TRUE,Mid outbreak,NA,Tristan Naidoo,Observed sample statistic,FALSE,NA,NA,Dominican Republic,General population,All municipalities,NA,Population based,Both,NA,NA,2016,NA,NA,2014,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,16,Attack rate,0.897 - 21.16,95% CI,0.897 - 21.548,Dominican Republic,NA,NA,FALSE,NA,NA,NA,2014,2016,2014 - 2016
c7d612892ae941250c2c45cec40e1a36,b27c50fa4f83122832961e295e59ebea,5951,Seroprevalence - IgM,Percentage (%),0,0,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,132,NA,0,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Tristan Naidoo,NA,FALSE,NA,NA,Brazil,Pregnant women,Recife,132,Population based,Female,NA,NA,2017,NA,NA,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,14,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,2016,2017,2016 - 2017
c7d612892ae941250c2c45cec40e1a36,51835091c59bc8ebe8dc81a7b4015488,5951,Seroprevalence - IgG,Percentage (%),0,61.3,Unspecified,52.9,69.7,95% CI,NA,NA,NA,NA,NA,NA,132,NA,81,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Tristan Naidoo,NA,FALSE,NA,NA,Brazil,Pregnant women,Recife,132,Population based,Female,NA,NA,2017,NA,NA,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,14,Seroprevalence,NA,95% CI,52.9 - 69.7,Brazil,NA,NA,FALSE,NA,NA,NA,2016,2017,2016 - 2017
c7d612892ae941250c2c45cec40e1a36,21ea2bafaffc1e68b5c057f2918450b0,5951,Seroprevalence - IgG,Percentage (%),0,0,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,132,NA,1,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Tristan Naidoo,NA,FALSE,NA,NA,Brazil,Children,Recife,132,Population based,Unspecified,NA,NA,2017,NA,NA,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,14,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,2016,2017,2016 - 2017
a70224381775a2acb492d751a2b08825,7c34bdc6e875f71c14d5a2d50589c75e,5952,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,Method,TRUE,FALSE,Unspecified,NA,Tristan Naidoo,NA,FALSE,NA,NA,Brazil,General population,Rio de Janeiro,NA,Population based,Unspecified,NA,NA,2016,NA,NA,2015,NA,Adjusted,Other,NA,Infection,Significant,NA,FALSE,NA,NA,4,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,2015,2016,2015 - 2016
a70224381775a2acb492d751a2b08825,bf41556e72cbfd7ab2e4897d67891700,5952,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,Method,TRUE,FALSE,Unspecified,NA,Tristan Naidoo,NA,FALSE,NA,NA,Brazil,General population,Rio de Janeiro,NA,Population based,Unspecified,NA,NA,2016,NA,NA,2015,NA,Adjusted,Other,NA,Infection,Not significant,NA,FALSE,NA,NA,4,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,2015,2016,2015 - 2016
0170f84b3c5f5901db82e3eaf223fab1,b421cef2b56d100081deef71ed19cf12,5961,Reproduction number (Basic R0) - Sexual,No units,0,1.519,Unspecified,1.508,1.531,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,Unspecified,Thomas Rawson,Estimated model parameter,FALSE,NA,NA,Costa Rica,General population,NA,10234,Population based,Both,NA,Dec,2017,NA,Jan,2016,Other,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,25,Reproduction number,NA,95% CI,1.508 - 1.531,Costa Rica,NA,NA,FALSE,NA,NA,NA,Jan 2016,Dec 2017,Jan 2016 - Dec 2017
befa429853b444317722a09e2a6467d3,b07b40fced0630345d2d7dd1950a8e0d,5971,Seroprevalence - IgM,Percentage (%),0,23.3,Unspecified,0,62,95% CI,NA,NA,0,45.6,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Region,FALSE,FALSE,Post outbreak,NA,Tristan Naidoo,Observed sample statistic,FALSE,75,2,France,General population,22 municipalities of French Guiana,2697,Population based,Both,NA,Oct,2017,NA,Jun,2017,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Both urban and rural areas,6,Seroprevalence,0 - 45.6,95% CI,0 - 62,France,NA,NA,FALSE,NA,NA,NA,Jun 2017,Oct 2017,Jun 2017 - Oct 2017
befa429853b444317722a09e2a6467d3,2d1af6a44a2f8b78b2f0060e5b046f5b,5971,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Tristan Naidoo,NA,FALSE,75,2,France,General population,22 municipalities of French Guiana,2697,Population based,Both,NA,Oct,2017,NA,Jun,2017,NA,Not adjusted,Age;Other;Sex,NA,Serology,Not significant,NA,FALSE,NA,Both urban and rural areas,6,Risk factors,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,Jun 2017,Oct 2017,Jun 2017 - Oct 2017
befa429853b444317722a09e2a6467d3,7ad4b31ed8fcaa38d9ce25e153c2a108,5971,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Tristan Naidoo,NA,FALSE,75,2,France,General population,22 municipalities of French Guiana,2697,Population based,Both,NA,Oct,2017,NA,Jun,2017,NA,Not adjusted,Other,NA,Serology,Significant,NA,FALSE,NA,Both urban and rural areas,6,Risk factors,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,Jun 2017,Oct 2017,Jun 2017 - Oct 2017
1abf8f99ac70cd9ae72b2d29e30174ab,c6ac73e17ba1a6422827b4c893a64f91,6015,Reproduction number (Basic R0) - Sexual,No units,0,1.3176,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Compartmental model,Christian,Estimated model parameter,FALSE,NA,NA,Brazil,General population,NA,NA,Population based,Unspecified,NA,NA,2015,NA,NA,2015,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,21,Reproduction number,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,2015,2015,2015
9ea079327902df3dcaf9cd4fc856329f,92981d669b351f11f4be63a03601da87,6024,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Shazia Ruybal-Pesantez,NA,FALSE,NA,NA,Brazil,Children,Ribeirão Preto,511,Population based,Both,NA,NA,2016,NA,NA,2015,NA,Adjusted,Infection during pregnancy,NA,Zika congenital syndrome/other birth defects,Significant,NA,FALSE,NA,Both urban and rural areas,13,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,2015,2016,2015 - 2016
9ea079327902df3dcaf9cd4fc856329f,99ccc3f2243af3054f632578388a0944,6024,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Shazia Ruybal-Pesantez,NA,FALSE,NA,NA,Brazil,Children,Ribeirão Preto,511,Population based,Both,NA,NA,2016,NA,NA,2015,NA,Adjusted,Infection during pregnancy,NA,Miscarriage/stillbirth,Significant,NA,FALSE,NA,Both urban and rural areas,13,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,2015,2016,2015 - 2016
9ea079327902df3dcaf9cd4fc856329f,89b834191870f2d53d42057228c42632,6024,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Shazia Ruybal-Pesantez,NA,FALSE,NA,NA,Brazil,Children,Ribeirão Preto,511,Population based,Both,NA,NA,2016,NA,NA,2015,NA,Not adjusted,Infection during pregnancy,NA,Zika congenital syndrome/other birth defects,Significant,NA,FALSE,NA,Both urban and rural areas,13,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,2015,2016,2015 - 2016
9ea079327902df3dcaf9cd4fc856329f,ee29ca6da8462d57404e4c69306d059c,6024,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Shazia Ruybal-Pesantez,NA,FALSE,NA,NA,Brazil,Children,Ribeirão Preto,511,Population based,Both,NA,NA,2016,NA,NA,2015,NA,Not adjusted,Infection during pregnancy,NA,Miscarriage/stillbirth,Significant,NA,FALSE,NA,Both urban and rural areas,13,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,2015,2016,2015 - 2016
9b2ae2aa9f7774ac95fe5f22a7d9061b,ff2ed70a6598a4bfccf46c36789f3072,6027,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Thomas Rawson,NA,FALSE,NA,NA,Brazil,Persons under investigation,"Salvador, Bahia",359,Population based,Both,NA,Jul,2016,NA,Aug,2015,NA,Adjusted,Other,NA,Serology,Significant,NA,FALSE,NA,Urban area,26,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Aug 2015,Jul 2016,Aug 2015 - Jul 2016
9b2ae2aa9f7774ac95fe5f22a7d9061b,bf4c2dd46b6f4a91836a6758eb11093d,6027,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Thomas Rawson,NA,FALSE,NA,NA,Brazil,Persons under investigation,"Salvador, Bahia",359,Population based,Both,NA,Jul,2016,NA,Aug,2015,NA,Adjusted,Other,NA,Serology,Not significant,NA,FALSE,NA,Urban area,26,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Aug 2015,Jul 2016,Aug 2015 - Jul 2016
9b2ae2aa9f7774ac95fe5f22a7d9061b,3bffdecc69b0304d5c57aa826d0fe204,6027,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Thomas Rawson,NA,FALSE,NA,NA,Brazil,Persons under investigation,"Salvador, Bahia",359,Population based,Both,NA,Jul,2016,NA,Aug,2015,NA,Not adjusted,Other,NA,Serology,Significant,NA,FALSE,NA,Urban area,26,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Aug 2015,Jul 2016,Aug 2015 - Jul 2016
9b2ae2aa9f7774ac95fe5f22a7d9061b,66163f82afb1134b049b6aebe76295b3,6027,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Thomas Rawson,NA,FALSE,NA,NA,Brazil,Persons under investigation,"Salvador, Bahia",359,Population based,Both,NA,Jul,2016,NA,Aug,2015,NA,Not adjusted,Other,NA,Serology,Not significant,NA,FALSE,NA,Urban area,26,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Aug 2015,Jul 2016,Aug 2015 - Jul 2016
23a9614af90d9191cc29068fb2e183a8,07af2bea6357787fdf9e542e61872cf7,6028,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Shazia Ruybal-Pesantez,NA,FALSE,NA,NA,France,Children,French Guiana,291,Mixed settings,Both,15,Jul,2016,1,Jan,2015,NA,Adjusted,Infection during pregnancy,NA,Zika congenital syndrome/other birth defects,Significant,NA,FALSE,NA,NA,14,Risk factors,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,1 Jan 2015,15 Jul 2016,1 Jan 2015 - 15 Jul 2016
23a9614af90d9191cc29068fb2e183a8,5f877f4cb2cbbc6ca8c407a903a35e78,6028,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Shazia Ruybal-Pesantez,NA,FALSE,NA,NA,France,Children,French Guiana,625,Mixed settings,Both,15,Jul,2016,1,Jan,2015,NA,Not adjusted,Infection;Infection during pregnancy,NA,Miscarriage/stillbirth,Significant,NA,FALSE,NA,NA,14,Risk factors,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,1 Jan 2015,15 Jul 2016,1 Jan 2015 - 15 Jul 2016
23a9614af90d9191cc29068fb2e183a8,5fd95e2241e6030232203f38ff7fcd23,6028,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Shazia Ruybal-Pesantez,NA,FALSE,NA,NA,France,Children,French Guiana,625,Mixed settings,Both,15,Jul,2016,1,Jan,2015,NA,Adjusted,Infection;Infection during pregnancy,NA,Other,Significant,NA,FALSE,NA,NA,14,Risk factors,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,1 Jan 2015,15 Jul 2016,1 Jan 2015 - 15 Jul 2016
23a9614af90d9191cc29068fb2e183a8,78916cc69675a134da56d0200bff8ffe,6028,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Shazia Ruybal-Pesantez,NA,FALSE,NA,NA,France,Children,French Guiana,291,Mixed settings,Both,15,Jul,2016,1,Jan,2015,NA,Adjusted,Infection;Infection during pregnancy,NA,Low birthweight,Significant,NA,FALSE,NA,NA,14,Risk factors,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,1 Jan 2015,15 Jul 2016,1 Jan 2015 - 15 Jul 2016
23a9614af90d9191cc29068fb2e183a8,f642cd916b533d48e3b0c63a83827bb0,6028,Seroprevalence - IgM,Percentage (%),0,26.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,291,NA,76,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Shazia Ruybal-Pesantez,NA,FALSE,NA,NA,France,Children,French Guiana,291,Mixed settings,Both,15,Jul,2016,1,Jan,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,14,Seroprevalence,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,1 Jan 2015,15 Jul 2016,1 Jan 2015 - 15 Jul 2016
aabdec322c2e6128939273fece4584ec,01a8774228c4e11670320a59d5b08d9b,6069,Reproduction number (Basic R0) - Sexual,No units,0,2.2,Unspecified,1.1,3.8,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Branching process,Thomas Rawson,NA,FALSE,NA,NA,Mexico,General population,Reynosa,330,Population based,Unspecified,NA,NA,2017,NA,NA,2017,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,27,Reproduction number,NA,95% CI,1.1 - 3.8,Mexico,NA,NA,FALSE,NA,NA,NA,2017,2017,2017
e2238ed0df780a321f3a67d43d62b0bc,43d990dd4572184f1786ace8bbb66b06,6072,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Shazia Ruybal-Pesantez,NA,FALSE,2,0,Brazil,Children,Rio de Janeiro,98,Other,Both,NA,NA,2016,NA,NA,2016,NA,Not adjusted,Infection,NA,Premature birth,Not significant,NA,FALSE,NA,NA,17,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,2016,2016,2016
e2238ed0df780a321f3a67d43d62b0bc,6f58680451720e2ca2f73c7c1b45c80f,6072,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Shazia Ruybal-Pesantez,NA,FALSE,2,0,Brazil,Children,Rio de Janeiro,98,Other,Both,NA,NA,2016,NA,NA,2016,NA,Not adjusted,Infection,NA,Other neurological symptoms in general population,Not significant,NA,FALSE,NA,NA,17,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,2016,2016,2016
e2238ed0df780a321f3a67d43d62b0bc,9756f3733a411089c82c4211a68b023c,6072,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Shazia Ruybal-Pesantez,NA,FALSE,2,0,Brazil,Children,Rio de Janeiro,98,Other,Both,NA,NA,2016,NA,NA,2016,NA,Not adjusted,Infection,NA,Microcephaly,Not significant,NA,FALSE,NA,NA,17,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,2016,2016,2016
9dae34c7a170b5e152f7be20f08f6b76,b120cd02031e6a7e69a91dd46795aefb,6106,Mosquito delay - extrinsic incubation period,Days,0,10,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Shazia Ruybal-Pesantez,Observed sample statistic,FALSE,NA,NA,Australia,NA,Queensland,NA,NA,NA,NA,NA,NA,NA,Apr,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,18,Mosquito,NA,NA,NA,Australia,NA,NA,FALSE,NA,NA,NA,Apr 2016,Unspecified,Apr 2016 - Unspecified
9dae34c7a170b5e152f7be20f08f6b76,12747e66a249fa9cfdfe6137e09bd428,6106,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Shazia Ruybal-Pesantez,Observed sample statistic,FALSE,NA,NA,Australia,NA,Queensland,NA,NA,NA,NA,NA,NA,NA,Apr,2016,NA,Not adjusted,Other,NA,Other,Significant,NA,FALSE,NA,NA,18,Risk factors,NA,NA,NA,Australia,NA,NA,FALSE,NA,NA,NA,Apr 2016,Unspecified,Apr 2016 - Unspecified
9dae34c7a170b5e152f7be20f08f6b76,78cd189c10f7e38547f06acb7d152b36,6106,Mosquito delay - extrinsic incubation period,Days,0,14,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Shazia Ruybal-Pesantez,Observed sample statistic,FALSE,NA,NA,Australia,NA,Queensland,NA,NA,NA,NA,NA,NA,NA,Apr,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,18,Mosquito,NA,NA,NA,Australia,NA,NA,FALSE,NA,NA,NA,Apr 2016,Unspecified,Apr 2016 - Unspecified
94d90316f97d547981f9511f4e4a2605,61047a796755f73bc3b75fa43291b296,6113,Seroprevalence - IgG,Percentage (%),0,80.6,Mean,76.4,84.1,95% CI,NA,NA,58.3,100,NA,Lab confirmed,401,Naive,323,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Sex",FALSE,FALSE,Endemic,NA,Christian,Observed sample statistic,FALSE,80,5,Brazil,Mixed groups,Pernambuco State,425,Household based,Both,NA,Dec,2017,NA,Apr,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,22,Seroprevalence,58.3 - 100,95% CI,76.4 - 84.1,Brazil,NA,NA,FALSE,NA,NA,NA,Apr 2017,Dec 2017,Apr 2017 - Dec 2017
94d90316f97d547981f9511f4e4a2605,1bdf3166a631319b80d8a1b4b0cbe69a,6113,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,65.7,Mean,61,70.1,95% CI,NA,NA,60,100,NA,Lab confirmed,414,Adjusted,272,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Sex",FALSE,FALSE,Endemic,NA,Christian,Observed sample statistic,FALSE,80,5,Brazil,Mixed groups,Pernambuco State,425,Household based,Both,NA,Dec,2017,NA,Apr,2017,NA,NA,NA,NA,NA,NA,Adjusted,FALSE,NA,NA,22,Seroprevalence,60 - 100,95% CI,61 - 70.1,Brazil,NA,NA,FALSE,NA,NA,NA,Apr 2017,Dec 2017,Apr 2017 - Dec 2017
94d90316f97d547981f9511f4e4a2605,dcc73011ef564d97de36a8e2cd8cea99,6113,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,End outbreak,NA,Christian,NA,FALSE,80,5,Brazil,Mixed groups,Pernambuco State,425,Household based,Both,NA,Dec,2017,NA,Apr,2017,NA,Not adjusted,Household contact;Other,NA,Serology,Significant,NA,FALSE,NA,NA,22,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Apr 2017,Dec 2017,Apr 2017 - Dec 2017
94d90316f97d547981f9511f4e4a2605,c4ecb5ef60bf575da6c58731cbe76398,6113,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Christian,NA,FALSE,80,5,Brazil,Mixed groups,Pernambuco State,425,Household based,Both,NA,Dec,2017,NA,Apr,2017,NA,Adjusted,Household contact;Other,NA,Serology,Significant,NA,FALSE,NA,NA,22,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Apr 2017,Dec 2017,Apr 2017 - Dec 2017
47698934ce4e266d4ffbe4682e8ebd18,6e961c696e867ab2c1fc7ab8801475c6,6120,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,End outbreak,NA,Shazia Ruybal-Pesantez,NA,FALSE,1,0,Brazil,Children,Tangará da Serra,109,Other,Both,31,Dec,2016,1,Jan,2016,NA,Not adjusted,Infection during pregnancy,NA,Microcephaly,Significant,NA,FALSE,NA,NA,19,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,31 Dec 2016,1 Jan 2016 - 31 Dec 2016
47698934ce4e266d4ffbe4682e8ebd18,e54e6b60eea9c89b57d20293804f018e,6120,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,End outbreak,NA,Shazia Ruybal-Pesantez,NA,FALSE,1,0,Brazil,Children,Tangará da Serra,109,Other,Both,31,Dec,2016,1,Jan,2016,NA,Not adjusted,Infection during pregnancy,NA,Other,Significant,NA,FALSE,NA,NA,19,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,31 Dec 2016,1 Jan 2016 - 31 Dec 2016
1d3e05ed8773dcc0309ee9d7d9671a55,33c609de519bf0ffd5028d9183262ee6,6144,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Shazia Ruybal-Pesantez,NA,FALSE,NA,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2016,NA,Adjusted,Other,NA,Infection,Significant,NA,FALSE,NA,NA,20,Risk factors,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,NA,2016,Unspecified,2016 - Unspecified
19d385264ff44b8515c8a6ca16d568ed,6bd33c4c2829821766344c42ae4fbd87,6171,Reproduction number (Basic R0),No units,0,2.37,Mean,2.35,2.39,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Next generation matrix,Thomas Rawson,Estimated model parameter,FALSE,NA,NA,Costa Rica,General population,NA,NA,Population based,Both,24,Aug,2016,12,Apr,2016,Other,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,28,Reproduction number,NA,95% CI,2.35 - 2.39,Costa Rica,NA,NA,FALSE,NA,NA,NA,12 Apr 2016,24 Aug 2016,12 Apr 2016 - 24 Aug 2016
19d385264ff44b8515c8a6ca16d568ed,72959f96f8813d11374e29c37904f254,6171,Reproduction number (Basic R0) - Sexual,No units,0,1.99,Mean,1.97,2.01,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Next generation matrix,Thomas Rawson,Estimated model parameter,FALSE,NA,NA,Costa Rica,General population,NA,NA,Population based,Both,24,Aug,2016,12,Apr,2016,Human-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,28,Reproduction number,NA,95% CI,1.97 - 2.01,Costa Rica,NA,NA,FALSE,NA,NA,NA,12 Apr 2016,24 Aug 2016,12 Apr 2016 - 24 Aug 2016
19d385264ff44b8515c8a6ca16d568ed,9b79d952d8222122540fce826ec2e109,6171,Reproduction number (Basic R0) - Vector-borne,No units,0,1.04,Mean,1.03,1.05,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Next generation matrix,Thomas Rawson,Estimated model parameter,FALSE,NA,NA,Costa Rica,General population,NA,NA,Population based,Both,24,Aug,2016,12,Apr,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,28,Reproduction number,NA,95% CI,1.03 - 1.05,Costa Rica,NA,NA,FALSE,NA,NA,NA,12 Apr 2016,24 Aug 2016,12 Apr 2016 - 24 Aug 2016
19d385264ff44b8515c8a6ca16d568ed,8569995acd37f4f212a8b925e8ffe6a2,6171,Relative contribution - sexual,Percentage (%),0,48.15,Mean,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Estimated model parameter,FALSE,NA,NA,Costa Rica,General population,NA,NA,Population based,Both,24,Aug,2016,12,Apr,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,28,Relative contribution,NA,NA,NA,Costa Rica,NA,NA,FALSE,NA,NA,NA,12 Apr 2016,24 Aug 2016,12 Apr 2016 - 24 Aug 2016
19d385264ff44b8515c8a6ca16d568ed,865686908e0c00c38dbacf6e4ef859cc,6171,Relative contribution - vector-borne,Percentage (%),0,51.85,Mean,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Estimated model parameter,FALSE,NA,NA,Costa Rica,General population,NA,NA,Population based,Both,24,Aug,2016,12,Apr,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,28,Relative contribution,NA,NA,NA,Costa Rica,NA,NA,FALSE,NA,NA,NA,12 Apr 2016,24 Aug 2016,12 Apr 2016 - 24 Aug 2016
9ffdc0638291233c5b6a413add1a4a98,886cf810280fd2186255fe9c8cf3631a,6175,Severity - case fatality rate (CFR),Percentage (%),0,38,Mean,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,16,Naive,6,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,0,0,Brazil,Persons under investigation,Rio de Janeiro,16,Hospital based,Unspecified,NA,Oct,2016,NA,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,29,Severity,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Jan 2016,Oct 2016,Jan 2016 - Oct 2016
c5a8145078f11a681e9417e0536e10c2,edc92e65301f6d0e8a4084827787ad9c,6182,Seroprevalence - IgG,Percentage (%),0,4.15,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,140,NA,7,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,Observed sample statistic,FALSE,NA,NA,Brazil,Blood donors,São Paulo,140,Population based,Unspecified,NA,May,2018,NA,May,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,33,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,May 2016,May 2018,May 2016 - May 2018
c5a8145078f11a681e9417e0536e10c2,9dbdec70b05ab4a80fc5a71a8a18252b,6182,Seroprevalence - IgM,Percentage (%),0,2.85,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,140,NA,4,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,Observed sample statistic,FALSE,NA,NA,Brazil,Blood donors,São Paulo,140,Population based,Unspecified,NA,May,2018,NA,May,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,33,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,May 2016,May 2018,May 2016 - May 2018
5473a9343a8f723858b69d69dff4a923,fecb2fa0dcd6e3ed660b31a6f6b5c23f,6197,Seroprevalence - IgG,Percentage (%),0,45.7,Unspecified,41.39,50.08,95% CI,NA,NA,NA,NA,NA,NA,501,NA,229,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,Unspecified,FALSE,NA,NA,Burkina Faso,Blood donors,"Ouagadougou, Bobo-Dioulasso",501,Population based,Both,NA,NA,2020,NA,NA,2020,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,34,Seroprevalence,NA,95% CI,41.39 - 50.08,Burkina Faso,NA,NA,FALSE,NA,NA,NA,2020,2020,2020
5473a9343a8f723858b69d69dff4a923,5b52bf50e4b3f16e88c8296a29322eb5,6197,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,22.75,Unspecified,19.29,26.62,95% CI,NA,NA,NA,NA,NA,NA,229,NA,114,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,Unspecified,FALSE,NA,NA,Burkina Faso,Blood donors,"Ouagadougou, Bobo-Dioulasso",501,Population based,Both,NA,NA,2020,NA,NA,2020,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,34,Seroprevalence,NA,95% CI,19.29 - 26.62,Burkina Faso,NA,NA,TRUE,NA,NA,NA,2020,2020,2020
5473a9343a8f723858b69d69dff4a923,d7876b98232203c5f71d87c3c460554c,6197,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,NA,FALSE,NA,NA,Burkina Faso,Blood donors,"Ouagadougou, Bobo-Dioulasso",501,Population based,Both,NA,NA,2020,NA,NA,2020,NA,Not adjusted,Age;Other,NA,Serology,Significant,NA,FALSE,NA,Unspecified,34,Risk factors,NA,NA,NA,Burkina Faso,NA,NA,FALSE,NA,NA,NA,2020,2020,2020
5473a9343a8f723858b69d69dff4a923,11ca6359771f3a0233d5d755b47225e8,6197,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,NA,FALSE,NA,NA,Burkina Faso,Blood donors,"Ouagadougou, Bobo-Dioulasso",501,Population based,Both,NA,NA,2020,NA,NA,2020,NA,Not adjusted,Sex,NA,Serology,Not significant,NA,FALSE,NA,Unspecified,34,Risk factors,NA,NA,NA,Burkina Faso,NA,NA,FALSE,NA,NA,NA,2020,2020,2020
b3bf80bbbac40f537992cc24e821d14d,5582fa0f55afa5a79b3d1268d8f02e92,6211,Reproduction number (Basic R0),No units,0,6.93,NA,5.82,8.05,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,Compartmental model,Tristan Naidoo,NA,FALSE,NA,NA,Singapore,General population,Singapore,NA,Population based,Both,31,Aug,2016,7,Aug,2016,Human-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,35,Reproduction number,NA,95% CI,5.82 - 8.05,Singapore,NA,NA,FALSE,NA,NA,NA,7 Aug 2016,31 Aug 2016,7 Aug 2016 - 31 Aug 2016
b3bf80bbbac40f537992cc24e821d14d,34e510cdaa71b94f2ae865dd2d826da7,6211,"Reproduction number (Effective, Re)",No units,0,0.24,NA,0.07,0.41,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,Compartmental model,Tristan Naidoo,NA,FALSE,NA,NA,Unspecified,General population,Singapore,NA,Population based,Both,30,Nov,2016,4,Sep,2016,Human-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,35,Reproduction number,NA,95% CI,0.07 - 0.41,NA,NA,NA,FALSE,NA,NA,NA,4 Sep 2016,30 Nov 2016,4 Sep 2016 - 30 Nov 2016
a71cedcc59e9d29daf635225dcb1ab99,aa9084fb4cd69599d6803796e5e70867,6216,Seroprevalence - Neutralisation/PRNT,NA,0,NA,NA,NA,NA,NA,NA,NA,6,100,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Other,TRUE,FALSE,Unspecified,NA,Tristan Naidoo,NA,FALSE,NA,NA,Indonesia,General population,Aceh Jaya,116,Population based,Both,NA,NA,2017,NA,NA,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,36,Seroprevalence,6 - 100,NA,NA,Indonesia,NA,NA,FALSE,NA,NA,NA,2017,2017,2017
a71cedcc59e9d29daf635225dcb1ab99,5a58e0709615260b9018bd377f0f601f,6216,Seroprevalence - IgG,Percentage (%),0,NA,Unspecified,13,33.4,95% CI,NA,NA,16.5,27.4,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Other, Sex, Time",TRUE,FALSE,Unspecified,NA,Tristan Naidoo,Observed sample statistic,FALSE,NA,NA,Thailand,General population,NA,1648,Population based,Both,NA,Dec,2017,NA,Dec,1997,NA,NA,NA,NA,NA,NA,NA,FALSE,Second trimester,Unspecified,36,Seroprevalence,16.5 - 27.4,95% CI,13 - 33.4,Thailand,NA,NA,FALSE,NA,NA,NA,Dec 1997,Dec 2017,Dec 1997 - Dec 2017
a71cedcc59e9d29daf635225dcb1ab99,2b0af888800db6e605c1281588e57c12,6216,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,NA,TRUE,FALSE,Unspecified,NA,Tristan Naidoo,NA,FALSE,25,18,Thailand,Pregnant women,NA,1295,Population based,Both,NA,Dec,2017,NA,Dec,1997,NA,Not adjusted,Age;Other,NA,Serology,Significant,NA,FALSE,Second trimester,Unspecified,36,Risk factors,NA,NA,NA,Thailand,NA,NA,FALSE,NA,NA,NA,Dec 1997,Dec 2017,Dec 1997 - Dec 2017
a71cedcc59e9d29daf635225dcb1ab99,8325b16450026321e4129a830bb7cb93,6216,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,NA,TRUE,FALSE,Unspecified,NA,Tristan Naidoo,NA,FALSE,25,18,Thailand,Pregnant women,NA,1295,Population based,Both,NA,Dec,2017,NA,Dec,1997,NA,Not adjusted,Age;Other,NA,Serology,Not significant,NA,FALSE,Second trimester,Unspecified,36,Risk factors,NA,NA,NA,Thailand,NA,NA,FALSE,NA,NA,NA,Dec 1997,Dec 2017,Dec 1997 - Dec 2017
a71cedcc59e9d29daf635225dcb1ab99,d2871fdcf9d24b052e504c0aea3258f5,6216,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,NA,TRUE,FALSE,Unspecified,NA,Tristan Naidoo,NA,FALSE,25,18,Thailand,Pregnant women,NA,1295,Population based,Both,NA,Dec,2017,NA,Dec,1997,NA,Adjusted,Age;Other,NA,Serology,Significant,NA,FALSE,Second trimester,Unspecified,36,Risk factors,NA,NA,NA,Thailand,NA,NA,FALSE,NA,NA,NA,Dec 1997,Dec 2017,Dec 1997 - Dec 2017
a71cedcc59e9d29daf635225dcb1ab99,085ffc083be584bcaeb36cfcd7bdeec6,6216,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,NA,TRUE,FALSE,Unspecified,NA,Tristan Naidoo,NA,FALSE,25,18,Thailand,Pregnant women,NA,1295,Population based,Both,NA,Dec,2017,NA,Dec,1997,NA,Adjusted,Age;Other,NA,Serology,Not significant,NA,FALSE,Second trimester,Unspecified,36,Risk factors,NA,NA,NA,Thailand,NA,NA,FALSE,NA,NA,NA,Dec 1997,Dec 2017,Dec 1997 - Dec 2017
fbcba02856651660ea853b50013ad59e,a1df82a1f450d29deff322940a4d4bc1,6233,Seroprevalence - IgM,Percentage (%),0,7.8,Mean,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,602,Naive,47,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,NA,Spain,Persons under investigation,Madrid,602,Hospital based,Both,NA,Jan,2017,NA,Jan,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,30,Seroprevalence,NA,NA,NA,Spain,NA,NA,FALSE,NA,NA,NA,Jan 2016,Jan 2017,Jan 2016 - Jan 2017
fbcba02856651660ea853b50013ad59e,f8d43ce043072a9d1f06188fe9baaf29,6233,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,NA,FALSE,NA,NA,Spain,Persons under investigation,Madrid,602,Hospital based,Both,NA,Jan,2017,NA,Jan,2016,NA,Adjusted,Other,NA,Infection,Significant,NA,FALSE,NA,Unspecified,30,Risk factors,NA,NA,NA,Spain,NA,NA,FALSE,NA,NA,NA,Jan 2016,Jan 2017,Jan 2016 - Jan 2017
6d863ef4bcf7a660150ddefcbab2e3ee,ad473917c9202d61a25bc2982d84e81d,6241,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,NA,FALSE,NA,NA,Brazil,Persons under investigation,Mato Grosso do Sul,120,Population based,Unspecified,NA,Oct,2018,NA,Nov,2017,NA,Not adjusted,Other,NA,Zika congenital syndrome/other birth defects,Significant,NA,FALSE,NA,Unspecified,41,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Nov 2017,Oct 2018,Nov 2017 - Oct 2018
6d863ef4bcf7a660150ddefcbab2e3ee,976883a2daeb54304811db04491e1c98,6241,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,NA,FALSE,NA,NA,Brazil,Persons under investigation,Mato Grosso do Sul,120,Population based,Unspecified,NA,Oct,2018,NA,Nov,2017,NA,Not adjusted,Comorbidity;Other,NA,Zika congenital syndrome/other birth defects,Not significant,NA,FALSE,NA,Unspecified,41,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Nov 2017,Oct 2018,Nov 2017 - Oct 2018
e41d7d9efa79c76104e2a13108cbab62,72e6ab007862176467ffe2d2041cc56a,6246,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,42.5,Mean,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,94,Naive,40,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,2,0,Brazil,Persons under investigation,Maranhao state,94,Hospital based,Unspecified,NA,NA,2018,NA,NA,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,31,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,2016,2018,2016 - 2018
e41d7d9efa79c76104e2a13108cbab62,bf58b58cd287536649aa6e7ebbea9ce4,6246,Seroprevalence - IgG,Percentage (%),0,6.8,Mean,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,88,Naive,6,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,2,0,Brazil,Persons under investigation,Maranhao state,88,Hospital based,Unspecified,NA,NA,2018,NA,NA,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,31,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,2016,2018,2016 - 2018
e41d7d9efa79c76104e2a13108cbab62,2b94fd37f809e2aa391301ace6860b38,6246,Seroprevalence - IgG,Percentage (%),0,86.7,Mean,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,90,Naive,78,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,NA,Brazil,Persons under investigation,Maranhao state,90,Hospital based,Female,NA,NA,2018,NA,NA,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,31,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,2016,2018,2016 - 2018
e41d7d9efa79c76104e2a13108cbab62,15939217bfb1d57cc4e935aa57fa6c0d,6246,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,NA,FALSE,2,0,Brazil,Persons under investigation,Maranhao state,94,Hospital based,Unspecified,NA,NA,2018,NA,NA,2016,NA,Adjusted,Other,NA,Serology,Significant,NA,FALSE,NA,Unspecified,31,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,2016,2018,2016 - 2018
eee0f9a4a68161b227e331f2b1702623,5f83089ad8bd7c6bd458e579eafa19f8,6250,Reproduction number (Basic R0) - Sexual,No units,0,NA,Unspecified,NA,NA,NA,NA,NA,0,4,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,TRUE,Unspecified,Unspecified,Thomas Rawson,Estimated model parameter,FALSE,NA,NA,Unspecified,General population,Global,NA,Mixed settings,Unspecified,NA,NA,2016,NA,NA,2015,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,42,Reproduction number,0 - 4,NA,NA,NA,NA,NA,FALSE,NA,NA,NA,2015,2016,2015 - 2016
0f367fe3a06e2a491b05b328fb9bace7,edaa0185ca317d23c161f2fb065811f0,6267,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,NA,FALSE,NA,NA,Thailand,Pregnant women,NA,174,Other,Female,NA,NA,2015,NA,NA,1997,NA,Adjusted,Infection during pregnancy,NA,Zika congenital syndrome/other birth defects,Not significant,NA,FALSE,Unspecified,Unspecified,14,Risk factors,NA,NA,NA,Thailand,NA,NA,FALSE,NA,NA,NA,1997,2015,1997 - 2015
0f367fe3a06e2a491b05b328fb9bace7,62cf949cd1a1a8936acfe19abb2e11cd,6267,Seroprevalence - IgM,Percentage (%),0,0,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,174,NA,0,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Thailand,Pregnant women,NA,174,Other,Female,NA,NA,2015,NA,NA,1997,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,14,Seroprevalence,NA,NA,NA,Thailand,NA,NA,FALSE,NA,NA,NA,1997,2015,1997 - 2015
0f367fe3a06e2a491b05b328fb9bace7,a3e9eaf909dea86e825b63bf7cc516fb,6267,Seroprevalence - IgG,Percentage (%),0,29,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,174,NA,50,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Thailand,Pregnant women,NA,174,Other,Female,NA,NA,2015,NA,NA,1997,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,14,Seroprevalence,NA,NA,NA,Thailand,NA,NA,FALSE,NA,NA,NA,1997,2015,1997 - 2015
5f6c23157cd5f1f79d4128ef6cdc1c47,9b3a54befea150d2ca94c23c294ff1ab,6268,Seroprevalence - IgG,Percentage (%),0,10.9,Mean,NA,NA,NA,NA,NA,NA,NA,NA,NA,431,NA,47,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Cabo Verde,General population,Santiago Island: Praia,431,Population based,Both,4,Nov,2014,24,Aug,2014,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Both urban and rural areas,12,Seroprevalence,NA,NA,NA,Cabo Verde,NA,NA,FALSE,NA,NA,NA,24 Aug 2014,4 Nov 2014,24 Aug 2014 - 4 Nov 2014
5f6c23157cd5f1f79d4128ef6cdc1c47,0a60e6904cdc9f27cb41df8e2c397ada,6268,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Kelly M,NA,FALSE,NA,NA,Cabo Verde,General population,Santiago Island: Praia,431,Population based,Both,4,Nov,2014,24,Aug,2014,NA,Not adjusted,Other;Prior immunity to arboviruses,NA,Serology,Significant,NA,FALSE,NA,Both urban and rural areas,12,Risk factors,NA,NA,NA,Cabo Verde,NA,NA,FALSE,NA,NA,NA,24 Aug 2014,4 Nov 2014,24 Aug 2014 - 4 Nov 2014
5f6c23157cd5f1f79d4128ef6cdc1c47,eb0f9cfa11a76fd48b5901c1906dd3a0,6268,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Kelly M,NA,FALSE,NA,NA,Cabo Verde,General population,Santiago Island: Praia,431,Population based,Both,4,Nov,2014,24,Aug,2014,NA,Not adjusted,Age;Other;Sex,NA,Serology,Not significant,NA,FALSE,NA,Both urban and rural areas,12,Risk factors,NA,NA,NA,Cabo Verde,NA,NA,FALSE,NA,NA,NA,24 Aug 2014,4 Nov 2014,24 Aug 2014 - 4 Nov 2014
9d14e21008389e032c8dee83e716c7f1,2295aacb20ef2ed57bda9fc40a879dd1,6270,Seroprevalence - IgM,Percentage (%),0,0.5,Central,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,406,Naive,2,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,46,15,Spain,Pregnant women,Barcelona,406,Population based,Female,NA,Apr,2019,NA,Jan,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,43,Seroprevalence,NA,NA,NA,Spain,NA,NA,FALSE,NA,NA,NA,Jan 2016,Apr 2019,Jan 2016 - Apr 2019
9d14e21008389e032c8dee83e716c7f1,99cd88de95072b15e8c1f0a57bc89a32,6270,Seroprevalence - IgG,Percentage (%),0,52.7,Central,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,406,Naive,214,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,46,15,Spain,Pregnant women,Barcelona,406,Population based,Female,NA,Apr,2019,NA,Jan,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,43,Seroprevalence,NA,NA,NA,Spain,NA,NA,FALSE,NA,NA,NA,Jan 2016,Apr 2019,Jan 2016 - Apr 2019
9d14e21008389e032c8dee83e716c7f1,ba9b24755b153f110519cb922c8b1055,6270,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,4.8,Central,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,209,Naive,10,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,NA,Spain,Pregnant women,Barcelona,209,Population based,Female,NA,Apr,2019,NA,Jan,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,43,Seroprevalence,NA,NA,NA,Spain,NA,NA,TRUE,NA,NA,NA,Jan 2016,Apr 2019,Jan 2016 - Apr 2019
0eaf6ff4d9a77668c80a823e64004b14,b4f438589faa7c4be117fc9c8b3b1636,6282,Seroprevalence - IgM,Percentage (%),0,31.3,Mean,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,284,Naive,89,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,52,18,Myanmar,General population,Yangon,284,Population based,Both,NA,NA,2018,NA,NA,2018,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,32,Seroprevalence,NA,NA,NA,Myanmar,NA,NA,FALSE,NA,NA,NA,2018,2018,2018
88f80e2f027595f579334c6ab241de51,9f463090503d1f05e397cabcb5a5aaab,6284,Seroprevalence - IgM,Percentage (%),0,14.7,Unspecified,8.8,22.4,95% CI,NA,NA,5.6,17.1,NA,Lab confirmed,116,Naive,17,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Time,FALSE,FALSE,Unspecified,NA,Richard Sheppard,Observed sample statistic,FALSE,NA,NA,Guinea,Persons under investigation,Faranah Prefecture Hospital,116,Hospital based,Unspecified,NA,Jul,2021,NA,May,2018,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,11,Seroprevalence,5.6 - 17.1,95% CI,8.8 - 22.4,Guinea,NA,NA,FALSE,NA,NA,NA,May 2018,Jul 2021,May 2018 - Jul 2021
52e34e82062139d3a940b711e9a6860f,4da72156c3d414a39590edccecf8ca50,6294,Reproduction number (Basic R0),No units,0,1.727,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Next generation matrix,Thomas Rawson,Estimated model parameter,FALSE,NA,NA,Colombia,General population,NA,NA,Population based,Unspecified,NA,Dec,2016,NA,NA,2015,Other,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,44,Reproduction number,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,2015,Dec 2016,2015 - Dec 2016
52e34e82062139d3a940b711e9a6860f,79a6c8be5169113c00c8d0a20ac177fc,6294,Reproduction number (Basic R0) - Sexual,No units,0,0.624,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Next generation matrix,Thomas Rawson,Estimated model parameter,FALSE,NA,NA,Colombia,General population,NA,NA,Population based,Unspecified,NA,Dec,2016,NA,NA,2015,Human-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,44,Reproduction number,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,2015,Dec 2016,2015 - Dec 2016
52e34e82062139d3a940b711e9a6860f,d7e03c4c89525a83f73d6613a27ea957,6294,Reproduction number (Basic R0) - Vector-borne,No units,0,1.103,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Next generation matrix,Thomas Rawson,Estimated model parameter,FALSE,NA,NA,Colombia,General population,NA,NA,Population based,Unspecified,NA,Dec,2016,NA,NA,2015,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,44,Reproduction number,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,2015,Dec 2016,2015 - Dec 2016
52e34e82062139d3a940b711e9a6860f,d7a4d37693cc26887d2895b5437c00f0,6294,Reproduction number (Basic R0),No units,0,2.227,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Next generation matrix,Thomas Rawson,Estimated model parameter,FALSE,NA,NA,United States,General population,Puerto Rico,NA,Population based,Unspecified,NA,Dec,2017,NA,Jan,2016,Other,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,44,Reproduction number,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,Jan 2016,Dec 2017,Jan 2016 - Dec 2017
52e34e82062139d3a940b711e9a6860f,56fb220076d79e0b0a47debea5d94326,6294,Reproduction number (Basic R0) - Sexual,No units,0,0.005,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Next generation matrix,Thomas Rawson,Estimated model parameter,FALSE,NA,NA,United States,General population,Puerto Rico,NA,Population based,Unspecified,NA,Dec,2017,NA,Jan,2016,Human-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,44,Reproduction number,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,Jan 2016,Dec 2017,Jan 2016 - Dec 2017
52e34e82062139d3a940b711e9a6860f,1897a4538beb7ed096292fdbb68532ef,6294,Reproduction number (Basic R0) - Vector-borne,No units,0,2.222,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Next generation matrix,Thomas Rawson,Estimated model parameter,FALSE,NA,NA,United States,General population,Puerto Rico,NA,Population based,Unspecified,NA,Dec,2017,NA,Jan,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,44,Reproduction number,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,Jan 2016,Dec 2017,Jan 2016 - Dec 2017
dc604c80b9eef2f83aabea4d16f88121,c2b968fef210a57768015ca04d9fedf2,6301,Seroprevalence - IgM,Percentage (%),0,22,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,329,Naive,22,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Richard Sheppard,Observed sample statistic,FALSE,1,0,United States,Persons under investigation,New York City,329,Hospital based,Unspecified,NA,Dec,2017,NA,Jan,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,14,Seroprevalence,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,Jan 2016,Dec 2017,Jan 2016 - Dec 2017
57a74e310d3abb0f9a4bc25e26bf46af,c61d7830b9158e41671af141a3174b79,6321,Attack rate,Unspecified,0,0.38,Mean,0.17,0.92,95% CrI,NA,NA,0.03,0.8,NA,NA,NA,NA,NA,Yes - on Github,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Region,FALSE,FALSE,Post outbreak,NA,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,Colombia,General population,"Arauca, Armenia, Barranquilla, Bucaramanga, Cali, Cartagena, Cúcuta, Florencia, Ibagué, Inírida, Leticia, Medellín, Mitú, Mocoa, Montería, Neiva, Pereira, Popayán, Puerto Carreño, Quibdó, Riohacha, San Andrés, San José del Guaviare, Santa Marta, Sincelejo, Valledupar, Villavicencio, Yopal",NA,Population based,Unspecified,NA,NA,2017,NA,NA,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,13,Attack rate,0.03 - 0.8,95% CrI,0.17 - 0.92,Colombia,NA,NA,FALSE,NA,NA,NA,2015,2017,2015 - 2017
57a74e310d3abb0f9a4bc25e26bf46af,7d7bc777ba7e2883e4b5984a54f73f0b,6321,Attack rate,Unspecified,0,0.03,Mean,0,0.1,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on Github,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,Colombia,General population,Quibdó,NA,Population based,Unspecified,NA,NA,2017,NA,NA,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,13,Attack rate,NA,95% CrI,0 - 0.1,Colombia,NA,NA,FALSE,NA,NA,NA,2015,2017,2015 - 2017
57a74e310d3abb0f9a4bc25e26bf46af,f050a960222610993ec2226cd77dbcd8,6321,Attack rate,Unspecified,0,0.8,Mean,0.56,0.99,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on Github,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,Colombia,General population,San Andrés,NA,Population based,Unspecified,NA,NA,2017,NA,NA,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,13,Attack rate,NA,95% CrI,0.56 - 0.99,Colombia,NA,NA,FALSE,NA,NA,NA,2015,2017,2015 - 2017
57a74e310d3abb0f9a4bc25e26bf46af,0c11269dea2eadf58e44ba831a81f8e4,6321,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on Github,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Richard Sheppard,NA,FALSE,NA,NA,Colombia,General population,"Arauca, Armenia, Barranquilla, Bucaramanga, Cali, Cartagena, Cúcuta, Florencia, Ibagué, Inírida, Leticia, Medellín, Mitú, Mocoa, Montería, Neiva, Pereira, Popayán, Puerto Carreño, Quibdó, Riohacha, San Andrés, San José del Guaviare, Santa Marta, Sincelejo, Valledupar, Villavicencio, Yopal",NA,Population based,Unspecified,NA,NA,2017,NA,NA,2015,NA,Adjusted,Age;Sex,NA,Other,Not significant,NA,FALSE,Unspecified,Unspecified,13,Risk factors,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,2015,2017,2015 - 2017
57a74e310d3abb0f9a4bc25e26bf46af,d0869019652666ae678edb30dd00ca5a,6321,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on Github,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Richard Sheppard,NA,FALSE,NA,NA,Colombia,General population,"Arauca, Armenia, Barranquilla, Bucaramanga, Cali, Cartagena, Cúcuta, Florencia, Ibagué, Inírida, Leticia, Medellín, Mitú, Mocoa, Montería, Neiva, Pereira, Popayán, Puerto Carreño, Quibdó, Riohacha, San Andrés, San José del Guaviare, Santa Marta, Sincelejo, Valledupar, Villavicencio, Yopal",NA,Population based,Unspecified,NA,NA,2017,NA,NA,2015,NA,Adjusted,Age;Sex,NA,Other neurological symptoms in general population,Not significant,NA,FALSE,Unspecified,Unspecified,13,Risk factors,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,2015,2017,2015 - 2017
4990e7d9c486629d64dadafaacbcfcb9,3a58b1e7a4ad1c381195924ef49ef1f9,6345,Reproduction number (Basic R0),No units,0,1.9472,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,Other,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,"Tahiti, French Polynesia",NA,Population based,NA,NA,NA,2014,NA,NA,2013,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,10,Reproduction number,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,2013,2014,2013 - 2014
4990e7d9c486629d64dadafaacbcfcb9,056e92e2457601c896a0f79dbe9650c3,6345,Reproduction number (Basic R0),No units,0,1.1854,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,Other,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,"Sous-le-vent Islands, French Polynesia",NA,Population based,NA,NA,NA,2014,NA,NA,2013,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,10,Reproduction number,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,2013,2014,2013 - 2014
4990e7d9c486629d64dadafaacbcfcb9,b0ef5df3f7ab555ece675ba9aeb067fe,6345,Reproduction number (Basic R0),No units,0,1.1508,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,Other,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,"Mo'orea, French Polynesia",NA,Population based,NA,NA,NA,2014,NA,NA,2013,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,10,Reproduction number,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,2013,2014,2013 - 2014
4990e7d9c486629d64dadafaacbcfcb9,b73a328d8c37ad37a17d0b94d4e7a639,6345,Reproduction number (Basic R0),No units,0,1.1169,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,Other,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,"Tuamotu-Gambier, French Polynesia",NA,Population based,NA,NA,NA,2014,NA,NA,2013,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,10,Reproduction number,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,2013,2014,2013 - 2014
4990e7d9c486629d64dadafaacbcfcb9,0623bc84fe6c2c2696f8904bc5639be2,6345,Reproduction number (Basic R0),No units,0,1.1417,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,Other,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,"Marquesas Islands, French Polynesia",NA,Population based,NA,NA,NA,2014,NA,NA,2013,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,10,Reproduction number,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,2013,2014,2013 - 2014
4990e7d9c486629d64dadafaacbcfcb9,25244e2e506072aad9810d4f90379cec,6345,Reproduction number (Basic R0),No units,0,1.2246,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,Other,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,"Australes, French Polynesia",NA,Population based,NA,NA,NA,2014,NA,NA,2013,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,10,Reproduction number,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,2013,2014,2013 - 2014
4990e7d9c486629d64dadafaacbcfcb9,2839ab11e95d47d1f361c3585f227967,6345,Reproduction number (Basic R0),No units,0,1.8658,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,Other,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,Costa Rica,Persons under investigation,NA,NA,Population based,NA,NA,NA,2016,NA,NA,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,10,Reproduction number,NA,NA,NA,Costa Rica,NA,NA,FALSE,NA,NA,NA,2016,2016,2016
4990e7d9c486629d64dadafaacbcfcb9,321cca2d9bad5b95e2df8d409e0b326f,6345,Reproduction number (Basic R0),No units,0,1.1717,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,Other,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,Colombia,Persons under investigation,NA,NA,Population based,NA,NA,NA,2016,NA,NA,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,10,Reproduction number,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,2016,2016,2016
7b5fa9f46884e83a6f83e28355b73812,beacc075755c1a1de00584e515f3a6a4,6361,Mutations - evolutionary rate,Substitutions/site/year,-4,8.61,Unspecified,6.34,11.1,HPDI 95%,NA,NA,NA,NA,Whole genome sequence,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Estimated model parameter,FALSE,NA,NA,"Multi-country: Africa (n = 3), Americas (n = 5), Asia (n = 6), Oceania (n = 3)",Unspecified,NA,88,Unspecified,NA,NA,Aug,2018,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,34,Mutations,NA,HPDI 95%,6.34 - 11.1,"USA, Malaysia, Philippines, Singapore, Thailand, Indonesia, China, Brazil, French Polynesia, Yap Island, Venezuela, Samoa, Suriname, Guatemala, Uganda, Senegal, Nigeria",NA,NA,FALSE,NA,NA,NA,Unspecified,Aug 2018,Unspecified - Aug 2018
a12f13117bee14651ef93453e6e4a02c,8bf9003939b7eb677554bf84ad9d3d98,6362,Reproduction number (Basic R0),No units,0,0.924,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Compartmental model,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,Costa Rica,General population,NA,NA,Population based,Unspecified,NA,NA,2018,NA,NA,2016,Other,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,12,Reproduction number,NA,NA,NA,Costa Rica,NA,NA,FALSE,NA,NA,NA,2016,2018,2016 - 2018
a12f13117bee14651ef93453e6e4a02c,31982a60fbfaadcfeee2e18f38f571ed,6362,Reproduction number (Basic R0),No units,0,0.737,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Compartmental model,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,Suriname,General population,NA,NA,Population based,Unspecified,NA,NA,NA,NA,NA,NA,Other,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,12,Reproduction number,NA,NA,NA,Suriname,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
a12f13117bee14651ef93453e6e4a02c,8461a1c10d99fda98702f717fa6fa588,6362,"Reproduction number (Effective, Re)",No units,0,1.47,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Compartmental model,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,Costa Rica,General population,NA,NA,Population based,Unspecified,NA,NA,2018,NA,NA,2016,Other,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,12,Reproduction number,NA,NA,NA,Costa Rica,NA,NA,FALSE,NA,NA,NA,2016,2018,2016 - 2018
a12f13117bee14651ef93453e6e4a02c,4b070ce4ee586ccca10838be1b0acb03,6362,"Reproduction number (Effective, Re)",No units,0,1.45,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Compartmental model,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,Suriname,General population,NA,NA,Population based,Unspecified,NA,NA,NA,NA,NA,NA,Other,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,12,Reproduction number,NA,NA,NA,Suriname,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
a12f13117bee14651ef93453e6e4a02c,cddb78022c4d9f195237593fe88e3340,6362,Relative contribution - sexual,Percentage (%),0,54,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,Costa Rica,General population,NA,NA,Population based,Unspecified,NA,NA,2018,NA,NA,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,12,Relative contribution,NA,NA,NA,Costa Rica,NA,NA,FALSE,NA,NA,NA,2016,2018,2016 - 2018
a12f13117bee14651ef93453e6e4a02c,e0530af38acc59f8b59991ebf9377ee5,6362,Relative contribution - sexual,Percentage (%),0,32,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,Suriname,General population,NA,NA,Population based,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,12,Relative contribution,NA,NA,NA,Suriname,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
6ddab803a52801626d0ce9e0b6fe5fed,0330b75163b70278d326e139e5bc479e,6372,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Richard Sheppard,NA,FALSE,46,13,Brazil,Pregnant women,"University Hospital of the Faculty of Medicine of Jundiaí, Jundiaí, São-Paulo",315,Hospital based,Female,NA,Aug,2017,NA,Mar,2016,NA,Not adjusted,Age;Occupation;Other,Other,ZIKV detection,Not significant,NA,FALSE,Unspecified,Unspecified,8,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Mar 2016,Aug 2017,Mar 2016 - Aug 2017
6ddab803a52801626d0ce9e0b6fe5fed,ee8439cd6ab007a7a4ae08487fe3f059,6372,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Richard Sheppard,NA,FALSE,46,13,Brazil,Pregnant women,"University Hospital of the Faculty of Medicine of Jundiaí, Jundiaí, São-Paulo",315,Hospital based,Female,NA,Aug,2017,NA,Mar,2016,NA,Adjusted,Other,NA,ZIKV detection,Not significant,NA,FALSE,Unspecified,Unspecified,8,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Mar 2016,Aug 2017,Mar 2016 - Aug 2017
6ff5f608b26f7f38df3ea5a26c15d9a1,27989f8eb79c321cc041665a73659b01,6400,Seroprevalence - IgG,Percentage (%),0,89,Mean,NA,NA,NA,NA,NA,NA,NA,NA,NA,90,NA,80,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Colombia,Pregnant women,Cereté: Córdoba state,90,Hospital based,Female,31,May,2016,1,May,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,11,Seroprevalence,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,1 May 2016,31 May 2016,1 May 2016 - 31 May 2016
6ff5f608b26f7f38df3ea5a26c15d9a1,42190604f4562bdf79fbc48713705189,6400,Seroprevalence - IgM,Percentage (%),0,1,Mean,NA,NA,NA,NA,NA,NA,NA,NA,NA,90,NA,1,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Colombia,Pregnant women,Cereté: Córdoba state,90,Hospital based,Female,31,May,2016,1,May,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,11,Seroprevalence,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,1 May 2016,31 May 2016,1 May 2016 - 31 May 2016
d226380f542a870e51574567459ec6ad,91c8bc0d2f2832440fbff3c05fb005b8,6423,Seroprevalence - IgM,Percentage (%),0,37,Mean,29,44,95% CI,NA,NA,NA,NA,NA,Lab confirmed,153,Naive,56,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,92,10,United States,Persons under investigation,NA,153,Population based,Both,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,35,Seroprevalence,NA,95% CI,29 - 44,United States,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
d226380f542a870e51574567459ec6ad,29c16dea362ebfb8fc4df607f891849d,6423,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,NA,FALSE,92,10,United States,Persons under investigation,NA,153,Population based,Both,NA,NA,NA,NA,NA,NA,NA,Unspecified,Age;Other,NA,Serology,Not significant,NA,FALSE,NA,Unspecified,35,Risk factors,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
d226380f542a870e51574567459ec6ad,47ef6afea309b6d274b783027e91da55,6423,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,NA,FALSE,92,10,United States,Persons under investigation,NA,153,Population based,Both,NA,NA,NA,NA,NA,NA,NA,Unspecified,Sex,NA,Serology,Significant,NA,FALSE,NA,Unspecified,35,Risk factors,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
f9b860d369779c4b8a8654d5b270bf19,2c054e707dfccf958a1f38026b53a470,6432,Seroprevalence - IgM,Percentage (%),0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,212,Naive,0,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,End outbreak,NA,Thomas Rawson,NA,FALSE,86,23,Taiwan,General population,Tainan City,212,Travel based,Both,NA,NA,2015,NA,NA,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,36,Seroprevalence,NA,NA,NA,Taiwan,NA,NA,FALSE,NA,NA,NA,2015,2015,2015
f9b860d369779c4b8a8654d5b270bf19,2f645c9f6cb6dc14856808057641fd10,6432,Seroprevalence - IgG,Percentage (%),0,4.2,Mean,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,212,Naive,9,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,End outbreak,NA,Thomas Rawson,Observed sample statistic,FALSE,86,23,Taiwan,General population,Tainan City,212,Travel based,Both,NA,NA,2015,NA,NA,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,36,Seroprevalence,NA,NA,NA,Taiwan,NA,NA,FALSE,NA,NA,NA,2015,2015,2015
f9b860d369779c4b8a8654d5b270bf19,4222632b447febd3921770eabdd18831,6432,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,11.11,Mean,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,9,Naive,1,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,End outbreak,NA,Thomas Rawson,Observed sample statistic,FALSE,86,23,Taiwan,General population,Tainan City,212,Travel based,Both,NA,NA,2015,NA,NA,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,36,Seroprevalence,NA,NA,NA,Taiwan,NA,NA,TRUE,NA,NA,NA,2015,2015,2015
80a344338a37d8a031d5332f7f16eac0,3b836032e7c6621b77ba2577cbec8ebc,6455,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,17,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,147,Naive,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,NA,Thailand,General population,NA,147,Population based,Both,NA,NA,2012,NA,NA,2011,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,47,Seroprevalence,NA,NA,NA,Thailand,NA,NA,FALSE,NA,NA,NA,2011,2012,2011 - 2012
80a344338a37d8a031d5332f7f16eac0,b8f28b72502cda60fd57484e59db19fc,6455,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,23.5,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,34,Naive,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,NA,Thailand,General population,Nakhon Sawan,34,Population based,Both,NA,NA,2012,NA,NA,2011,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,47,Seroprevalence,NA,NA,NA,Thailand,NA,NA,FALSE,NA,NA,NA,2011,2012,2011 - 2012
80a344338a37d8a031d5332f7f16eac0,08ffe8233962a0d5335cfe5aad31a6cf,6455,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,21.6,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,51,Naive,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,NA,Thailand,General population,Phuket,51,Population based,Both,NA,NA,2012,NA,NA,2011,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,47,Seroprevalence,NA,NA,NA,Thailand,NA,NA,FALSE,NA,NA,NA,2011,2012,2011 - 2012
0aa83ab047bfef00f46f73a22946ed9d,f9f400125219912754d34fbe74e101a5,6477,Seroprevalence - IgM,Percentage (%),0,7,Central,NA,NA,NA,NA,NA,NA,NA,NA,Clinically diagnosed/symptomatic;Lab confirmed,301,Adjusted,22,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Thomas Rawson,Observed sample statistic,FALSE,14,0,Colombia,Children,NA,301,Hospital based,Both,31,Dec,2019,1,Dec,2015,NA,NA,NA,NA,NA,NA,Adjusted,FALSE,NA,Unspecified,48,Seroprevalence,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,1 Dec 2015,31 Dec 2019,1 Dec 2015 - 31 Dec 2019
9c21d78c17ff855ed754a0cc74d2f020,7855fbbca4152efff3d71facdf9e7b33,6501,Seroprevalence - IgM,Percentage (%),0,7.2,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,2293,Naive,166,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,15,Kenya,Pregnant women,Mombasa,1916,Hospital based,Female,NA,Jul,2019,NA,Oct,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,49,Seroprevalence,NA,NA,NA,Kenya,NA,NA,FALSE,NA,NA,NA,Oct 2017,Jul 2019,Oct 2017 - Jul 2019
9c21d78c17ff855ed754a0cc74d2f020,2e136694db1bcce099ea7c01d04ad8e9,6501,Seroprevalence - Neutralisation/PRNT,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,144,Naive,3,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,NA,FALSE,NA,15,Kenya,Pregnant women,Mombasa,1916,Hospital based,Female,NA,Jul,2019,NA,Oct,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,49,Seroprevalence,NA,NA,NA,Kenya,NA,NA,TRUE,NA,NA,NA,Oct 2017,Jul 2019,Oct 2017 - Jul 2019
9c21d78c17ff855ed754a0cc74d2f020,801d2cdfd9e23db293356a76ee40f880,6501,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,NA,FALSE,0,0,Kenya,Children,Mombasa,1236,Hospital based,Both,NA,Jul,2019,NA,Oct,2017,NA,Not adjusted,Infection during pregnancy,NA,Zika congenital syndrome/other birth defects,Not significant,NA,FALSE,Unspecified,Unspecified,49,Risk factors,NA,NA,NA,Kenya,NA,NA,FALSE,NA,NA,NA,Oct 2017,Jul 2019,Oct 2017 - Jul 2019
82be803a3d8630d90a6a265d2d2da1b8,59097283a17f23cd8ffa07b873759350,6505,Seroprevalence - IgM,Percentage (%),0,19,Central,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,161,Naive,31,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,NA,United Kingdom,Persons under investigation,NA,161,Travel based,Both,31,Dec,2017,1,Jan,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,50,Seroprevalence,NA,NA,NA,United Kingdom,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,31 Dec 2017,1 Jan 2016 - 31 Dec 2017
1f716500ec7250a4991afa4155cf6724,fa1441ae790ea49c13d273ab5715299f,6511,Mutations - evolutionary rate,Substitutions/site/year,-3,5.71,Unspecified,NA,NA,NA,NA,NA,NA,NA,Whole genome sequence,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,TRUE,FALSE,FALSE,FALSE,NA,FALSE,TRUE,Unspecified,NA,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,"Multi-country: Pacific, Americas",Unspecified,Pacific and Americas,269,Unspecified,Unspecified,NA,Aug,2018,NA,NA,2013,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,NA,NA,6,Mutations,NA,NA,NA,"Multi-country: Pacific, Americas",NA,NA,FALSE,NA,NA,NA,2013,Aug 2018,2013 - Aug 2018
095eb85f24443607be615636376e2e0a,52d791992e68977d8ff4422458462f3d,6520,Seroprevalence - IgM,Percentage (%),0,1.7,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,349,NA,6,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Brazil,Pregnant women,Rio de Janeiro,349,Hospital based,Female,NA,Dec,2017,NA,Jun,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,NA,23,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Jun 2017,Dec 2017,Jun 2017 - Dec 2017
095eb85f24443607be615636376e2e0a,f12d367ffadc10d237a1b0dd0944fb50,6520,Seroprevalence - IgG,Percentage (%),0,46.7,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,349,NA,163,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Brazil,Pregnant women,Rio de Janeiro,349,Hospital based,Female,NA,Dec,2017,NA,Jul,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,23,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Jul 2017,Dec 2017,Jul 2017 - Dec 2017
ef665216b252ff657a609fc21386dd54,20337421016e1b6ddf687ef57ac4b80c,6521,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,84,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,150,Unspecified,126,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Richard Sheppard,Observed sample statistic,FALSE,NA,NA,Spain,Pregnant women,"Hospital Universitari Vall d’Hebron Barcelona, Catalonia",150,Mixed settings,Female,NA,Dec,2021,NA,May,2016,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,Unspecified,Unspecified,5,Seroprevalence,NA,NA,NA,Spain,NA,NA,FALSE,NA,NA,NA,May 2016,Dec 2021,May 2016 - Dec 2021
8115e94659e1cdad57574570cbe17501,0acf2f3a8fa033dddedb47aadf3eb9db,6542,"Reproduction number (Effective, Re)",No units,0,2.13,Unspecified,2.07,2.19,95% CI,NA,NA,2.12,3.45,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,TRUE,FALSE,Post outbreak,Branching process,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,Brazil,Persons under investigation,Acre,803513,Population based,Unspecified,NA,May,2016,NA,Oct,2015,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,2,Reproduction number,2.12 - 3.45,95% CI,2.07 - 2.19,Brazil,NA,NA,FALSE,NA,NA,NA,Oct 2015,May 2016,Oct 2015 - May 2016
8115e94659e1cdad57574570cbe17501,6fa0335548763e55eb7770468589c9f2,6542,Attack rate,Unspecified,0,0.006863459475183615,Unspecified,595,772,95% CI,NA,NA,0.005289842471158357,0.006863459475183615,NA,NA,11247972,NA,772,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,TRUE,TRUE,Method,TRUE,FALSE,Post outbreak,NA,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,Brazil,Persons under investigation,Rio Grande,11247972,Population based,Unspecified,NA,May,2016,NA,Oct,2015,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,2,Attack rate,595 - 772,95% CI,595 - 772,Brazil,NA,NA,FALSE,NA,NA,NA,Oct 2015,May 2016,Oct 2015 - May 2016
8115e94659e1cdad57574570cbe17501,cfa8df0eef0a00d97087f4faa04be89a,6542,Attack rate,Unspecified,0,0.09744708548586022,Unspecified,772,925,95% CI,NA,NA,0.09607809705630152,0.11511948157652707,NA,NA,803513,NA,783,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,TRUE,FALSE,Post outbreak,NA,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,Brazil,Persons under investigation,Acre,803513,Population based,Unspecified,NA,May,2016,NA,Oct,2015,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,2,Attack rate,772 - 925,95% CI,772 - 925,Brazil,NA,NA,FALSE,NA,NA,NA,Oct 2015,May 2016,Oct 2015 - May 2016
8115e94659e1cdad57574570cbe17501,2f4011dccdd8c60569ae1bfcdd73942b,6542,Attack rate,Unspecified,0,0.3648529387196761,Unspecified,50249,59773,95% CI,NA,NA,0.3304999877005517,0.3931416697809922,NA,NA,15203934,NA,55472,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,TRUE,FALSE,Post outbreak,NA,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,Brazil,Persons under investigation,Bahia,15203934,Population based,Unspecified,NA,May,2016,NA,Oct,2015,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,2,Attack rate,50249 - 59773,95% CI,50249 - 59773,Brazil,NA,NA,FALSE,NA,NA,NA,Oct 2015,May 2016,Oct 2015 - May 2016
8115e94659e1cdad57574570cbe17501,32f71951e02c05816bac49b11e231113,6542,Attack rate,Unspecified,0,0.0542505924434421,Unspecified,1671,2364,95% CI,NA,NA,0.042520046891647165,0.06015403402265344,NA,NA,3929911,NA,2132,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,TRUE,FALSE,Post outbreak,NA,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,Brazil,Persons under investigation,Espirito Santo,3929911,Population based,Unspecified,NA,May,2016,NA,Oct,2015,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,2,Attack rate,1671 - 2364,95% CI,1671 - 2364,Brazil,NA,NA,FALSE,NA,NA,NA,Oct 2015,May 2016,Oct 2015 - May 2016
8115e94659e1cdad57574570cbe17501,7b80384023f2ecf7d88cce6c726c63ef,6542,Attack rate,Unspecified,0,0.03392993853432044,Unspecified,2040,2578,95% CI,NA,NA,0.03085915051717062,0.03899749511434601,NA,NA,6610681,NA,2243,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,TRUE,FALSE,Post outbreak,NA,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,Brazil,Persons under investigation,Goiania City,6610681,Population based,Unspecified,NA,May,2016,NA,Oct,2015,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,2,Attack rate,2040 - 2578,95% CI,2040 - 2578,Brazil,NA,NA,FALSE,NA,NA,NA,Oct 2015,May 2016,Oct 2015 - May 2016
8115e94659e1cdad57574570cbe17501,bdb5213803fa68711a3e2227d835b54e,6542,Attack rate,Unspecified,0,0.6060659883398674,Unspecified,12901,19791,95% CI,NA,NA,0.39507136150637295,0.6060659883398674,NA,NA,3265486,NA,19791,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,TRUE,FALSE,Post outbreak,NA,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,Brazil,Persons under investigation,Mato Grosso,3265486,Population based,Unspecified,NA,May,2016,NA,Oct,2015,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,2,Attack rate,12901 - 19791,95% CI,12901 - 19791,Brazil,NA,NA,FALSE,NA,NA,NA,Oct 2015,May 2016,Oct 2015 - May 2016
8115e94659e1cdad57574570cbe17501,8cca7f63d48f7bf4bdf4e562229feb45,6542,Attack rate,Unspecified,0,0.03590426889932454,Unspecified,3610,4382,95% CI,NA,NA,0.032338924831976444,0.03925461734452099,NA,NA,11163018,NA,4008,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,TRUE,FALSE,Post outbreak,NA,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,Brazil,Persons under investigation,Panara,11163018,Population based,Unspecified,NA,May,2016,NA,Oct,2015,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,2,Attack rate,3610 - 4382,95% CI,3610 - 4382,Brazil,NA,NA,FALSE,NA,NA,NA,Oct 2015,May 2016,Oct 2015 - May 2016
8115e94659e1cdad57574570cbe17501,c2269077d387ceec07957529cba00739,6542,Attack rate,Unspecified,0,0.10632226926136092,Unspecified,9320,10721,95% CI,NA,NA,0.0997306309899239,0.11472232777285128,NA,NA,9345173,NA,9936,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,TRUE,FALSE,Post outbreak,NA,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,Brazil,Persons under investigation,Pernambuco State,9345173,Population based,Unspecified,NA,May,2016,NA,Oct,2015,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,2,Attack rate,9320 - 10721,95% CI,9320 - 10721,Brazil,NA,NA,FALSE,NA,NA,NA,Oct 2015,May 2016,Oct 2015 - May 2016
8115e94659e1cdad57574570cbe17501,f1b9702c5ef9eab201ce753e1801f82e,6542,"Reproduction number (Effective, Re)",No units,0,1.63,Unspecified,1.58,1.68,95% CI,NA,NA,1.63,2.21,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,TRUE,FALSE,Post outbreak,Branching process,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,Brazil,Persons under investigation,Bahia,15203934,Population based,Unspecified,NA,May,2016,NA,Oct,2015,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,2,Reproduction number,1.63 - 2.21,95% CI,1.58 - 1.68,Brazil,NA,NA,FALSE,NA,NA,NA,Oct 2015,May 2016,Oct 2015 - May 2016
8115e94659e1cdad57574570cbe17501,c2aa152dc5d7d0fcf3b1667d5f5559c9,6542,"Reproduction number (Effective, Re)",No units,0,3.05,Unspecified,2.73,3.41,95% CI,NA,NA,2.11,3.05,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,TRUE,FALSE,Post outbreak,Branching process,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,Brazil,Persons under investigation,Espirito Santo,3929911,Population based,Unspecified,NA,May,2016,NA,Oct,2015,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,2,Reproduction number,2.11 - 3.05,95% CI,2.73 - 3.41,Brazil,NA,NA,FALSE,NA,NA,NA,Oct 2015,May 2016,Oct 2015 - May 2016
8115e94659e1cdad57574570cbe17501,79aedcffaf8978b6ed6560f7e08336c4,6542,"Reproduction number (Effective, Re)",No units,0,3.07,Unspecified,2.92,3.24,95% CI,NA,NA,1.89,3.33,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,TRUE,FALSE,Post outbreak,Branching process,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,Brazil,Persons under investigation,Goiania City,6610681,Population based,Unspecified,NA,May,2016,NA,Oct,2015,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,2,Reproduction number,1.89 - 3.33,95% CI,2.92 - 3.24,Brazil,NA,NA,FALSE,NA,NA,NA,Oct 2015,May 2016,Oct 2015 - May 2016
8115e94659e1cdad57574570cbe17501,3e59ddb6ebf9b8d3e4d836730ce27058,6542,"Reproduction number (Effective, Re)",No units,0,1.67,Unspecified,1.56,1.79,95% CI,NA,NA,1.67,2.47,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,TRUE,FALSE,Post outbreak,Branching process,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,Brazil,Persons under investigation,Mato Grosso,3265486,Population based,Unspecified,NA,May,2016,NA,Oct,2015,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,2,Reproduction number,1.67 - 2.47,95% CI,1.56 - 1.79,Brazil,NA,NA,FALSE,NA,NA,NA,Oct 2015,May 2016,Oct 2015 - May 2016
8115e94659e1cdad57574570cbe17501,a0ec1e71644b6f6133298fdbd6c12d10,6542,"Reproduction number (Effective, Re)",No units,0,2.82,Unspecified,2.66,2.99,95% CI,NA,NA,1.92,3.12,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,TRUE,FALSE,Post outbreak,Branching process,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,Brazil,Persons under investigation,Panara,11163018,Population based,Unspecified,NA,May,2016,NA,Oct,2015,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,2,Reproduction number,1.92 - 3.12,95% CI,2.66 - 2.99,Brazil,NA,NA,FALSE,NA,NA,NA,Oct 2015,May 2016,Oct 2015 - May 2016
8115e94659e1cdad57574570cbe17501,33ccdac4351f73717d0898f7db4ce68a,6542,"Reproduction number (Effective, Re)",No units,0,1.85,Unspecified,1.75,1.95,95% CI,NA,NA,1.77,2.33,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,TRUE,FALSE,Post outbreak,Branching process,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,Brazil,Persons under investigation,Pernambuco State,9345173,Population based,Unspecified,NA,May,2016,NA,Oct,2015,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,2,Reproduction number,1.77 - 2.33,95% CI,1.75 - 1.95,Brazil,NA,NA,FALSE,NA,NA,NA,Oct 2015,May 2016,Oct 2015 - May 2016
8115e94659e1cdad57574570cbe17501,1405977af6599ad2d08b9330d0df843c,6542,"Reproduction number (Effective, Re)",No units,0,1.54,Unspecified,1.43,1.65,95% CI,NA,NA,1.54,2.15,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,TRUE,FALSE,Post outbreak,Branching process,Richard Sheppard,Estimated model parameter,FALSE,NA,NA,Brazil,Persons under investigation,Rio Grande,11247972,Population based,Unspecified,NA,May,2016,NA,Oct,2015,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,2,Reproduction number,1.54 - 2.15,95% CI,1.43 - 1.65,Brazil,NA,NA,FALSE,NA,NA,NA,Oct 2015,May 2016,Oct 2015 - May 2016
eb974bf2994666ec49af5f0051a4281b,72f940bde84ba1927d4fc9d0c51b12b6,6547,Seroprevalence - IgM,Percentage (%),0,37,Mean,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,112,Naive,41,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Thomas Rawson,Observed sample statistic,FALSE,0,0,Brazil,Persons under investigation,Rio de Janeiro,112,Population based,Unspecified,NA,NA,2016,NA,NA,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,37,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,2015,2016,2015 - 2016
94857410e6c0ed0e8ae544b9120045a0,96917662164353f5270b80fea39895fd,6561,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Thomas Rawson,NA,FALSE,NA,NA,Colombia,General population,Barranquilla,7029,Population based,Both,NA,NA,2016,NA,NA,2014,NA,Adjusted,Other,NA,Infection,Significant,NA,TRUE,NA,Urban area,38,Risk factors,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,2014,2016,2014 - 2016
94857410e6c0ed0e8ae544b9120045a0,91031f6001d64e520d9dfbd75df2f0ba,6561,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Thomas Rawson,NA,FALSE,NA,NA,Colombia,General population,Barranquilla,7029,Population based,Both,NA,NA,2016,NA,NA,2014,NA,Adjusted,Other;Sex,NA,Infection,Not significant,NA,FALSE,NA,Urban area,38,Risk factors,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,2014,2016,2014 - 2016
e833e4e95de10ae999739a35977f6021,33c3d6deca9a651738c83562805940f8,6571,Mutations - substitution rate,Substitutions/site/year,-3,1.114,Unspecified,0.993,1.254,HPDI 95%,NA,NA,NA,NA,Whole genome sequence,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Thomas Rawson,Estimated model parameter,FALSE,NA,NA,"Multi-country: Americas (n = 17), Asia (n = 7), Oceania (n = 3), Europe (n = 2)",Unspecified,Global samples,182,Mixed settings,NA,1,Mar,2017,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,39,Mutations,NA,HPDI 95%,0.993 - 1.254,"Malaysia, Micronesia, Cambodia, Philippines, Thailand, Canada, French Polynesia, Haiti, Honduras, Brazil, Suriname, Colombia, Guatemala, Mexico, Puerto Rico, Panama, Martinique, French Guiana, Nicaragua, Italy, China, Australia, Venezuela, USA, Dominican Republic, Ecuador, United Kingdom, Japan, Singapore",NA,Asian lineage,FALSE,NA,NA,NA,Unspecified,1 Mar 2017,Unspecified - 1 Mar 2017
6fc4580341a16466ded9ccd7e9aa85d7,cd961918e10ff281e3967402853722e8,6583,Human delay - Onset to Admission to care,Days,0,8,Median,4,21,IQR,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,92,3,Brazil,Persons under investigation,Cases acquired in travellers in Americas or Caribbean,335,Travel based,Both,31,Dec,2019,1,Mar,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,27,Human delay,NA,IQR,4 - 21,Brazil,Onset to admission to care,NA,FALSE,NA,NA,NA,1 Mar 2016,31 Dec 2019,1 Mar 2016 - 31 Dec 2019
8479250bf4abb1f87b1d074e39d1090b,842b38b5efecddc55313300e0175a5ad,6591,Seroprevalence - IgG,Percentage (%),0,6.2,Central,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,65,Naive,4,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,15,Mali,General population,Niono,65,Population based,Both,NA,Nov,2016,NA,Oct,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,40,Seroprevalence,NA,NA,NA,Mali,NA,NA,FALSE,NA,NA,NA,Oct 2016,Nov 2016,Oct 2016 - Nov 2016
8479250bf4abb1f87b1d074e39d1090b,5f06793840d8b11f76a9b694d425b9f8,6591,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,3.1,Central,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,8,Naive,2,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,15,Mali,General population,Niono,65,Population based,Both,NA,Nov,2016,NA,Oct,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,40,Seroprevalence,NA,NA,NA,Mali,NA,NA,TRUE,NA,NA,NA,Oct 2016,Nov 2016,Oct 2016 - Nov 2016
8479250bf4abb1f87b1d074e39d1090b,ed6ccb315cdc44f02f05b0bfaff69311,6591,Seroprevalence - IgG,Percentage (%),0,8.5,Central,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,129,Naive,11,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,15,Mali,General population,Bamako,129,Population based,Both,NA,Nov,2016,NA,Oct,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,40,Seroprevalence,NA,NA,NA,Mali,NA,NA,FALSE,NA,NA,NA,Oct 2016,Nov 2016,Oct 2016 - Nov 2016
8479250bf4abb1f87b1d074e39d1090b,cc4a16b7185368cc838cc2b38dff4bb3,6591,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,5.4,Central,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,11,Naive,7,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,15,Mali,General population,Bamako,129,Population based,Both,NA,Nov,2016,NA,Oct,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,40,Seroprevalence,NA,NA,NA,Mali,NA,NA,TRUE,NA,NA,NA,Oct 2016,Nov 2016,Oct 2016 - Nov 2016
8479250bf4abb1f87b1d074e39d1090b,0056c0ee4c3f6fb7b272285e81d16a46,6591,Seroprevalence - IgG,Percentage (%),0,10.5,Central,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,637,Naive,67,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,NA,Mali,General population,Bamako,637,Population based,Both,NA,NA,2013,NA,NA,2013,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,40,Seroprevalence,NA,NA,NA,Mali,NA,NA,FALSE,NA,NA,NA,2013,2013,2013
8479250bf4abb1f87b1d074e39d1090b,ec6316b6bf54fa73b4d998b8e909a111,6591,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,7.4,Central,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,85,Naive,47,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,NA,Mali,General population,Bamako,637,Population based,Both,NA,NA,2013,NA,NA,2013,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,40,Seroprevalence,NA,NA,NA,Mali,NA,NA,TRUE,NA,NA,NA,2013,2013,2013
8479250bf4abb1f87b1d074e39d1090b,cd3b4ab8315aa1bc922310a57dfcb367,6591,Seroprevalence - IgG,Percentage (%),0,16.2,Central,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,136,Naive,22,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,15,Mali,General population,Kadiolo,136,Population based,Both,NA,Nov,2016,NA,Oct,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,40,Seroprevalence,NA,NA,NA,Mali,NA,NA,FALSE,NA,NA,NA,Oct 2016,Nov 2016,Oct 2016 - Nov 2016
8479250bf4abb1f87b1d074e39d1090b,be20ebed4a23efce3da8ef940618c040,6591,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,10.3,Central,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,23,Naive,14,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,15,Mali,General population,Kadiolo,136,Population based,Both,NA,Nov,2016,NA,Oct,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,40,Seroprevalence,NA,NA,NA,Mali,NA,NA,TRUE,NA,NA,NA,Oct 2016,Nov 2016,Oct 2016 - Nov 2016
8479250bf4abb1f87b1d074e39d1090b,5bb2688e90b9c79c1ff6dac44be28e21,6591,Seroprevalence - IgG,Percentage (%),0,17.3,Central,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,127,Naive,22,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,15,Mali,General population,Bougouni,127,Population based,Both,NA,Nov,2016,NA,Oct,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,40,Seroprevalence,NA,NA,NA,Mali,NA,NA,FALSE,NA,NA,NA,Oct 2016,Nov 2016,Oct 2016 - Nov 2016
8479250bf4abb1f87b1d074e39d1090b,e019b19ffbae247cf1bd4155524c4974,6591,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,11.8,Central,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,25,Naive,15,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,15,Mali,General population,Bougouni,127,Population based,Both,NA,Nov,2016,NA,Oct,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,40,Seroprevalence,NA,NA,NA,Mali,NA,NA,TRUE,NA,NA,NA,Oct 2016,Nov 2016,Oct 2016 - Nov 2016
8479250bf4abb1f87b1d074e39d1090b,e34e7058d586c5735eb1527e87a4a95d,6591,Seroprevalence - IgG,Percentage (%),0,17.5,Central,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,40,Naive,7,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,15,Mali,General population,Kita,40,Population based,Both,NA,Nov,2016,NA,Oct,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,40,Seroprevalence,NA,NA,NA,Mali,NA,NA,FALSE,NA,NA,NA,Oct 2016,Nov 2016,Oct 2016 - Nov 2016
8479250bf4abb1f87b1d074e39d1090b,92223dcf2e3558cb90119eeea4ad6bc8,6591,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,15,Central,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,12,Naive,6,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,15,Mali,General population,Kita,40,Population based,Both,NA,Nov,2016,NA,Oct,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,40,Seroprevalence,NA,NA,NA,Mali,NA,NA,TRUE,NA,NA,NA,Oct 2016,Nov 2016,Oct 2016 - Nov 2016
8479250bf4abb1f87b1d074e39d1090b,f76ad52d4c8169cd4c3e7a1d8a593bb2,6591,Seroprevalence - IgG,Percentage (%),0,43.3,Central,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,187,Naive,81,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,15,Mali,General population,Bandiagara,187,Population based,Both,NA,Nov,2016,NA,Oct,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,40,Seroprevalence,NA,NA,NA,Mali,NA,NA,FALSE,NA,NA,NA,Oct 2016,Nov 2016,Oct 2016 - Nov 2016
8479250bf4abb1f87b1d074e39d1090b,978b52fb20b1878a40037580e42d72be,6591,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,15.5,Central,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,105,Naive,29,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,15,Mali,General population,Bandiagara,187,Population based,Both,NA,Nov,2016,NA,Oct,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,40,Seroprevalence,NA,NA,NA,Mali,NA,NA,TRUE,NA,NA,NA,Oct 2016,Nov 2016,Oct 2016 - Nov 2016
8479250bf4abb1f87b1d074e39d1090b,c8ce9438e9480e4620c5f444c8bba739,6591,Seroprevalence - IgG,Percentage (%),0,35.8,Central,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,109,Naive,39,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,15,Mali,General population,Diema,109,Population based,Both,NA,Nov,2016,NA,Oct,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,40,Seroprevalence,NA,NA,NA,Mali,NA,NA,FALSE,NA,NA,NA,Oct 2016,Nov 2016,Oct 2016 - Nov 2016
8479250bf4abb1f87b1d074e39d1090b,b02d38ea53474578105bde3c6eb7b095,6591,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,20.2,Central,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,53,Naive,22,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,15,Mali,General population,Diema,109,Population based,Both,NA,Nov,2016,NA,Oct,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,40,Seroprevalence,NA,NA,NA,Mali,NA,NA,TRUE,NA,NA,NA,Oct 2016,Nov 2016,Oct 2016 - Nov 2016
8479250bf4abb1f87b1d074e39d1090b,730a7c7b5fa199f0d02d2a3534411248,6591,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Thomas Rawson,NA,FALSE,NA,NA,Mali,General population,NA,1430,Population based,Both,NA,Nov,2016,NA,NA,2013,NA,Not adjusted,Age,NA,Serology,Significant,NA,FALSE,NA,Unspecified,40,Risk factors,NA,NA,NA,Mali,NA,NA,FALSE,NA,NA,NA,2013,Nov 2016,2013 - Nov 2016
8479250bf4abb1f87b1d074e39d1090b,a3e1e869b55139dd117e3c0a08c33cc3,6591,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Thomas Rawson,NA,FALSE,NA,NA,Mali,General population,NA,1430,Population based,Both,NA,Nov,2016,NA,NA,2013,NA,Not adjusted,Sex,NA,Serology,Not significant,NA,FALSE,NA,Unspecified,40,Risk factors,NA,NA,NA,Mali,NA,NA,FALSE,NA,NA,NA,2013,Nov 2016,2013 - Nov 2016
08976cd8a63cc57d626d8688c6fa5c8a,eb37a62a3162e0325784546fba1108b1,6592,Seroprevalence - IgG,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,179,NA,51,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,France,Pregnant women,Guadeloupe,179,Population based,Both,NA,Mar,2017,NA,Apr,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,43,Seroprevalence,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,Apr 2016,Mar 2017,Apr 2016 - Mar 2017
8bb8cc7e1db892dfb61c810f3b2d5d44,dcd5532021b67a185fc4f9f65bb3407f,6603,Seroprevalence - IgG,Percentage (%),0,21.7,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,152,Naive,33,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Richard Sheppard,Observed sample statistic,FALSE,80,0,Nigeria,Mixed groups,"Abia State  University Teaching Hospital, Aba, Abia state",152,Hospital based,Unspecified,NA,Nov,2021,NA,Dec,2020,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Both urban and rural areas,1,Seroprevalence,NA,NA,NA,Nigeria,NA,NA,FALSE,NA,NA,NA,Dec 2020,Nov 2021,Dec 2020 - Nov 2021
8bb8cc7e1db892dfb61c810f3b2d5d44,1920ffdfaf31d164e5278fc72770d338,6603,Seroprevalence - IgG,Percentage (%),0,18.9,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,419,Naive,79,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Richard Sheppard,Observed sample statistic,FALSE,80,0,Nigeria,Mixed groups,"Federal Medical Centre, Keffi, Nasarawa State.",419,Hospital based,Unspecified,NA,Nov,2021,NA,Dec,2020,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Both urban and rural areas,1,Seroprevalence,NA,NA,NA,Nigeria,NA,NA,FALSE,NA,NA,NA,Dec 2020,Nov 2021,Dec 2020 - Nov 2021
8bb8cc7e1db892dfb61c810f3b2d5d44,b2ec0575c6f4ec1be937f70bcf1c4ad2,6603,Seroprevalence - IgG,Percentage (%),0,18.3,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,300,Naive,55,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Richard Sheppard,Observed sample statistic,FALSE,80,0,Nigeria,Mixed groups,"Baru-Dokp Teaching Hospital, Kaduna, Kaduna State",300,Hospital based,Unspecified,NA,Nov,2021,NA,Dec,2020,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Both urban and rural areas,1,Seroprevalence,NA,NA,NA,Nigeria,NA,NA,FALSE,NA,NA,NA,Dec 2020,Nov 2021,Dec 2020 - Nov 2021
8bb8cc7e1db892dfb61c810f3b2d5d44,3b55f091414050cadfed7857288bf586,6603,Seroprevalence - IgG,Percentage (%),0,19.2,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,871,Naive,167,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Other, Region, Sex",FALSE,FALSE,Endemic,NA,Richard Sheppard,Observed sample statistic,FALSE,80,0,Nigeria,Mixed groups,"Abia State  University Teaching Hospital, Aba, Abia state, Federal Medical Centre, Keffi, Nasarawa State, Baru-Dokp Teaching Hospital, Kaduna, Kaduna State",871,Hospital based,Unspecified,NA,Nov,2021,NA,Dec,2020,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Both urban and rural areas,1,Seroprevalence,NA,NA,NA,Nigeria,NA,NA,FALSE,NA,NA,NA,Dec 2020,Nov 2021,Dec 2020 - Nov 2021
8bb8cc7e1db892dfb61c810f3b2d5d44,4f0022ee0356ce43cf89163d35fc041b,6603,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Richard Sheppard,NA,FALSE,80,0,Nigeria,Mixed groups,"Abia State  University Teaching Hospital, Aba, Abia state, Federal Medical Centre, Keffi, Nasarawa State, Baru-Dokp Teaching Hospital, Kaduna, Kaduna State",871,Hospital based,Unspecified,NA,Nov,2021,NA,Dec,2020,NA,Not adjusted,Age;Comorbidity;Other,NA,Serology,Significant,NA,FALSE,Unspecified,Both urban and rural areas,1,Risk factors,NA,NA,NA,Nigeria,NA,NA,FALSE,NA,NA,NA,Dec 2020,Nov 2021,Dec 2020 - Nov 2021
8bb8cc7e1db892dfb61c810f3b2d5d44,fdcf21e5dd7a1324d5054c4db3e41859,6603,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Richard Sheppard,NA,FALSE,80,0,Nigeria,Mixed groups,"Abia State  University Teaching Hospital, Aba, Abia state, Federal Medical Centre, Keffi, Nasarawa State, Baru-Dokp Teaching Hospital, Kaduna, Kaduna State",871,Hospital based,Unspecified,NA,Nov,2021,NA,Dec,2020,NA,Not adjusted,Other;Sex,NA,Serology,Not significant,NA,FALSE,Unspecified,Both urban and rural areas,1,Risk factors,NA,NA,NA,Nigeria,NA,NA,FALSE,NA,NA,NA,Dec 2020,Nov 2021,Dec 2020 - Nov 2021
d4d7d8634777fbde9ea48f21fae665c6,d7e1a0d5761214177ae9c4f9e0dea358,6604,Seroprevalence - IgM,Percentage (%),0,1.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,295,NA,4,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Sri Lanka,Persons under investigation,Kandy,NA,Hospital based,Both,NA,NA,2019,NA,NA,2017,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,42,Seroprevalence,NA,NA,NA,Sri Lanka,NA,NA,FALSE,NA,NA,NA,2017,2019,2017 - 2019
d4d7d8634777fbde9ea48f21fae665c6,873726a934f30dc926e5a85f0e6454f0,6604,Seroprevalence - IgM,Percentage (%),0,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,300,NA,17,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Sri Lanka,Persons under investigation,Negombo,NA,Hospital based,Both,NA,NA,2019,NA,NA,2018,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,42,Seroprevalence,NA,NA,NA,Sri Lanka,NA,NA,FALSE,NA,NA,NA,2018,2019,2018 - 2019
d4d7d8634777fbde9ea48f21fae665c6,884687ccc4e0d64ee8151fc7ffd10c45,6604,Seroprevalence - IgG,Percentage (%),0,34.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,295,NA,102,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Sri Lanka,Persons under investigation,Kandy,NA,Hospital based,Both,NA,NA,2019,NA,NA,2017,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,42,Seroprevalence,NA,NA,NA,Sri Lanka,NA,NA,FALSE,NA,NA,NA,2017,2019,2017 - 2019
d4d7d8634777fbde9ea48f21fae665c6,b9fce5b986fcfa53678f75fc4e857e02,6604,Seroprevalence - IgG,Percentage (%),0,42.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,300,NA,128,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Sri Lanka,Persons under investigation,Negombo,NA,Hospital based,Both,NA,NA,2019,NA,NA,2018,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,42,Seroprevalence,NA,NA,NA,Sri Lanka,NA,NA,FALSE,NA,NA,NA,2018,2019,2018 - 2019
e5c7ec30eb545d73256b268899bc723c,d56fa8865783c4673360e7dd6fad8d18,6618,Seroprevalence - IgM,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,339,NA,110,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,United States,Persons under investigation,Puerto Rico,339,Population based,Both,NA,Dec,2016,NA,Apr,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,41,Seroprevalence,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,Apr 2016,Dec 2016,Apr 2016 - Dec 2016
c7c487d03be27cd772b0a45dca22a6a4,bd5cf23c1e0b9346166bb4bf545d03f3,6619,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,NA,FALSE,NA,NA,Brazil,General population,Rio de Janeiro,39331,Population based,Unspecified,NA,NA,2016,NA,NA,2015,NA,Adjusted,Other,NA,Other,Significant,NA,FALSE,NA,Urban area,25,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,2015,2016,2015 - 2016
50136ace92e1daddec1569d39dc229b2,e8956207767e2607f6198b5cfce3d4d3,6658,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Colombia,Pregnant women,NA,102,Hospital based,Female,NA,Jan,2017,NA,Oct,2015,NA,Not adjusted,Infection during pregnancy,NA,Zika congenital syndrome/other birth defects,Not significant,NA,FALSE,NA,NA,40,Risk factors,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,Oct 2015,Jan 2017,Oct 2015 - Jan 2017
50136ace92e1daddec1569d39dc229b2,8c0d3014fa9b51c429e0a8e9f5a83636,6658,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Colombia,Pregnant women,NA,102,Hospital based,Female,NA,Jan,2017,NA,Oct,2015,NA,Not adjusted,Infection during pregnancy,NA,Other,Significant,NA,FALSE,NA,NA,40,Risk factors,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,Oct 2015,Jan 2017,Oct 2015 - Jan 2017
cd52b648ebdca9b9d49a0f8946e7696a,b29a9c8db96e6daa2d30ce64a8d5d3b0,6670,Attack rate,Unspecified,0,0.25,Median,0.19,0.31,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,TRUE,Unspecified,NA,Tristan Naidoo,Estimated model parameter,FALSE,NA,NA,Brazil,General population,NA,NA,Population based,Unspecified,31,Dec,2018,NA,Apr,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,25,Attack rate,NA,95% CrI,0.19 - 0.31,Brazil,NA,NA,FALSE,NA,NA,NA,Apr 2015,31 Dec 2018,Apr 2015 - 31 Dec 2018
cd52b648ebdca9b9d49a0f8946e7696a,32c84dfc69110df7f27f5f670be792d9,6670,Attack rate,Unspecified,0,0.16,Median,0.07,0.29,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,TRUE,Unspecified,NA,Tristan Naidoo,Estimated model parameter,FALSE,NA,NA,Bolivia,General population,NA,NA,Population based,Unspecified,30,Jun,2018,1,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,25,Attack rate,NA,95% CrI,0.07 - 0.29,Bolivia,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,30 Jun 2018,1 Jan 2016 - 30 Jun 2018
cd52b648ebdca9b9d49a0f8946e7696a,ddf1e44a4992fa53295c4ee4ad02eb5d,6670,Attack rate,Unspecified,0,0.23,Median,0.07,0.49,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,TRUE,Unspecified,NA,Tristan Naidoo,Estimated model parameter,FALSE,NA,NA,Belize,General population,NA,NA,Population based,Unspecified,31,Dec,2017,1,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,25,Attack rate,NA,95% CrI,0.07 - 0.49,Belize,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,31 Dec 2017,1 Jan 2016 - 31 Dec 2017
cd52b648ebdca9b9d49a0f8946e7696a,a95722b280945c3078e2c256b0a386e3,6670,Attack rate,Unspecified,0,0.19,Median,0.15,0.23,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,TRUE,Unspecified,NA,Tristan Naidoo,Estimated model parameter,FALSE,NA,NA,Colombia,General population,NA,NA,Population based,Unspecified,31,Dec,2017,9,Aug,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,25,Attack rate,NA,95% CrI,0.15 - 0.23,Colombia,NA,NA,FALSE,NA,NA,NA,9 Aug 2015,31 Dec 2017,9 Aug 2015 - 31 Dec 2017
cd52b648ebdca9b9d49a0f8946e7696a,6719da99fe544495c056ad542f26373f,6670,Attack rate,Unspecified,0,0.09,Median,0.02,0.19,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,TRUE,Unspecified,NA,Tristan Naidoo,Estimated model parameter,FALSE,NA,NA,Costa Rica,General population,NA,NA,Population based,Unspecified,31,Dec,2017,1,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,25,Attack rate,NA,95% CrI,0.02 - 0.19,Costa Rica,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,31 Dec 2017,1 Jan 2016 - 31 Dec 2017
cd52b648ebdca9b9d49a0f8946e7696a,762f68080932e5b313a83f790d47e551,6670,Attack rate,Unspecified,0,0.25,Median,0.18,0.33,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,TRUE,Unspecified,NA,Tristan Naidoo,Estimated model parameter,FALSE,NA,NA,Dominican Republic,General population,NA,NA,Population based,Unspecified,25,Mar,2018,1,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,25,Attack rate,NA,95% CrI,0.18 - 0.33,Dominican Republic,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,25 Mar 2018,1 Jan 2016 - 25 Mar 2018
cd52b648ebdca9b9d49a0f8946e7696a,d70d9d4ff489dd67492922d44f29b87c,6670,Attack rate,Unspecified,0,0.361,Median,0.214,0.514,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,Estimated model parameter,FALSE,NA,NA,Ecuador,General population,NA,NA,Population based,Unspecified,23,Oct,2018,20,Dec,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,25,Attack rate,NA,95% CrI,0.214 - 0.514,Ecuador,NA,NA,FALSE,NA,NA,NA,20 Dec 2015,23 Oct 2018,20 Dec 2015 - 23 Oct 2018
cd52b648ebdca9b9d49a0f8946e7696a,72cafdea17ce39956fa6c0f560dbd678,6670,Attack rate,Unspecified,0,0.28,Median,0.16,0.4,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,TRUE,Unspecified,NA,Tristan Naidoo,Estimated model parameter,FALSE,NA,NA,El Salvador,General population,NA,NA,Population based,Unspecified,16,Dec,2017,22,Nov,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,25,Attack rate,NA,95% CrI,0.16 - 0.4,El Salvador,NA,NA,FALSE,NA,NA,NA,22 Nov 2015,16 Dec 2017,22 Nov 2015 - 16 Dec 2017
cd52b648ebdca9b9d49a0f8946e7696a,5858804b3171dbf6f674bce95f7b7305,6670,Attack rate,Unspecified,0,0.23,Median,0.16,0.29,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,TRUE,Unspecified,NA,Tristan Naidoo,Estimated model parameter,FALSE,NA,NA,Guatemala,General population,NA,NA,Population based,Unspecified,20,Oct,2018,29,Nov,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,25,Attack rate,NA,95% CrI,0.16 - 0.29,Guatemala,NA,NA,FALSE,NA,NA,NA,29 Nov 2015,20 Oct 2018,29 Nov 2015 - 20 Oct 2018
cd52b648ebdca9b9d49a0f8946e7696a,5960603af6ff9bed2a91af597cd92a20,6670,Attack rate,Unspecified,0,0.36,Median,0.22,0.49,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,TRUE,Unspecified,NA,Tristan Naidoo,Estimated model parameter,FALSE,NA,NA,Honduras,General population,NA,NA,Population based,Unspecified,4,Jan,2018,13,Dec,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,25,Attack rate,NA,95% CrI,0.22 - 0.49,Honduras,NA,NA,FALSE,NA,NA,NA,13 Dec 2015,4 Jan 2018,13 Dec 2015 - 4 Jan 2018
cd52b648ebdca9b9d49a0f8946e7696a,e0e397a6898deb5d3e2316ef1a37f7e0,6670,Attack rate,Unspecified,0,0.2,Median,0.15,0.25,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,TRUE,Unspecified,NA,Tristan Naidoo,Estimated model parameter,FALSE,NA,NA,Mexico,General population,NA,NA,Population based,Unspecified,5,Nov,2018,28,Nov,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,25,Attack rate,NA,95% CrI,0.15 - 0.25,Mexico,NA,NA,FALSE,NA,NA,NA,28 Nov 2015,5 Nov 2018,28 Nov 2015 - 5 Nov 2018
cd52b648ebdca9b9d49a0f8946e7696a,3e51dc273f45c9a030e94a073889da01,6670,Attack rate,Unspecified,0,0.12,Median,0.06,0.22,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,TRUE,Unspecified,NA,Tristan Naidoo,Estimated model parameter,FALSE,NA,NA,Panama,General population,NA,NA,Population based,Unspecified,10,Nov,2018,22,Nov,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,25,Attack rate,NA,95% CrI,0.06 - 0.22,Panama,NA,NA,FALSE,NA,NA,NA,22 Nov 2015,10 Nov 2018,22 Nov 2015 - 10 Nov 2018
cd52b648ebdca9b9d49a0f8946e7696a,2a212848d802c21256004a6b5dac5f65,6670,Attack rate,Unspecified,0,0.33,Median,0.21,0.46,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,TRUE,Unspecified,NA,Tristan Naidoo,Estimated model parameter,FALSE,NA,NA,Nicaragua,General population,NA,NA,Population based,Unspecified,31,Dec,2017,27,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,25,Attack rate,NA,95% CrI,0.21 - 0.46,Nicaragua,NA,NA,FALSE,NA,NA,NA,27 Jan 2016,31 Dec 2017,27 Jan 2016 - 31 Dec 2017
cd52b648ebdca9b9d49a0f8946e7696a,ebab67fbd047bcaa201bbc5b4022ab14,6670,Attack rate,Unspecified,0,0.084,Median,0.067,0.096,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,Estimated model parameter,FALSE,NA,NA,Peru,General population,NA,NA,Population based,Unspecified,15,Sep,2018,1,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,25,Attack rate,NA,95% CrI,0.067 - 0.096,Peru,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,15 Sep 2018,1 Jan 2016 - 15 Sep 2018
cd52b648ebdca9b9d49a0f8946e7696a,bb6547559926cc8c57b0040882e594c4,6670,Attack rate,Unspecified,0,0.32,Median,0.29,0.35,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,TRUE,Unspecified,NA,Tristan Naidoo,Estimated model parameter,FALSE,NA,NA,United States,General population,Puerto Rico,NA,Population based,Unspecified,7,Jan,2017,1,Jan,2007,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,25,Attack rate,NA,95% CrI,0.29 - 0.35,United States,NA,NA,FALSE,NA,NA,NA,1 Jan 2007,7 Jan 2017,1 Jan 2007 - 7 Jan 2017
cd52b648ebdca9b9d49a0f8946e7696a,5b6a6f2df0930c946671b4fa1a58d463,6670,Attack rate,Unspecified,0,0.016,Median,0.01,0.025,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,Estimated model parameter,FALSE,NA,NA,Brazil,General population,State of Paraná,NA,Population based,Unspecified,31,Dec,2018,NA,Apr,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,25,Attack rate,NA,95% CrI,0.01 - 0.025,Brazil,NA,NA,FALSE,NA,NA,NA,Apr 2015,31 Dec 2018,Apr 2015 - 31 Dec 2018
cd52b648ebdca9b9d49a0f8946e7696a,2d64988413865d745612cd2cf1f11e02,6670,Attack rate,Unspecified,0,0.766,Median,0.569,0.942,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,Estimated model parameter,FALSE,NA,NA,Brazil,General population,State of Sergipe,NA,Population based,Unspecified,31,Dec,2018,NA,Apr,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,25,Attack rate,NA,95% CrI,0.569 - 0.942,Brazil,NA,NA,FALSE,NA,NA,NA,Apr 2015,31 Dec 2018,Apr 2015 - 31 Dec 2018
cd52b648ebdca9b9d49a0f8946e7696a,9bf9bc0e6608087fa4d75b6e94660ebd,6670,Attack rate,Unspecified,0,0,Median,0,0,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,Estimated model parameter,FALSE,NA,NA,Mexico,General population,Federal District,NA,Population based,Unspecified,5,Nov,2018,28,Nov,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,25,Attack rate,NA,95% CrI,0 - 0,Mexico,NA,NA,FALSE,NA,NA,NA,28 Nov 2015,5 Nov 2018,28 Nov 2015 - 5 Nov 2018
cd52b648ebdca9b9d49a0f8946e7696a,acc1a19b7f3ed4001b3f089faba946fe,6670,Attack rate,Unspecified,0,0.793,Median,0.524,0.963,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,Estimated model parameter,FALSE,NA,NA,Mexico,General population,State of Yucatán,NA,Population based,Unspecified,5,Nov,2018,28,Nov,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,25,Attack rate,NA,95% CrI,0.524 - 0.963,Mexico,NA,NA,FALSE,NA,NA,NA,28 Nov 2015,5 Nov 2018,28 Nov 2015 - 5 Nov 2018
cd52b648ebdca9b9d49a0f8946e7696a,2f73ed9234b4ece607320fa815d234e4,6670,Attack rate,Unspecified,0,0.514,Median,0.388,0.631,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,Estimated model parameter,FALSE,NA,NA,Brazil,General population,Bahia,NA,Population based,Unspecified,31,Dec,2018,NA,Apr,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,25,Attack rate,NA,95% CrI,0.388 - 0.631,Brazil,NA,NA,FALSE,NA,NA,NA,Apr 2015,31 Dec 2018,Apr 2015 - 31 Dec 2018
cd52b648ebdca9b9d49a0f8946e7696a,50ceb31c4016a2bb7b4fc15ceeeb5010,6670,Attack rate,Unspecified,0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,Estimated model parameter,TRUE,NA,NA,Multi-country: South and Central America (n = 13),General population,NA,NA,Population based,Female,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,25,Attack rate,NA,NA,NA,"Belize, Bolivia, Colombia, Costa Rica, Dominican Republic, Ecuador, El Salvador, Guatemala, Honduras, Mexico, Panama, Peru, Puerto Rico",NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
cd52b648ebdca9b9d49a0f8946e7696a,65bb47c1e5694d6854192d4259fa1c01,6670,Attack rate,Unspecified,0,NA,Median,NA,NA,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Region,TRUE,FALSE,Unspecified,NA,Tristan Naidoo,Estimated model parameter,TRUE,NA,NA,Multi-country: South and Central America (n = 5),General population,NA,NA,Population based,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,25,Attack rate,NA,NA,NA,"Bolivia, Brazil, Ecuador, Nicaragua, Puerto Rico",NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
cd52b648ebdca9b9d49a0f8946e7696a,1d27d1155871492aef0c2256a8330cff,6670,Attack rate,Unspecified,0,NA,Median,NA,NA,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Region,TRUE,TRUE,Unspecified,NA,Tristan Naidoo,Estimated model parameter,TRUE,NA,NA,Multi-country: South and Central America (n = 10),General population,NA,NA,Population based,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,25,Attack rate,NA,NA,NA,"Belize, Colombia, Costa Rica, Dominican Republic, El Salvador, Guatemala, Honduras, Mexico, Panama, Peru",NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
4d1ec9b774028eb5f532d36d386a4eed,8b1c9ef83158e4ac9eb9ea603a3bfdf3,6680,Seroprevalence - MIA,Percentage (%),0,6.7,NA,4.5,9.4,95% CI,NA,NA,NA,NA,NA,NA,451,NA,30,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Fiji,Persons under investigation,Central division,778,Population based,Both,NA,Nov,2013,NA,Sep,2013,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,39,Seroprevalence,NA,95% CI,4.5 - 9.4,Fiji,NA,NA,FALSE,NA,NA,NA,Sep 2013,Nov 2013,Sep 2013 - Nov 2013
4d1ec9b774028eb5f532d36d386a4eed,ade6d26ca55b8df62b9afb03cc4eb471,6680,Seroprevalence - MIA,Percentage (%),0,11.9,NA,4.9,22.9,95% CI,NA,NA,NA,NA,NA,NA,59,NA,7,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Fiji,Persons under investigation,Northern division,778,Population based,Both,NA,Nov,2013,NA,Sep,2013,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,39,Seroprevalence,NA,95% CI,4.9 - 22.9,Fiji,NA,NA,FALSE,NA,NA,NA,Sep 2013,Nov 2013,Sep 2013 - Nov 2013
4d1ec9b774028eb5f532d36d386a4eed,29778d1a936e57776e1d62c540143bff,6680,Seroprevalence - MIA,Percentage (%),0,9,NA,5.8,13,95% CI,NA,NA,NA,NA,NA,NA,268,NA,24,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Fiji,Persons under investigation,Western division,778,Population based,Both,NA,Nov,2013,NA,Sep,2013,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,39,Seroprevalence,NA,95% CI,5.8 - 13,Fiji,NA,NA,FALSE,NA,NA,NA,Sep 2013,Nov 2013,Sep 2013 - Nov 2013
4d1ec9b774028eb5f532d36d386a4eed,eb39e2b3c41c09b7bc2dd9dd97117b0f,6680,Seroprevalence - MIA,Percentage (%),0,21.9,NA,17.9,26.8,95% CI,NA,NA,NA,NA,NA,NA,333,NA,73,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Fiji,Persons under investigation,Central division,333,Population based,Both,NA,Nov,2015,NA,Oct,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,39,Seroprevalence,NA,95% CI,17.9 - 26.8,Fiji,NA,NA,FALSE,NA,NA,NA,Oct 2015,Nov 2015,Oct 2015 - Nov 2015
4d1ec9b774028eb5f532d36d386a4eed,182d5beef039af5b51175f5d9d04e67d,6680,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Fiji,Persons under investigation,NA,NA,Population based,Both,NA,Nov,2015,NA,Sep,2013,NA,NA,Other,NA,Infection,Significant,NA,FALSE,NA,NA,39,Risk factors,NA,NA,NA,Fiji,NA,NA,FALSE,NA,NA,NA,Sep 2013,Nov 2015,Sep 2013 - Nov 2015
4d1ec9b774028eb5f532d36d386a4eed,91edc558eba02221a49f2b042ee92ae0,6680,Seroprevalence - MIA,Percentage (%),0,NA,NA,NA,NA,NA,NA,NA,6.1,25.2,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,"Age, Sex, Time",TRUE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Fiji,Persons under investigation,NA,NA,Population based,Both,NA,Nov,2015,NA,Sep,2013,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,39,Seroprevalence,6.1 - 25.2,NA,NA,Fiji,NA,NA,FALSE,NA,NA,NA,Sep 2013,Nov 2015,Sep 2013 - Nov 2015
4d1ec9b774028eb5f532d36d386a4eed,b663f54e6108bbbaa25fc6c6cabb5377,6680,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Fiji,Persons under investigation,NA,NA,Population based,Both,NA,Nov,2015,NA,Sep,2013,NA,NA,Other,NA,Infection,Not significant,NA,FALSE,NA,NA,39,Risk factors,NA,NA,NA,Fiji,NA,NA,FALSE,NA,NA,NA,Sep 2013,Nov 2015,Sep 2013 - Nov 2015
42ca375409886e54bb3987ce7db7f0f8,623d0582e47b1c0f6e124e76efe8bd34,6681,Seroprevalence - IgG,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1226,NA,311,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Tristan Naidoo,NA,FALSE,NA,NA,Cabo Verde,Persons under investigation,NA,1226,Population based,Unspecified,NA,NA,2016,NA,Oct,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,26,Seroprevalence,NA,NA,NA,Cabo Verde,NA,NA,FALSE,NA,NA,NA,Oct 2015,2016,Oct 2015 - 2016
42ca375409886e54bb3987ce7db7f0f8,fe9bb6bb2901ba3fd0632be94a836988,6681,Seroprevalence - Neutralisation/PRNT,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,311,NA,311,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Tristan Naidoo,NA,FALSE,NA,NA,Cabo Verde,Persons under investigation,NA,1226,Population based,Unspecified,NA,NA,2016,NA,Oct,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,26,Seroprevalence,NA,NA,NA,Cabo Verde,NA,NA,TRUE,NA,NA,NA,Oct 2015,2016,Oct 2015 - 2016
fe0b2636260badbeeefec450911672e4,d4643f25f0ffcae4f0d93c78c2c9283e,6689,Seroprevalence - IgG,Percentage (%),0,80.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,102,NA,82,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Tristan Naidoo,NA,FALSE,NA,NA,Nicaragua,Pregnant women,León,102,Hospital based,Female,NA,NA,NA,5,Feb,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,Post-partum,Unspecified,27,Seroprevalence,NA,NA,NA,Nicaragua,NA,NA,FALSE,NA,NA,NA,5 Feb 2017,Unspecified,5 Feb 2017 - Unspecified
fe0b2636260badbeeefec450911672e4,eba66cb6ed029673391bace8bd86e9fb,6689,Seroprevalence - IgG,Percentage (%),0,66.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,134,NA,89,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Tristan Naidoo,NA,FALSE,NA,NA,Nicaragua,Pregnant women,León,134,Hospital based,Female,NA,NA,NA,5,Feb,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,Post-partum,Unspecified,27,Seroprevalence,NA,NA,NA,Nicaragua,NA,NA,FALSE,NA,NA,NA,5 Feb 2017,Unspecified,5 Feb 2017 - Unspecified
f27c20d1bf48acea3572c2933719f03c,a69658a888b2d2aff909faa42c4d246c,6711,Seroprevalence - IgM,Percentage (%),0,44.4,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,90,NA,40,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Brazil,Pregnant women,Bahia,90,Hospital based,Female,NA,Feb,2016,NA,Mar,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,26,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Mar 2015,Feb 2016,Mar 2015 - Feb 2016
f27c20d1bf48acea3572c2933719f03c,793892c1f2fd2422c60286abe95cc749,6711,Seroprevalence - IgG,Percentage (%),0,96.7,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,90,NA,87,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Brazil,Pregnant women,Bahia,90,Hospital based,Female,NA,Feb,2016,NA,Mar,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,26,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Mar 2015,Feb 2016,Mar 2015 - Feb 2016
f27c20d1bf48acea3572c2933719f03c,3b928580e59592a64217fe55f3a1920e,6711,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,90,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,90,NA,81,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Brazil,Pregnant women,Bahia,90,Hospital based,Female,NA,Feb,2016,NA,Mar,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,26,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Mar 2015,Feb 2016,Mar 2015 - Feb 2016
f27c20d1bf48acea3572c2933719f03c,1b511982a5ff212a415426e6ea5d0efa,6711,Seroprevalence - IgM,Percentage (%),0,7.1,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,70,NA,5,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Brazil,Children,Bahia,70,Hospital based,Both,NA,Feb,2016,NA,Mar,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,26,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Mar 2015,Feb 2016,Mar 2015 - Feb 2016
f27c20d1bf48acea3572c2933719f03c,17e03079460a8f119cbe7c036ca9f863,6711,Seroprevalence - IgG,Percentage (%),0,88.6,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,70,NA,62,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Brazil,Children,Bahia,70,Hospital based,Both,NA,Feb,2016,NA,Mar,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,26,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Mar 2015,Feb 2016,Mar 2015 - Feb 2016
f27c20d1bf48acea3572c2933719f03c,b3c339f0bb3b3169d0ec4e549732099f,6711,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,84.8,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,46,NA,39,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Brazil,Children,Bahia,70,Hospital based,Both,NA,Feb,2016,NA,Mar,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,26,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Mar 2015,Feb 2016,Mar 2015 - Feb 2016
ed43f86fe6ae5c02f2629948d3194ad9,7864038c0215a23be1753edc3718f990,6715,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Keith Fraser,NA,FALSE,2,0,Brazil,Children,Ceará,174,Population based,Both,NA,Jun,2017,NA,Oct,2015,NA,Adjusted,Infection;Infection during pregnancy;Other,NA,Zika congenital syndrome/other birth defects,Significant,NA,FALSE,First trimester,Unspecified,1,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Oct 2015,Jun 2017,Oct 2015 - Jun 2017
afc53e9ab1ddea2077405574f76f3579,d7d6a3cff0c7bef37055be9b00560184,6717,Reproduction number (Basic R0),No units,0,2.69,Unspecified,2.31,3.11,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,Growth rate,Tristan Naidoo,Estimated model parameter,FALSE,NA,NA,Brazil,General population,Manaus,NA,Population based,Both,NA,NA,NA,NA,Nov,2015,Unspecified,NA,NA,NA,NA,NA,NA,TRUE,NA,Unspecified,28,Reproduction number,NA,95% CrI,2.31 - 3.11,Brazil,NA,NA,FALSE,NA,NA,NA,Nov 2015,Unspecified,Nov 2015 - Unspecified
afc53e9ab1ddea2077405574f76f3579,155cbd1eeef7b18e873cc9ae6f688c15,6717,Mutations - evolutionary rate,Substitutions/site/year,-3,1.09,Unspecified,0.77,1.43,95% CrI,NA,NA,NA,NA,Whole genome sequence,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Tristan Naidoo,Estimated model parameter,FALSE,NA,NA,Brazil,General population,Manaus,59,Population based,Both,NA,Mar,2017,15,Dec,2015,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,Unspecified,28,Mutations,NA,95% CrI,0.00077 - 0.00143,Brazil,NA,Manaus clade,FALSE,NA,NA,NA,15 Dec 2015,Mar 2017,15 Dec 2015 - Mar 2017
afc53e9ab1ddea2077405574f76f3579,33cdc9cbb0aa7a020dbe11c075d6b198,6717,Risk factors,NA,0,NA,NA,8e-4,0.0014,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Tristan Naidoo,NA,FALSE,NA,NA,Brazil,General population,Manaus,NA,Population based,Both,NA,NA,NA,NA,NA,NA,NA,Not adjusted,Other,NA,Infection,Significant,NA,TRUE,NA,Unspecified,28,Risk factors,NA,95% CrI,8e-04 - 0.0014,Brazil,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
220cb6dee3b143db40b2441417de6648,630cba71541e28fb52b057ced814d7c0,6731,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,61.2,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,469,NA,287,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,Observed sample statistic,FALSE,NA,NA,Brazil,Pregnant women,Salvador (Hospital Geral Roberto Santos),469,Population based,Female,NA,NA,NA,NA,Oct,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,Post-partum,Unspecified,29,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Oct 2015,Unspecified,Oct 2015 - Unspecified
220cb6dee3b143db40b2441417de6648,fd3ecbc1c6039c23847033656e38d749,6731,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,NA,FALSE,NA,NA,Unspecified,Pregnant women,Salvador (Hospital Geral Roberto Santos),469,Population based,Female,NA,NA,NA,NA,Oct,2015,NA,Not adjusted,Age;Other,NA,Serology,Significant,NA,FALSE,Post-partum,Unspecified,29,Risk factors,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,NA,Oct 2015,Unspecified,Oct 2015 - Unspecified
220cb6dee3b143db40b2441417de6648,5417e244c1ecd8310b026f36407ca5f5,6731,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,NA,FALSE,NA,NA,Unspecified,Pregnant women,Salvador (Hospital Geral Roberto Santos),469,Population based,Female,NA,NA,NA,NA,Oct,2015,NA,Not adjusted,Other,NA,Serology,Not significant,NA,FALSE,Post-partum,Unspecified,29,Risk factors,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,NA,Oct 2015,Unspecified,Oct 2015 - Unspecified
220cb6dee3b143db40b2441417de6648,00e500208cfacd3001199a2c21ab76b7,6731,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,NA,FALSE,NA,NA,Unspecified,Pregnant women,Salvador (Hospital Geral Roberto Santos),469,Population based,Female,NA,NA,NA,NA,Oct,2015,NA,Adjusted,Age;Other,NA,Serology,Significant,NA,FALSE,Post-partum,Unspecified,29,Risk factors,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,NA,Oct 2015,Unspecified,Oct 2015 - Unspecified
220cb6dee3b143db40b2441417de6648,b1de4d188f012b28b406a5f4a0b43a5c,6731,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,NA,FALSE,NA,NA,Unspecified,Pregnant women,Salvador (Hospital Geral Roberto Santos),469,Population based,Female,NA,NA,NA,NA,Oct,2015,NA,Not adjusted,Other,NA,Serology,Significant,NA,FALSE,Post-partum,Unspecified,29,Risk factors,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,NA,Oct 2015,Unspecified,Oct 2015 - Unspecified
cbcf53f1e06bfc311939b2f832ea456b,7db116b7b043b4da3d87322419d296e3,6738,Seroprevalence - IgM,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,41,Naive,19,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Keith Fraser,NA,FALSE,NA,NA,Brazil,Persons under investigation,"Hospital da Restauração, Recife, Pernambuco,",41,Hospital based,Both,NA,Apr,2016,NA,Nov,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Urban area,2,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Nov 2015,Apr 2016,Nov 2015 - Apr 2016
cbcf53f1e06bfc311939b2f832ea456b,2315c81ffc304a55c4028570dd9d15a8,6738,Human delay - Admission to care to Discharge from care,Days,0,17,Median,NA,NA,NA,NA,NA,9,23,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Keith Fraser,NA,FALSE,NA,NA,Brazil,Persons under investigation,Hospital,41,Hospital based,Both,NA,Apr,2016,NA,Nov,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,2,Human delay,9 - 23,NA,NA,Brazil,Admission to care to discharge from care,NA,FALSE,NA,NA,NA,Nov 2015,Apr 2016,Nov 2015 - Apr 2016
1cf618680e4419b236d209edfdc41f68,b4ba5a24eac8a885679ebc93defc9a25,6744,Seroprevalence - IgM,Percentage (%),0,1.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,217,Naive,4,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Keith Fraser,NA,FALSE,NA,NA,Saudi Arabia,Pregnant women,Abha,217,Hospital based,Female,NA,NA,2020,NA,NA,2019,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,Unspecified,Unspecified,3,Seroprevalence,NA,NA,NA,Saudi Arabia,NA,NA,FALSE,NA,NA,NA,2019,2020,2019 - 2020
1cf618680e4419b236d209edfdc41f68,c70be00267c05b73f9cd9724fb8c793f,6744,Seroprevalence - IgG,Percentage (%),0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,217,Naive,2,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Keith Fraser,NA,FALSE,NA,NA,Saudi Arabia,Pregnant women,Abha,217,Hospital based,Female,NA,NA,2020,NA,NA,2019,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,NA,Unspecified,3,Seroprevalence,NA,NA,NA,Saudi Arabia,NA,NA,FALSE,NA,NA,NA,2019,2020,2019 - 2020
0de6f30d457e3830bc0611b058bb7bce,690d6ec6ae11a853b1775f4c71949e55,6762,Seroprevalence - IgG,Percentage (%),0,NA,Unspecified,NA,NA,NA,NA,NA,0,21.4,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Tristan Naidoo,Observed sample statistic,FALSE,NA,NA,Brazil,General population,"Ribeirão Preto, São Paulo State",NA,Population based,Unspecified,NA,May,2017,NA,Jul,2010,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,30,Seroprevalence,0 - 21.4,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Jul 2010,May 2017,Jul 2010 - May 2017
0de6f30d457e3830bc0611b058bb7bce,d8283ab9086766d913969419d8039e63,6762,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,NA,Unspecified,NA,NA,NA,NA,NA,0,16.9,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Tristan Naidoo,Observed sample statistic,FALSE,NA,NA,Brazil,General population,"Ribeirão Preto, São Paulo State",NA,Population based,Unspecified,NA,May,2017,NA,Jul,2010,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,30,Seroprevalence,0 - 16.9,NA,NA,Brazil,NA,NA,TRUE,NA,NA,NA,Jul 2010,May 2017,Jul 2010 - May 2017
824c8b225a23fb9227dd0e14977ad1f1,935f79d317478082634b23af3420a102,6765,Reproduction number (Basic R0),No units,0,2.3383,Central,2.1787,2.4877,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Keith Fraser,Estimated model parameter,FALSE,NA,NA,France,General population,"Tahiti, French Polynesia",NA,Population based,NA,NA,Mar,2014,NA,Oct,2013,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,5,Reproduction number,NA,95% CI,2.1787 - 2.4877,France,NA,NA,FALSE,NA,NA,NA,Oct 2013,Mar 2014,Oct 2013 - Mar 2014
824c8b225a23fb9227dd0e14977ad1f1,7fcce5a65168c35978aee3a6754ee571,6765,Reproduction number (Basic R0),No units,0,2.4977,Central,2.0424,3.1481,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Keith Fraser,Estimated model parameter,FALSE,NA,NA,France,General population,"Sous-le-vent Islands, French Polynesia",NA,Population based,NA,NA,Mar,2014,NA,Oct,2013,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,5,Reproduction number,NA,95% CI,2.0424 - 3.1481,France,NA,NA,FALSE,NA,NA,NA,Oct 2013,Mar 2014,Oct 2013 - Mar 2014
824c8b225a23fb9227dd0e14977ad1f1,e9fb1b2f8d38acb5853577b7f6e03c71,6765,Reproduction number (Basic R0),No units,0,3.1876,Central,2.6095,3.6759,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Keith Fraser,Estimated model parameter,FALSE,NA,NA,France,General population,"Mo'orea, French Polynesia",NA,Population based,NA,NA,Mar,2014,NA,Oct,2013,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,5,Reproduction number,NA,95% CI,2.6095 - 3.6759,France,NA,NA,FALSE,NA,NA,NA,Oct 2013,Mar 2014,Oct 2013 - Mar 2014
824c8b225a23fb9227dd0e14977ad1f1,150c9a84f58b986035e407cebd5d3c3b,6765,Reproduction number (Basic R0),No units,0,2.3367,Central,2.1522,2.5076,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Keith Fraser,Estimated model parameter,FALSE,NA,NA,France,General population,"Tuamotu-Gambier, French Polynesia",NA,Population based,NA,NA,Mar,2014,NA,Oct,2013,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,5,Reproduction number,NA,95% CI,2.1522 - 2.5076,France,NA,NA,FALSE,NA,NA,NA,Oct 2013,Mar 2014,Oct 2013 - Mar 2014
824c8b225a23fb9227dd0e14977ad1f1,4f2eeabf2415054abf812a3d115ccb0d,6765,Reproduction number (Basic R0),No units,0,2.0691,Central,1.2613,4.3165,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Keith Fraser,Estimated model parameter,FALSE,NA,NA,France,General population,"Marquesas Islands, French Polynesia",NA,Population based,NA,NA,Mar,2014,NA,Oct,2013,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,5,Reproduction number,NA,95% CI,1.2613 - 4.3165,France,NA,NA,FALSE,NA,NA,NA,Oct 2013,Mar 2014,Oct 2013 - Mar 2014
824c8b225a23fb9227dd0e14977ad1f1,aeab851f9c758cdc0691abd634afd079,6765,Reproduction number (Basic R0),No units,0,2.0274,Central,1.9068,2.1397,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Keith Fraser,Estimated model parameter,FALSE,NA,NA,France,General population,"Australes, French Polynesia",NA,Population based,NA,NA,Mar,2014,NA,Oct,2013,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,5,Reproduction number,NA,95% CI,1.9068 - 2.1397,France,NA,NA,FALSE,NA,NA,NA,Oct 2013,Mar 2014,Oct 2013 - Mar 2014
824c8b225a23fb9227dd0e14977ad1f1,f35796c29396f75fa17d97d6590192e7,6765,Reproduction number (Basic R0),No units,0,3.1985,Central,3.0727,3.3196,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Keith Fraser,Estimated model parameter,FALSE,NA,NA,Federated States of Micronesia,General population,Yap Island,NA,Population based,NA,NA,Mar,2014,NA,Oct,2013,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,5,Reproduction number,NA,95% CI,3.0727 - 3.3196,Federated States of Micronesia,NA,NA,FALSE,NA,NA,NA,Oct 2013,Mar 2014,Oct 2013 - Mar 2014
824c8b225a23fb9227dd0e14977ad1f1,83d7817758e1f3185f2e2d13edf89239,6765,Human delay - incubation period (inverse parameter),Days,0,0.2253,Central,0.161,0.2896,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,TRUE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Keith Fraser,Estimated model parameter,FALSE,NA,NA,France,General population,"Tahiti, French Polynesia",NA,Population based,NA,NA,Mar,2014,NA,Oct,2013,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,5,Human delay,NA,95% CI,0.161 - 0.2896,France,Incubation period,NA,FALSE,NA,NA,NA,Oct 2013,Mar 2014,Oct 2013 - Mar 2014
824c8b225a23fb9227dd0e14977ad1f1,f996b274d2cd1bbb25ebac3a5d12b53f,6765,Human delay - incubation period (inverse parameter),Days,0,0.0836,Central,0.0589,0.1083,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,TRUE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Keith Fraser,Estimated model parameter,FALSE,NA,NA,France,General population,"Mo'orea, French Polynesia",NA,Population based,NA,NA,Mar,2014,NA,Oct,2013,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,5,Human delay,NA,95% CI,0.0589 - 0.1083,France,Incubation period,NA,FALSE,NA,NA,NA,Oct 2013,Mar 2014,Oct 2013 - Mar 2014
824c8b225a23fb9227dd0e14977ad1f1,1ec30ad1bbd843ae54243a84ecfc3d69,6765,Human delay - incubation period (inverse parameter),Days,0,0.0865,Central,0.071,0.102,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,TRUE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Keith Fraser,Estimated model parameter,FALSE,NA,NA,France,General population,"Tuamotu-Gambier, French Polynesia",NA,Population based,NA,NA,Mar,2014,NA,Oct,2013,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,5,Human delay,NA,95% CI,0.071 - 0.102,France,Incubation period,NA,FALSE,NA,NA,NA,Oct 2013,Mar 2014,Oct 2013 - Mar 2014
824c8b225a23fb9227dd0e14977ad1f1,edba9842508e65963151ee9e65624e5b,6765,Human delay - incubation period (inverse parameter),Days,0,0.25,Central,0.1826,0.3174,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,TRUE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Keith Fraser,Estimated model parameter,FALSE,NA,NA,France,General population,"Australes, French Polynesia",NA,Population based,NA,NA,Mar,2014,NA,Oct,2013,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,5,Human delay,NA,95% CI,0.1826 - 0.3174,France,Incubation period,NA,FALSE,NA,NA,NA,Oct 2013,Mar 2014,Oct 2013 - Mar 2014
824c8b225a23fb9227dd0e14977ad1f1,489096aa6a84bcaeb126fea73a8ed3ca,6765,Human delay - infectious period (inverse parameter),Days,0,0.0833,Central,0.06,0.1066,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,TRUE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Keith Fraser,Estimated model parameter,FALSE,NA,NA,France,General population,"Sous-le-vent Islands, French Polynesia",NA,Population based,NA,NA,Mar,2014,NA,Oct,2013,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,5,Human delay,NA,95% CI,0.06 - 0.1066,France,Infectious period,NA,FALSE,NA,NA,NA,Oct 2013,Mar 2014,Oct 2013 - Mar 2014
824c8b225a23fb9227dd0e14977ad1f1,60b500b4a43312286dff362807b58576,6765,Human delay - infectious period (inverse parameter),Days,0,0.0833,Central,0.0263,0.1403,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,TRUE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Keith Fraser,Estimated model parameter,FALSE,NA,NA,France,General population,"Marquesas Islands, French Polynesia",NA,Population based,NA,NA,Mar,2014,NA,Oct,2013,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,5,Human delay,NA,95% CI,0.0263 - 0.1403,France,Infectious period,NA,FALSE,NA,NA,NA,Oct 2013,Mar 2014,Oct 2013 - Mar 2014
823fb990a2de2b798f6eebdf4cd8fd38,6ebf1402dcda1c8270457683dd78a25d,6771,Seroprevalence - IgG,Percentage (%),0,57,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,302,Naive,172,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,Brazil,Other,"Salvador, Bahia",302,Hospital based,Female,NA,Nov,2017,NA,Sep,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,Post-partum,Unspecified,25,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Sep 2017,Nov 2017,Sep 2017 - Nov 2017
c2bc5acb65604d8873dd266fa9ee32e8,d22fabe594ce396c9e4b554d4ee49644,6795,Reproduction number (Basic R0),No units,0,2.23,Mean,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Other,FALSE,FALSE,Unspecified,Next generation matrix,Christian,Estimated model parameter,FALSE,NA,NA,Colombia,Unspecified,NA,NA,Unspecified,Unspecified,NA,NA,NA,NA,NA,NA,Other,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,18,Reproduction number,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
47fd2ebf625c9097740af34659fd5e94,5d6d7d8171c854057f9ea6bc6ab71e4c,6798,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Patrick,NA,FALSE,NA,0,Colombia,Persons under investigation,NA,106033,Population based,Both,NA,Jun,2017,NA,Aug,2015,NA,Unspecified,Age;Other;Sex,NA,Infection,Significant,NA,FALSE,NA,Both urban and rural areas,2,Risk factors,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,Aug 2015,Jun 2017,Aug 2015 - Jun 2017
47fd2ebf625c9097740af34659fd5e94,15591f304c15cb40a7299e0080a9007c,6798,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Patrick,NA,FALSE,NA,0,Colombia,Persons under investigation,NA,106033,Population based,Both,NA,Jun,2017,NA,Aug,2015,NA,Unspecified,Age;Sex,NA,Infection,Not significant,NA,FALSE,NA,Both urban and rural areas,2,Risk factors,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,Aug 2015,Jun 2017,Aug 2015 - Jun 2017
47fd2ebf625c9097740af34659fd5e94,b302410fea98f28dd9c6eebfe5c5e511,6798,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Patrick,NA,FALSE,NA,NA,Colombia,Other,NA,418,Population based,Both,NA,Oct,2017,NA,Jul,2015,NA,Unspecified,Age;Sex,NA,Other neurological symptoms in general population,Significant,NA,FALSE,NA,Both urban and rural areas,2,Risk factors,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,Jul 2015,Oct 2017,Jul 2015 - Oct 2017
47fd2ebf625c9097740af34659fd5e94,bf43a0c9862158ec6e8a48abe6a7b3d4,6798,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Patrick,NA,FALSE,NA,NA,Colombia,Other,NA,418,Population based,Both,NA,Oct,2017,NA,Jul,2015,NA,Unspecified,Age;Sex,NA,Other neurological symptoms in general population,Not significant,NA,FALSE,NA,Both urban and rural areas,2,Risk factors,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,Jul 2015,Oct 2017,Jul 2015 - Oct 2017
47fd2ebf625c9097740af34659fd5e94,f6153fd6e90cb70a6b3e88c3ffc6d2f0,6798,Severity - case fatality rate (CFR),Percentage (%),0,8.4,Central,NA,NA,NA,NA,NA,NA,NA,NA,Other,418,Unspecified,35,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Patrick,Observed sample statistic,FALSE,NA,NA,Colombia,Persons under investigation,NA,418,Population based,Both,NA,Oct,2017,NA,Jul,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Both urban and rural areas,2,Severity,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,Jul 2015,Oct 2017,Jul 2015 - Oct 2017
3545b37c8f1aa3d8195481299c1ef918,341009c16e821bd36033a02e9482b319,6827,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,NA,FALSE,NA,NA,Brazil,Children,NA,11366686,Population based,Both,31,Dec,2018,1,Jan,2015,NA,Adjusted,Age,NA,Zika congenital syndrome/other birth defects,Not significant,NA,FALSE,NA,Unspecified,28,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,1 Jan 2015,31 Dec 2018,1 Jan 2015 - 31 Dec 2018
3545b37c8f1aa3d8195481299c1ef918,4f328b7b9bf76f91baecee8c1164d0ef,6827,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,NA,FALSE,NA,NA,Brazil,Children,NA,11366686,Population based,Both,31,Dec,2018,1,Jan,2015,NA,Adjusted,Other;Sex,NA,Zika congenital syndrome/other birth defects,Significant,NA,FALSE,NA,Unspecified,28,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,1 Jan 2015,31 Dec 2018,1 Jan 2015 - 31 Dec 2018
0c2a4f94ca354cfc3ae1a6aa2cf1df47,4186888ff56d4134083e88b975ece4a0,6833,Human delay - NAAT-detectable infection to Seroconversion (IgM),Days,0,7.7,Mean,6.1,9.2,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,United States,Persons under investigation,"Florida, Puerto Rico, Texas, Nevada",25,Population based,Both,7,Mar,2017,6,Jul,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,29,Human delay,NA,95% CI,6.1 - 9.2,United States,Naat-detectable infection to seroconversion (igm),NA,FALSE,NA,NA,NA,6 Jul 2016,7 Mar 2017,6 Jul 2016 - 7 Mar 2017
0c2a4f94ca354cfc3ae1a6aa2cf1df47,87a4d868fb8a4f7239aa834e04a7aad8,6833,Human delay - NAAT-detectable infection to Seroreversion (IgM),Days,0,237,Mean,128.7,459.5,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,United States,Persons under investigation,"Florida, Puerto Rico, Texas, Nevada",25,Population based,Both,7,Mar,2017,6,Jul,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,29,Human delay,NA,95% CI,128.7 - 459.5,United States,Naat-detectable infection to seroreversion (igm),NA,FALSE,NA,NA,NA,6 Jul 2016,7 Mar 2017,6 Jul 2016 - 7 Mar 2017
c78052340ea828cc589c288dbeb08497,3a10f12ae1db7f84c433594c1e20b0e8,6841,Seroprevalence - Biotinylated-EDIII antigen capture ELISA,Percentage (%),0,18,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,547,NA,98,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,14,9,Philippines,Children,Balamban and Bogo City in Cebu Province,547,Other,Both,NA,NA,2017,NA,NA,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Both urban and rural areas,30,Seroprevalence,NA,NA,NA,Philippines,NA,NA,FALSE,NA,NA,NA,2017,2017,2017
8f8526a091200188123d83558825f09b,1fc30966816c670b4cba0c48a12bf3d4,6850,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,79.3,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,227,NA,180,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Kelly M,Observed sample statistic,FALSE,16,9,Honduras,Children,NA,227,Other,Unspecified,NA,Mar,2012,NA,Jun,2011,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,32,Seroprevalence,NA,NA,NA,Honduras,NA,NA,FALSE,NA,NA,NA,Jun 2011,Mar 2012,Jun 2011 - Mar 2012
8f8526a091200188123d83558825f09b,27f8fc4807da10db2a1b93c5e58f7f62,6850,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,47.6,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,712,NA,339,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Kelly M,Observed sample statistic,FALSE,16,9,Colombia,Children,NA,712,Other,Unspecified,NA,Mar,2012,NA,Jun,2011,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,32,Seroprevalence,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,Jun 2011,Mar 2012,Jun 2011 - Mar 2012
8f8526a091200188123d83558825f09b,241e9f2d610793dfb51c423770b814c4,6850,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,38.3,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,269,NA,103,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Kelly M,Observed sample statistic,FALSE,16,9,Mexico,Children,NA,269,Other,Unspecified,NA,Mar,2012,NA,Jun,2011,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,32,Seroprevalence,NA,NA,NA,Mexico,NA,NA,FALSE,NA,NA,NA,Jun 2011,Mar 2012,Jun 2011 - Mar 2012
8f8526a091200188123d83558825f09b,9f1a68c1db289578d759eb51c6a20650,6850,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,25,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,92,NA,23,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Kelly M,Observed sample statistic,FALSE,16,9,United States,Children,Puerto Rico,92,Other,Unspecified,NA,Mar,2012,NA,Jun,2011,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,32,Seroprevalence,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,Jun 2011,Mar 2012,Jun 2011 - Mar 2012
8f8526a091200188123d83558825f09b,898817d288ebf0fb5446e210d9df2177,6850,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,20.5,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,239,NA,49,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Kelly M,Observed sample statistic,FALSE,16,9,Brazil,Children,NA,239,Other,Unspecified,NA,Mar,2012,NA,Jun,2011,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,32,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Jun 2011,Mar 2012,Jun 2011 - Mar 2012
0701329aeb45060f48607b55e5d56dbb,2bbbccb5cdb0523c1ea4fef8d6898068,6868,Seroprevalence - IgM,Percentage (%),0,3,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,196,Naive,6,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,35,19,Brazil,Pregnant women,Maranhao state,196,Hospital based,Female,NA,Jun,2018,NA,Apr,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,47,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Apr 2017,Jun 2018,Apr 2017 - Jun 2018
0701329aeb45060f48607b55e5d56dbb,276215e0b2237e1bfca15330f67ec178,6868,Seroprevalence - IgG,Percentage (%),0,17.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,196,Naive,34,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,35,19,Brazil,Pregnant women,Maranhao state,196,Hospital based,Female,NA,Jun,2018,NA,Apr,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,47,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Apr 2017,Jun 2018,Apr 2017 - Jun 2018
9e39a2a08027a36844d52fbdee0c020e,774dd79f8f6bd0c28f982b5e6fb2a6fb,6869,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Richard Sheppard,NA,FALSE,NA,NA,France,Pregnant women,"Centre Hospitalier de l’Ouest Guyanais (CHOG, Saint-Laurent-du-Maroni, in French Guiana)",NA,Hospital based,Unspecified,NA,Jul,2016,NA,Jan,2015,NA,Not adjusted,Infection during pregnancy,NA,Miscarriage/stillbirth,Significant,Unspecified,FALSE,NA,NA,7,Risk factors,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,Jan 2015,Jul 2016,Jan 2015 - Jul 2016
9e39a2a08027a36844d52fbdee0c020e,f4028582037299c0f342240c37ae5b99,6869,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Richard Sheppard,NA,FALSE,NA,NA,France,Pregnant women,"Centre Hospitalier de l’Ouest Guyanais (CHOG, Saint-Laurent-du-Maroni, in French Guiana)",NA,Hospital based,Unspecified,NA,Jul,2016,NA,Jan,2015,NA,Adjusted,Infection during pregnancy,NA,Miscarriage/stillbirth,Significant,Unspecified,FALSE,NA,NA,7,Risk factors,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,Jan 2015,Jul 2016,Jan 2015 - Jul 2016
9e39a2a08027a36844d52fbdee0c020e,6b87a95e4dcd155bf2067d9c1dfbd707,6869,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Richard Sheppard,NA,FALSE,NA,NA,France,Pregnant women,"Centre Hospitalier de l’Ouest Guyanais (CHOG, Saint-Laurent-du-Maroni, in French Guiana)",NA,Hospital based,Unspecified,NA,Jul,2016,NA,Jan,2015,NA,Not adjusted,Other,NA,Infection,Not significant,Unspecified,FALSE,NA,NA,7,Risk factors,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,Jan 2015,Jul 2016,Jan 2015 - Jul 2016
9e39a2a08027a36844d52fbdee0c020e,94f8227c3749ed4e59b85245993b4f2d,6869,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Richard Sheppard,NA,FALSE,NA,NA,France,Pregnant women,"Centre Hospitalier de l’Ouest Guyanais (CHOG, Saint-Laurent-du-Maroni, in French Guiana)",NA,Hospital based,Unspecified,NA,Jul,2016,NA,Jan,2015,NA,Adjusted,Other,NA,Infection,Not significant,Unspecified,FALSE,NA,NA,7,Risk factors,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,Jan 2015,Jul 2016,Jan 2015 - Jul 2016
9e39a2a08027a36844d52fbdee0c020e,4ef71a354c02ace7822ff0ee1164f4dc,6869,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Richard Sheppard,NA,FALSE,NA,NA,France,Pregnant women,"Centre Hospitalier de l’Ouest Guyanais (CHOG, Saint-Laurent-du-Maroni, in French Guiana)",NA,Hospital based,Unspecified,NA,Jul,2016,NA,Jan,2015,NA,Not adjusted,Infection during pregnancy,NA,Other neurological symptoms in general population,Significant,Unspecified,FALSE,NA,NA,7,Risk factors,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,Jan 2015,Jul 2016,Jan 2015 - Jul 2016
9e39a2a08027a36844d52fbdee0c020e,799ac33e9c5f5f2f1df66b339f6bfdda,6869,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Richard Sheppard,NA,FALSE,NA,NA,France,Pregnant women,"Centre Hospitalier de l’Ouest Guyanais (CHOG, Saint-Laurent-du-Maroni, in French Guiana)",NA,Hospital based,Unspecified,NA,Jul,2016,NA,Jan,2015,NA,Adjusted,Infection during pregnancy,NA,Other neurological symptoms in general population,Significant,Unspecified,FALSE,NA,NA,7,Risk factors,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,Jan 2015,Jul 2016,Jan 2015 - Jul 2016
9e39a2a08027a36844d52fbdee0c020e,402d9e1dd7bae1bd42088b545391d5f4,6869,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Richard Sheppard,NA,FALSE,NA,NA,France,Pregnant women,"Centre Hospitalier de l’Ouest Guyanais (CHOG, Saint-Laurent-du-Maroni, in French Guiana)",NA,Hospital based,Unspecified,NA,Jul,2016,NA,Jan,2015,NA,Not adjusted,Other,NA,Other neurological symptoms in general population,Not significant,Unspecified,FALSE,NA,NA,7,Risk factors,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,Jan 2015,Jul 2016,Jan 2015 - Jul 2016
9e39a2a08027a36844d52fbdee0c020e,38d99c64a4bec45b1761192a2036f83c,6869,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Richard Sheppard,NA,FALSE,NA,NA,France,Pregnant women,"Centre Hospitalier de l’Ouest Guyanais (CHOG, Saint-Laurent-du-Maroni, in French Guiana)",NA,Hospital based,Unspecified,NA,Jul,2016,NA,Jan,2015,NA,Adjusted,Other,NA,Other neurological symptoms in general population,Not significant,Unspecified,FALSE,NA,NA,7,Risk factors,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,Jan 2015,Jul 2016,Jan 2015 - Jul 2016
9e39a2a08027a36844d52fbdee0c020e,be61b1471d145f38c25b8b2631aac380,6869,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Richard Sheppard,NA,FALSE,NA,NA,France,Pregnant women,"Centre Hospitalier de l’Ouest Guyanais (CHOG, Saint-Laurent-du-Maroni, in French Guiana)",NA,Hospital based,Unspecified,NA,Jul,2016,NA,Jan,2015,NA,Not adjusted,Infection during pregnancy,NA,Miscarriage/stillbirth,Not significant,Unspecified,FALSE,NA,NA,7,Risk factors,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,Jan 2015,Jul 2016,Jan 2015 - Jul 2016
9e39a2a08027a36844d52fbdee0c020e,b68cb9ca237151ee09cd0300aae5ecea,6869,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Richard Sheppard,NA,FALSE,NA,NA,France,Pregnant women,"Centre Hospitalier de l’Ouest Guyanais (CHOG, Saint-Laurent-du-Maroni, in French Guiana)",NA,Hospital based,Unspecified,NA,Jul,2016,NA,Jan,2015,NA,Not adjusted,Infection during pregnancy,NA,Other neurological symptoms in general population,Not significant,Unspecified,FALSE,NA,NA,7,Risk factors,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,Jan 2015,Jul 2016,Jan 2015 - Jul 2016
13b59ba3c23077242a180e881233cf46,168424f8bfd2837e0ee67763ce6d82f0,6903,Human delay - infectious period (inverse parameter),Per day,0,0.17,Median,0.1,0.23,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,TRUE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Patrick,Estimated model parameter,FALSE,NA,NA,Brazil,Persons under investigation,Rio de Janeiro,NA,Population based,Unspecified,NA,NA,2016,NA,NA,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Urban area,6,Human delay,NA,95% CrI,0.1 - 0.23,Brazil,Infectious period,NA,FALSE,NA,NA,NA,2016,2016,2016
c7f209b7b723a1e27dc8b636d45c114e,34dbe39bde8ad8746103d711630c5d6c,6948,Reproduction number (Basic R0),No units,0,2.75,Central,2.53,2.98,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,TRUE,Post outbreak,Compartmental model,Ruth,Estimated model parameter,FALSE,NA,NA,France,Persons under investigation,French Polynesia,NA,Population based,Unspecified,NA,NA,2013,NA,NA,2013,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,9,Reproduction number,NA,95% CI,2.53 - 2.98,France,NA,NA,FALSE,NA,NA,NA,2013,2013,2013
d1b66d8f75d319556d0f7c8fd04a1903,d8cafca855e693d554606d1058fc4cdf,6952,Seroprevalence - IgG,Percentage (%),0,NA,NA,NA,NA,NA,NA,NA,15,94,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Time,TRUE,FALSE,Unspecified,NA,sangeeta,Observed sample statistic,FALSE,NA,16,Brazil,Persons under investigation,NA,NA,Hospital based,Both,NA,Sep,2016,NA,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,9,Seroprevalence,15 - 94,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Jan 2016,Sep 2016,Jan 2016 - Sep 2016
d1b66d8f75d319556d0f7c8fd04a1903,ef516de8ab51962d785c5bb5d54d42b1,6952,Seroprevalence - IgG,Percentage (%),0,15,NA,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,72,Naive,11,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Other, Time",TRUE,FALSE,Unspecified,NA,sangeeta,Observed sample statistic,FALSE,NA,NA,Brazil,Persons under investigation,São Paulo state,72,Hospital based,Both,NA,Sep,2016,NA,Jan,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,9,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Jan 2016,Sep 2016,Jan 2016 - Sep 2016
d1b66d8f75d319556d0f7c8fd04a1903,74ae8e6a0c66cd0becbc77578ccd9480,6952,Seroprevalence - IgM,Percentage (%),0,NA,NA,NA,NA,NA,NA,NA,6,86,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Time,TRUE,FALSE,Unspecified,NA,sangeeta,Observed sample statistic,FALSE,NA,16,Brazil,Persons under investigation,São Paulo state,NA,Hospital based,Both,NA,Sep,2016,NA,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,9,Seroprevalence,6 - 86,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Jan 2016,Sep 2016,Jan 2016 - Sep 2016
bcf6d708eb25f4b2f1f1692f4f179287,58acaad3cecf77b6d8f56a1d49c76aaa,6961,Seroprevalence - IgG,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1021,Naive,11,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Age,FALSE,FALSE,Unspecified,NA,sangeeta,NA,FALSE,NA,NA,Solomon Islands,General population,NA,NA,Community based,Both,NA,Nov,2018,NA,Apr,2018,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,10,Seroprevalence,NA,NA,NA,Solomon Islands,NA,NA,FALSE,NA,NA,NA,Apr 2018,Nov 2018,Apr 2018 - Nov 2018
3ce956b1e959af2b4f26fb01fc3f9c3e,2cb070ffbf1049e7c04fc789c3439bab,6972,Seroprevalence - IgG,Percentage (%),0,86.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,114,Naive,99,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,sangeeta,Observed sample statistic,FALSE,NA,NA,Colombia,Pregnant women,Risaralda,115,Hospital based,Female,5,Jun,2019,22,Nov,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,12,Seroprevalence,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,22 Nov 2017,5 Jun 2019,22 Nov 2017 - 5 Jun 2019
3ce956b1e959af2b4f26fb01fc3f9c3e,97aca169054bac51b47717f090ded1b7,6972,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,2.63,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,114,Naive,3,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,sangeeta,Observed sample statistic,FALSE,NA,NA,Colombia,Pregnant women,Risaralda,115,Other,Female,5,Jun,2019,22,Nov,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,12,Seroprevalence,NA,NA,NA,Colombia,NA,NA,TRUE,NA,NA,NA,22 Nov 2016,5 Jun 2019,22 Nov 2016 - 5 Jun 2019
b2061a18786baa6ebb5a4771c1e5ab05,13aef7632ea3d87fa739d8522f36b68e,6998,Human delay - First infection in country to first reporting in country,Weeks,0,NA,Median,NA,NA,NA,NA,NA,12,35,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Estimated model parameter,FALSE,NA,NA,Unspecified,General population,NA,NA,Population based,NA,NA,Dec,2017,NA,Jan,2014,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,42,Human delay,12 - 35,NA,NA,NA,First infection in country to first reporting in country,NA,FALSE,NA,NA,NA,Jan 2014,Dec 2017,Jan 2014 - Dec 2017
f81c297f60df7bb4ef633beb6bfcf212,c0842fefe07df2a6b224634c6b07d869,7022,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,NA,FALSE,0,0,Brazil,Children,Paraíba,191,Community based,Unspecified,NA,Dec,2016,NA,Jan,2015,NA,Adjusted,Infection;Other,NA,Microcephaly,Significant,NA,FALSE,NA,NA,45,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Jan 2015,Dec 2016,Jan 2015 - Dec 2016
b4f5534019c378836f1b13b9c9db1d0b,99832f2b611f10983fdb3b2e527526e9,7034,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,NA,FALSE,80,1,Nicaragua,Persons under investigation,León,225,Hospital based,Both,NA,Aug,2017,NA,Jan,2016,NA,Adjusted,Age;Other;Sex,NA,Infection,Not significant,NA,FALSE,NA,NA,63,Risk factors,NA,NA,NA,Nicaragua,NA,NA,FALSE,NA,NA,NA,Jan 2016,Aug 2017,Jan 2016 - Aug 2017
b4f5534019c378836f1b13b9c9db1d0b,fa8a6e6049a35e10bda59ff5d136aaaa,7034,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,NA,FALSE,80,1,Nicaragua,Persons under investigation,León,225,Hospital based,Both,NA,Aug,2017,NA,Jan,2016,NA,Adjusted,Infection during pregnancy;Prior immunity to arboviruses,NA,Infection,Significant,NA,FALSE,NA,NA,63,Risk factors,NA,NA,NA,Nicaragua,NA,NA,FALSE,NA,NA,NA,Jan 2016,Aug 2017,Jan 2016 - Aug 2017
efa836f41ca0252a92845f064d4c0f3e,d462f440ca7375f15773d3338cf22a28,7047,Reproduction number (Basic R0),No units,0,1.58,Median,1.56,1.59,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on Github,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Next generation matrix,Christian,Estimated model parameter,FALSE,NA,NA,Nicaragua,General population,Managua,NA,Population based,Unspecified,NA,NA,2016,NA,NA,2016,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,64,Reproduction number,NA,95% CrI,1.56 - 1.59,Nicaragua,NA,NA,FALSE,NA,NA,NA,2016,2016,2016
efa836f41ca0252a92845f064d4c0f3e,3d0f16b0f092fa16c1300e53c57ad15a,7047,Human delay - infectious period,Days,0,4.8,Median,4.3,5.4,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on Github,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Estimated model parameter,FALSE,NA,NA,Nicaragua,General population,Managua,NA,Population based,Unspecified,NA,NA,2016,NA,NA,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,64,Human delay,NA,95% CrI,4.3 - 5.4,Nicaragua,Infectious period,NA,FALSE,NA,NA,NA,2016,2016,2016
efa836f41ca0252a92845f064d4c0f3e,43485f68c4eb77e63a404c9ce84e4159,7047,Attack rate,Unspecified,0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on Github,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Time",TRUE,FALSE,Unspecified,NA,Christian,NA,TRUE,NA,NA,Nicaragua,General population,Managua,NA,Population based,Unspecified,NA,NA,2016,NA,NA,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,64,Attack rate,NA,NA,NA,Nicaragua,NA,NA,FALSE,NA,NA,NA,2016,2016,2016
efa836f41ca0252a92845f064d4c0f3e,0e73ef22a61a4c16908cd7121e0e4449,7047,"Reproduction number (Effective, Re)",No units,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on Github,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Next generation matrix,Christian,NA,TRUE,NA,NA,Nicaragua,General population,Managua,NA,Population based,Unspecified,NA,NA,2016,NA,NA,2016,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,64,Reproduction number,NA,NA,NA,Nicaragua,NA,NA,FALSE,NA,NA,NA,2016,2016,2016
efa836f41ca0252a92845f064d4c0f3e,1340c065f6d174b67b65b226d9d7a96b,7047,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on Github,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Time,TRUE,FALSE,Unspecified,NA,Christian,NA,FALSE,NA,NA,Nicaragua,General population,Managua,NA,Population based,Unspecified,NA,NA,2016,NA,NA,2016,NA,Unspecified,Age,NA,Infection,Significant,NA,FALSE,NA,NA,64,Risk factors,NA,NA,NA,Nicaragua,NA,NA,FALSE,NA,NA,NA,2016,2016,2016
efa836f41ca0252a92845f064d4c0f3e,4ae120d861b6d4334412f6163bf4b40a,7047,Zika congenital syndrome (microcephaly) probability,"Per 100,000 population",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on Github,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Time,TRUE,FALSE,Unspecified,NA,Christian,NA,TRUE,NA,NA,Nicaragua,General population,Managua,NA,Population based,Unspecified,NA,NA,2016,NA,NA,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,64,Other transmission parameters,NA,NA,NA,Nicaragua,NA,NA,FALSE,NA,NA,NA,2016,2016,2016
174c8ec0c316f5c7658a185aed848f71,d372e7ddc4d4067839f644aa0fbd389e,7048,Seroprevalence - IgM,Percentage (%),0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,2013,Naive,21,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,0,0,Vietnam,Children,Nha Trang,2013,Hospital based,Both,NA,Sep,2018,NA,jul,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,43,Seroprevalence,NA,NA,NA,Vietnam,NA,NA,FALSE,NA,NA,NA,jul 2017,Sep 2018,jul 2017 - Sep 2018
174c8ec0c316f5c7658a185aed848f71,2ed237cbace4db4685d000108901c96d,7048,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,0.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,21,Adjusted,11,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,0,0,Vietnam,Children,Nha Trang,2013,Hospital based,Both,NA,Sep,2018,NA,Jul,2017,NA,NA,NA,NA,NA,NA,Adjusted,FALSE,Unspecified,Unspecified,43,Seroprevalence,NA,NA,NA,Vietnam,NA,NA,TRUE,NA,NA,NA,Jul 2017,Sep 2018,Jul 2017 - Sep 2018
9ce0a7a66c759e6282a0c81d07899950,c2c2649d54c86ae60d6edcadaf034466,7083,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,NA,FALSE,NA,NA,Brazil,Pregnant women,Goiania,31,Population based,Unspecified,31,Dec,2017,1,Jan,2016,NA,Not adjusted,Other,NA,Microcephaly,Not significant,NA,FALSE,NA,NA,46,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,31 Dec 2017,1 Jan 2016 - 31 Dec 2017
9ce0a7a66c759e6282a0c81d07899950,5e81e9d13ecb12df36d89eceaf52b334,7083,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,NA,FALSE,NA,NA,Brazil,Pregnant women,Goiania,382,Population based,Female,31,Dec,2017,1,Jan,2016,NA,Not adjusted,Other,NA,Infection,Significant,NA,FALSE,NA,NA,46,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,31 Dec 2017,1 Jan 2016 - 31 Dec 2017
099649bbd2362e120ef3c9d2d439bd43,0d53114560bb764853c4b2c95e26c6f4,7090,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,NA,FALSE,NA,NA,Mexico,Persons under investigation,NA,12823,Population based,Unspecified,NA,Dec,2020,NA,Jan,2012,NA,Adjusted,Other,NA,Infection,Significant,NA,FALSE,NA,Both urban and rural areas,11,Risk factors,NA,NA,NA,Mexico,NA,NA,FALSE,NA,NA,NA,Jan 2012,Dec 2020,Jan 2012 - Dec 2020
099649bbd2362e120ef3c9d2d439bd43,b600298e8b3ddd8d55882a338467a3b9,7090,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,NA,FALSE,NA,NA,Mexico,Persons under investigation,NA,12823,Population based,Unspecified,NA,Dec,2020,NA,Jan,2012,NA,Adjusted,Other,NA,Infection,Not significant,NA,FALSE,NA,Both urban and rural areas,11,Risk factors,NA,NA,NA,Mexico,NA,NA,FALSE,NA,NA,NA,Jan 2012,Dec 2020,Jan 2012 - Dec 2020
212975af7ff4095bc769d876caa5ed3a,c8ae1a83863ebd9cc87ca1ba8323372b,7111,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,NA,FALSE,NA,NA,Brazil,Pregnant women,Recife,144,Community based,Female,NA,Apr,2017,NA,Dec,2015,NA,Not adjusted,Other,NA,Infection,Significant,NA,FALSE,Unspecified,Urban area,44,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Dec 2015,Apr 2017,Dec 2015 - Apr 2017
ea64f3638e1147a39485fab263f316a1,1fdb542e41c7d2e90cc17f68ab07ea68,7114,Seroprevalence - IgG,Percentage (%),0,62,Mean,NA,NA,NA,NA,NA,33.3,75,NA,Lab confirmed,136,Naive,85,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Age,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,Mexico,Pregnant women,Chiapas,136,Hospital based,Female,NA,Aug,2019,NA,Feb,2019,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,68,Seroprevalence,33.3 - 75,NA,NA,Mexico,NA,NA,FALSE,NA,NA,NA,Feb 2019,Aug 2019,Feb 2019 - Aug 2019
68eed78cba6b4609901ef3c74b1900ca,e2c34a4b6b4a49344306faf122c3283b,7123,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Other,FALSE,FALSE,Mid outbreak,NA,Ruth,NA,FALSE,NA,NA,Brazil,Pregnant women,Manaus,762,Community based,Female,NA,NA,2016,NA,NA,2015,NA,Not adjusted,Infection during pregnancy,NA,Miscarriage/stillbirth,Not significant,NA,FALSE,NA,Unspecified,12,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,2015,2016,2015 - 2016
68eed78cba6b4609901ef3c74b1900ca,ee4449f1e85072a713ea058a6e332c2c,7123,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Other,FALSE,FALSE,Mid outbreak,NA,Ruth,NA,FALSE,NA,NA,Brazil,Pregnant women,Manaus,745,Community based,Female,NA,NA,2016,NA,NA,2015,NA,Not adjusted,Infection during pregnancy,NA,Premature birth,Significant,NA,FALSE,NA,Unspecified,12,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,2015,2016,2015 - 2016
68eed78cba6b4609901ef3c74b1900ca,8bf09e2c3e4e47214dce63af4d1d4814,7123,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Other,FALSE,FALSE,Mid outbreak,NA,Ruth,NA,FALSE,NA,NA,Brazil,Pregnant women,Manaus,745,Community based,Female,NA,NA,2016,NA,NA,2015,NA,Not adjusted,Infection during pregnancy,NA,Low birthweight,Not significant,NA,FALSE,NA,Unspecified,12,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,2015,2016,2015 - 2016
68eed78cba6b4609901ef3c74b1900ca,cf1c3115470e8b1a19d3cb096ada35dd,7123,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Other,FALSE,FALSE,Mid outbreak,NA,Ruth,NA,FALSE,NA,NA,Brazil,Pregnant women,Manaus,745,Community based,Female,NA,NA,2016,NA,NA,2015,NA,Not adjusted,Infection during pregnancy,NA,Other,Not significant,NA,FALSE,NA,Unspecified,12,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,2015,2016,2015 - 2016
68eed78cba6b4609901ef3c74b1900ca,a9a5b1e4f5253a8b605b38e45bd7865f,7123,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Other,FALSE,FALSE,Mid outbreak,NA,Ruth,NA,FALSE,NA,NA,Brazil,Pregnant women,Manaus,745,Community based,Female,NA,NA,2016,NA,NA,2015,NA,Not adjusted,Infection during pregnancy,NA,Microcephaly,Significant,NA,FALSE,NA,Unspecified,12,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,2015,2016,2015 - 2016
3881b7a78b91f3da9491e90a3fa547be,59e796587edbe652d099f232a5ca1e6c,7136,Human delay - Exposure/Infection to Recovery/non-Infectiousness,Days,0,9,Median,8,10,IQR,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,France,Unspecified,"Marseille, La Reunion",NA,Unspecified,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,75,Human delay,NA,IQR,8 - 10,France,Exposure/infection to recovery/non-infectiousness,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
3881b7a78b91f3da9491e90a3fa547be,738763c4109ed065d7fd40243a075ea3,7136,Mosquito delay - extrinsic incubation period,Days,0,NA,Mean,NA,NA,NA,NA,NA,17.8,24.2,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Level of exposure,TRUE,FALSE,Unspecified,NA,Christian,Estimated model parameter,FALSE,NA,NA,France,Unspecified,"Marseille, La Reunion",NA,Unspecified,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,75,Mosquito,17.8 - 24.2,NA,NA,France,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
8da73ecd29c56855e9b1d1e67b509a18,ef0f6e435a1568239ddb44ae554b5d53,7162,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,NA,FALSE,NA,NA,Mexico,Persons under investigation,9 unspecified states,281,Hospital based,Both,30,Jun,2018,1,Jul,2016,NA,Not adjusted,Infection,NA,Guillain Barre syndrome,Significant,NA,FALSE,NA,NA,36,Risk factors,NA,NA,NA,Mexico,NA,NA,FALSE,NA,NA,NA,1 Jul 2016,30 Jun 2018,1 Jul 2016 - 30 Jun 2018
665868f396c441c6ca7fba10235a0384,4f24a3cec3e4e9ced41b65b56542d382,7165,Seroprevalence - IgG,NA,0,NA,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,20,NA,18,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Vietnam,Pregnant women,Ho Chi Minh City,20,Hospital based,Female,NA,Nov,2017,NA,Mar,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Both urban and rural areas,39,Seroprevalence,NA,NA,NA,Vietnam,NA,NA,FALSE,NA,NA,NA,Mar 2016,Nov 2017,Mar 2016 - Nov 2017
665868f396c441c6ca7fba10235a0384,3f1e2fc0137e0b513febd3b013a7919d,7165,Seroprevalence - IgG,NA,0,NA,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,21,NA,1,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Vietnam,Children,Ho Chi Minh City,21,Hospital based,Both,NA,Nov,2017,NA,Mar,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Both urban and rural areas,39,Seroprevalence,NA,NA,NA,Vietnam,NA,NA,FALSE,NA,NA,NA,Mar 2016,Nov 2017,Mar 2016 - Nov 2017
d3682dc969e41c21309a1985919f52f8,59879e2a2600c3087c2b00c6b3325bc2,7195,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - with a DOI,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,NA,FALSE,NA,NA,Brazil,Other,NA,NA,Population based,Both,31,Dec,2019,1,Aug,2015,NA,Adjusted,Other,NA,Other,Significant,NA,FALSE,NA,NA,35,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,1 Aug 2015,31 Dec 2019,1 Aug 2015 - 31 Dec 2019
cfc96c7310d35c270cfd6a91187d3d96,c7a5def998d25a634ecfe135480ca1d1,7202,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,55.8,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,581,NA,324,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Brazil,Pregnant women,Pernambuco State,581,Hospital based,Female,NA,Jun,2017,NA,Dec,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Both urban and rural areas,38,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Dec 2015,Jun 2017,Dec 2015 - Jun 2017
cfc96c7310d35c270cfd6a91187d3d96,adf71d4603e1de02bfb6b639a48b54bd,7202,Seroprevalence - IgM,Percentage (%),0,10.2,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,694,NA,71,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Brazil,Pregnant women,Pernambuco State,694,Hospital based,Female,NA,Jun,2017,NA,Dec,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Both urban and rural areas,38,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Dec 2015,Jun 2017,Dec 2015 - Jun 2017
cfc96c7310d35c270cfd6a91187d3d96,4a34e39c985519cbc0729b1a278ebb1f,7202,Seroprevalence - IgG,Percentage (%),0,8.3,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,240,NA,20,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Brazil,Pregnant women,Pernambuco State,240,Hospital based,Female,NA,Jun,2017,NA,Dec,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Both urban and rural areas,38,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Dec 2015,Jun 2017,Dec 2015 - Jun 2017
6eeb725d44dfa3dd429a89a6c42b1ad6,19720490578546b037358c4268cf71ee,7234,Seroprevalence - IgM,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,404,Naive,9,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Christian,Observed sample statistic,FALSE,NA,NA,Brazil,General population,Juazeiro do Norte,404,Community based,Both,NA,Dec,2018,NA,Jun,2018,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,77,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Jun 2018,Dec 2018,Jun 2018 - Dec 2018
6eeb725d44dfa3dd429a89a6c42b1ad6,3210842a51aaebf1372b4e4eb2ba23db,7234,Seroprevalence - IgG,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,404,Naive,216,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,End outbreak,NA,Christian,Observed sample statistic,FALSE,NA,NA,Brazil,General population,Juazeiro do Norte,404,Community based,Both,NA,Dec,2018,NA,Jun,2018,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,77,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Jun 2018,Dec 2018,Jun 2018 - Dec 2018
b02ca771c56d551fa1b6a45ca990db04,da0dc674afe98fa749cb7ec22f651482,7236,Seroprevalence - IgG,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,6654,NA,837,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Other,FALSE,FALSE,Unspecified,NA,Ruth,NA,FALSE,52,12,Guyana,Pregnant women,"Cayenne, Kourou, Saint Laurent",6654,Hospital based,Female,NA,Dec,2016,NA,Jan,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Urban area,21,Seroprevalence,NA,NA,NA,Guyana,NA,NA,FALSE,NA,NA,NA,Jan 2016,Dec 2016,Jan 2016 - Dec 2016
b02ca771c56d551fa1b6a45ca990db04,44575d256a0ad800f1e4911ab7a4cd75,7236,Seroprevalence - IgG,Percentage (%),0,16.5,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,52,12,Guyana,Pregnant women,"Cayenne, Kourou, Saint Laurent",NA,Hospital based,Female,NA,Dec,2016,NA,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Urban area,21,Seroprevalence,NA,NA,NA,Guyana,NA,NA,FALSE,NA,NA,NA,Jan 2016,Dec 2016,Jan 2016 - Dec 2016
b02ca771c56d551fa1b6a45ca990db04,4b0ef999a2607a8ef6c8c5e4aa05e2c2,7236,Seroprevalence - IgG,Percentage (%),0,9.82,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,52,12,Guyana,Pregnant women,"Cayenne, Kourou, Saint Laurent",NA,Hospital based,Female,NA,Dec,2016,NA,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Urban area,21,Seroprevalence,NA,NA,NA,Guyana,NA,NA,FALSE,NA,NA,NA,Jan 2016,Dec 2016,Jan 2016 - Dec 2016
b02ca771c56d551fa1b6a45ca990db04,77f38584c345b1b352c187e059f944c4,7236,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,NA,FALSE,52,12,Guyana,Pregnant women,"Cayenne, Kourou, Saint Laurent",3493,Hospital based,Female,NA,Dec,2016,NA,Jan,2016,NA,Not adjusted,Other,NA,Infection,Significant,NA,FALSE,NA,Urban area,21,Risk factors,NA,NA,NA,Guyana,NA,NA,FALSE,NA,NA,NA,Jan 2016,Dec 2016,Jan 2016 - Dec 2016
b02ca771c56d551fa1b6a45ca990db04,6f2e700bcc3e030f1f0977ac8bc64f57,7236,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,NA,FALSE,52,12,Guyana,Pregnant women,"Cayenne, Kourou, Saint Laurent",3493,Hospital based,Female,NA,Dec,2016,NA,Jan,2016,NA,Not adjusted,Age,NA,Infection,Not significant,NA,FALSE,NA,Urban area,21,Risk factors,NA,NA,NA,Guyana,NA,NA,FALSE,NA,NA,NA,Jan 2016,Dec 2016,Jan 2016 - Dec 2016
b02ca771c56d551fa1b6a45ca990db04,3f803810154be938b4e207396626383f,7236,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,NA,FALSE,52,12,Guyana,Pregnant women,"Cayenne, Kourou, Saint Laurent",3493,Hospital based,Female,NA,Dec,2016,NA,Jan,2016,NA,Adjusted,Other,NA,Infection,Significant,NA,FALSE,NA,Urban area,21,Risk factors,NA,NA,NA,Guyana,NA,NA,FALSE,NA,NA,NA,Jan 2016,Dec 2016,Jan 2016 - Dec 2016
b02ca771c56d551fa1b6a45ca990db04,e4315bd69335dcbb37a8174677ea93a8,7236,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,NA,FALSE,52,12,Guyana,Pregnant women,"Cayenne, Kourou, Saint Laurent",3493,Hospital based,Female,NA,Dec,2016,NA,Jan,2016,NA,Adjusted,Age;Other,NA,Infection,Not significant,NA,FALSE,NA,Urban area,21,Risk factors,NA,NA,NA,Guyana,NA,NA,FALSE,NA,NA,NA,Jan 2016,Dec 2016,Jan 2016 - Dec 2016
b09e2a7df181aadd51c5885819cc5ca5,568db885039c84f87416d5fba3694ce7,7252,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,NA,Central,NA,NA,NA,NA,NA,0,14,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,FALSE,FALSE,Start outbreak,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Guatemala,Children,Coastal lowlands of SW Guatemala,196,Population based,NA,NA,Nov,2015,NA,Oct,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Rural area,37,Seroprevalence,0 - 14,NA,NA,Guatemala,NA,NA,FALSE,NA,NA,NA,Oct 2015,Nov 2015,Oct 2015 - Nov 2015
b09e2a7df181aadd51c5885819cc5ca5,6d3bebf188486aaa3fe7a0765d3def59,7252,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,NA,Central,NA,NA,NA,NA,NA,19,40,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,FALSE,FALSE,Mid outbreak,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Guatemala,Children,Coastal lowlands of SW Guatemala,186,Population based,NA,NA,Feb,2016,NA,Jan,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Rural area,37,Seroprevalence,19 - 40,NA,NA,Guatemala,NA,NA,FALSE,NA,NA,NA,Jan 2016,Feb 2016,Jan 2016 - Feb 2016
b09e2a7df181aadd51c5885819cc5ca5,3ff7af3790bcc4c229c40326b9c904ad,7252,Seroprevalence - NS1 BOB ELISA,Percentage (%),0,10,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,196,NA,20,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Start outbreak,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Guatemala,Children,Coastal lowlands of SW Guatemala,196,Population based,NA,NA,Nov,2015,NA,Oct,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Rural area,37,Seroprevalence,NA,NA,NA,Guatemala,NA,NA,FALSE,NA,NA,NA,Oct 2015,Nov 2015,Oct 2015 - Nov 2015
b09e2a7df181aadd51c5885819cc5ca5,c52af066f45218fc525be603a276f296,7252,Seroprevalence - NS1 BOB ELISA,Percentage (%),0,37,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,186,NA,69,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Guatemala,Children,Coastal lowlands of SW Guatemala,186,Population based,NA,NA,Feb,2016,NA,Jan,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Rural area,37,Seroprevalence,NA,NA,NA,Guatemala,NA,NA,FALSE,NA,NA,NA,Jan 2016,Feb 2016,Jan 2016 - Feb 2016
b09e2a7df181aadd51c5885819cc5ca5,fd21d219029ed767ccb22772eab74914,7252,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Kelly M,NA,FALSE,NA,NA,Guatemala,Children,Coastal lowlands of SW Guatemala,NA,Population based,NA,NA,NA,2016,NA,NA,2015,NA,Adjusted,Age;Other,NA,Serology,Significant,NA,FALSE,NA,Rural area,37,Risk factors,NA,NA,NA,Guatemala,NA,NA,FALSE,NA,NA,NA,2015,2016,2015 - 2016
b09e2a7df181aadd51c5885819cc5ca5,c6056c34611097d1358cfd2cd3d2c7dd,7252,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Kelly M,NA,FALSE,NA,NA,Guatemala,Children,Coastal lowlands of SW Guatemala,NA,Population based,NA,NA,NA,2016,NA,NA,2015,NA,Not adjusted,Other;Sex,NA,Serology,Not significant,NA,FALSE,NA,Rural area,37,Risk factors,NA,NA,NA,Guatemala,NA,NA,FALSE,NA,NA,NA,2015,2016,2015 - 2016
11089954efa94fec11f4f53ad185f20e,78a088e9cb2207852fd7361f5b68dad7,7312,Reproduction number (Basic R0) - Sexual,No units,0,0.19,Median,0.05,0.48,95% CI,NA,NA,0,0.29,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Region,FALSE,FALSE,Unspecified,Ross-Macdonald formula,Christian,Estimated model parameter,FALSE,NA,NA,United States,General population,Texas,NA,Population based,NA,NA,Jan,2017,NA,Jan,2016,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Both urban and rural areas,67,Reproduction number,0 - 0.29,95% CI,0.05 - 0.48,United States,NA,NA,FALSE,NA,NA,NA,Jan 2016,Jan 2017,Jan 2016 - Jan 2017
ad50411a298a7991e96e7b6be022e0b6,f4b3e6587d2cb71b189332f08380e27f,7336,"Reproduction number (Effective, Re)",No units,0,2.2,Central,NA,NA,NA,NA,NA,1.1,3.3,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Time,FALSE,FALSE,Mid outbreak,Next generation matrix,Ruth,NA,FALSE,NA,NA,Brazil,Persons under investigation,Northeastern,NA,Population based,NA,NA,Nov,2016,NA,Jan,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,14,Reproduction number,1.1 - 3.3,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Jan 2015,Nov 2016,Jan 2015 - Nov 2016
ad50411a298a7991e96e7b6be022e0b6,6d24b25254ca2bc1befcbb012fdcbec7,7336,"Reproduction number (Effective, Re)",No units,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Time,TRUE,TRUE,Mid outbreak,Other,Ruth,NA,TRUE,NA,NA,Brazil,Persons under investigation,Northeastern,NA,Population based,NA,NA,Sep,2016,NA,Jan,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,14,Reproduction number,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Jan 2015,Sep 2016,Jan 2015 - Sep 2016
ad50411a298a7991e96e7b6be022e0b6,87a2734ca3ad278a60feb31da8896336,7336,Attack rate,Unspecified,0,NA,Unspecified,NA,NA,NA,NA,NA,0.219,0.285,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,FALSE,FALSE,Mid outbreak,NA,Ruth,NA,FALSE,NA,NA,Brazil,Persons under investigation,Northeastern,NA,Population based,NA,NA,Nov,2016,NA,Jan,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,14,Attack rate,0.219 - 0.285,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Jan 2015,Nov 2016,Jan 2015 - Nov 2016
be0b89b8b78e7c516450e6f6ae100fd7,558da68aa84e15f7272e660da404c4a8,7349,Seroprevalence - IgM,Percentage (%),0,12,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,26,Unspecified,3,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,"Other, Symptoms",TRUE,FALSE,Post outbreak,NA,Ruth,Observed sample statistic,FALSE,NA,NA,Mexico,Persons under investigation,Monterrey City,26,Hospital based,Unspecified,30,Jun,2018,1,Aug,2017,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,Unspecified,Urban area,30,Seroprevalence,NA,NA,NA,Mexico,NA,NA,FALSE,NA,NA,NA,1 Aug 2017,30 Jun 2018,1 Aug 2017 - 30 Jun 2018
be0b89b8b78e7c516450e6f6ae100fd7,fedd04759366dd90e897af7eb85ff140,7349,Seroprevalence - IgM,Percentage (%),0,8,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,113,Unspecified,9,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Other, Symptoms",FALSE,FALSE,Post outbreak,NA,Ruth,Observed sample statistic,FALSE,NA,NA,Mexico,Persons under investigation,Monterrey City,113,Hospital based,Unspecified,30,Jun,2018,1,Aug,2017,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,Unspecified,Urban area,30,Seroprevalence,NA,NA,NA,Mexico,NA,NA,FALSE,NA,NA,NA,1 Aug 2017,30 Jun 2018,1 Aug 2017 - 30 Jun 2018
be0b89b8b78e7c516450e6f6ae100fd7,70c1c1871cb3216e943c88db91c588a4,7349,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Ruth,NA,FALSE,70,2,Mexico,Persons under investigation,Monterrey City,191,Hospital based,Both,30,Jun,2018,1,Aug,2017,NA,Unspecified,Infection,NA,Guillain Barre syndrome,Not significant,NA,FALSE,Unspecified,Urban area,30,Risk factors,NA,NA,NA,Mexico,NA,NA,FALSE,NA,NA,NA,1 Aug 2017,30 Jun 2018,1 Aug 2017 - 30 Jun 2018
be0b89b8b78e7c516450e6f6ae100fd7,10df035e26064fa90cbcf96042d2822b,7349,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Ruth,NA,FALSE,70,2,Mexico,Persons under investigation,Monterrey City,191,Hospital based,Both,30,Jun,2018,1,Aug,2017,NA,Unspecified,Other,NA,Guillain Barre syndrome,Significant,NA,FALSE,Unspecified,Urban area,30,Risk factors,NA,NA,NA,Mexico,NA,NA,FALSE,NA,NA,NA,1 Aug 2017,30 Jun 2018,1 Aug 2017 - 30 Jun 2018
2cba114b764b23d202345fcb54e0d461,1698cf55d4d95aaed8c46b58549bb4b9,7409,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Anna-Maria Hartner,NA,FALSE,NA,NA,Mexico,Persons under investigation,NA,10319,Population based,Both,NA,Mar,2020,NA,Jan,2012,NA,Not adjusted,Age;Other;Sex,NA,Severe disease (in general population),Significant,NA,FALSE,NA,Unspecified,9,Risk factors,NA,NA,NA,Mexico,NA,NA,FALSE,NA,NA,NA,Jan 2012,Mar 2020,Jan 2012 - Mar 2020
b293fefc72c828c187debe33a3b3dde3,40e6a2e871201618ac54a12153bfa493,7416,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Ruth,NA,FALSE,NA,NA,Brazil,Mixed groups,"Jundiai, Parana",NA,Hospital based,Unspecified,NA,NA,2016,NA,NA,2015,NA,Not adjusted,Other,NA,Other,Significant,NA,FALSE,Unspecified,Unspecified,31,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,2015,2016,2015 - 2016
b293fefc72c828c187debe33a3b3dde3,1a6d0446c2f60e5b209b26fb27b57640,7416,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Ruth,NA,FALSE,NA,NA,Brazil,Mixed groups,"Jundiai, Parana",NA,Hospital based,Unspecified,NA,NA,2016,NA,NA,2015,NA,Not adjusted,Other,NA,Other,Not significant,NA,FALSE,Unspecified,Unspecified,31,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,2015,2016,2015 - 2016
95b87785195c099cbee19d15e6448cd1,4f5c2d7046eb5f75a8c3943c6a619275,7432,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,8,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,100,Unspecified,8,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,NA,Kenya,General population,"Kokipei, West Pokot",100,Population based,Unspecified,NA,Feb,2016,NA,Feb,2016,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,Unspecified,Unspecified,32,Seroprevalence,NA,NA,NA,Kenya,NA,NA,FALSE,NA,NA,NA,Feb 2016,Feb 2016,Feb 2016
95b87785195c099cbee19d15e6448cd1,7548b7db6a77bad7f35522b17463f799,7432,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,9.09,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,66,Unspecified,6,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,NA,Kenya,General population,"Sangakai, West Pokot",66,Population based,Unspecified,NA,Feb,2016,NA,Feb,2016,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,Unspecified,Unspecified,32,Seroprevalence,NA,NA,NA,Kenya,NA,NA,FALSE,NA,NA,NA,Feb 2016,Feb 2016,Feb 2016
95b87785195c099cbee19d15e6448cd1,562e36a828c716e214075acfb63f8163,7432,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,11.5,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,113,Unspecified,13,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,NA,Kenya,General population,"Kanyerus, West Pokot",113,Population based,Unspecified,NA,Feb,2016,NA,Feb,2016,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,Unspecified,Unspecified,32,Seroprevalence,NA,NA,NA,Kenya,NA,NA,FALSE,NA,NA,NA,Feb 2016,Feb 2016,Feb 2016
95b87785195c099cbee19d15e6448cd1,793771363974d0459c0ed86e8fac8234,7432,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,4.11,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,73,Unspecified,3,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,NA,Kenya,General population,"Shaba, West Pokot",73,Population based,Unspecified,NA,Feb,2016,NA,Feb,2016,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,Unspecified,Unspecified,32,Seroprevalence,NA,NA,NA,Kenya,NA,NA,FALSE,NA,NA,NA,Feb 2016,Feb 2016,Feb 2016
95b87785195c099cbee19d15e6448cd1,853719db9b860f59fe86b7e19ea7e411,7432,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,1.67,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,60,Unspecified,1,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,NA,Kenya,General population,"Longarkau, West Pokot",60,Population based,Unspecified,NA,Feb,2016,NA,Feb,2016,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,Unspecified,Unspecified,32,Seroprevalence,NA,NA,NA,Kenya,NA,NA,FALSE,NA,NA,NA,Feb 2016,Feb 2016,Feb 2016
95b87785195c099cbee19d15e6448cd1,ae8a85f0996c58411883c25849699b97,7432,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,3.85,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,52,Unspecified,2,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,NA,Kenya,General population,"Pkotong, West Pokot",52,Population based,Unspecified,NA,Feb,2016,NA,Feb,2016,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,Unspecified,Unspecified,32,Seroprevalence,NA,NA,NA,Kenya,NA,NA,FALSE,NA,NA,NA,Feb 2016,Feb 2016,Feb 2016
95b87785195c099cbee19d15e6448cd1,3a3f86072d7bd97ea305795c05c652f4,7432,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,7.11,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,464,Unspecified,33,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Region",FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,NA,Kenya,General population,West Pokot,464,Population based,Unspecified,NA,Feb,2016,NA,Feb,2016,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,Unspecified,Unspecified,32,Seroprevalence,NA,NA,NA,Kenya,NA,NA,FALSE,NA,NA,NA,Feb 2016,Feb 2016,Feb 2016
95b87785195c099cbee19d15e6448cd1,6c868fe2e438b7896a9c80bc75991cce,7432,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,1.59,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,63,Unspecified,1,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,NA,Kenya,General population,"Elelea, Turkana",63,Population based,Unspecified,NA,Aug,2017,NA,Aug,2017,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,Unspecified,Unspecified,32,Seroprevalence,NA,NA,NA,Kenya,NA,NA,FALSE,NA,NA,NA,Aug 2017,Aug 2017,Aug 2017
95b87785195c099cbee19d15e6448cd1,e435e8cd70206ce2e8e36a893e9132fb,7432,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,0,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,25,Unspecified,0,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,NA,Kenya,General population,"Prigan, Turkana",25,Population based,Unspecified,NA,Aug,2017,NA,Aug,2017,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,Unspecified,Unspecified,32,Seroprevalence,NA,NA,NA,Kenya,NA,NA,FALSE,NA,NA,NA,Aug 2017,Aug 2017,Aug 2017
95b87785195c099cbee19d15e6448cd1,815f33d008bb70df23c40c30092d9e7b,7432,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,0,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,61,Unspecified,0,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,NA,Kenya,General population,"Kare Edome, Turkana",61,Population based,Unspecified,NA,Aug,2017,NA,Aug,2017,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,Unspecified,Unspecified,32,Seroprevalence,NA,NA,NA,Kenya,NA,NA,FALSE,NA,NA,NA,Aug 2017,Aug 2017,Aug 2017
95b87785195c099cbee19d15e6448cd1,c3e826e382e949cf54cee4ac3053629a,7432,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,0,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,69,Unspecified,0,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,NA,Kenya,General population,"Nayanaesanyati, Turkana",69,Population based,Unspecified,NA,Aug,2017,NA,Aug,2017,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,Unspecified,Unspecified,32,Seroprevalence,NA,NA,NA,Kenya,NA,NA,FALSE,NA,NA,NA,Aug 2017,Aug 2017,Aug 2017
95b87785195c099cbee19d15e6448cd1,4ab2b38965f279dd19c703571fe97aaf,7432,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,0,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,56,Unspecified,0,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,NA,Kenya,General population,"Old Gunner, Turkana",56,Population based,Unspecified,NA,Aug,2017,NA,Aug,2017,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,Unspecified,Unspecified,32,Seroprevalence,NA,NA,NA,Kenya,NA,NA,FALSE,NA,NA,NA,Aug 2017,Aug 2017,Aug 2017
95b87785195c099cbee19d15e6448cd1,04d4288aef9903747b5b57afdccc1688,7432,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,0,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,139,Unspecified,0,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,NA,Kenya,General population,"Lowarengak, Turkana",139,Population based,Unspecified,NA,Aug,2017,NA,Aug,2017,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,Unspecified,Unspecified,32,Seroprevalence,NA,NA,NA,Kenya,NA,NA,FALSE,NA,NA,NA,Aug 2017,Aug 2017,Aug 2017
95b87785195c099cbee19d15e6448cd1,67b3ef600e0219d66948fdae4bd5ac7c,7432,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,0.24,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,413,Unspecified,1,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Region",FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,NA,Kenya,General population,Turkana,413,Population based,Unspecified,NA,Aug,2017,NA,Aug,2017,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,Unspecified,Unspecified,32,Seroprevalence,NA,NA,NA,Kenya,NA,NA,FALSE,NA,NA,NA,Aug 2017,Aug 2017,Aug 2017
95b87785195c099cbee19d15e6448cd1,f8889b0fcd1ba2cbf34c67996ae68a26,7432,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,NA,FALSE,NA,13,Kenya,General population,West Pokot,33,Population based,Both,NA,Feb,2016,NA,Feb,2016,NA,Adjusted,Other,NA,Serology,Significant,NA,FALSE,Unspecified,Unspecified,32,Risk factors,NA,NA,NA,Kenya,NA,NA,FALSE,NA,NA,NA,Feb 2016,Feb 2016,Feb 2016
95b87785195c099cbee19d15e6448cd1,7d0499b6381ff6aa55ae6e1cbba91f71,7432,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,NA,FALSE,NA,13,Kenya,General population,West Pokot,33,Population based,Both,NA,Feb,2016,NA,Feb,2016,NA,Adjusted,Age;Occupation;Other;Prior immunity to arboviruses;Sex,Livestock and animal herders,Serology,Not significant,NA,FALSE,Unspecified,Unspecified,32,Risk factors,NA,NA,NA,Kenya,NA,NA,FALSE,NA,NA,NA,Feb 2016,Feb 2016,Feb 2016
8ce019236764188f36c3eb177c9bcb9f,e225660b2670eee290503ff5836c2367,7437,Seroprevalence - IgM,Percentage (%),0,63.1,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,19,Unspecified,12,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,NA,Czech Republic,Persons under investigation,"University Hospital Bulovka, Prague",19,Travel based,Unspecified,NA,Dec,2019,NA,Jan,2004,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,Unspecified,Unspecified,33,Seroprevalence,NA,NA,NA,Czech Republic,NA,NA,FALSE,NA,NA,NA,Jan 2004,Dec 2019,Jan 2004 - Dec 2019
8ce019236764188f36c3eb177c9bcb9f,46bd63db0f23f85b719eb64ad41192d3,7437,Seroprevalence - IgG,Percentage (%),0,42.1,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,19,Unspecified,8,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,NA,Czech Republic,Persons under investigation,"University Hospital Bulovka, Prague",19,Travel based,Unspecified,NA,Dec,2019,NA,Jan,2004,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,Unspecified,Unspecified,33,Seroprevalence,NA,NA,NA,Czech Republic,NA,NA,FALSE,NA,NA,NA,Jan 2004,Dec 2019,Jan 2004 - Dec 2019
8ce019236764188f36c3eb177c9bcb9f,530baa64affe6d7129a757b4e9ead0c4,7437,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,84.2,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,19,Unspecified,16,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,NA,Czech Republic,Persons under investigation,"University Hospital Bulovka, Prague",19,Travel based,Unspecified,NA,Dec,2019,NA,Jan,2004,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,Unspecified,Unspecified,33,Seroprevalence,NA,NA,NA,Czech Republic,NA,NA,FALSE,NA,NA,NA,Jan 2004,Dec 2019,Jan 2004 - Dec 2019
8ce019236764188f36c3eb177c9bcb9f,10a2e277a9154ef010ae3ffd426edcad,7437,Human delay - Onset to Admission to care,Days,0,7,Median,3,19,IQR,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,NA,Czech Republic,Persons under investigation,"University Hospital Bulovka, Prague",19,Travel based,Unspecified,NA,Dec,2019,NA,Jan,2004,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,33,Human delay,NA,IQR,3 - 19,Czech Republic,Onset to admission to care,NA,FALSE,NA,NA,NA,Jan 2004,Dec 2019,Jan 2004 - Dec 2019
8ce019236764188f36c3eb177c9bcb9f,5271f2fd7e523733d6dc3ebdb5339166,7437,Human delay - Onset to Recovery/non-Infectiousness,Days,0,5,Median,4,6,IQR,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,NA,Czech Republic,Persons under investigation,"University Hospital Bulovka, Prague",19,Travel based,Unspecified,NA,Dec,2019,NA,Jan,2004,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,33,Human delay,NA,IQR,4 - 6,Czech Republic,Onset to recovery/non-infectiousness,NA,FALSE,NA,NA,NA,Jan 2004,Dec 2019,Jan 2004 - Dec 2019
333e85941418e96d487005d7c2d837c3,69260203f04bb13e31f4df426ec57585,7448,Seroprevalence - IgG,Percentage (%),0,31.4,NA,30,32.9,95% CI,NA,NA,NA,NA,NA,NA,4035,NA,1268,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Occupation, Other, Sex",FALSE,FALSE,Post outbreak,NA,Anna-Maria Hartner,NA,FALSE,50,1,United States,General population,"Ponce, Puerto Rico",4090,Household based,Both,NA,May,2019,NA,Apr,2018,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,18,Seroprevalence,NA,95% CI,30 - 32.9,United States,NA,NA,FALSE,NA,NA,NA,Apr 2018,May 2019,Apr 2018 - May 2019
333e85941418e96d487005d7c2d837c3,d428a6b17746016e10f2f11b4d4a5dc3,7448,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Anna-Maria Hartner,NA,FALSE,50,1,United States,General population,"Ponce, Puerto Rico",4090,Household based,Unspecified,NA,May,2019,NA,Apr,2018,NA,Adjusted,Age;Other;Sex,NA,Infection,Significant,NA,FALSE,NA,Unspecified,18,Risk factors,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,Apr 2018,May 2019,Apr 2018 - May 2019
333e85941418e96d487005d7c2d837c3,463efc2bd683b316cc02604240d4bb39,7448,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Anna-Maria Hartner,NA,FALSE,50,1,United States,General population,"Ponce, Puerto Rico",4090,Household based,Unspecified,NA,May,2019,NA,Apr,2018,NA,Adjusted,Other,NA,Infection,Not significant,NA,FALSE,NA,Unspecified,18,Risk factors,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,Apr 2018,May 2019,Apr 2018 - May 2019
2eef54eff845688441d1c374b66dedac,4527ebc467082b34f995ceef945524eb,7452,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,NA,FALSE,NA,NA,Dominican Republic,Children,"Santo Domingo, Santiago",80,Hospital based,Both,NA,NA,2019,NA,NA,2016,NA,Not adjusted,Infection during pregnancy;Other;Sex,NA,Zika congenital syndrome/other birth defects,Not significant,NA,FALSE,Unspecified,Unspecified,34,Risk factors,NA,NA,NA,Dominican Republic,NA,NA,FALSE,NA,NA,NA,2016,2019,2016 - 2019
1a2a922ca2033cc1b26d53a0d4fa0fef,75d41da3a5fa89c9b7d69da40e2394db,7483,Seroprevalence - IgG,Percentage (%),0,NA,Unspecified,NA,NA,NA,NA,NA,0.1,74.7,NA,Lab confirmed,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Method, Other, Sex",TRUE,FALSE,Unspecified,NA,Ruth,Estimated model parameter,FALSE,65,5,Brazil,General population,Recife,2070,Household based,Both,NA,Feb,2019,NA,Aug,2018,NA,NA,NA,NA,NA,NA,Adjusted,FALSE,NA,Urban area,22,Seroprevalence,0.1 - 74.7,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Aug 2018,Feb 2019,Aug 2018 - Feb 2019
1a2a922ca2033cc1b26d53a0d4fa0fef,a22591fdf513b14fb03ca6760aa819c7,7483,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Other,TRUE,FALSE,Unspecified,NA,Ruth,NA,FALSE,NA,NA,Brazil,General population,Recife,NA,Household based,Both,NA,Feb,2019,NA,Aug,2018,NA,Not adjusted,Age;Other;Prior immunity to arboviruses;Sex,NA,Serology,Not significant,NA,FALSE,NA,Urban area,22,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Aug 2018,Feb 2019,Aug 2018 - Feb 2019
1a2a922ca2033cc1b26d53a0d4fa0fef,212c451b750e35c07bee2f5f5214da7d,7483,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Other,TRUE,FALSE,Unspecified,NA,Ruth,NA,FALSE,NA,NA,Brazil,General population,Recife,NA,Household based,Both,NA,Feb,2019,NA,Aug,2018,NA,Not adjusted,Age;Other;Prior immunity to arboviruses,NA,Serology,Significant,NA,FALSE,NA,Urban area,22,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Aug 2018,Feb 2019,Aug 2018 - Feb 2019
1a2a922ca2033cc1b26d53a0d4fa0fef,063e60779dd5b6434d810ad11cc502dd,7483,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Other,TRUE,FALSE,Unspecified,NA,Ruth,NA,FALSE,NA,NA,Brazil,General population,Recife,NA,Household based,Both,NA,Feb,2019,NA,Aug,2018,NA,Adjusted,Age;Other,NA,Serology,Not significant,NA,FALSE,NA,Urban area,22,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Aug 2018,Feb 2019,Aug 2018 - Feb 2019
1a2a922ca2033cc1b26d53a0d4fa0fef,7b51f5eb5f2f1e07d39a244024766b65,7483,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Other,TRUE,FALSE,Unspecified,NA,Ruth,NA,FALSE,NA,NA,Brazil,General population,Recife,NA,Household based,Both,NA,Feb,2019,NA,Aug,2018,NA,Adjusted,Age;Other;Prior immunity to arboviruses,NA,Serology,Significant,NA,FALSE,NA,Urban area,22,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Aug 2018,Feb 2019,Aug 2018 - Feb 2019
a78fa05461b4d2c6515387d885b48381,d1281edd1602b599e88d428784f9ce50,7491,Seroprevalence - IgM,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Suspected,400,Naive,38,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Anna-Maria Hartner,NA,FALSE,NA,18,Malaysia,Persons under investigation,Sabah,400,Hospital based,Unspecified,NA,NA,2017,NA,NA,2017,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,NA,Unspecified,10,Seroprevalence,NA,NA,NA,Malaysia,NA,NA,FALSE,NA,NA,NA,2017,2017,2017
a78fa05461b4d2c6515387d885b48381,9153bf92a7f34eb1b3cd6e1e519c1b7a,7491,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,6,NA,4,8,95% CI,NA,NA,NA,NA,NA,Lab confirmed,38,Naive,24,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Anna-Maria Hartner,NA,FALSE,NA,18,Malaysia,Persons under investigation,Sabah,38,Hospital based,Unspecified,NA,NA,2017,NA,NA,2017,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,NA,Unspecified,10,Seroprevalence,NA,95% CI,4 - 8,Malaysia,NA,NA,TRUE,NA,NA,NA,2017,2017,2017
a78fa05461b4d2c6515387d885b48381,c688303dd4d3861895867c75ec1b38bd,7491,Seroprevalence - IgG,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Suspected,400,Naive,36,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Anna-Maria Hartner,NA,FALSE,NA,18,Malaysia,Persons under investigation,Sabah,400,Hospital based,Unspecified,NA,NA,2017,NA,NA,2017,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,NA,Unspecified,10,Seroprevalence,NA,NA,NA,Malaysia,NA,NA,FALSE,NA,NA,NA,2017,2017,2017
a78fa05461b4d2c6515387d885b48381,17f12666cd9930efd0faed3e26fd1198,7491,Seroprevalence - IgM,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Suspected,418,Naive,16,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Anna-Maria Hartner,NA,FALSE,NA,18,Malaysia,Blood donors,Sabah,418,Hospital based,Unspecified,NA,NA,2018,NA,NA,2018,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,NA,Unspecified,10,Seroprevalence,NA,NA,NA,Malaysia,NA,NA,FALSE,NA,NA,NA,2018,2018,2018
a78fa05461b4d2c6515387d885b48381,7387f59b03c80b9e78e7f22b771b5ea6,7491,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,1.4,NA,0.65,3,95% CI,NA,NA,NA,NA,NA,Lab confirmed,16,Naive,6,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Anna-Maria Hartner,NA,FALSE,NA,18,Malaysia,Blood donors,Sabah,26,Hospital based,Unspecified,NA,NA,2018,NA,NA,2018,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,NA,Unspecified,10,Seroprevalence,NA,95% CI,0.65 - 3,Malaysia,NA,NA,TRUE,NA,NA,NA,2018,2018,2018
a78fa05461b4d2c6515387d885b48381,201fbed2da8bdcc2bce3418870ad90b7,7491,Seroprevalence - IgG,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Suspected,418,Naive,15,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Anna-Maria Hartner,NA,FALSE,NA,18,Malaysia,Blood donors,Sabah,418,Hospital based,Unspecified,NA,NA,2018,NA,NA,2018,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,NA,Unspecified,10,Seroprevalence,NA,NA,NA,Malaysia,NA,NA,FALSE,NA,NA,NA,2018,2018,2018
a78fa05461b4d2c6515387d885b48381,1db44529669e60d4dfd31bda3feea349,7491,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,0.5,NA,0.13,1.8,95% CI,NA,NA,NA,NA,NA,Probable,38,Naive,2,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Anna-Maria Hartner,NA,FALSE,NA,18,Malaysia,Persons under investigation,Sabah,38,Hospital based,Unspecified,NA,NA,2017,NA,NA,2017,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,NA,Unspecified,10,Seroprevalence,NA,95% CI,0.13 - 1.8,Malaysia,NA,NA,TRUE,NA,NA,NA,2017,2017,2017
a78fa05461b4d2c6515387d885b48381,1cc3a0f3cd603b1d2c315f2cd68d04d0,7491,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,1.4,NA,0.65,3,95% CI,NA,NA,NA,NA,NA,Probable,16,Naive,6,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Anna-Maria Hartner,NA,FALSE,NA,18,Malaysia,Blood donors,Sabah,26,Hospital based,Unspecified,NA,NA,2018,NA,NA,2018,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,NA,Unspecified,10,Seroprevalence,NA,95% CI,0.65 - 3,Malaysia,NA,NA,TRUE,NA,NA,NA,2018,2018,2018
d89fcd688e7b58c4fb03b89ee1aeb104,8511a2e5a532c274a14b53b015ae8673,7498,Seroprevalence - IgG,Percentage (%),0,27.3,Central,20.7,35.1,95% CI,NA,NA,NA,NA,NA,NA,150,NA,41,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,65,18,Ethiopia,General population,"Itang special district, Lare district",150,Community based,Both,NA,Jun,2019,NA,Oct,2018,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,63,Seroprevalence,NA,95% CI,20.7 - 35.1,Ethiopia,NA,NA,FALSE,NA,NA,NA,Oct 2018,Jun 2019,Oct 2018 - Jun 2019
d89fcd688e7b58c4fb03b89ee1aeb104,053c273c18621d68a002991875c8da2b,7498,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,NA,FALSE,65,18,Ethiopia,General population,"Itang special district, Lare district",150,Community based,Both,NA,Jun,2019,NA,Oct,2018,NA,Adjusted,Occupation;Other;Sex,Livestock and animal herders,Serology,Significant,NA,FALSE,NA,Unspecified,63,Risk factors,NA,NA,NA,Ethiopia,NA,NA,FALSE,NA,NA,NA,Oct 2018,Jun 2019,Oct 2018 - Jun 2019
d89fcd688e7b58c4fb03b89ee1aeb104,645d889920a3ba0bdecef59abd22a551,7498,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,NA,FALSE,65,18,Ethiopia,General population,"Itang special district, Lare district",150,Community based,Both,NA,Jun,2019,NA,Oct,2018,NA,Adjusted,Age;Other,NA,Serology,Not significant,NA,FALSE,NA,Unspecified,63,Risk factors,NA,NA,NA,Ethiopia,NA,NA,FALSE,NA,NA,NA,Oct 2018,Jun 2019,Oct 2018 - Jun 2019
157cfccf9655154975c1043a572e8f0f,ecee1b4de26494368a66a9ce8ccd6046,7503,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,NA,FALSE,NA,NA,Brazil,Children,"Jundiai, São Paulo",557,Hospital based,Unspecified,23,Aug,2017,1,Mar,2016,NA,Not adjusted,Infection during pregnancy,NA,Zika congenital syndrome/other birth defects,Not significant,NA,FALSE,Unspecified,Unspecified,36,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,1 Mar 2016,23 Aug 2017,1 Mar 2016 - 23 Aug 2017
157cfccf9655154975c1043a572e8f0f,d295ac3c79952f4731bdbb18aff79227,7503,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,NA,FALSE,NA,NA,Brazil,Children,"Jundiai, São Paulo",557,Hospital based,Unspecified,23,Aug,2017,1,Mar,2016,NA,Not adjusted,Infection during pregnancy,NA,Zika congenital syndrome/other birth defects,Significant,NA,FALSE,Unspecified,Unspecified,36,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,1 Mar 2016,23 Aug 2017,1 Mar 2016 - 23 Aug 2017
685ae6530e309563aa942584992a5da1,0f8a25657a54a1c0abb9ec361ad3afd1,7567,Seroprevalence - IgM,Percentage (%),0,1.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,Suspected,1006,NA,14,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Symptoms,FALSE,FALSE,Endemic,NA,Anna-Maria Hartner,NA,FALSE,45,18,Nigeria,Pregnant women,Jos,1006,Hospital based,Female,31,Jan,2022,1,Apr,2019,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,13,Seroprevalence,NA,NA,NA,Nigeria,NA,NA,FALSE,NA,NA,NA,1 Apr 2019,31 Jan 2022,1 Apr 2019 - 31 Jan 2022
685ae6530e309563aa942584992a5da1,bb5b328e9fcab380772d2512c65bbec0,7567,Seroprevalence - IgG,Percentage (%),0,0.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,Suspected,1006,NA,4,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Symptoms,FALSE,FALSE,Endemic,NA,Anna-Maria Hartner,NA,FALSE,45,18,Nigeria,Pregnant women,Jos,1006,Hospital based,Female,31,Jan,2022,1,Apr,2019,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,13,Seroprevalence,NA,NA,NA,Nigeria,NA,NA,FALSE,NA,NA,NA,1 Apr 2019,31 Jan 2022,1 Apr 2019 - 31 Jan 2022
f04c0d5ef6c125276abe2cbc8e04f9c0,b6221e686ca67a1f791a371fb3f35763,7625,Seroprevalence - IgG,Percentage (%),0,19.2,NA,0.16,0.21,95% CI,NA,NA,NA,NA,NA,Unspecified,871,Naive,167,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Other, Region, Sex, Symptoms",FALSE,FALSE,Endemic,NA,Anna-Maria Hartner,NA,FALSE,80,0,Nigeria,General population,"3 states in Nigeria Nigeria, Abia State in Southern Nigeria, and Kaduna
State in Northern Nigeria",871,Hospital based,Both,NA,Nov,2021,NA,Dec,2020,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,11,Seroprevalence,NA,95% CI,0.16 - 0.21,Nigeria,NA,NA,FALSE,NA,NA,NA,Dec 2020,Nov 2021,Dec 2020 - Nov 2021
3591a7fb9fe0abafb155f621f9f38461,8eb6bae1e43071c84db8ac079428b225,7647,Reproduction number (Basic R0),No units,0,1.12,Mean,0.8,1.5,95% CrI,NA,NA,0.7,1.6,NA,NA,NA,NA,NA,Yes - on Github,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Method, Time",FALSE,TRUE,Unspecified,Compartmental model,Ruth,Estimated model parameter,FALSE,NA,NA,Fiji,Persons under investigation,NA,NA,Population based,NA,NA,NA,2018,NA,NA,2013,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,37,Reproduction number,0.7 - 1.6,95% CrI,0.8 - 1.5,Fiji,NA,NA,FALSE,NA,NA,NA,2013,2018,2013 - 2018
3591a7fb9fe0abafb155f621f9f38461,ca5506275fba678c4deb139ad23a74ff,7647,"Reproduction number (Effective, Re)",No units,0,NA,Median,NA,NA,95% CrI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on Github,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Method, Time",TRUE,TRUE,Unspecified,Compartmental model,Ruth,Estimated model parameter,TRUE,NA,NA,Fiji,Persons under investigation,NA,NA,Population based,Unspecified,NA,NA,2018,NA,NA,2013,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,37,Reproduction number,NA,NA,NA,Fiji,NA,NA,FALSE,NA,NA,NA,2013,2018,2013 - 2018
3591a7fb9fe0abafb155f621f9f38461,19ebbe30fb7492e5ae28a34835261450,7647,Attack rate,Percentage (%),0,NA,Unspecified,NA,NA,NA,NA,NA,46,53,NA,NA,NA,NA,NA,Yes - on Github,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Method,TRUE,FALSE,Unspecified,NA,Ruth,Unspecified,TRUE,NA,NA,Fiji,Persons under investigation,NA,NA,Population based,Unspecified,NA,Nov,2017,NA,May,2013,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,37,Attack rate,46 - 53,NA,NA,Fiji,NA,NA,FALSE,NA,NA,NA,May 2013,Nov 2017,May 2013 - Nov 2017
e4d9e323b771d3ce4517984ea504e798,ee424162364014449f6c749d80f72b64,7654,Seroprevalence - IgG,Percentage (%),0,13.2,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,872,NA,115,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Region, Sex",FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,5,Malaysia,General population,NA,872,Community based,Both,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Rural area,23,Seroprevalence,NA,NA,NA,Malaysia,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
e4d9e323b771d3ce4517984ea504e798,15645f955b8868a9ff9190c001684570,7654,Seroprevalence - IgG,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,374,NA,57,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,NA,FALSE,NA,5,Malaysia,General population,NA,374,Community based,Male,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Rural area,23,Seroprevalence,NA,NA,NA,Malaysia,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
e4d9e323b771d3ce4517984ea504e798,72915af0d5757578d74f0707597beb5f,7654,Seroprevalence - IgG,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,498,NA,58,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,NA,FALSE,NA,5,Malaysia,General population,NA,498,Community based,Female,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Rural area,23,Seroprevalence,NA,NA,NA,Malaysia,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
e4d9e323b771d3ce4517984ea504e798,96b51e4e43120802fa4bf4dd758fb31f,7654,Seroprevalence - IgG,Percentage (%),0,17.3,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,81,NA,14,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,5,Malaysia,General population,Lubuk Legong,81,Community based,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Rural area,23,Seroprevalence,NA,NA,NA,Malaysia,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
e4d9e323b771d3ce4517984ea504e798,205c8b42a8dd9448d02d6dd44ca8106e,7654,Seroprevalence - IgG,Percentage (%),0,22,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,91,NA,20,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,5,Malaysia,General population,Sungai Perah,91,Community based,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Rural area,23,Seroprevalence,NA,NA,NA,Malaysia,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
e4d9e323b771d3ce4517984ea504e798,5129e79c04db3afd01c22ab450237ee1,7654,Seroprevalence - IgG,Percentage (%),0,6.9,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,87,NA,6,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,5,Malaysia,General population,Tumboh Hangat,87,Community based,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Rural area,23,Seroprevalence,NA,NA,NA,Malaysia,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
e4d9e323b771d3ce4517984ea504e798,da51d66c038ab5d50c36641e855003ac,7654,Seroprevalence - IgG,Percentage (%),0,4.5,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,67,NA,3,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,5,Malaysia,General population,Jekjok,67,Community based,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Rural area,23,Seroprevalence,NA,NA,NA,Malaysia,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
e4d9e323b771d3ce4517984ea504e798,06b6be2ceca516e2b46fcbde74d57c31,7654,Seroprevalence - IgG,Percentage (%),0,4,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,101,NA,4,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,5,Malaysia,General population,Sangwai,101,Community based,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Rural area,23,Seroprevalence,NA,NA,NA,Malaysia,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
e4d9e323b771d3ce4517984ea504e798,e40067cca0b43daac0e801a0a41dcd87,7654,Seroprevalence - IgG,Percentage (%),0,0,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,22,NA,0,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,5,Malaysia,General population,Paya Pelong,22,Community based,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Rural area,23,Seroprevalence,NA,NA,NA,Malaysia,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
e4d9e323b771d3ce4517984ea504e798,3d94279d96539cf728af15bbc981be01,7654,Seroprevalence - IgG,Percentage (%),0,9.4,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,90,NA,12,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,5,Malaysia,General population,Paya Sendayan,90,Community based,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Rural area,23,Seroprevalence,NA,NA,NA,Malaysia,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
e4d9e323b771d3ce4517984ea504e798,04a6ba61b4270480b6a47b987ca9c1f1,7654,Seroprevalence - IgG,Percentage (%),0,22.5,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,45,NA,8,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,5,Malaysia,General population,Donglai Baru,45,Community based,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Rural area,23,Seroprevalence,NA,NA,NA,Malaysia,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
e4d9e323b771d3ce4517984ea504e798,eecc065c96073051c99cf73e7e097054,7654,Seroprevalence - IgG,Percentage (%),0,21.3,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,47,NA,10,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,5,Malaysia,General population,Paya Lebar,47,Community based,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Rural area,23,Seroprevalence,NA,NA,NA,Malaysia,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
e4d9e323b771d3ce4517984ea504e798,77e65c75b161774eaede26c51510aacf,7654,Seroprevalence - IgG,Percentage (%),0,22.5,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,120,NA,27,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,5,Malaysia,General population,Dusun Kubur,120,Community based,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Rural area,23,Seroprevalence,NA,NA,NA,Malaysia,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
e4d9e323b771d3ce4517984ea504e798,42d61b69984b76603fbf99184323e0f5,7654,Seroprevalence - IgG,Percentage (%),0,17.4,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,46,NA,8,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,5,Malaysia,General population,Ulu Kelaka,46,Community based,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Rural area,23,Seroprevalence,NA,NA,NA,Malaysia,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
e4d9e323b771d3ce4517984ea504e798,ba574afc88d90fc76b33f72758bf8769,7654,Seroprevalence - IgG,Percentage (%),0,5.9,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,17,NA,1,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,5,Malaysia,General population,Bukit Payung,17,Community based,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Rural area,23,Seroprevalence,NA,NA,NA,Malaysia,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
e4d9e323b771d3ce4517984ea504e798,d2a4ca2e02dccaeebab224fabad587b8,7654,Seroprevalence - IgG,Percentage (%),0,5.3,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,19,NA,1,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,5,Malaysia,General population,Pasir Intan,19,Community based,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Rural area,23,Seroprevalence,NA,NA,NA,Malaysia,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
e4d9e323b771d3ce4517984ea504e798,2eb526a50418c63a786f153f54073302,7654,Seroprevalence - IgG,Percentage (%),0,7.7,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,39,NA,3,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,5,Malaysia,General population,Semanggar,39,Community based,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Rural area,23,Seroprevalence,NA,NA,NA,Malaysia,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
e4d9e323b771d3ce4517984ea504e798,d182c05dbd497d3f9657d81c0895d302,7654,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,NA,FALSE,NA,NA,Malaysia,General population,NA,NA,Community based,Unspecified,NA,NA,NA,NA,NA,NA,NA,Unspecified,Age;Other,NA,Serology,Significant,NA,FALSE,NA,Rural area,23,Risk factors,NA,NA,NA,Malaysia,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
d6b7cc126d20699f723d002ada84ae4c,a91e2af988081245e5a6bbd1935614df,7717,Mutations - evolutionary rate,Substitutions/site/year,-3,0.6,Mean,0.3,0.8,95% CI,NA,NA,0.1,5.3,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Estimated model parameter,FALSE,NA,NA,"Multi-country: Americas (n = 13), Asia (n = 5), Oceania (n = 2)",Unspecified,NA,40,Unspecified,NA,NA,NA,2017,NA,NA,1966,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,38,Mutations,0.1 - 5.3,95% CI,0.3 - 0.8,"Mexico, United States, Nicaragua, Honduras, Haiti, Puerto Rico, Panama, Guatemala, Suriname, Brazil, Venezuela, Colombia, Ecuador, Singapore, Australia, Thailand, China, Japan, French Polynesia, South Korea",NA,NA,FALSE,NA,NA,NA,1966,2017,1966 - 2017
d6b7cc126d20699f723d002ada84ae4c,597380b36e6ad03e4aaee13aa06f9bf9,7717,Mutations - evolutionary rate,Substitutions/site/year,-3,0.8,Mean,0.5,1.1,95% CI,NA,NA,0.3,6,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Estimated model parameter,FALSE,NA,NA,"Multi-country: Africa (n = 2), Americas (n = 11), Asia (n = 8), Oceania (n = 2), Europe (n = 1)",Unspecified,NA,40,Unspecified,NA,NA,NA,2017,NA,NA,2013,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,38,Mutations,0.3 - 6,95% CI,0.5 - 1.1,"Uganda, Malaysia, Honduras, Puerto Rico, China, Japan, South Korea, Colombia, Brazil, Nicaragua, Dominican Republic, Philippines, Thailand, Australia, Ecuador, French Polynesia, Austria, Cambodia, Haiti, United States, Panama, Senegal, Singapore, Mexico",NA,NA,FALSE,NA,NA,NA,2013,2017,2013 - 2017
8a8efdbbf8f03a1b1f9115a58b2fd442,11b6b0f6dcddd8ee4e0f3992e5bec2a0,7755,Seroprevalence - IgG,NA,0,10.8,NA,6.9,15.7,95% CI,NA,NA,NA,NA,NA,NA,214,Naive,23,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,"Age, Occupation, Other, Sex",TRUE,FALSE,Endemic,NA,Anna-Maria Hartner,NA,FALSE,NA,18,Zambia,Other,"Lukanga swamps, Central Province of Zambia",214,Community based,Both,NA,Nov,2016,NA,Oct,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,12,Seroprevalence,NA,95% CI,6.9 - 15.7,Zambia,NA,NA,FALSE,NA,NA,NA,Oct 2016,Nov 2016,Oct 2016 - Nov 2016
291cbef26d87518c95bfa5e0bbeae4bd,7d3cede169a9d0dc5416468351a49570,7760,Severity - case fatality rate (CFR),Percentage (%),0,0.04,Central,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,Unspecified,NA,Yes - on Github,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Dominican Republic,General population,NA,5161,Population based,Unspecified,NA,NA,2016,NA,NA,2016,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,40,Severity,NA,NA,NA,Dominican Republic,NA,NA,FALSE,NA,NA,NA,2016,2016,2016
291cbef26d87518c95bfa5e0bbeae4bd,bb16002a59fbb2c74120a2db77affb62,7760,"Reproduction number (Effective, Re)",No units,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on Github,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,Other,Kelly M,NA,TRUE,NA,NA,Dominican Republic,General population,NA,5161,Population based,Unspecified,NA,NA,2016,NA,NA,2016,Unspecified,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,40,Reproduction number,NA,NA,NA,Dominican Republic,NA,NA,FALSE,NA,NA,NA,2016,2016,2016
dc552c88157ae19b8d4cdfab26e1b561,7f4e3141bfc7c49f0a515cab149bf6e9,7939,Reproduction number (Basic R0),No units,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Method, Region, Time",TRUE,FALSE,Unspecified,Ross-Macdonald formula,Christian,NA,TRUE,NA,NA,Colombia,Other,"Neiva, Sincelejo, Soledad",NA,Other,NA,NA,Jul,2020,NA,Jul,2019,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,39,Reproduction number,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,Jul 2019,Jul 2020,Jul 2019 - Jul 2020
30a8ac0cea016bee87cddfff4195d52e,104229a4be0cb85a2e423630bdf9e4d8,8012,Seroprevalence - IgM,Percentage (%),0,NA,NA,NA,NA,NA,NA,NA,0,1,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,Philippines,Persons under investigation,NA,508,Hospital based,Both,NA,NA,2016,NA,NA,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,76,Seroprevalence,0 - 1,NA,NA,Philippines,NA,NA,FALSE,NA,NA,NA,2016,2016,2016
30a8ac0cea016bee87cddfff4195d52e,7d0d0947b83daa62336ffa5c6c5518f3,8012,Seroprevalence - IgG,Percentage (%),0,23,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,508,Naive,118,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,Philippines,Persons under investigation,NA,NA,Hospital based,Both,NA,NA,2016,NA,NA,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,76,Seroprevalence,NA,NA,NA,Philippines,NA,NA,FALSE,NA,NA,NA,2016,2016,2016
417c78ffce59aa3e295084928c0501af,83055bb270ebb490e7b100df3c56557b,8141,Seroprevalence - HAI/HI,Percentage (%),0,52.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,447,Naive,235,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Age,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,18,Brazil,Other,Manaus,447,Community based,Both,NA,Dec,2015,NA,Jan,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Urban area,40,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Jan 2015,Dec 2015,Jan 2015 - Dec 2015
6b8a70fffc8ad13affd31b9a35aea3b8,9b84498b985862f2bfae913f2ca9cb78,8155,Seroprevalence - MIA,Percentage (%),0,NA,Mean,NA,NA,NA,NA,NA,0,45.6,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,Region,TRUE,FALSE,Unspecified,NA,Anna Vicco,Observed sample statistic,FALSE,75,2,France,General population,French Guiana,2697,Population based,Both,NA,Oct,2017,NA,Jun,2017,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,8,Seroprevalence,0 - 45.6,NA,NA,France,NA,NA,FALSE,NA,NA,NA,Jun 2017,Oct 2017,Jun 2017 - Oct 2017
6b8a70fffc8ad13affd31b9a35aea3b8,1d6cec21145e0ecc9a60e266fd628446,8155,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Occupation, Other",TRUE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,75,2,France,General population,French Guiana,2697,Population based,Both,NA,Oct,2017,NA,Jun,2017,NA,Adjusted,Age;Other;Sex,Unspecified,Serology,Not significant,NA,FALSE,NA,NA,8,Risk factors,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,Jun 2017,Oct 2017,Jun 2017 - Oct 2017
6b8a70fffc8ad13affd31b9a35aea3b8,dd64274642be1a21e49452d5f208baec,8155,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Occupation, Other",TRUE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,75,2,France,General population,French Guiana,2697,Population based,Both,NA,Oct,2017,NA,Jun,2017,NA,Adjusted,Other,Unspecified,Serology,Significant,NA,FALSE,NA,NA,8,Risk factors,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,Jun 2017,Oct 2017,Jun 2017 - Oct 2017
aaf4d00a0ab8eabf287959d2bfb9c517,29f57564985542b9d40bc9f19ec24d56,8184,Seroprevalence - IgG,Percentage (%),0,31.4,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,156,NA,49,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Paraguay,Other,Central department and Asuncion,156,Hospital based,Unspecified,NA,May,2018,NA,Jan,2018,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Both urban and rural areas,43,Seroprevalence,NA,NA,NA,Paraguay,NA,NA,FALSE,NA,NA,NA,Jan 2018,May 2018,Jan 2018 - May 2018
a0f3db3f3e18692622c7374f71ddb974,b92d5f8bf80380c2aa50857f319da67d,8302,Reproduction number (Effective; Re) - Sexual,No units,0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on Github,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Time,TRUE,FALSE,Unspecified,Branching process,Ruth,Estimated model parameter,TRUE,NA,NA,Colombia,Persons under investigation,NA,NA,Population based,NA,NA,Sep,2016,NA,Nov,2015,Human-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Both urban and rural areas,24,Reproduction number,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,Nov 2015,Sep 2016,Nov 2015 - Sep 2016
a0f3db3f3e18692622c7374f71ddb974,6ae4958387d0e08f76686eae1098965c,8302,Reproduction number (Effective; Re) - Sexual,No units,0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on Github,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Time,TRUE,FALSE,Unspecified,Branching process,Ruth,Estimated model parameter,TRUE,NA,NA,Colombia,Persons under investigation,Valle del Cauca,NA,Population based,NA,NA,Sep,2016,NA,Jan,2016,Human-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,24,Reproduction number,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,Jan 2016,Sep 2016,Jan 2016 - Sep 2016
a0f3db3f3e18692622c7374f71ddb974,0db857ac20438cb137bfa65a891323b8,8302,Reproduction number (Effective; Re) - Sexual,No units,0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on Github,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Time,TRUE,FALSE,Unspecified,Branching process,Ruth,Estimated model parameter,TRUE,NA,NA,Colombia,Persons under investigation,Norte de Santander,NA,Population based,NA,NA,Sep,2016,NA,Jan,2016,Human-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,24,Reproduction number,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,Jan 2016,Sep 2016,Jan 2016 - Sep 2016
a0f3db3f3e18692622c7374f71ddb974,6fe22063dc5c18f31bc02b0e191dcc40,8302,Reproduction number (Effective; Re) - Sexual,No units,0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on Github,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Time,TRUE,FALSE,Unspecified,Branching process,Ruth,Estimated model parameter,TRUE,NA,NA,Colombia,Persons under investigation,Santander,NA,Population based,NA,NA,Sep,2016,NA,Jan,2016,Human-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,24,Reproduction number,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,Jan 2016,Sep 2016,Jan 2016 - Sep 2016
a0f3db3f3e18692622c7374f71ddb974,d1dd2bcb8b2b5ee67f7931887f50fd30,8302,Reproduction number (Effective; Re) - Sexual,No units,0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on Github,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Time,TRUE,FALSE,Unspecified,Branching process,Ruth,Estimated model parameter,TRUE,NA,NA,Colombia,Persons under investigation,Tolima,NA,Population based,NA,NA,Sep,2016,NA,Dec,2015,Human-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,24,Reproduction number,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,Dec 2015,Sep 2016,Dec 2015 - Sep 2016
a0f3db3f3e18692622c7374f71ddb974,93d18b0c65f780f80948b3a41d9cd4f0,8302,Reproduction number (Effective; Re) - Sexual,No units,0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on Github,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Time,TRUE,FALSE,Unspecified,Branching process,Ruth,Estimated model parameter,TRUE,NA,NA,Colombia,Persons under investigation,"Cucuta, Norte de Santander",NA,Population based,NA,NA,Sep,2016,NA,Jan,2016,Human-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,24,Reproduction number,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,Jan 2016,Sep 2016,Jan 2016 - Sep 2016
a0f3db3f3e18692622c7374f71ddb974,85a64c3ec93c8b8c51aaf9f0c37a9c07,8302,Reproduction number (Effective; Re) - Sexual,No units,0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on Github,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Time,TRUE,FALSE,Unspecified,Branching process,Ruth,Estimated model parameter,TRUE,NA,NA,Colombia,Persons under investigation,"Villa del Rosario, Norte de Santander",NA,Population based,NA,NA,Sep,2016,NA,Jan,2016,Human-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,24,Reproduction number,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,Jan 2016,Sep 2016,Jan 2016 - Sep 2016
a0f3db3f3e18692622c7374f71ddb974,e60269b2609b791905076b7e41d8b05e,8302,Reproduction number (Effective; Re) - Sexual,No units,0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on Github,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Time,TRUE,FALSE,Unspecified,Branching process,Ruth,Estimated model parameter,TRUE,NA,NA,Colombia,Persons under investigation,"Los Patios, Norte de Santander",NA,Population based,NA,NA,Sep,2016,NA,Jan,2016,Human-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,24,Reproduction number,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,Jan 2016,Sep 2016,Jan 2016 - Sep 2016
a0f3db3f3e18692622c7374f71ddb974,17d9383e41a328dc9067fec3828fe86e,8302,Reproduction number (Effective; Re) - Sexual,No units,0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on Github,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Time,TRUE,FALSE,Unspecified,Branching process,Ruth,Estimated model parameter,TRUE,NA,NA,Colombia,Persons under investigation,"Ocana, Norte de Santander",NA,Population based,NA,NA,Sep,2016,NA,Mar,2016,Human-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,24,Reproduction number,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,Mar 2016,Sep 2016,Mar 2016 - Sep 2016
8a02d150ed17924a22da693a32d2acd6,12d9267e0c365395ca5f4fbde9cf9cc2,8803,Seroprevalence - IgM,Percentage (%),0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,150,NA,0,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,NA,China,Persons under investigation,Affiliated Hospital of Jining Medical University,150,Hospital based,Both,NA,Jun,2017,NA,Oct,2013,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Both urban and rural areas,25,Seroprevalence,NA,NA,NA,China,NA,NA,FALSE,NA,NA,NA,Oct 2013,Jun 2017,Oct 2013 - Jun 2017
cf6c4da6f3e7e75720d1f6992dd54c1e,fb368b0801cbcfe2a90bbee016f471a9,9768,Seroprevalence - IgM,Percentage (%),0,44,Unspecified,NA,NA,NA,NA,NA,0,97,NA,Lab confirmed,61,Naive,27,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Other,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,NA,United States,Pregnant women,Congenital Zika Program at Children’s National (CZPCN) in Washington DC,61,Hospital based,Female,NA,Jun,2018,NA,Jan,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,38,Seroprevalence,0 - 97,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,Jan 2016,Jun 2018,Jan 2016 - Jun 2018
cf6c4da6f3e7e75720d1f6992dd54c1e,863a265b3aa171aa4637214f42112d32,9768,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,8,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,26,Naive,2,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,NA,United States,Pregnant women,Congenital Zika Program at Children’s National (CZPCN) in Washington DC,26,Hospital based,Female,NA,Jun,2018,NA,Jan,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,38,Seroprevalence,NA,NA,NA,United States,NA,NA,TRUE,NA,NA,NA,Jan 2016,Jun 2018,Jan 2016 - Jun 2018
cf6c4da6f3e7e75720d1f6992dd54c1e,2a46747eaaacacec97654d74abb68d14,9768,Seroprevalence - IgM,Percentage (%),0,16,Unspecified,NA,NA,NA,NA,NA,0,33,NA,Lab confirmed,31,Naive,5,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Other,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,NA,United States,Children,Congenital Zika Program at Children’s National (CZPCN) in Washington DC,31,Hospital based,Unspecified,NA,Jun,2018,NA,Jan,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,38,Seroprevalence,0 - 33,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,Jan 2016,Jun 2018,Jan 2016 - Jun 2018
cf6c4da6f3e7e75720d1f6992dd54c1e,88c7a37c9baa58426fc2e6e3d01ffd7f,9768,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,0,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,5,Naive,0,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,NA,United States,Children,Congenital Zika Program at Children’s National (CZPCN) in Washington DC,5,Hospital based,Unspecified,NA,Jun,2018,NA,Jan,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,38,Seroprevalence,NA,NA,NA,United States,NA,NA,TRUE,NA,NA,NA,Jan 2016,Jun 2018,Jan 2016 - Jun 2018
cf6c4da6f3e7e75720d1f6992dd54c1e,87bd0c346ad7b227080543d4e03a1805,9768,Severity - proportion of symptomatic cases,Percentage (%),0,24,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,29,Naive,7,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,NA,United States,Pregnant women,Congenital Zika Program at Children’s National (CZPCN) in Washington DC,29,Hospital based,Female,NA,Jun,2018,NA,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,38,Severity,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,Jan 2016,Jun 2018,Jan 2016 - Jun 2018
24bfb2e0340fb49aedf1168e33fff4a0,670c43c6a479400465e09eaf25022078,9777,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Ruth,NA,FALSE,NA,NA,Virgin Islands (U.S.),Persons under investigation,"St. Croix, St. John, St. Thomas",739,Population based,Unspecified,24,Jan,2018,3,Jan,2016,NA,Adjusted,Other,NA,Infection,Significant,NA,FALSE,Unspecified,Unspecified,39,Risk factors,NA,NA,NA,Virgin Islands (U.S.),NA,NA,FALSE,NA,NA,NA,3 Jan 2016,24 Jan 2018,3 Jan 2016 - 24 Jan 2018
24bfb2e0340fb49aedf1168e33fff4a0,7284711f4fb1e3772bd74eb80632577d,9777,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Ruth,NA,FALSE,NA,NA,Virgin Islands (U.S.),Persons under investigation,St. Thomas,1031,Population based,Unspecified,24,Jan,2018,3,Jan,2016,NA,Adjusted,Other,NA,Infection,Significant,NA,FALSE,Unspecified,Unspecified,39,Risk factors,NA,NA,NA,Virgin Islands (U.S.),NA,NA,FALSE,NA,NA,NA,3 Jan 2016,24 Jan 2018,3 Jan 2016 - 24 Jan 2018
24bfb2e0340fb49aedf1168e33fff4a0,4854dc07c1292e0222abce048a554161,9777,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Ruth,NA,FALSE,NA,NA,Virgin Islands (U.S.),Persons under investigation,St. Thomas,1031,Population based,Unspecified,24,Jan,2018,3,Jan,2016,NA,Adjusted,Other,NA,Infection,Not significant,NA,FALSE,Unspecified,Unspecified,39,Risk factors,NA,NA,NA,Virgin Islands (U.S.),NA,NA,FALSE,NA,NA,NA,3 Jan 2016,24 Jan 2018,3 Jan 2016 - 24 Jan 2018
24bfb2e0340fb49aedf1168e33fff4a0,a83d05e54190a79b48cf51704b9b1a98,9777,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Ruth,NA,FALSE,NA,NA,Virgin Islands (U.S.),Persons under investigation,St. Croix,1031,Population based,Unspecified,24,Jan,2018,3,Jan,2016,NA,Adjusted,Other,NA,Infection,Significant,NA,FALSE,Unspecified,Unspecified,39,Risk factors,NA,NA,NA,Virgin Islands (U.S.),NA,NA,FALSE,NA,NA,NA,3 Jan 2016,24 Jan 2018,3 Jan 2016 - 24 Jan 2018
24bfb2e0340fb49aedf1168e33fff4a0,150a638056656257af29d53518cb6730,9777,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Ruth,NA,FALSE,NA,NA,Virgin Islands (U.S.),Persons under investigation,St. Croix,1031,Population based,Unspecified,24,Jan,2018,3,Jan,2016,NA,Adjusted,Other,NA,Infection,Not significant,NA,FALSE,Unspecified,Unspecified,39,Risk factors,NA,NA,NA,Virgin Islands (U.S.),NA,NA,FALSE,NA,NA,NA,3 Jan 2016,24 Jan 2018,3 Jan 2016 - 24 Jan 2018
24bfb2e0340fb49aedf1168e33fff4a0,0c4548b6987c6978dd3a54047862a647,9777,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Ruth,NA,FALSE,NA,NA,Virgin Islands (U.S.),Persons under investigation,St. John,1031,Population based,Unspecified,24,Jan,2018,3,Jan,2016,NA,Adjusted,Other,NA,Infection,Significant,NA,FALSE,Unspecified,Unspecified,39,Risk factors,NA,NA,NA,Virgin Islands (U.S.),NA,NA,FALSE,NA,NA,NA,3 Jan 2016,24 Jan 2018,3 Jan 2016 - 24 Jan 2018
24bfb2e0340fb49aedf1168e33fff4a0,b5bda87740df9e1b25802a2c8ec0051c,9777,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Ruth,NA,FALSE,NA,NA,Virgin Islands (U.S.),Persons under investigation,St. John,1031,Population based,Unspecified,24,Jan,2018,3,Jan,2016,NA,Adjusted,Other,NA,Infection,Not significant,NA,FALSE,Unspecified,Unspecified,39,Risk factors,NA,NA,NA,Virgin Islands (U.S.),NA,NA,FALSE,NA,NA,NA,3 Jan 2016,24 Jan 2018,3 Jan 2016 - 24 Jan 2018
50235e1425a879c0d43e11509e5b2ebb,700fa08c2bbaf9b45be07270c21cccfd,9881,Human delay - Onset to Test result,Days,0,14,Other,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,Observed sample statistic,FALSE,NA,NA,Brazil,Persons under investigation,Recife and Manaus,10,Hospital based,Both,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,6,Human delay,NA,NA,NA,Brazil,Onset to test result,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
20f7e8507900f898502647ff237d6d1b,59c2ac0ecd7300a70cee21840cb722d4,9964,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Age,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Brazil,Pregnant women,Rio de Janeiro and Manaus,50,Population based,NA,NA,Jun,2016,NA,Sep,2015,NA,NA,Infection during pregnancy,NA,Zika congenital syndrome/other birth defects,Significant,NA,FALSE,First trimester,NA,7,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Sep 2015,Jun 2016,Sep 2015 - Jun 2016
45208dfda26a99e51fc3e9db2d978793,51f092d88ba79f202e2993f5fa814a72,10010,Seroprevalence - IgM,Percentage (%),0,29.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,180,NA,53,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna-Maria Hartner,NA,FALSE,48,19,Nigeria,Pregnant women,Zaria,180,Hospital based,Female,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Both urban and rural areas,15,Seroprevalence,NA,NA,NA,Nigeria,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
0d64294a113aabb7232504ede81a43fd,8db12e0f675df262abd2554056f9ceb5,10045,Seroprevalence - IgG,Percentage (%),0,83.6,Unspecified,NA,NA,NA,NA,NA,70,100,NA,Lab confirmed,61,Naive,51,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Sex",FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,69,18,Thailand,General population,Nakhon Ratchasima,61,Population based,Both,NA,Jun,2016,NA,Apr,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,40,Seroprevalence,70 - 100,NA,NA,Thailand,NA,NA,FALSE,NA,NA,NA,Apr 2016,Jun 2016,Apr 2016 - Jun 2016
0d64294a113aabb7232504ede81a43fd,0fe9fdaa73927b27a407b57faeb89e53,10045,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,44.3,Unspecified,NA,NA,NA,NA,NA,35,75,NA,Lab confirmed,61,Naive,27,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Sex",FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,69,18,Thailand,General population,Nakhon Ratchasima,61,Population based,Both,NA,Jun,2016,NA,Apr,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,40,Seroprevalence,35 - 75,NA,NA,Thailand,NA,NA,FALSE,NA,NA,NA,Apr 2016,Jun 2016,Apr 2016 - Jun 2016
dcaa73762f923cf411cc94eba64a6637,75edc61b585b14ada251e9f35857c615,10094,Seroprevalence - IgM,Percentage (%),0,3.2,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,189,Naive,6,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,20,Dominican Republic,Other,NA,189,Travel based,Both,NA,NA,NA,NA,NA,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,41,Seroprevalence,NA,NA,NA,Dominican Republic,NA,NA,FALSE,NA,NA,NA,2016,Unspecified,2016 - Unspecified
dcaa73762f923cf411cc94eba64a6637,451299ed6d7b015db3fe82ca0e2d1483,10094,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,3.2,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,6,Naive,6,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,20,Dominican Republic,Other,NA,189,Travel based,Both,NA,NA,NA,NA,NA,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,41,Seroprevalence,NA,NA,NA,Dominican Republic,NA,NA,TRUE,NA,NA,NA,2016,Unspecified,2016 - Unspecified
dcaa73762f923cf411cc94eba64a6637,fd35aef069f1f8b2d3c564f9138beb55,10094,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,NA,FALSE,NA,20,Dominican Republic,Other,NA,189,Travel based,Both,NA,NA,NA,NA,NA,2016,NA,Not adjusted,Other,NA,Infection,Significant,NA,FALSE,Unspecified,Unspecified,41,Risk factors,NA,NA,NA,Dominican Republic,NA,NA,FALSE,NA,NA,NA,2016,Unspecified,2016 - Unspecified
dcaa73762f923cf411cc94eba64a6637,76718e046443ed4ac2992bc6b47cc9fd,10094,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,NA,FALSE,NA,20,Dominican Republic,Other,NA,189,Travel based,Both,NA,NA,NA,NA,NA,2016,NA,Not adjusted,Other,NA,Infection,Not significant,NA,FALSE,Unspecified,Unspecified,41,Risk factors,NA,NA,NA,Dominican Republic,NA,NA,FALSE,NA,NA,NA,2016,Unspecified,2016 - Unspecified
312afd4b1878bd0c1951208d9c41f2db,4c84f0e01b7f6be42956602ac8de7765,10112,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna-Maria Hartner,NA,FALSE,35,18,Unspecified,Pregnant women,NA,865,Other,Female,NA,Jul,2019,NA,Jan,2016,NA,Adjusted,Other,NA,Infection,Significant,NA,FALSE,Unspecified,Unspecified,20,Risk factors,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,NA,Jan 2016,Jul 2019,Jan 2016 - Jul 2019
312afd4b1878bd0c1951208d9c41f2db,5cee5a8e77700392315063026ad45558,10112,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna-Maria Hartner,NA,FALSE,35,18,Unspecified,Pregnant women,NA,865,Other,Female,NA,Jul,2019,NA,Jan,2016,NA,Not adjusted,Infection during pregnancy;Other,NA,Zika congenital syndrome/other birth defects,Significant,NA,FALSE,Unspecified,Unspecified,20,Risk factors,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,NA,Jan 2016,Jul 2019,Jan 2016 - Jul 2019
d54f5a5a437cd83fdc0fe28b19222817,cd9dd6c25774d25e1b9abe3b0d6881a4,10125,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,United States,Pregnant women,New York,70,Hospital based,Both,NA,Apr,2016,NA,Mar,2016,NA,Not adjusted,Infection during pregnancy,NA,Zika congenital syndrome/other birth defects,Not significant,NA,FALSE,NA,NA,35,Risk factors,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,Mar 2016,Apr 2016,Mar 2016 - Apr 2016
8e7d02c2721afa53ed9899b215bf6a33,2ed2354f49f37a80346662f15dd45e03,10168,Seroprevalence - IgM,Percentage (%),0,63,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,30,Naive,19,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Ruth,Observed sample statistic,FALSE,NA,18,United States,Persons under investigation,"Miami-Dade County, Florida",30,Other,Both,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,48,Seroprevalence,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
fae8432e987cca2bc7c1c9b3c4180617,fbd7210629e0431b88184464980564ca,10180,Mutations - evolutionary rate,Substitutions/site/year,-3,1.18,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Brazil,Persons under investigation,Manaus,238,Population based,Both,NA,Jun,2019,NA,Jun,2017,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,10,Mutations,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Jun 2017,Jun 2019,Jun 2017 - Jun 2019
70eb9419a13bd1ba3fc114b26a022bdf,27dce0deb5f05f6e9b559b84bf55e86e,10252,Seroprevalence - IgG,Percentage (%),0,0.9,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,577,NA,5,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,NA,Kenya,Mixed groups,"Eldoret, Kisumu, Nairobi",577,Population based,Unspecified,NA,Jan,2014,NA,Mar,2009,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,42,Seroprevalence,NA,NA,NA,Kenya,NA,NA,FALSE,NA,NA,NA,Mar 2009,Jan 2014,Mar 2009 - Jan 2014
70eb9419a13bd1ba3fc114b26a022bdf,c7f9c7999125df3d610d3c2978aa5598,10252,Seroprevalence - Neutralisation/PRNT,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,11,NA,0,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,NA,Kenya,Persons under investigation,"Eldoret, Kisumu, Nairobi",11,Population based,Unspecified,NA,Jan,2014,NA,Mar,2009,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,42,Seroprevalence,NA,NA,NA,Kenya,NA,NA,TRUE,NA,NA,NA,Mar 2009,Jan 2014,Mar 2009 - Jan 2014
70eb9419a13bd1ba3fc114b26a022bdf,2ea94b4e27b1787e099038077194c066,10252,Seroprevalence - IgG,Percentage (%),0,0,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,135,NA,0,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,NA,Kenya,Other,Eldoret,135,Population based,Unspecified,NA,Feb,2013,NA,Jan,2013,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,42,Seroprevalence,NA,NA,NA,Kenya,NA,NA,FALSE,NA,NA,NA,Jan 2013,Feb 2013,Jan 2013 - Feb 2013
70eb9419a13bd1ba3fc114b26a022bdf,46ec6544d30b0c8e6340a13311cc6df1,10252,Seroprevalence - IgG,Percentage (%),0,1.5,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,134,NA,2,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,NA,Kenya,Other,Kisumu,134,Population based,Unspecified,NA,Jan,2014,NA,Dec,2013,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,42,Seroprevalence,NA,NA,NA,Kenya,NA,NA,FALSE,NA,NA,NA,Dec 2013,Jan 2014,Dec 2013 - Jan 2014
70eb9419a13bd1ba3fc114b26a022bdf,56c111c486aa45a603e1bfba6491af2a,10252,Seroprevalence - IgG,Percentage (%),0,0,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,96,NA,0,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,NA,Kenya,Other,Nairobi,96,Population based,Unspecified,NA,Sep,2013,NA,Aug,2013,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,42,Seroprevalence,NA,NA,NA,Kenya,NA,NA,FALSE,NA,NA,NA,Aug 2013,Sep 2013,Aug 2013 - Sep 2013
70eb9419a13bd1ba3fc114b26a022bdf,de1bccf416c4ca140ec7a269f4d5fc09,10252,Seroprevalence - IgG,Percentage (%),0,1.4,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,212,NA,3,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,NA,Kenya,Other,Nairobi,212,Population based,Unspecified,NA,Nov,2012,NA,Mar,2009,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,42,Seroprevalence,NA,NA,NA,Kenya,NA,NA,FALSE,NA,NA,NA,Mar 2009,Nov 2012,Mar 2009 - Nov 2012
2e10c0103a09f150f219ebf337fed82a,e707f008f47d86845072e73fa5f1ad07,10318,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,NA,FALSE,NA,NA,France,Mixed groups,western French Guiana,129,Hospital based,Unspecified,NA,Sep,2016,NA,Jan,2016,NA,Not adjusted,Infection during pregnancy,NA,Zika congenital syndrome/other birth defects,Significant,NA,FALSE,Unspecified,Unspecified,43,Risk factors,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,Jan 2016,Sep 2016,Jan 2016 - Sep 2016
2e10c0103a09f150f219ebf337fed82a,31323728326c739c3054eeb8a0ee37a4,10318,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,NA,FALSE,NA,NA,France,Mixed groups,western French Guiana,129,Hospital based,Unspecified,NA,Sep,2016,NA,Jan,2016,NA,Adjusted,Infection during pregnancy,NA,Zika congenital syndrome/other birth defects,Significant,NA,FALSE,Unspecified,Unspecified,43,Risk factors,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,Jan 2016,Sep 2016,Jan 2016 - Sep 2016
0a0286d27e5687173ada95063ca012ed,74c0c2b70034f18164f9e69c542a5c42,10429,Seroprevalence - NS1 BOB ELISA,Percentage (%),0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,17,9,Colombia,General population,NA,703,Population based,NA,NA,NA,2014,NA,NA,2013,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,34,Seroprevalence,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,2013,2014,2013 - 2014
0a0286d27e5687173ada95063ca012ed,89d5e8eb588f556fcbde442b4cb6e97c,10429,Seroprevalence - NS1 BOB ELISA,Percentage (%),0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,17,9,Honduras,General population,NA,223,Population based,NA,NA,NA,2014,NA,NA,2013,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,34,Seroprevalence,NA,NA,NA,Honduras,NA,NA,FALSE,NA,NA,NA,2013,2014,2013 - 2014
0a0286d27e5687173ada95063ca012ed,a6ab23e8e48e1ca21dbc5635f39559dd,10429,Seroprevalence - NS1 BOB ELISA,Percentage (%),0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,17,9,Mexico,General population,NA,266,Population based,NA,NA,NA,2014,NA,NA,2013,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,34,Seroprevalence,NA,NA,NA,Mexico,NA,NA,FALSE,NA,NA,NA,2013,2014,2013 - 2014
0a0286d27e5687173ada95063ca012ed,5a5f0d0cf33fc8c05b398d3d6dc97387,10429,Seroprevalence - NS1 BOB ELISA,Percentage (%),0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,17,9,United States,General population,Puerto Rico,91,Population based,NA,NA,NA,2014,NA,NA,2013,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,34,Seroprevalence,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,2013,2014,2013 - 2014
0a0286d27e5687173ada95063ca012ed,097e86ec8e85437c54178ee5da20083c,10429,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,17,9,Colombia,General population,NA,703,Population based,NA,NA,NA,2014,NA,NA,2013,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,34,Seroprevalence,NA,NA,NA,Colombia,NA,NA,TRUE,NA,NA,NA,2013,2014,2013 - 2014
0a0286d27e5687173ada95063ca012ed,99179ea5d9868f5bf727e5982286b3b8,10429,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,17,9,Honduras,General population,NA,223,Population based,NA,NA,NA,2014,NA,NA,2013,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,34,Seroprevalence,NA,NA,NA,Honduras,NA,NA,TRUE,NA,NA,NA,2013,2014,2013 - 2014
0a0286d27e5687173ada95063ca012ed,19eb01d8246977705a93e8361e8adaae,10429,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,17,9,Mexico,General population,NA,266,Population based,NA,NA,NA,2014,NA,NA,2013,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,34,Seroprevalence,NA,NA,NA,Mexico,NA,NA,TRUE,NA,NA,NA,2013,2014,2013 - 2014
0a0286d27e5687173ada95063ca012ed,dd2b1e31bc77cc6221d2d58a3f4fe141,10429,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,17,9,United States,General population,Puerto Rico,91,Population based,NA,NA,NA,2014,NA,NA,2013,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,34,Seroprevalence,NA,NA,NA,United States,NA,NA,TRUE,NA,NA,NA,2013,2014,2013 - 2014
0a0286d27e5687173ada95063ca012ed,9efe7c0e8d4c58df40f9cb84885cb230,10429,Seroprevalence - NS1 BOB ELISA,Percentage (%),0,32,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,17,9,Colombia,General population,NA,703,Population based,NA,NA,NA,2018,NA,NA,2017,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,34,Seroprevalence,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,2017,2018,2017 - 2018
0a0286d27e5687173ada95063ca012ed,c4b8cd5f675a16d8be5579303bae4853,10429,Seroprevalence - NS1 BOB ELISA,Percentage (%),0,57,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,17,9,Honduras,General population,NA,223,Population based,NA,NA,NA,2018,NA,NA,2017,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,34,Seroprevalence,NA,NA,NA,Honduras,NA,NA,FALSE,NA,NA,NA,2017,2018,2017 - 2018
0a0286d27e5687173ada95063ca012ed,829e1242503baaa8f64fb967fb85a79f,10429,Seroprevalence - NS1 BOB ELISA,Percentage (%),0,31,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,17,9,Mexico,General population,NA,266,Population based,NA,NA,NA,2018,NA,NA,2017,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,34,Seroprevalence,NA,NA,NA,Mexico,NA,NA,FALSE,NA,NA,NA,2017,2018,2017 - 2018
0a0286d27e5687173ada95063ca012ed,2ecec12469884d1f1177697c6ae8c03a,10429,Seroprevalence - NS1 BOB ELISA,Percentage (%),0,20,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,17,9,United States,General population,Puerto Rico,91,Population based,NA,NA,NA,2018,NA,NA,2017,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,34,Seroprevalence,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,2017,2018,2017 - 2018
0a0286d27e5687173ada95063ca012ed,e0eb6ceb676c44cd69f880094f6c2b13,10429,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,16,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,17,9,Colombia,General population,NA,703,Population based,NA,NA,NA,2018,NA,NA,2017,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,34,Seroprevalence,NA,NA,NA,Colombia,NA,NA,TRUE,NA,NA,NA,2017,2018,2017 - 2018
0a0286d27e5687173ada95063ca012ed,eacc2ae844e8dfedfc4c67fad09b1437,10429,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,23,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,17,9,Honduras,General population,NA,223,Population based,NA,NA,NA,2018,NA,NA,2017,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,34,Seroprevalence,NA,NA,NA,Honduras,NA,NA,TRUE,NA,NA,NA,2017,2018,2017 - 2018
0a0286d27e5687173ada95063ca012ed,68c22f4e9b266eb5f670ba3a9564eaf4,10429,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,17,9,Mexico,General population,NA,266,Population based,NA,NA,NA,2018,NA,NA,2017,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,34,Seroprevalence,NA,NA,NA,Mexico,NA,NA,TRUE,NA,NA,NA,2017,2018,2017 - 2018
0a0286d27e5687173ada95063ca012ed,4cfa0683c8d1b11f9face9581e906a88,10429,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,17,9,United States,General population,Puerto Rico,91,Population based,NA,NA,NA,2018,NA,NA,2017,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,34,Seroprevalence,NA,NA,NA,United States,NA,NA,TRUE,NA,NA,NA,2017,2018,2017 - 2018
606f62ee098100681cc615904323264d,e5899ae2dca129e2a3d6ba3735964d98,10437,Seroprevalence - IgM,Percentage (%),0,4.9,Unspecified,3.5,6.6,95% CI,NA,NA,1.2,35.4,NA,Lab confirmed,850,NA,42,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Sex, Time",FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,0,Mozambique,Other,NA,850,Population based,Both,NA,NA,2015,NA,NA,2009,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Both urban and rural areas,27,Seroprevalence,1.2 - 35.4,95% CI,3.5 - 6.6,Mozambique,NA,NA,FALSE,NA,NA,NA,2009,2015,2009 - 2015
606f62ee098100681cc615904323264d,30f5a8e0141ee5c671af38ea15fa01de,10437,Seroprevalence - IgM,Percentage (%),0,6.6,Unspecified,10.2,17,95% CI,NA,NA,NA,NA,NA,Lab confirmed,301,NA,20,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,0,Mozambique,Other,North Region,301,Population based,Both,NA,NA,2015,NA,NA,2009,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,27,Seroprevalence,NA,95% CI,10.2 - 17,Mozambique,NA,NA,FALSE,NA,NA,NA,2009,2015,2009 - 2015
606f62ee098100681cc615904323264d,1a56cbc17dc7f4ed9e7709f8fc6cd903,10437,Seroprevalence - IgM,Percentage (%),0,4.7,Unspecified,3.9,9,95% CI,NA,NA,NA,NA,NA,Lab confirmed,356,NA,17,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,0,Mozambique,Other,Central Region,356,Population based,Both,NA,NA,2015,NA,NA,2009,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,27,Seroprevalence,NA,95% CI,3.9 - 9,Mozambique,NA,NA,FALSE,NA,NA,NA,2009,2015,2009 - 2015
606f62ee098100681cc615904323264d,54341c96b8006364821c4ce9768a687e,10437,Seroprevalence - IgM,Percentage (%),0,2.5,Unspecified,8.5,17.4,95% CI,NA,NA,NA,NA,NA,Lab confirmed,193,NA,5,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,0,Mozambique,Other,South Region,193,Population based,Both,NA,NA,2015,NA,NA,2009,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,27,Seroprevalence,NA,95% CI,8.5 - 17.4,Mozambique,NA,NA,FALSE,NA,NA,NA,2009,2015,2009 - 2015
606f62ee098100681cc615904323264d,9db2e5c8bdfbb2adcf40756e92ec32de,10437,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,NA,FALSE,NA,0,Mozambique,Other,NA,850,Population based,Both,NA,NA,2015,NA,NA,2009,NA,Unspecified,Age;Other;Sex,NA,Serology,Not significant,NA,FALSE,NA,Both urban and rural areas,27,Risk factors,NA,NA,NA,Mozambique,NA,NA,FALSE,NA,NA,NA,2009,2015,2009 - 2015
c653f27395d6ac77653e7762b70d90dd,a5c9ff7a09e2a19be5a94224bf99af9c,10526,Human delay - Onset to Test result,Days,0,3.5,Median,3,5,IQR,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,71,1,Thailand,Persons under investigation,"Bangkok, Samut Prakan, Samut Sakhon, Ratchaburi, Chon Buri",90,Hospital based,Both,NA,Mar,2023,NA,Mar,2020,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,28,Human delay,NA,IQR,3 - 5,Thailand,Onset to test result,NA,FALSE,NA,NA,NA,Mar 2020,Mar 2023,Mar 2020 - Mar 2023
c653f27395d6ac77653e7762b70d90dd,97a74a46f4cb43a63dcd615fffa187ef,10526,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,NA,FALSE,92,1,Thailand,Persons under investigation,"Bangkok, Samut Prakan, Samut Sakhon, Ratchaburi, Chon Buri",751,Hospital based,Both,NA,Mar,2023,NA,Mar,2020,NA,Unspecified,Age;Other;Sex,NA,Infection,Not significant,NA,FALSE,NA,Unspecified,28,Risk factors,NA,NA,NA,Thailand,NA,NA,FALSE,NA,NA,NA,Mar 2020,Mar 2023,Mar 2020 - Mar 2023
c653f27395d6ac77653e7762b70d90dd,9220a0f443ff50252e223ab1c67e7c4a,10526,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,NA,FALSE,92,1,Thailand,Persons under investigation,"Bangkok, Samut Prakan, Samut Sakhon, Ratchaburi, Chon Buri",751,Hospital based,Both,NA,Mar,2023,NA,Mar,2020,NA,Not adjusted,Other,NA,Infection,Significant,NA,FALSE,NA,Unspecified,28,Risk factors,NA,NA,NA,Thailand,NA,NA,FALSE,NA,NA,NA,Mar 2020,Mar 2023,Mar 2020 - Mar 2023
c653f27395d6ac77653e7762b70d90dd,66ce72dc66a9688e2e3c24480fdd5164,10526,Mutations - substitution rate,Substitutions/site/year,-4,7.95,Unspecified,NA,NA,NA,NA,NA,NA,NA,Whole genome sequence,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Estimated model parameter,FALSE,NA,NA,"Multi-country: Americas (n = 13), Asia: (n = 9), Oceania (n = 2)",Persons under investigation,NA,214,Mixed settings,Unspecified,NA,NA,2023,NA,NA,1966,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,28,Mutations,NA,NA,NA,"Cambodia, Singapore, Myanmar, China, Vietnam, French Polynesia, United States, Puerto Rico, Nicaragua, Haiti, Honduras, Dominican Republic, Mexico, Brazil, French Guiana, Ecuador, Suriname, Venezuela, Colombia, India, Indonesia, Philippines, Micronesia, Malaysia",NA,Asian lineage (Thai strains),FALSE,NA,NA,NA,1966,2023,1966 - 2023
4cc1aea4c437b558fce151711feadc73,fcb60c8fabf261d45b8a59941f72c246,10561,Seroprevalence - IgM,Percentage (%),0,3,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,600,Naive,18,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Other, Sex",FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,20,Taiwan,Other,NA,600,Travel based,Both,NA,Aug,2017,NA,Jun,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,45,Seroprevalence,NA,NA,NA,Taiwan,NA,NA,FALSE,NA,NA,NA,Jun 2017,Aug 2017,Jun 2017 - Aug 2017
4cc1aea4c437b558fce151711feadc73,633d9c52a89773f36936d24791791b32,10561,Seroprevalence - IgG,Percentage (%),0,38.8,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,600,Naive,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Other, Sex",FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,20,Taiwan,Other,NA,600,Travel based,Both,NA,Aug,2017,NA,Jun,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,45,Seroprevalence,NA,NA,NA,Taiwan,NA,NA,FALSE,NA,NA,NA,Jun 2017,Aug 2017,Jun 2017 - Aug 2017
f81d2d44a71b4b283227ed75cbe1301a,fbf3f7a6eb966791bb624df28aa9b9e4,10625,Seroprevalence - IgG,Percentage (%),0,30.77,Unspecified,NA,NA,NA,NA,NA,18.75,50,NA,Lab confirmed,650,NA,200,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Other, Time",FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,45,18,Thailand,Pregnant women,Siriraj Hospital,650,Hospital based,Female,NA,Oct,2019,NA,May,2019,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,NA,Unspecified,29,Seroprevalence,18.75 - 50,NA,NA,Thailand,NA,NA,FALSE,NA,NA,NA,May 2019,Oct 2019,May 2019 - Oct 2019
f81d2d44a71b4b283227ed75cbe1301a,15acad5f94803fd02d0b0d1d8d25f4f4,10625,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,NA,FALSE,45,18,Thailand,Pregnant women,Siriraj Hospital,650,Hospital based,Female,NA,Oct,2019,NA,May,2019,NA,Unspecified,Age;Other,NA,Serology,Not significant,NA,FALSE,NA,Unspecified,29,Risk factors,NA,NA,NA,Thailand,NA,NA,FALSE,NA,NA,NA,May 2019,Oct 2019,May 2019 - Oct 2019
f81d2d44a71b4b283227ed75cbe1301a,e744d9855c392c8d7d820d30ac83d7b7,10625,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,8.14,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,258,NA,21,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,45,18,Thailand,Pregnant women,Siriraj Hospital,258,Hospital based,Female,NA,Oct,2019,NA,May,2019,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,29,Seroprevalence,NA,NA,NA,Thailand,NA,NA,TRUE,NA,NA,NA,May 2019,Oct 2019,May 2019 - Oct 2019
e1b218f9b0f9916aadd934c264062a73,d429e33e2b1e3333a681b2be62e280c2,10681,Seroprevalence - IgG,Percentage (%),0,68,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,188,NA,127,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,NA,Brazil,Pregnant women,"Salvador, Bahia",188,Hospital based,Female,31,Jan,2017,1,Jan,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Urban area,47,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,1 Jan 2015,31 Jan 2017,1 Jan 2015 - 31 Jan 2017
e1b218f9b0f9916aadd934c264062a73,a4de36096a29abb29abf02a875a4e0f1,10681,Seroprevalence - IgG,Percentage (%),0,64,Median,61,67,IQR,NA,NA,NA,NA,NA,Lab confirmed,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Estimated model parameter,FALSE,NA,NA,Brazil,Pregnant women,"Salvador, Bahia",188,Hospital based,Female,31,Jan,2017,1,Jan,2015,NA,NA,NA,NA,NA,NA,Adjusted,FALSE,Unspecified,Urban area,47,Seroprevalence,NA,IQR,61 - 67,Brazil,NA,NA,FALSE,NA,NA,NA,1 Jan 2015,31 Jan 2017,1 Jan 2015 - 31 Jan 2017
e1b218f9b0f9916aadd934c264062a73,44cdc6f41b53b3823778ea6a8762a5ec,10681,Seroprevalence - IgG,Percentage (%),0,19,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,227,NA,43,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,NA,Brazil,Pregnant women,"Salvador, Bahia",227,Hospital based,Female,31,Jan,2017,1,Jan,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Urban area,47,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,1 Jan 2015,31 Jan 2017,1 Jan 2015 - 31 Jan 2017
e1b218f9b0f9916aadd934c264062a73,587c7ad4bd8e6b1fb72c3a45f3f0fb62,10681,Seroprevalence - IgG,Percentage (%),0,19,Median,16,22,IQR,NA,NA,NA,NA,NA,Lab confirmed,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Estimated model parameter,FALSE,NA,NA,Brazil,Pregnant women,"Salvador, Bahia",227,Hospital based,Female,31,Jan,2017,1,Jan,2015,NA,NA,NA,NA,NA,NA,Adjusted,FALSE,Unspecified,Urban area,47,Seroprevalence,NA,IQR,16 - 22,Brazil,NA,NA,FALSE,NA,NA,NA,1 Jan 2015,31 Jan 2017,1 Jan 2015 - 31 Jan 2017
e1b218f9b0f9916aadd934c264062a73,0d320b445097eb605cd504003311e9a3,10681,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,NA,FALSE,NA,NA,Brazil,Pregnant women,"Salvador, Bahia",NA,Hospital based,Unspecified,31,Jan,2017,1,Jan,2015,NA,Not adjusted,Other,NA,Serology,Significant,NA,FALSE,Unspecified,Urban area,47,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,1 Jan 2015,31 Jan 2017,1 Jan 2015 - 31 Jan 2017
e1b218f9b0f9916aadd934c264062a73,8d1fe7c7cc54f8214484f013cd8bc6ec,10681,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,NA,FALSE,0,0,Brazil,Mixed groups,"Salvador, Bahia",NA,Hospital based,Unspecified,31,Jan,2017,1,Jan,2015,NA,Not adjusted,Other,NA,Zika congenital syndrome/other birth defects,Significant,NA,FALSE,Unspecified,Urban area,47,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,1 Jan 2015,31 Jan 2017,1 Jan 2015 - 31 Jan 2017
49b5a1aa3bdac8b40ab8f609688d6152,71a70a87f7766048777ba3ca8dc48ecc,10697,Seroprevalence - MIA,Percentage (%),0,30.3,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,400,NA,121,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,NA,Panama,Persons under investigation,NA,400,Population based,Unspecified,NA,NA,2016,NA,NA,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,26,Seroprevalence,NA,NA,NA,Panama,NA,NA,FALSE,NA,NA,NA,2015,2016,2015 - 2016
42a32e55c835f4f8872a8e1fdbe6b3a2,8aa151e954f8b5842c47e60044d58d45,10743,Seroprevalence - IgM,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,16,NA,1,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Ruth,NA,FALSE,NA,NA,Brazil,Persons under investigation,Northeast Brazil,16,Hospital based,Both,NA,Feb,2017,NA,Dec,2014,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,49,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Dec 2014,Feb 2017,Dec 2014 - Feb 2017
42a32e55c835f4f8872a8e1fdbe6b3a2,e2e9aa3e062948ef4377eefba7469b15,10743,Seroprevalence - IgM,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,15,NA,3,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Ruth,NA,FALSE,NA,NA,Brazil,Persons under investigation,Northeast Brazil,15,Hospital based,Unspecified,NA,Feb,2017,NA,Dec,2014,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,49,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Dec 2014,Feb 2017,Dec 2014 - Feb 2017
42a32e55c835f4f8872a8e1fdbe6b3a2,e6796d84ea841e6a29f399d8fdaf3bb3,10743,Seroprevalence - IgM,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,68,Naive,17,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Ruth,NA,FALSE,NA,NA,Brazil,Persons under investigation,Northeast Brazil,68,Hospital based,Both,NA,Feb,2017,NA,Dec,2014,NA,NA,NA,NA,NA,NA,Naive,FALSE,Unspecified,Unspecified,49,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Dec 2014,Feb 2017,Dec 2014 - Feb 2017
5e6ef97b7fc269b49cf2a26486449a71,83dcd06b45fd4d6d4fac0fd19188f172,10749,Attack rate,Percentage (%),0,NA,Unspecified,NA,NA,NA,NA,NA,0,0.9,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Method, Other",TRUE,FALSE,Unspecified,NA,Tristan Naidoo,NA,FALSE,NA,NA,Netherlands,General population,NA,481,Travel based,Both,NA,Oct,2017,NA,Mar,2014,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,19,Attack rate,0 - 0.9,NA,NA,Netherlands,NA,NA,FALSE,NA,NA,NA,Mar 2014,Oct 2017,Mar 2014 - Oct 2017
5e6ef97b7fc269b49cf2a26486449a71,93f9c2d8dc490ec5604c515ed8548477,10749,Seroprevalence - IgG,Percentage (%),0,14,NA,8.5,21,NA,NA,NA,NA,NA,NA,NA,129,Naive,18,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,NA,FALSE,NA,NA,Netherlands,General population,NA,129,Travel based,Both,NA,Oct,2017,NA,Mar,2014,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,19,Seroprevalence,NA,NA,8.5 - 21,Netherlands,NA,NA,FALSE,NA,NA,NA,Mar 2014,Oct 2017,Mar 2014 - Oct 2017
5e6ef97b7fc269b49cf2a26486449a71,f2954d82c7fedbb872cf42704cba595b,10749,Seroprevalence - IgG,Percentage (%),0,0.6,NA,0.1,2.1,95% CI,NA,NA,NA,NA,NA,NA,326,Naive,2,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,NA,FALSE,NA,NA,Netherlands,General population,NA,326,Travel based,Both,NA,Oct,2017,NA,Mar,2014,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,19,Seroprevalence,NA,95% CI,0.1 - 2.1,Netherlands,NA,NA,FALSE,NA,NA,NA,Mar 2014,Oct 2017,Mar 2014 - Oct 2017
5e6ef97b7fc269b49cf2a26486449a71,b6b87f16fb3d1039ecbc4ecf8f65255e,10749,Risk factors,NA,0,NA,NA,0.1,2.1,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,NA,FALSE,NA,NA,Unspecified,General population,NA,455,Travel based,Both,NA,Oct,2017,NA,Mar,2014,NA,Not adjusted,Age;Other,NA,Serology,Significant,NA,FALSE,NA,Unspecified,19,Risk factors,NA,95% CI,0.1 - 2.1,NA,NA,NA,FALSE,NA,NA,NA,Mar 2014,Oct 2017,Mar 2014 - Oct 2017
5e6ef97b7fc269b49cf2a26486449a71,63fd240430b31382d956cb8e476182fb,10749,Risk factors,NA,0,NA,NA,0.1,2.1,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,NA,FALSE,NA,NA,Unspecified,General population,NA,455,Travel based,Both,NA,Oct,2017,NA,Mar,2014,NA,Not adjusted,Other;Sex,NA,Serology,Not significant,NA,FALSE,NA,Unspecified,19,Risk factors,NA,95% CI,0.1 - 2.1,NA,NA,NA,FALSE,NA,NA,NA,Mar 2014,Oct 2017,Mar 2014 - Oct 2017
94579bfba3b445f2ddadb8e4959a686a,76457140ea62da8c7abc63a475564c5b,10795,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,29.7,NA,23.3,26,95% CI,NA,NA,NA,NA,NA,NA,499,Adjusted,385,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Anna Vicco,NA,FALSE,NA,NA,Thailand,Mixed groups,Narathiwat,499,Household based,Both,NA,Sep,2018,NA,Mar,2018,NA,NA,NA,NA,NA,NA,Adjusted,FALSE,NA,NA,32,Seroprevalence,NA,95% CI,23.3 - 26,Thailand,NA,NA,FALSE,NA,NA,NA,Mar 2018,Sep 2018,Mar 2018 - Sep 2018
94579bfba3b445f2ddadb8e4959a686a,998114bc5608e1d5318f69a208de885d,10795,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,24.3,NA,20.1,28.8,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Anna Vicco,NA,FALSE,NA,NA,Thailand,Pregnant women,Surat Thani,NA,Household based,Both,NA,Mar,2019,NA,Jul,2018,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,32,Seroprevalence,NA,95% CI,20.1 - 28.8,Thailand,NA,NA,FALSE,NA,NA,NA,Jul 2018,Mar 2019,Jul 2018 - Mar 2019
94579bfba3b445f2ddadb8e4959a686a,bb50cffe170a9e49caa4ec1e52f79c37,10795,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,12.8,NA,9.7,16.5,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Anna Vicco,NA,FALSE,NA,NA,Thailand,Pregnant women,Narathiwat,NA,Household based,Both,NA,Mar,2019,NA,Jul,2018,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,32,Seroprevalence,NA,95% CI,9.7 - 16.5,Thailand,NA,NA,FALSE,NA,NA,NA,Jul 2018,Mar 2019,Jul 2018 - Mar 2019
94579bfba3b445f2ddadb8e4959a686a,261a7b88e3fbe59fdf8b2a59e4d78bfd,10795,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Anna Vicco,NA,FALSE,NA,NA,Thailand,Mixed groups,Narathiwat and Surat Thani,805,Household based,Both,NA,Mar,2019,NA,Mar,2018,NA,Adjusted,Age;Other,NA,Infection,Significant,NA,FALSE,NA,NA,32,Risk factors,NA,NA,NA,Thailand,NA,NA,FALSE,NA,NA,NA,Mar 2018,Mar 2019,Mar 2018 - Mar 2019
94579bfba3b445f2ddadb8e4959a686a,5be48b88a18af4c711866a2155ac0e53,10795,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Anna Vicco,NA,FALSE,NA,NA,Thailand,Mixed groups,Narathiwat and Surat Thani,805,Household based,Both,NA,Mar,2019,NA,Mar,2018,NA,Adjusted,Household contact;Other,NA,Infection,Not significant,NA,FALSE,NA,NA,32,Risk factors,NA,NA,NA,Thailand,NA,NA,FALSE,NA,NA,NA,Mar 2018,Mar 2019,Mar 2018 - Mar 2019
94579bfba3b445f2ddadb8e4959a686a,f13f8cedd766508ffb4c9f856ebea82c,10795,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,43.7,NA,35.9,51.6,95% CI,NA,NA,NA,NA,NA,NA,504,NA,377,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Anna Vicco,NA,FALSE,NA,NA,Thailand,Mixed groups,Surat Thani,504,Household based,Both,NA,Sep,2018,NA,Mar,2018,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,32,Seroprevalence,NA,95% CI,35.9 - 51.6,Thailand,NA,NA,FALSE,NA,NA,NA,Mar 2018,Sep 2018,Mar 2018 - Sep 2018
d2c7cad34dfe9f308c4351e8927f016b,3e9a9e59a88ebe6ad1d9d8a24cc2f83c,10816,Seroprevalence - Neutralisation/PRNT,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,263,NA,2,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Mexico,Other,Guerrero,48,Hospital based,NA,NA,Nov,2019,NA,May,2019,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,45,Seroprevalence,NA,NA,NA,Mexico,NA,NA,FALSE,NA,NA,NA,May 2019,Nov 2019,May 2019 - Nov 2019
d2c7cad34dfe9f308c4351e8927f016b,0985bce4c8da1ab61c76e100b18aed2f,10816,Seroprevalence - Neutralisation/PRNT,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,263,NA,6,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Mexico,Other,Guerrero,60,Hospital based,NA,NA,Nov,2019,NA,May,2019,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,45,Seroprevalence,NA,NA,NA,Mexico,NA,NA,FALSE,NA,NA,NA,May 2019,Nov 2019,May 2019 - Nov 2019
fac3dbd9200fd7641ce41b5c09f2b5eb,8375e375be9ca1f4c4501d97ed3a29c7,10818,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,NA,FALSE,NA,NA,Brazil,Children,Rio de Janeiro,42,Hospital based,Unspecified,NA,Oct,2017,NA,Apr,2015,NA,Not adjusted,Infection during pregnancy,NA,Zika congenital syndrome/other birth defects,Significant,NA,FALSE,NA,Urban area,46,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Apr 2015,Oct 2017,Apr 2015 - Oct 2017
fac3dbd9200fd7641ce41b5c09f2b5eb,475ce6942db5d92a1384e11cb6811e41,10818,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,NA,FALSE,NA,NA,Brazil,Children,Rio de Janeiro,42,Hospital based,Unspecified,NA,Oct,2017,NA,Apr,2015,NA,Not adjusted,Age;Other,NA,Zika congenital syndrome/other birth defects,Not significant,NA,FALSE,NA,Urban area,46,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Apr 2015,Oct 2017,Apr 2015 - Oct 2017
f4e0a65226a3db4c915b1f55204126f8,2fa6b17c349fa8b86e3ff0fb6cf98daf,10933,Seroprevalence - IgG,Percentage (%),0,NA,NA,0,16.74,95% CI,NA,NA,0,5.35,NA,NA,NA,NA,NA,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Time,TRUE,FALSE,Start outbreak,NA,Tristan Naidoo,NA,FALSE,NA,NA,Colombia,General population,Barranquilla,390,Population based,Unspecified,31,Aug,2015,6,May,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,18,Seroprevalence,0 - 5.35,95% CI,0 - 16.74,Colombia,NA,NA,FALSE,NA,NA,NA,6 May 2015,31 Aug 2015,6 May 2015 - 31 Aug 2015
e12d008e95b54ce28b7b23b081fef034,8ec99ad90fe5be832d047169ed18ce9f,10946,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Kelly M,NA,FALSE,NA,NA,Honduras,Children,Tegucigalpa,152,Hospital based,Unspecified,NA,Dec,2016,NA,Jul,2016,NA,Adjusted,Infection during pregnancy,NA,Other neurological symptoms in general population,Not significant,NA,FALSE,Unspecified,Unspecified,47,Risk factors,NA,NA,NA,Honduras,NA,NA,FALSE,NA,NA,NA,Jul 2016,Dec 2016,Jul 2016 - Dec 2016
e12d008e95b54ce28b7b23b081fef034,5c5abea0f8edddb08b42196d63c3f757,10946,Seroprevalence - IgM,Percentage (%),0,NA,Central,NA,NA,NA,NA,NA,1.7,66.3,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,Method,TRUE,FALSE,Mid outbreak,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Honduras,Children,Tegucigalpa,60,Hospital based,Unspecified,NA,Dec,2016,NA,Jul,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Urban area,47,Seroprevalence,1.7 - 66.3,NA,NA,Honduras,NA,NA,FALSE,NA,NA,NA,Jul 2016,Dec 2016,Jul 2016 - Dec 2016
faaf70811c73321c24da9dc888cf7566,f8742c39651428668d928a8f6cd18ffb,10965,Seroprevalence - IgM,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,43,NA,9,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Brazil,Pregnant women,Central-West,43,Hospital based,Female,NA,Apr,2019,NA,Jan,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,48,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Jan 2017,Apr 2019,Jan 2017 - Apr 2019
faaf70811c73321c24da9dc888cf7566,6fb447e6d3d58a5d5dc1a22386eb5a7b,10965,Seroprevalence - Neutralisation/PRNT,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,43,NA,5,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Brazil,Pregnant women,Central-West,43,Hospital based,Female,NA,Apr,2019,NA,Jan,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,48,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Jan 2017,Apr 2019,Jan 2017 - Apr 2019
2d8889111c931a2ec14a9edafad63910,cdaeb5a0e9e5702514d6b3006602ebb6,10999,Seroprevalence - IgM,Percentage (%),0,12.1,Unspecified,NA,NA,NA,NA,NA,0,15.4,NA,NA,496,NA,60,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Other,FALSE,FALSE,Endemic,NA,Tristan Naidoo,Observed sample statistic,FALSE,NA,NA,Nigeria,Persons under investigation,"Adamawa, Bauchi, and Borno states",496,Population based,Both,NA,Aug,2018,NA,Apr,2018,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Both urban and rural areas,21,Seroprevalence,0 - 15.4,NA,NA,Nigeria,NA,NA,FALSE,NA,NA,NA,Apr 2018,Aug 2018,Apr 2018 - Aug 2018
2d8889111c931a2ec14a9edafad63910,3a9e31e1e20dba81d51077bb9d1b9695,10999,Seroprevalence - IgG,Percentage (%),0,85,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,200,NA,170,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Tristan Naidoo,Observed sample statistic,FALSE,NA,NA,Nigeria,Persons under investigation,Borno state,200,Population based,Both,NA,Aug,2018,NA,Apr,2018,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,21,Seroprevalence,NA,NA,NA,Nigeria,NA,NA,FALSE,NA,NA,NA,Apr 2018,Aug 2018,Apr 2018 - Aug 2018
2d8889111c931a2ec14a9edafad63910,b47a018b2810a1c6fa87c875679665f2,10999,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,13.1,Unspecified,NA,NA,NA,NA,NA,10.8,22.2,NA,NA,496,NA,65,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Other,FALSE,FALSE,Endemic,NA,Tristan Naidoo,Observed sample statistic,FALSE,NA,NA,Nigeria,Persons under investigation,"Adamawa, Bauchi, and Borno states",496,Population based,Both,NA,Aug,2018,NA,Apr,2018,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Both urban and rural areas,21,Seroprevalence,10.8 - 22.2,NA,NA,Nigeria,NA,NA,FALSE,NA,NA,NA,Apr 2018,Aug 2018,Apr 2018 - Aug 2018
2d8889111c931a2ec14a9edafad63910,cf909059879fd0dbafc631d3a32b204d,10999,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Tristan Naidoo,NA,FALSE,NA,NA,Nigeria,Persons under investigation,"Adamawa, Bauchi, and Borno states",496,Population based,Both,NA,Aug,2018,NA,Apr,2018,NA,Adjusted,Age;Other;Sex,NA,Serology,Not significant,NA,FALSE,NA,Both urban and rural areas,21,Risk factors,NA,NA,NA,Nigeria,NA,NA,FALSE,NA,NA,NA,Apr 2018,Aug 2018,Apr 2018 - Aug 2018
2d8889111c931a2ec14a9edafad63910,dc7829bca1f8d9736ed43529f238c36e,10999,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Tristan Naidoo,NA,FALSE,NA,NA,Nigeria,Persons under investigation,"Adamawa, Bauchi, and Borno states",496,Population based,Both,NA,Aug,2018,NA,Apr,2018,NA,Adjusted,Other,NA,Serology,Significant,NA,FALSE,NA,Both urban and rural areas,21,Risk factors,NA,NA,NA,Nigeria,NA,NA,FALSE,NA,NA,NA,Apr 2018,Aug 2018,Apr 2018 - Aug 2018
2d8889111c931a2ec14a9edafad63910,a07de3214c2da0bb5f31aeb8545f429c,10999,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Tristan Naidoo,NA,FALSE,NA,NA,Nigeria,Persons under investigation,"Adamawa, Bauchi, and Borno states",496,Population based,Both,NA,Aug,2018,NA,Apr,2018,NA,Not adjusted,Age;Other;Sex,NA,Serology,Not significant,NA,FALSE,NA,Both urban and rural areas,21,Risk factors,NA,NA,NA,Nigeria,NA,NA,FALSE,NA,NA,NA,Apr 2018,Aug 2018,Apr 2018 - Aug 2018
2d8889111c931a2ec14a9edafad63910,7d2e42e4cf331e1779c786ccd6cd2b32,10999,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Tristan Naidoo,NA,FALSE,NA,NA,Nigeria,Persons under investigation,"Adamawa, Bauchi, and Borno states",496,Population based,Both,NA,Aug,2018,NA,Apr,2018,NA,Not adjusted,Other,NA,Serology,Significant,NA,FALSE,NA,Both urban and rural areas,21,Risk factors,NA,NA,NA,Nigeria,NA,NA,FALSE,NA,NA,NA,Apr 2018,Aug 2018,Apr 2018 - Aug 2018
2d8889111c931a2ec14a9edafad63910,63a8c1572c85badad9bfcbffbb850729,10999,Seroprevalence - IgM,Percentage (%),0,15.5,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,200,NA,31,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Tristan Naidoo,Observed sample statistic,FALSE,NA,NA,Nigeria,Persons under investigation,Adamawa state,200,Population based,Both,NA,Aug,2018,NA,Apr,2018,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Both urban and rural areas,21,Seroprevalence,NA,NA,NA,Nigeria,NA,NA,FALSE,NA,NA,NA,Apr 2018,Aug 2018,Apr 2018 - Aug 2018
2d8889111c931a2ec14a9edafad63910,db43d4f9b77b1252e570ee1549265414,10999,Seroprevalence - IgM,Percentage (%),0,14.5,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,96,NA,29,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Tristan Naidoo,Observed sample statistic,FALSE,NA,NA,Nigeria,Persons under investigation,Borno state,200,Population based,Both,NA,Aug,2018,NA,Apr,2018,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Both urban and rural areas,21,Seroprevalence,NA,NA,NA,Nigeria,NA,NA,FALSE,NA,NA,NA,Apr 2018,Aug 2018,Apr 2018 - Aug 2018
2d8889111c931a2ec14a9edafad63910,5747df8f7558b065565b4ea989981b56,10999,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,3,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,200,NA,6,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Tristan Naidoo,Observed sample statistic,FALSE,NA,NA,Nigeria,Persons under investigation,Adamawa state,200,Population based,Both,NA,Aug,2018,NA,Apr,2018,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Both urban and rural areas,21,Seroprevalence,NA,NA,NA,Nigeria,NA,NA,FALSE,NA,NA,NA,Apr 2018,Aug 2018,Apr 2018 - Aug 2018
2d8889111c931a2ec14a9edafad63910,e208c9b89f662817de55780a2b8c6130,10999,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,36.5,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,96,NA,35,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Tristan Naidoo,Observed sample statistic,FALSE,NA,NA,Nigeria,Persons under investigation,Bauchi state,96,Population based,Both,NA,Aug,2018,NA,Apr,2018,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Both urban and rural areas,21,Seroprevalence,NA,NA,NA,Nigeria,NA,NA,FALSE,NA,NA,NA,Apr 2018,Aug 2018,Apr 2018 - Aug 2018
2d8889111c931a2ec14a9edafad63910,12d574a27a5a817010086e6ef1134789,10999,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,12,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,200,NA,24,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Tristan Naidoo,Observed sample statistic,FALSE,NA,NA,Nigeria,Persons under investigation,Borno state,200,Population based,Both,NA,Aug,2018,NA,Apr,2018,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Both urban and rural areas,21,Seroprevalence,NA,NA,NA,Nigeria,NA,NA,FALSE,NA,NA,NA,Apr 2018,Aug 2018,Apr 2018 - Aug 2018
2d8889111c931a2ec14a9edafad63910,2446a49bd9bb69f7274442775e759e50,10999,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,9.4,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,170,NA,16,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Tristan Naidoo,Observed sample statistic,FALSE,NA,NA,Nigeria,Persons under investigation,Borno state,200,Population based,Both,NA,Aug,2018,NA,Apr,2018,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,21,Seroprevalence,NA,NA,NA,Nigeria,NA,NA,FALSE,NA,NA,NA,Apr 2018,Aug 2018,Apr 2018 - Aug 2018
6b17be35b78bff9c0ca5adf4d714b243,476ce2f4bf65da7282602c6c0a25290f,11010,Seroprevalence - IgG,Percentage (%),0,2.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Peru,General population,Chincha Baja,200,Population based,Both,NA,May,2019,NA,Mar,2019,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,31,Seroprevalence,NA,NA,NA,Peru,NA,NA,FALSE,NA,NA,NA,Mar 2019,May 2019,Mar 2019 - May 2019
6b17be35b78bff9c0ca5adf4d714b243,d588b54820309e1ac8d4f8f8cda3e8ce,11010,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Peru,General population,Chincha Baja and Pueblo Nuevo,200,Population based,Both,NA,May,2019,NA,Mar,2019,NA,Adjusted,Other,NA,Other,Significant,NA,FALSE,NA,NA,31,Risk factors,NA,NA,NA,Peru,NA,NA,FALSE,NA,NA,NA,Mar 2019,May 2019,Mar 2019 - May 2019
6b17be35b78bff9c0ca5adf4d714b243,c82cc53fab5bb74dfc494a91d61924f4,11010,Seroprevalence - IgG,Percentage (%),0,23.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Peru,General population,Pueblo Nuevo,200,Population based,Both,NA,May,2019,NA,Mar,2019,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,31,Seroprevalence,NA,NA,NA,Peru,NA,NA,FALSE,NA,NA,NA,Mar 2019,May 2019,Mar 2019 - May 2019
81fe40b127b3c2ec40bd4a1966f44b7b,e0206f7f84cffcb1e336f140a192520c,11011,Seroprevalence - IgG,Percentage (%),0,59,NA,50.7,66.7,95% CI,NA,NA,NA,NA,NA,NA,144,NA,85,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,End outbreak,NA,Anna-Maria Hartner,NA,FALSE,NA,NA,Brazil,Other,University Hospital Professor Edgard Santos (UHPES) in Salvador de Bahia,144,Hospital based,Unspecified,NA,May,2016,NA,Feb,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,22,Seroprevalence,NA,95% CI,50.7 - 66.7,Brazil,NA,NA,FALSE,NA,NA,NA,Feb 2016,May 2016,Feb 2016 - May 2016
81fe40b127b3c2ec40bd4a1966f44b7b,d27851ffe2192f5a71652509301f6286,11011,Seroprevalence - IgG,Percentage (%),0,38.6,NA,31.3,47,95% CI,NA,NA,NA,NA,NA,NA,144,NA,56,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,End outbreak,NA,Anna-Maria Hartner,NA,FALSE,NA,NA,Brazil,Other,University Hospital Professor Edgard Santos (UHPES) in Salvador de Bahia,144,Hospital based,Unspecified,NA,Feb,2018,NA,Aug,2017,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,22,Seroprevalence,NA,95% CI,31.3 - 47,Brazil,NA,NA,FALSE,NA,NA,NA,Aug 2017,Feb 2018,Aug 2017 - Feb 2018
81fe40b127b3c2ec40bd4a1966f44b7b,20e9f3ce54f46377ee67b5fd5725191a,11011,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,30,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,85,NA,24,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,End outbreak,NA,Anna-Maria Hartner,NA,FALSE,NA,NA,Brazil,Other,University Hospital Professor Edgard Santos (UHPES) in Salvador de Bahia,85,Hospital based,Unspecified,NA,May,2016,NA,Feb,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,22,Seroprevalence,NA,NA,NA,Brazil,NA,NA,TRUE,NA,NA,NA,Feb 2016,May 2016,Feb 2016 - May 2016
c55c0519e23d025e759117682b701c03,bcb3a8b7d3161fc224bbcad22ea24434,11114,Seroprevalence - IgM,Percentage (%),0,23.8,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,21,NA,5,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Brazil,Other,"Salvador, Bahia",21,Hospital based,Both,16,Dec,2016,18,Jan,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,53,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,18 Jan 2016,16 Dec 2016,18 Jan 2016 - 16 Dec 2016
c55c0519e23d025e759117682b701c03,a8e97b9e624fe0e7eff03532a7a04496,11114,Seroprevalence - IgG,Percentage (%),0,80.9,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,21,NA,17,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Brazil,Other,"Salvador, Bahia",21,Hospital based,Both,16,Dec,2016,18,Jan,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,53,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,18 Jan 2016,16 Dec 2016,18 Jan 2016 - 16 Dec 2016
c55c0519e23d025e759117682b701c03,eb710f3b0e2c53b22fa883b1dd08d896,11114,Seroprevalence - IgM,Percentage (%),0,4.2,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,95,NA,4,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Brazil,Other,"Salvador, Bahia",95,Hospital based,Both,16,Dec,2016,18,Jan,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,53,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,18 Jan 2016,16 Dec 2016,18 Jan 2016 - 16 Dec 2016
c55c0519e23d025e759117682b701c03,839835f5cab6927f695e76ef0af2039b,11114,Seroprevalence - IgG,Percentage (%),0,74.7,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,95,NA,71,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Brazil,Other,"Salvador, Bahia",95,Hospital based,Both,16,Dec,2016,18,Jan,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,53,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,18 Jan 2016,16 Dec 2016,18 Jan 2016 - 16 Dec 2016
7f6e9ec2430dc22d5115dbc67b684e95,cee8c7d66d0ad6fbcb7570b53abad152,11133,Seroprevalence - HAI/HI,Percentage (%),0,NA,NA,NA,NA,NA,NA,NA,27.7,36.6,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,Age,FALSE,FALSE,Unspecified,NA,Anna Vicco,Observed sample statistic,FALSE,NA,NA,Brazil,Other,Manaus (Amazonas state),298,Other,NA,NA,Dec,2015,NA,Jan,2014,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,30,Seroprevalence,27.7 - 36.6,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Jan 2014,Dec 2015,Jan 2014 - Dec 2015
70e4ea0bcd25216d36644899c62b52fd,5a59cc1394c4a525894c03d3be47118e,11206,Seroprevalence - IgM,Percentage (%),0,16.7,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,30,NA,5,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Tristan Naidoo,Observed sample statistic,FALSE,NA,NA,Italy,Persons under investigation,NA,30,Travel based,Both,NA,Nov,2022,NA,Nov,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,22,Seroprevalence,NA,NA,NA,Italy,NA,NA,FALSE,NA,NA,NA,Nov 2015,Nov 2022,Nov 2015 - Nov 2022
70e4ea0bcd25216d36644899c62b52fd,ee66610927f269547bb83ac2e0e16db5,11206,Seroprevalence - IgM,Percentage (%),0,21.4,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,487,NA,104,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Tristan Naidoo,Observed sample statistic,FALSE,NA,NA,Italy,Persons under investigation,NA,497,Travel based,Both,NA,Nov,2022,NA,Nov,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,22,Seroprevalence,NA,NA,NA,Italy,NA,NA,FALSE,NA,NA,NA,Nov 2015,Nov 2022,Nov 2015 - Nov 2022
70e4ea0bcd25216d36644899c62b52fd,09d2ed20c087c470cc6f06597c5714c1,11206,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,16,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,594,NA,95,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Tristan Naidoo,Observed sample statistic,FALSE,NA,NA,Italy,Persons under investigation,NA,594,Travel based,Both,NA,Nov,2022,NA,Nov,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,22,Seroprevalence,NA,NA,NA,Italy,NA,NA,FALSE,NA,NA,NA,Nov 2015,Nov 2022,Nov 2015 - Nov 2022
70e4ea0bcd25216d36644899c62b52fd,19ab4a62015c1d484fa892ad534e2a12,11206,Seroprevalence - IgM,Percentage (%),0,57.1,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,7,NA,4,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Tristan Naidoo,Observed sample statistic,FALSE,NA,NA,Italy,Persons under investigation,NA,7,Travel based,Both,NA,Nov,2022,NA,Nov,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,22,Seroprevalence,NA,NA,NA,Italy,NA,NA,FALSE,NA,NA,NA,Nov 2015,Nov 2022,Nov 2015 - Nov 2022
70e4ea0bcd25216d36644899c62b52fd,e42dbd7e261cadbbb2fc1d6b319f3ad9,11206,Seroprevalence - IgM,Percentage (%),0,77.3,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,44,NA,34,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Tristan Naidoo,Observed sample statistic,FALSE,NA,NA,Italy,Persons under investigation,NA,44,Travel based,Both,NA,Nov,2022,NA,Nov,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,22,Seroprevalence,NA,NA,NA,Italy,NA,NA,FALSE,NA,NA,NA,Nov 2015,Nov 2022,Nov 2015 - Nov 2022
70e4ea0bcd25216d36644899c62b52fd,ca9c324330be111f76121d1946c9728a,11206,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,86,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,44,NA,38,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Endemic,NA,Tristan Naidoo,Observed sample statistic,FALSE,NA,NA,Italy,Persons under investigation,NA,44,Travel based,Both,NA,Nov,2022,NA,Nov,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,22,Seroprevalence,NA,NA,NA,Italy,NA,NA,FALSE,NA,NA,NA,Nov 2015,Nov 2022,Nov 2015 - Nov 2022
e41a8653980200b9ea5f7750aed315bb,8dfa65f137187af078ccefd5f9fbdf68,11213,Seroprevalence - IgM,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Suspected,160,NA,30,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Sex",FALSE,FALSE,Endemic,NA,Anna-Maria Hartner,NA,FALSE,NA,3,Ghana,NA,Greater Accra Regional Hospital,160,Hospital based,Both,NA,Nov,2017,NA,Dec,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,16,Seroprevalence,NA,NA,NA,Ghana,NA,NA,FALSE,NA,NA,NA,Dec 2016,Nov 2017,Dec 2016 - Nov 2017
e41a8653980200b9ea5f7750aed315bb,8fea8172712fa0659a86ec681126d1d4,11213,Seroprevalence - IgG,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Suspected,160,NA,3,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Sex",FALSE,FALSE,Endemic,NA,Anna-Maria Hartner,NA,FALSE,NA,3,Ghana,NA,Greater Accra Regional Hospital,160,Hospital based,Both,NA,Nov,2017,NA,Dec,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,16,Seroprevalence,NA,NA,NA,Ghana,NA,NA,FALSE,NA,NA,NA,Dec 2016,Nov 2017,Dec 2016 - Nov 2017
1b14ab9afc1ad361490e7372abc312a3,fc482a914611b7da49f0984a1959b708,11271,Seroprevalence - IgM,NA,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,45,NA,0,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Tristan Naidoo,NA,FALSE,0,0,Indonesia,Children,NA,45,Population based,Both,NA,Apr,2017,NA,Oct,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,20,Seroprevalence,NA,NA,NA,Indonesia,NA,NA,FALSE,NA,NA,NA,Oct 2016,Apr 2017,Oct 2016 - Apr 2017
1b14ab9afc1ad361490e7372abc312a3,bf68116e894a653034032bfe7e55b8f5,11271,Seroprevalence - IgM,NA,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,113,NA,0,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Tristan Naidoo,NA,FALSE,0,0,Indonesia,Children,NA,113,Population based,Both,NA,Apr,2017,NA,Oct,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,20,Seroprevalence,NA,NA,NA,Indonesia,NA,NA,FALSE,NA,NA,NA,Oct 2016,Apr 2017,Oct 2016 - Apr 2017
1b14ab9afc1ad361490e7372abc312a3,c0db02ddfdf8799c7fc57a3d349cdf13,11271,Seroprevalence - Neutralisation/PRNT,NA,0,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,46,NA,1,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Tristan Naidoo,NA,FALSE,0,0,Indonesia,Children,NA,46,Population based,Both,NA,Apr,2017,NA,Oct,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,20,Seroprevalence,NA,NA,NA,Indonesia,NA,NA,FALSE,NA,NA,NA,Oct 2016,Apr 2017,Oct 2016 - Apr 2017
1b14ab9afc1ad361490e7372abc312a3,27f0ba2b39c31ba268114dd231949803,11271,Seroprevalence - Neutralisation/PRNT,NA,0,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,110,NA,2,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Tristan Naidoo,NA,FALSE,0,0,Indonesia,Children,NA,110,Population based,Both,NA,Apr,2017,NA,Oct,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,20,Seroprevalence,NA,NA,NA,Indonesia,NA,NA,FALSE,NA,NA,NA,Oct 2016,Apr 2017,Oct 2016 - Apr 2017
e8bee166b2917509435850c106624cb9,c7b078300ada4f53ff55a6f1d72581b5,11277,Seroprevalence - IgG,Percentage (%),0,1.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,81,Naive,1,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,Observed sample statistic,FALSE,NA,NA,Germany,Persons under investigation,Germany travelling to Asia,81,Travel based,Both,NA,Jan,2018,NA,Jan,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,29,Seroprevalence,NA,NA,NA,Germany,NA,NA,FALSE,NA,NA,NA,Jan 2017,Jan 2018,Jan 2017 - Jan 2018
e8bee166b2917509435850c106624cb9,1e00b3f73b325e77eb4ee1058c5af0c4,11277,Seroprevalence - IgM,Percentage (%),0,1.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,Lab confirmed,81,Naive,1,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,Observed sample statistic,FALSE,NA,NA,Germany,Persons under investigation,Germany travelling to Asia,81,Travel based,Both,NA,Jan,2018,NA,Jan,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,29,Seroprevalence,NA,NA,NA,Germany,NA,NA,FALSE,NA,NA,NA,Jan 2017,Jan 2018,Jan 2017 - Jan 2018
181f1736f3c5dd712a123217b8dc119c,dcbf92a0425df7843f4d43953dcbcbfd,11297,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Brazil,Pregnant women,Pernambuco (Recife),376,Hospital based,NA,NA,Jun,2017,NA,Dec,2015,NA,Adjusted,Infection during pregnancy,NA,Zika congenital syndrome/other birth defects,Not significant,NA,FALSE,NA,NA,28,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Dec 2015,Jun 2017,Dec 2015 - Jun 2017
3e06351e9b906fb67a4b2e176a890887,30c44ee233f1cc3333d09ed7c3efd5d7,11328,Seroprevalence - IgG,Percentage (%),0,7.25,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Brazil,Pregnant women,Recife,262,Population based,Female,NA,Dec,2016,NA,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,27,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Jan 2016,Dec 2016,Jan 2016 - Dec 2016
3e06351e9b906fb67a4b2e176a890887,80a49cc26bfb1feb67f8042883346a9a,11328,Seroprevalence - IgM,Percentage (%),0,5.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Brazil,Pregnant women,Recife,262,Population based,Female,NA,Dec,2016,NA,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,27,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Jan 2016,Dec 2016,Jan 2016 - Dec 2016
3e06351e9b906fb67a4b2e176a890887,a6565243f076eb88963b23790e9cbb92,11328,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,40.54,NA,NA,NA,NA,NA,NA,NA,NA,NA,Other,37,NA,15,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Brazil,Pregnant women,Recife,262,Population based,Female,NA,Dec,2016,NA,Jan,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,27,Seroprevalence,NA,NA,NA,Brazil,NA,NA,TRUE,NA,NA,NA,Jan 2016,Dec 2016,Jan 2016 - Dec 2016
abf0e02c462fe9c39deb56e463bcd887,802bb203ea072b7aec0ec2b042fe567a,11434,Seroprevalence - IgM,Percentage (%),0,1.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,Other,273,Adjusted,5,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,China,General population,"Nanning City, Guanxi",273,Population based,Both,NA,Mar,2019,NA,Mar,2019,NA,NA,NA,NA,NA,NA,Adjusted,FALSE,NA,NA,26,Seroprevalence,NA,NA,NA,China,NA,NA,FALSE,NA,NA,NA,Mar 2019,Mar 2019,Mar 2019
abf0e02c462fe9c39deb56e463bcd887,8b248fd3577f335f4d9002e2ee4b4de5,11434,Seroprevalence - IgG,Percentage (%),0,9.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,Other,273,Adjusted,26,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,China,General population,"Nanning City, Guanxi",273,Population based,Both,NA,Mar,2019,NA,Mar,2019,NA,NA,NA,NA,NA,NA,Adjusted,FALSE,NA,NA,26,Seroprevalence,NA,NA,NA,China,NA,NA,FALSE,NA,NA,NA,Mar 2019,Mar 2019,Mar 2019
abf0e02c462fe9c39deb56e463bcd887,5b358204c4142e0a3dabbefb558d313b,11434,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,65.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,Other,26,Adjusted,17,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,China,General population,"Nanning City, Guanxi",273,Population based,Both,NA,Mar,2019,NA,Mar,2019,NA,NA,NA,NA,NA,NA,Adjusted,FALSE,NA,NA,26,Seroprevalence,NA,NA,NA,China,NA,NA,TRUE,NA,NA,NA,Mar 2019,Mar 2019,Mar 2019
566c61975ab51782fb18e09192ac62b8,142d70b0068d88d4346dae010e377812,11438,Seroprevalence - IgG,Percentage (%),0,3,NA,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,2749,Naive,63,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Brazil,General population,Rio de Janeiro,2749,Population based,Both,NA,Oct,2018,NA,Jul,2018,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,25,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Jul 2018,Oct 2018,Jul 2018 - Oct 2018
566c61975ab51782fb18e09192ac62b8,a201b7f064125243d4974edf7cf5a5e1,11438,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Brazil,General population,Rio de Janeiro,2749,Population based,Both,NA,Oct,2018,NA,Jul,2018,NA,Adjusted,Age;Prior immunity to arboviruses,NA,Infection,Not significant,NA,FALSE,NA,NA,25,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Jul 2018,Oct 2018,Jul 2018 - Oct 2018
dc07d8467b4a1476ff14ddad50f4d5e7,739592698f3b83e19f699513ea06c929,11477,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,0.2,NA,0.01,1.1,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,United States,Other,Puerto Rico,494,Other,NA,1,Jun,2015,1,Jan,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,24,Seroprevalence,NA,95% CI,0.01 - 1.1,United States,NA,NA,FALSE,NA,NA,NA,1 Jan 2015,1 Jun 2015,1 Jan 2015 - 1 Jun 2015
d5072db91e7d3e9ea264e4888fe2b2e0,0e0eb43dee04f8f2ff6e033a735e7f8a,11493,Seroprevalence - IgG,Percentage (%),0,5.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,989,Naive,59,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Tanzania,Mixed groups,"Buhigwe, Kalambo, Kilindi, Kinondoni, Kondoa, Kyela, Mvomero and Ukerewe districts",1818,Population based,Female,NA,Nov,2018,NA,Apr,2018,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,23,Seroprevalence,NA,NA,NA,Tanzania,NA,NA,FALSE,NA,NA,NA,Apr 2018,Nov 2018,Apr 2018 - Nov 2018
d5072db91e7d3e9ea264e4888fe2b2e0,f997589ddd6bbdcde665da0a7e89c794,11493,Seroprevalence - IgG,Percentage (%),0,7.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,829,Naive,62,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Tanzania,Mixed groups,"Buhigwe, Kalambo, Kilindi, Kinondoni, Kondoa, Kyela, Mvomero and Ukerewe districts",1818,Population based,Male,NA,Nov,2018,NA,Apr,2018,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,23,Seroprevalence,NA,NA,NA,Tanzania,NA,NA,FALSE,NA,NA,NA,Apr 2018,Nov 2018,Apr 2018 - Nov 2018
d5072db91e7d3e9ea264e4888fe2b2e0,6c115de8eb66c88776607009bb9f3873,11493,Seroprevalence - IgG,Percentage (%),0,NA,NA,NA,NA,NA,NA,NA,6.1,7.6,NA,Unspecified,1818,Naive,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,Age,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Tanzania,Mixed groups,"Buhigwe, Kalambo, Kilindi, Kinondoni, Kondoa, Kyela, Mvomero and Ukerewe districts",1818,Population based,Both,NA,Nov,2018,NA,Apr,2018,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,23,Seroprevalence,6.1 - 7.6,NA,NA,Tanzania,NA,NA,FALSE,NA,NA,NA,Apr 2018,Nov 2018,Apr 2018 - Nov 2018
d5072db91e7d3e9ea264e4888fe2b2e0,a2429cd5046e92d87ea1d7b062e67f8f,11493,Seroprevalence - IgG,Percentage (%),0,3.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Tanzania,Mixed groups,Buhigwe,NA,Population based,Both,NA,Nov,2018,NA,Apr,2018,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,23,Seroprevalence,NA,NA,NA,Tanzania,NA,NA,FALSE,NA,NA,NA,Apr 2018,Nov 2018,Apr 2018 - Nov 2018
d5072db91e7d3e9ea264e4888fe2b2e0,4fbd6ee42113c37e2a8024e5d2aad16e,11493,Seroprevalence - IgG,Percentage (%),0,7.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Tanzania,Mixed groups,Kalambo,NA,Population based,Both,NA,Nov,2018,NA,Apr,2018,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,23,Seroprevalence,NA,NA,NA,Tanzania,NA,NA,FALSE,NA,NA,NA,Apr 2018,Nov 2018,Apr 2018 - Nov 2018
d5072db91e7d3e9ea264e4888fe2b2e0,d4881601d32a6844496ffcc93384c05b,11493,Seroprevalence - IgG,Percentage (%),0,5.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Tanzania,Mixed groups,Kilindi,NA,Population based,Both,NA,Nov,2018,NA,Apr,2018,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,23,Seroprevalence,NA,NA,NA,Tanzania,NA,NA,FALSE,NA,NA,NA,Apr 2018,Nov 2018,Apr 2018 - Nov 2018
d5072db91e7d3e9ea264e4888fe2b2e0,7f2d431f099663c661f8462828457058,11493,Seroprevalence - IgG,Percentage (%),0,6.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Tanzania,Mixed groups,"Buhigwe, Kalambo, Kilindi, Kinondoni, Kondoa, Kyela, Mvomero and Ukerewe districts",1818,Population based,Both,NA,Nov,2018,NA,Apr,2018,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,23,Seroprevalence,NA,NA,NA,Tanzania,NA,NA,FALSE,NA,NA,NA,Apr 2018,Nov 2018,Apr 2018 - Nov 2018
d5072db91e7d3e9ea264e4888fe2b2e0,a47dd18c9f28284dc07956bc47a64741,11493,Seroprevalence - IgG,Percentage (%),0,5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Tanzania,Mixed groups,Kinondoni,NA,Population based,Both,NA,Nov,2018,NA,Apr,2018,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,23,Seroprevalence,NA,NA,NA,Tanzania,NA,NA,FALSE,NA,NA,NA,Apr 2018,Nov 2018,Apr 2018 - Nov 2018
d5072db91e7d3e9ea264e4888fe2b2e0,e80496f54c396f32e9f2e142e765c101,11493,Seroprevalence - IgG,Percentage (%),0,2.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Tanzania,Mixed groups,Kondoa,NA,Population based,Both,NA,Nov,2018,NA,Apr,2018,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,23,Seroprevalence,NA,NA,NA,Tanzania,NA,NA,FALSE,NA,NA,NA,Apr 2018,Nov 2018,Apr 2018 - Nov 2018
d5072db91e7d3e9ea264e4888fe2b2e0,c56f141eefc6395003ed9c8d414f8c37,11493,Seroprevalence - IgG,Percentage (%),0,8.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Tanzania,Mixed groups,Kyela,NA,Population based,Both,NA,Nov,2018,NA,Apr,2018,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,23,Seroprevalence,NA,NA,NA,Tanzania,NA,NA,FALSE,NA,NA,NA,Apr 2018,Nov 2018,Apr 2018 - Nov 2018
d5072db91e7d3e9ea264e4888fe2b2e0,66e8b21f50e338742a3f65b2fa85a62f,11493,Seroprevalence - IgG,Percentage (%),0,10.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Tanzania,Mixed groups,Mvomero,NA,Population based,Both,NA,Nov,2018,NA,Apr,2018,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,23,Seroprevalence,NA,NA,NA,Tanzania,NA,NA,FALSE,NA,NA,NA,Apr 2018,Nov 2018,Apr 2018 - Nov 2018
d5072db91e7d3e9ea264e4888fe2b2e0,2fc8acb681b4be4d722837592734993d,11493,Seroprevalence - IgG,Percentage (%),0,10.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Tanzania,Mixed groups,Ukerewe,NA,Population based,Both,NA,Nov,2018,NA,Apr,2018,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,23,Seroprevalence,NA,NA,NA,Tanzania,NA,NA,FALSE,NA,NA,NA,Apr 2018,Nov 2018,Apr 2018 - Nov 2018
d5072db91e7d3e9ea264e4888fe2b2e0,15a54c9b533875264394f9f83dfe43e5,11493,Risk factors,Percentage (%),0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Tanzania,Mixed groups,Buhigwe,NA,Population based,Both,NA,Nov,2018,NA,Apr,2018,NA,Adjusted,Age;Occupation;Other,NA,Infection,Not significant,NA,FALSE,NA,NA,23,Risk factors,NA,NA,NA,Tanzania,NA,NA,FALSE,NA,NA,NA,Apr 2018,Nov 2018,Apr 2018 - Nov 2018
d5072db91e7d3e9ea264e4888fe2b2e0,c8f9a2dfd7a86f40338bf2f74c9f7e03,11493,Risk factors,Percentage (%),0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Tanzania,Mixed groups,Buhigwe,NA,Population based,Both,NA,Nov,2018,NA,Apr,2018,NA,Not adjusted,Age;Occupation;Other,NA,Infection,Not significant,NA,FALSE,NA,NA,23,Risk factors,NA,NA,NA,Tanzania,NA,NA,FALSE,NA,NA,NA,Apr 2018,Nov 2018,Apr 2018 - Nov 2018
ce5c039a5c3d9b43e4928b2438948c52,9e26c65a4aaf21358ca28b770e4fc3c9,11538,Seroprevalence - IgM,Percentage (%),0,84.8,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,48,NA,39,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Brazil,Pregnant women,"Salvador, Bahia",48,Community based,Female,NA,Dec,2016,NA,Jan,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Urban area,15,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Jan 2015,Dec 2016,Jan 2015 - Dec 2016
808d3184c2a5da93e402a36af1f9fad0,a8ee5ef59d81ab08a1b83e5e2edbb189,11565,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Brazil,Pregnant women,Jundiai Hospital Medical school,83,Hospital based,NA,30,Jun,2019,1,Mar,2016,NA,Adjusted,Infection during pregnancy,NA,Zika congenital syndrome/other birth defects,Significant,NA,FALSE,NA,NA,22,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,1 Mar 2016,30 Jun 2019,1 Mar 2016 - 30 Jun 2019
808d3184c2a5da93e402a36af1f9fad0,a28e870955790828f11fb4f7af80625e,11565,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Brazil,Pregnant women,Jundiai Hospital Medical school,83,Hospital based,NA,30,Jun,2019,1,Mar,2016,NA,Adjusted,Infection during pregnancy,NA,Other,Not significant,NA,FALSE,NA,NA,22,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,1 Mar 2016,30 Jun 2019,1 Mar 2016 - 30 Jun 2019
621761cc1859761553cf5abede0d83ed,0a9fd29e8d9a51f61fdd61a56012f8a2,11575,Seroprevalence - IgG,Percentage (%),0,NA,NA,NA,NA,NA,NA,NA,0,3.4,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,Age,TRUE,FALSE,Unspecified,NA,Anna Vicco,Observed sample statistic,FALSE,NA,NA,Brazil,Pregnant women,Diamantina,135,Population based,Both,NA,NA,2019,NA,NA,2018,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,21,Seroprevalence,0 - 3.4,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,2018,2019,2018 - 2019
621761cc1859761553cf5abede0d83ed,1e1f853e2ab59d7d6281d51efd7b737e,11575,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Brazil,Pregnant women,Diamantina,135,Population based,Both,NA,NA,2019,NA,NA,2018,NA,Not adjusted,Age;Other,NA,Infection,Not significant,NA,FALSE,NA,NA,21,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,2018,2019,2018 - 2019
4bbe9ea84d5728784c35d3993c17b813,26e621809bbf536a5d5c672f9070ede7,11720,Seroprevalence - IgG,Percentage (%),0,4.9,Unspecified,NA,NA,NA,NA,NA,3.6,6.2,NA,Lab confirmed,1036,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Region, Sex, Time",FALSE,FALSE,Endemic,NA,Ruth,Unspecified,FALSE,NA,NA,Madagascar,Other,NA,1036,Hospital based,Both,NA,Jun,2021,NA,Jan,2018,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,NA,Both urban and rural areas,15,Seroprevalence,3.6 - 6.2,NA,NA,Madagascar,NA,NA,FALSE,NA,NA,NA,Jan 2018,Jun 2021,Jan 2018 - Jun 2021
e7509a6f16e5e76afe1f1545e654ea94,14bc11a35faebbb688ba4a76c439d949,11866,Attack rate,Percentage (%),0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,1110,Naive,560,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Ruth,NA,FALSE,14,2,Nicaragua,Persons under investigation,Managua,1110,Hospital based,Both,NA,Feb,2017,NA,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,16,Attack rate,NA,NA,NA,Nicaragua,NA,NA,FALSE,NA,NA,NA,Jan 2016,Feb 2017,Jan 2016 - Feb 2017
0e8a2a9e3f370fe29807432d31fda8df,97dfe4a6d0080f8c8324e6cedf6db511,11891,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,2.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,Other,NA,Naive,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Thailand,General population,NA,254,Population based,Both,NA,Feb,2020,NA,Dec,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,20,Seroprevalence,NA,NA,NA,Thailand,NA,NA,FALSE,NA,NA,NA,Dec 2017,Feb 2020,Dec 2017 - Feb 2020
0e8a2a9e3f370fe29807432d31fda8df,0630e9851d33ad9305cba0de4802a366,11891,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Thailand,General population,NA,254,Population based,Both,NA,Feb,2020,NA,Dec,2017,NA,Not adjusted,Occupation;Other,NA,Serology,Not significant,NA,FALSE,NA,NA,20,Risk factors,NA,NA,NA,Thailand,NA,NA,FALSE,NA,NA,NA,Dec 2017,Feb 2020,Dec 2017 - Feb 2020
19aacfaf96583f563c50313267f04ea9,cd4131e1221319cdcddb83d2c1fbc8dd,11944,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,33.2,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,713,NA,237,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,16,1,United States,Children,"Ponce, Puerto Rico",713,Community based,Both,NA,NA,2019,NA,NA,2018,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,16,Seroprevalence,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,2018,2019,2018 - 2019
19aacfaf96583f563c50313267f04ea9,ab1a2805b6cdd7fb191c379e206599d0,11944,Seroprevalence - IgM,Percentage (%),0,12.5,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,713,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,16,1,United States,Children,"Ponce, Puerto Rico",713,Community based,Both,NA,NA,2019,NA,NA,2018,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Urban area,16,Seroprevalence,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,2018,2019,2018 - 2019
6e1e617f6713eb3614af4871edc4bbc9,0b5b676a90251d803fca87a1c1c58872,12061,Seroprevalence - IgG,Percentage (%),0,NA,NA,NA,NA,NA,NA,NA,29.1,55,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,"Age, Sex, Time",FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Gabon,General population,Lambarene,462,Population based,NA,NA,Jan,2017,NA,Nov,2014,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,61,Seroprevalence,29.1 - 55,NA,NA,Gabon,NA,NA,FALSE,NA,NA,NA,Nov 2014,Jan 2017,Nov 2014 - Jan 2017
040de971dfee282b74a321f1becbec6e,5123f63fcfabd8970060cc21de4f7985,12064,Seroprevalence - IgG,Percentage (%),0,72.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,Suspected,101,NA,73,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,Observed sample statistic,FALSE,NA,NA,Brazil,Pregnant women,"Salvador, Bahia",101,Population based,Female,NA,Dec,2016,NA,Jan,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,18,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Jan 2016,Dec 2016,Jan 2016 - Dec 2016
ed91a76412eb005410f0a2e5f8fab861,e60923d016e25c444cde0c1ec392c646,12128,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Anna Vicco,NA,FALSE,NA,NA,France,Persons under investigation,"Guadeloupe, Martinique",NA,Hospital based,NA,13,Sep,NA,6,Jan,2016,NA,Not adjusted,Other,NA,Infection,Not significant,NA,FALSE,NA,NA,62,Risk factors,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,6 Jan 2016,13 Sep NA,6 Jan 2016 - 13 Sep NA
ed91a76412eb005410f0a2e5f8fab861,f00c7e83d7c4544a12243500d181777e,12128,Severity - case fatality rate (CFR),Percentage (%),0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,87,NA,2,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Anna Vicco,NA,FALSE,NA,NA,France,Persons under investigation,"Guadeloupe, Martinique",NA,Hospital based,NA,13,Sep,NA,6,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,62,Severity,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,6 Jan 2016,13 Sep NA,6 Jan 2016 - 13 Sep NA
ed91a76412eb005410f0a2e5f8fab861,a5e87c3b4914f135402c857e4383969a,12128,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Anna Vicco,NA,FALSE,NA,NA,France,Persons under investigation,"Guadeloupe, Martinique",NA,Hospital based,NA,13,Sep,NA,6,Jan,2016,NA,Not adjusted,Infection,NA,Other neurological symptoms in general population,Significant,NA,FALSE,NA,NA,62,Risk factors,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,6 Jan 2016,13 Sep NA,6 Jan 2016 - 13 Sep NA
ed91a76412eb005410f0a2e5f8fab861,49741f54e27e3f71682d804de4649b1b,12128,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Anna Vicco,NA,FALSE,NA,NA,France,Persons under investigation,"Guadeloupe, Martinique",NA,Hospital based,NA,13,Sep,NA,6,Jan,2016,NA,Not adjusted,Other,NA,Other neurological symptoms in general population,Not significant,NA,FALSE,NA,NA,62,Risk factors,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,6 Jan 2016,13 Sep NA,6 Jan 2016 - 13 Sep NA
ed91a76412eb005410f0a2e5f8fab861,b52a7505204694ea9816a8628cf26a56,12128,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Anna Vicco,NA,FALSE,NA,NA,France,Persons under investigation,"Guadeloupe, Martinique",NA,Hospital based,NA,13,Sep,NA,6,Jan,2016,NA,Not adjusted,Age,NA,Infection,Significant,NA,FALSE,NA,NA,62,Risk factors,NA,NA,NA,France,NA,NA,FALSE,NA,NA,NA,6 Jan 2016,13 Sep NA,6 Jan 2016 - 13 Sep NA
6f6b09eb29c31ba96b91086609898611,ff376b59844bee1031f07fd8c9712465,12153,Mosquito delay - extrinsic incubation period,Days,0,6,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,Observed sample statistic,FALSE,NA,NA,China,NA,Guangzhou,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,16,Mosquito,NA,NA,NA,China,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
7f79efc1efd4ec66d728c224e913ff10,82c8abbe8ecb698940c6809b72446e9e,12202,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,United States,Pregnant women,New York,250,Population based,Female,NA,NA,2016,NA,NA,2016,NA,Not adjusted,Infection,NA,Premature birth,Not significant,NA,FALSE,Unspecified,NA,15,Risk factors,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,2016,2016,2016
2df479d5fb66c6e87575352caa3170e7,785f2a3523a9f529c7ea1a1c897d142f,12234,Mosquito delay - extrinsic incubation period,Days,0,NA,NA,NA,NA,NA,NA,NA,16.2,18.2,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,Other,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,United States,NA,Florida,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,14,Mosquito,16.2 - 18.2,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
cc45b654b49ebbe1adf1d61d1317eb73,3f9ad76c4326249fc2c007b2ce2c4327,12555,Seroprevalence - IgG,Percentage (%),0,69.7,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,76,NA,53,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,62,23,Papua New Guinea,Other,Manus Island,76,Other,Male,NA,Apr,2019,NA,Apr,2019,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,18,Seroprevalence,NA,NA,NA,Papua New Guinea,NA,NA,FALSE,NA,NA,NA,Apr 2019,Apr 2019,Apr 2019
cc45b654b49ebbe1adf1d61d1317eb73,385873c1760382b9fba25ed9866854f3,12555,Seroprevalence - IgG,Percentage (%),0,66,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,132,NA,87,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,59,20,Papua New Guinea,Other,Wewak,132,Other,Both,NA,Apr,2019,NA,Apr,2019,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,18,Seroprevalence,NA,NA,NA,Papua New Guinea,NA,NA,FALSE,NA,NA,NA,Apr 2019,Apr 2019,Apr 2019
cc45b654b49ebbe1adf1d61d1317eb73,448eae6b55c02ee5f07bcb2b7b1a2327,12555,Seroprevalence - IgM,Percentage (%),0,9,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,76,NA,7,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,62,23,Papua New Guinea,Other,Manus Island,76,Other,Male,NA,Apr,2019,NA,Apr,2019,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,18,Seroprevalence,NA,NA,NA,Papua New Guinea,NA,NA,FALSE,NA,NA,NA,Apr 2019,Apr 2019,Apr 2019
cc45b654b49ebbe1adf1d61d1317eb73,f7cbfdf38851c9a7b838573cdc6fb136,12555,Seroprevalence - IgM,Percentage (%),0,9.1,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,132,NA,12,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,59,20,Papua New Guinea,Other,Wewak,132,Other,Both,NA,Apr,2019,NA,Apr,2019,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,18,Seroprevalence,NA,NA,NA,Papua New Guinea,NA,NA,FALSE,NA,NA,NA,Apr 2019,Apr 2019,Apr 2019
cc45b654b49ebbe1adf1d61d1317eb73,5503511b6e62f93bd46a27d18e165cc4,12555,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,63.2,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,55,NA,48,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,62,23,Papua New Guinea,Other,Manus Island,76,Other,Male,NA,Apr,2019,NA,Apr,2019,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,18,Seroprevalence,NA,NA,NA,Papua New Guinea,NA,NA,TRUE,NA,NA,NA,Apr 2019,Apr 2019,Apr 2019
cc45b654b49ebbe1adf1d61d1317eb73,50189db43f612a192cdcfcf57923f0a1,12555,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,65.9,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,93,NA,87,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,59,20,Papua New Guinea,Other,Wewak,132,Other,Both,NA,Apr,2019,NA,Apr,2019,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,18,Seroprevalence,NA,NA,NA,Papua New Guinea,NA,NA,TRUE,NA,NA,NA,Apr 2019,Apr 2019,Apr 2019
384b3cbc37d374a478ad121a0178924d,69764a99f4b2f66b718f06ba54edaf75,12630,Seroprevalence - IgG,NA,0,NA,NA,NA,NA,NA,NA,NA,2.4,27.1,NA,Clinically diagnosed/symptomatic;Suspected,768,NA,286,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Age,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Mexico,Persons under investigation,Merida,768,Hospital based,Both,NA,NA,2020,NA,NA,2020,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,13,Seroprevalence,2.4 - 27.1,NA,NA,Mexico,NA,NA,FALSE,NA,NA,NA,2020,2020,2020
a61ce08971da72670cf8e0afc42d78da,7b21aabbec7b28b716342ddee86f25e4,12777,Mutations - mutation rate,Mutations/site/generation (mu),0,0.3695,Mean,0.2976,0.4482,HPDI 95%,NA,NA,NA,NA,NS5; 1st codon,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Estimated model parameter,FALSE,NA,NA,"Multi-country: Americas (n = 13), Asia (n = 3), Africa (n = 2), Oceania (n = 1)",Persons under investigation,NA,108,Population based,NA,NA,Oct,2017,NA,NA,1947,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,18,Mutations,NA,HPDI 95%,0.2976 - 0.4482,"Brazil, China, Colombia, Cuba, Dominican Republic, French Polynesia, Haiti, Honduras, Jamaica, Malaysia, Mexico, Nicaragua, Nigeria, Panama, Puerto Rico, Senegal, Thailand, Uganda, United States, Venezuela",NA,NA,FALSE,NA,NA,NA,1947,Oct 2017,1947 - Oct 2017
a61ce08971da72670cf8e0afc42d78da,6b1739e39d517902b8b281d274288d1b,12777,Mutations - mutation rate,Mutations/site/generation (mu),0,0.1596,Mean,0.1133,0.2111,HPDI 95%,NA,NA,NA,NA,NS5; 2nd codon,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Estimated model parameter,FALSE,NA,NA,"Multi-country: Americas (n = 13), Asia (n = 3), Africa (n = 2), Oceania (n = 1)",Persons under investigation,NA,108,Population based,NA,NA,Oct,2017,NA,NA,1947,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,18,Mutations,NA,HPDI 95%,0.1133 - 0.2111,"Brazil, China, Colombia, Cuba, Dominican Republic, French Polynesia, Haiti, Honduras, Jamaica, Malaysia, Mexico, Nicaragua, Nigeria, Panama, Puerto Rico, Senegal, Thailand, Uganda, United States, Venezuela",NA,NA,FALSE,NA,NA,NA,1947,Oct 2017,1947 - Oct 2017
a61ce08971da72670cf8e0afc42d78da,1ee3f8dbfe5aea53435db47ed27241d0,12777,Mutations - mutation rate,Mutations/site/generation (mu),0,2.4709,Mean,2.3819,2.5546,HPDI 95%,NA,NA,NA,NA,NS5; 3rd codon,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Estimated model parameter,FALSE,NA,NA,"Multi-country: Americas (n = 13), Asia (n = 3), Africa (n = 2), Oceania (n = 1)",Persons under investigation,NA,108,Population based,NA,NA,Oct,2017,NA,NA,1947,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,18,Mutations,NA,HPDI 95%,2.3819 - 2.5546,"Brazil, China, Colombia, Cuba, Dominican Republic, French Polynesia, Haiti, Honduras, Jamaica, Malaysia, Mexico, Nicaragua, Nigeria, Panama, Puerto Rico, Senegal, Thailand, Uganda, United States, Venezuela",NA,NA,FALSE,NA,NA,NA,1947,Oct 2017,1947 - Oct 2017
94f7dc92b3dc030955fb581d19e77d8b,84a352a8fa142fd1eac6c721f239fa02,12798,Seroprevalence - IgM,Percentage (%),0,25,NA,NA,NA,NA,NA,NA,NA,NA,NA,Clinically diagnosed/symptomatic,200,NA,51,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,Observed sample statistic,FALSE,NA,NA,Nigeria,Persons under investigation,Borno state,200,Hospital based,Both,NA,Apr,2018,NA,Mar,2018,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,12,Seroprevalence,NA,NA,NA,Nigeria,NA,NA,FALSE,NA,NA,NA,Mar 2018,Apr 2018,Mar 2018 - Apr 2018
94f7dc92b3dc030955fb581d19e77d8b,0b926ad2b4f2597bf85a0ca4d17fe674,12798,Seroprevalence - IgM,Percentage (%),0,22,NA,NA,NA,NA,NA,NA,NA,NA,NA,Clinically diagnosed/symptomatic,137,NA,30,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,Observed sample statistic,FALSE,NA,NA,Nigeria,Persons under investigation,Borno state,200,Hospital based,Both,NA,Apr,2018,NA,Mar,2018,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,12,Seroprevalence,NA,NA,NA,Nigeria,NA,NA,FALSE,NA,NA,NA,Mar 2018,Apr 2018,Mar 2018 - Apr 2018
915596f261a39d93191eb36bccdfc69b,ec24b8fbb5f466005dc3f372fe78b8ed,13242,Reproduction number (Basic R0),No units,0,0.2374,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Method, Other",FALSE,FALSE,Unspecified,Compartmental model,Ruth,Estimated model parameter,FALSE,NA,NA,Brazil,Persons under investigation,Amazonas,NA,Population based,Unspecified,30,Apr,2021,6,Feb,2021,Other,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,19,Reproduction number,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,6 Feb 2021,30 Apr 2021,6 Feb 2021 - 30 Apr 2021
9cf02b626bda5272ad1d465ba861cfd7,8524665b432e7bdc9df504ea0da2c9c4,17295,Reproduction number (Basic R0),No units,0,2.13,Unspecified,1.61,2.64,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,Next generation matrix,Thomas Rawson,Estimated model parameter,FALSE,NA,NA,Brazil,General population,NA,NA,Population based,Both,NA,Sep,2016,NA,Jan,2015,Other,NA,NA,NA,NA,NA,NA,FALSE,NA,Both urban and rural areas,62,Reproduction number,NA,95% CI,1.61 - 2.64,Brazil,NA,NA,FALSE,NA,NA,NA,Jan 2015,Sep 2016,Jan 2015 - Sep 2016
9cf02b626bda5272ad1d465ba861cfd7,40f49c6c5f9d9c2e3ef80b7b136b703f,17295,Reproduction number (Basic R0) - Vector-borne,No units,0,2.04,Unspecified,1.53,2.55,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,Next generation matrix,Thomas Rawson,Estimated model parameter,FALSE,NA,NA,Brazil,General population,NA,NA,Population based,Both,NA,Sep,2016,NA,Jan,2015,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,Both urban and rural areas,62,Reproduction number,NA,95% CI,1.53 - 2.55,Brazil,NA,NA,FALSE,NA,NA,NA,Jan 2015,Sep 2016,Jan 2015 - Sep 2016
9cf02b626bda5272ad1d465ba861cfd7,fcffceb5a7c9eb1e427f618abe872acd,17295,Relative contribution - sexual,Percentage (%),0,3.5,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Thomas Rawson,Estimated model parameter,FALSE,NA,NA,Brazil,General population,NA,NA,Population based,Both,NA,Sep,2016,NA,Jan,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Both urban and rural areas,62,Relative contribution,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Jan 2015,Sep 2016,Jan 2015 - Sep 2016
562b415cded1413e4daf143e55e42c3d,9439b86da832d1b55a0a7c7569e7e40a,17988,Seroprevalence - IgM,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,384,NA,5,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Thomas Rawson,NA,FALSE,NA,NA,Uganda,Other,Nkonkonjeru,384,Hospital based,Unspecified,NA,Oct,2017,NA,Feb,2014,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,64,Seroprevalence,NA,NA,NA,Uganda,NA,NA,FALSE,NA,NA,NA,Feb 2014,Oct 2017,Feb 2014 - Oct 2017
562b415cded1413e4daf143e55e42c3d,01f528db6ffd9938cc120da9037f3c2b,17988,Seroprevalence - Neutralisation/PRNT,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,NA,3,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Thomas Rawson,NA,FALSE,NA,NA,Uganda,Other,Nkonkonjeru,384,Hospital based,Unspecified,NA,Oct,2017,NA,Feb,2014,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,64,Seroprevalence,NA,NA,NA,Uganda,NA,NA,TRUE,NA,NA,NA,Feb 2014,Oct 2017,Feb 2014 - Oct 2017
ef1fc2a69d49a37217458f51c0b5e7b8,8b10f94996d46fd68eecb3aa7a3c21d6,18107,Seroprevalence - IgG,Percentage (%),0,6.66,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,75,NA,5,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,India,Blood donors,Bhopal region,75,Unspecified,Female,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,65,Seroprevalence,NA,NA,NA,India,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
ef1fc2a69d49a37217458f51c0b5e7b8,2b3dc379dda7611cef8aa8336a0c62fc,18107,Seroprevalence - IgG,Percentage (%),0,15.38,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,75,NA,10,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,India,Blood donors,Bhopal region,75,Unspecified,Both,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,65,Seroprevalence,NA,NA,NA,India,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
8e88b9e535b71bbc3bffa2b0625640c0,cb68dc126d870e187a6ebc1580486d24,18335,Human delay - Onset to Admission to care,Days,0,2,Median,0,7,95% CI,NA,NA,1,2,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Age,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,18,0,United States,Children,"Ponce, Puerto Rico",351,Hospital based,Both,31,Dec,2016,NA,NA,2012,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,66,Human delay,1 - 2,95% CI,0 - 7,United States,Onset to admission to care,NA,FALSE,NA,NA,NA,2012,31 Dec 2016,2012 - 31 Dec 2016
df4ae12804cdc381c318af76dac13642,61d46824c33bddcd9f4fc02aec9dbda7,18800,Seroprevalence - IgM,Percentage (%),0,4.3,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,66,NA,1519,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Colombia,Pregnant women,NA,1519,Population based,Female,NA,Mar,2019,NA,Feb,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,68,Seroprevalence,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,Feb 2017,Mar 2019,Feb 2017 - Mar 2019
df4ae12804cdc381c318af76dac13642,9bac09da1ab86397847bdce9e55243c7,18800,Seroprevalence - IgM,Percentage (%),0,0.8,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,1080,NA,9,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Colombia,Children,NA,1108,Population based,Both,NA,Mar,2019,NA,Feb,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,68,Seroprevalence,NA,NA,NA,Colombia,NA,NA,FALSE,NA,NA,NA,Feb 2017,Mar 2019,Feb 2017 - Mar 2019
89cdb925aea479f31e8c48ebd15061d4,8aed4fb1a4f742b6d6daf71df0bd761e,19672,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,21.7,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,106,NA,23,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,NA,Sudan,Other,NA,106,Population based,Unspecified,NA,Jan,2013,NA,Dec,2012,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,67,Seroprevalence,NA,NA,NA,Sudan,NA,NA,FALSE,NA,NA,NA,Dec 2012,Jan 2013,Dec 2012 - Jan 2013
89cdb925aea479f31e8c48ebd15061d4,58087ccc4b79ae74b6133dce8889a8dc,19672,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,3.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,92,NA,3,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Thomas Rawson,NA,FALSE,NA,NA,Sudan,Other,NA,92,Population based,Unspecified,NA,Jan,2013,NA,Dec,2012,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,67,Seroprevalence,NA,NA,NA,Sudan,NA,NA,FALSE,NA,NA,NA,Dec 2012,Jan 2013,Dec 2012 - Jan 2013
d74d1427c7f560eb585dbf32fd169694,08c3c1601711dc2ef9d99700ef22e7ad,20107,Seroprevalence - IgM,Percentage (%),0,0,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,223,NA,0,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,NA,Brazil,Other,"Salvador, Bahia",223,Population based,Both,NA,Oct,2021,NA,May,2021,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Both urban and rural areas,68,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,May 2021,Oct 2021,May 2021 - Oct 2021
d74d1427c7f560eb585dbf32fd169694,230e7339f2e6a1d7eef83d2f59b09876,20107,Seroprevalence - IgG,Percentage (%),0,43.95,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,223,NA,98,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,NA,Brazil,Other,"Salvador, Bahia",223,Population based,Both,NA,Oct,2021,NA,May,2021,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Both urban and rural areas,68,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,May 2021,Oct 2021,May 2021 - Oct 2021
d74d1427c7f560eb585dbf32fd169694,546fc05c848568e956a8df7242e73be8,20107,Seroprevalence - IgM,Percentage (%),0,0,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,186,NA,0,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,NA,Brazil,Other,Manaus,186,Population based,Both,NA,Oct,2021,NA,May,2021,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Both urban and rural areas,68,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,May 2021,Oct 2021,May 2021 - Oct 2021
d74d1427c7f560eb585dbf32fd169694,114ad36b35464256f5e542136cf9f5c4,20107,Seroprevalence - IgG,Percentage (%),0,33.87,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,186,NA,63,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,NA,Brazil,Other,Manaus,186,Population based,Both,NA,Oct,2021,NA,May,2021,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Both urban and rural areas,68,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,May 2021,Oct 2021,May 2021 - Oct 2021
17a19a02a3c5244bb52797179b11551c,10dc637b6300ced301152344620bd5a9,20108,Seroprevalence - IgG,Percentage (%),0,51.8,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,197,NA,102,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Sex",FALSE,FALSE,Post outbreak,NA,Thomas Rawson,Observed sample statistic,FALSE,86,1,Vanuatu,General population,Espiritu Santo,197,Population based,Both,NA,Jan,2017,NA,Aug,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,69,Seroprevalence,NA,NA,NA,Vanuatu,NA,NA,FALSE,NA,NA,NA,Aug 2016,Jan 2017,Aug 2016 - Jan 2017
17a19a02a3c5244bb52797179b11551c,487d81fb37d4d7ea017f9a5ce190a03f,20108,Seroprevalence - IgG,Percentage (%),0,67.8,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,208,NA,141,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Sex",FALSE,FALSE,Post outbreak,NA,Thomas Rawson,Observed sample statistic,FALSE,88,8,New Zealand,General population,"Rarotonga, Cook Islands",208,Population based,Both,NA,Apr,2017,NA,Jan,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,69,Seroprevalence,NA,NA,NA,New Zealand,NA,NA,FALSE,NA,NA,NA,Jan 2017,Apr 2017,Jan 2017 - Apr 2017
17a19a02a3c5244bb52797179b11551c,571d4964b02a8d565d789c5f8af353f4,20108,Seroprevalence - IgG,Percentage (%),0,58.3,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,60,NA,35,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Sex",FALSE,FALSE,Post outbreak,NA,Thomas Rawson,Observed sample statistic,FALSE,80,16,New Zealand,General population,Aitutaki,60,Population based,Both,NA,Apr,2017,NA,Jan,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,69,Seroprevalence,NA,NA,NA,New Zealand,NA,NA,FALSE,NA,NA,NA,Jan 2017,Apr 2017,Jan 2017 - Apr 2017
727a46ae40620336eef9ea05e39d6e72,df32b7f46d963cfc08ea252dde8d9839,20275,Seroprevalence - IgG,Percentage (%),0,34,Central,27.4,40.6,95% CI,NA,NA,NA,NA,NA,NA,200,NA,68,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Thomas Rawson,Observed sample statistic,FALSE,83,0,Mali,General population,"Bamba, Sibirila, Bougouni, Sikasso",200,Population based,Both,NA,Feb,2015,NA,Feb,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Rural area,70,Seroprevalence,NA,95% CI,27.4 - 40.6,Mali,NA,NA,FALSE,NA,NA,NA,Feb 2015,Feb 2015,Feb 2015
727a46ae40620336eef9ea05e39d6e72,3e2a5156d650804ec5c282a972b0a75a,20275,Seroprevalence - IgG,Percentage (%),0,24.5,Central,18.5,30.5,95% CI,NA,NA,NA,NA,NA,NA,200,NA,49,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Thomas Rawson,Observed sample statistic,FALSE,83,0,Mali,General population,"Banzana, Sibirila, Bougouni, Sikasso",200,Population based,Both,NA,Feb,2015,NA,Feb,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Rural area,70,Seroprevalence,NA,95% CI,18.5 - 30.5,Mali,NA,NA,FALSE,NA,NA,NA,Feb 2015,Feb 2015,Feb 2015
727a46ae40620336eef9ea05e39d6e72,177f9c6f7cb802ec5d574de6c765cdcd,20275,Seroprevalence - IgG,Percentage (%),0,19,Central,13.6,24.4,95% CI,NA,NA,NA,NA,NA,NA,200,NA,38,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Thomas Rawson,Observed sample statistic,FALSE,83,0,Mali,General population,"Soromba, Sibirila, Bougouni, Sikasso",200,Population based,Both,NA,Feb,2015,NA,Feb,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Rural area,70,Seroprevalence,NA,95% CI,13.6 - 24.4,Mali,NA,NA,FALSE,NA,NA,NA,Feb 2015,Feb 2015,Feb 2015
4f8adcfa8f3a00949df277dbd77e4b7f,ac4928e0b2758e39ffbd9ab1963d5f71,22284,Seroprevalence - IgG,Percentage (%),0,41.7,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,585,NA,244,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,TRUE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,82,5,Malaysia,General population,"""Peninsula""",585,Population based,Both,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Rural area,72,Seroprevalence,NA,NA,NA,Malaysia,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
4f8adcfa8f3a00949df277dbd77e4b7f,9f08251f98bd6faea39a56555a5c0e83,22284,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,NA,FALSE,82,5,Malaysia,General population,"""Peninsula""",585,Population based,Both,NA,NA,NA,NA,NA,NA,NA,Not adjusted,Age;Other,NA,Serology,Significant,NA,FALSE,NA,Rural area,72,Risk factors,NA,NA,NA,Malaysia,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
4f8adcfa8f3a00949df277dbd77e4b7f,30c00080baefb8ceb8666a0390052f92,22284,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,NA,FALSE,82,5,Malaysia,General population,"""Peninsula""",585,Population based,Both,NA,NA,NA,NA,NA,NA,NA,Not adjusted,Sex,NA,Serology,Not significant,NA,FALSE,NA,Rural area,72,Risk factors,NA,NA,NA,Malaysia,NA,NA,FALSE,NA,NA,NA,Unspecified,Unspecified,Unspecified
e796098376dcb67a774f1c70295e8240,89a6bd1cc4b1483066964948b75d21ef,22561,Human delay - Onset to Admission to care,Days,0,3.3,Mean,NA,NA,NA,0.98,Standard Deviation,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,0,Ecuador,General population,"Portoviejo, Manabi",467,Hospital based,Both,31,Aug,2016,1,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,73,Human delay,NA,Standard Deviation,0.98,Ecuador,Onset to admission to care,NA,FALSE,NA,NA,NA,1 Jan 2016,31 Aug 2016,1 Jan 2016 - 31 Aug 2016
e796098376dcb67a774f1c70295e8240,6ad49efd9d22fcbdbf8d2b7e5e9707f5,22561,Human delay - Onset to Recovery/non-Infectiousness,Days,0,4.5,Mean,2,7,Range,1.8,Standard Deviation,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,0,Ecuador,General population,"Portoviejo, Manabi",467,Hospital based,Both,31,Aug,2016,1,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,73,Human delay,NA,Range,2 - 7,Ecuador,Onset to recovery/non-infectiousness,NA,FALSE,NA,NA,NA,1 Jan 2016,31 Aug 2016,1 Jan 2016 - 31 Aug 2016
e796098376dcb67a774f1c70295e8240,e4ab0e48b95c9798ca2ae79694bb7caa,22561,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,NA,FALSE,NA,0,Ecuador,General population,"Portoviejo, Manabi",467,Hospital based,Both,31,Aug,2016,1,Jan,2016,NA,Not adjusted,Age;Other;Sex,NA,Infection,Significant,NA,FALSE,NA,Unspecified,73,Risk factors,NA,NA,NA,Ecuador,NA,NA,FALSE,NA,NA,NA,1 Jan 2016,31 Aug 2016,1 Jan 2016 - 31 Aug 2016
d20feef2efd3eb83fa5e7c98f673a843,b5f52df87e6b090188a83f863101e62e,22699,Seroprevalence - IgM,Percentage (%),0,22.7,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,198,NA,45,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,45,NA,El Salvador,Pregnant women,Sonsonate,198,Population based,Both,NA,Sep,2022,NA,Mar,2022,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,74,Seroprevalence,NA,NA,NA,El Salvador,NA,NA,FALSE,NA,NA,NA,Mar 2022,Sep 2022,Mar 2022 - Sep 2022
2a99b242305f399720eb7d7a20d55207,d3cb9bf5aa71ec81e59dbf8925f2e326,23129,Seroprevalence - IgG,Percentage (%),0,28.6,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,126,NA,36,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Mexico,Pregnant women,Oaxaca,126,Hospital based,Female,NA,Feb,2018,NA,Dec,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,74,Seroprevalence,NA,NA,NA,Mexico,NA,NA,FALSE,NA,NA,NA,Dec 2017,Feb 2018,Dec 2017 - Feb 2018
2a99b242305f399720eb7d7a20d55207,814d89a8b373ae3e4f89c2d5da9ecaa6,23129,Seroprevalence - IgM,Percentage (%),0,31,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,126,NA,39,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Mexico,Pregnant women,Oaxaca,126,Hospital based,Female,NA,Feb,2018,NA,Dec,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,74,Seroprevalence,NA,NA,NA,Mexico,NA,NA,FALSE,NA,NA,NA,Dec 2017,Feb 2018,Dec 2017 - Feb 2018
2a99b242305f399720eb7d7a20d55207,7a4a8c86a53750fcf3c737ed2ea18219,23129,Seroprevalence - IgG,Percentage (%),0,5.5,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Mexico,Children,Oaxaca,126,Hospital based,Both,NA,Feb,2018,NA,Dec,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,74,Seroprevalence,NA,NA,NA,Mexico,NA,NA,FALSE,NA,NA,NA,Dec 2017,Feb 2018,Dec 2017 - Feb 2018
2a99b242305f399720eb7d7a20d55207,5925092742b9178f4d33be0a2c2cc969,23129,Seroprevalence - Neutralisation/PRNT,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,13,NA,9,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,NA,FALSE,NA,NA,Mexico,Children,Oaxaca,13,Hospital based,Both,NA,Feb,2018,NA,Dec,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,74,Seroprevalence,NA,NA,NA,Mexico,NA,NA,FALSE,NA,NA,NA,Dec 2017,Feb 2018,Dec 2017 - Feb 2018
a0ac948732f0656a4980f81341596e07,4ee12b0fff1af7eb10ea959ce633579a,23230,Seroprevalence - NS1 BOB ELISA,Percentage (%),0,42,Central,39,45,95% CI,NA,NA,17,66,NA,NA,1192,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Other, Region, Sex",FALSE,TRUE,Post outbreak,NA,Patrick,Estimated model parameter,FALSE,60,2,Ecuador,General population,"Borbón, Maldonado, Timbiré, Santa Maria, Santo Domingo, Colon Eloy",1192,Community based,Both,NA,Oct,2018,NA,Jul,2018,NA,NA,NA,NA,NA,NA,Adjusted,FALSE,NA,Both urban and rural areas,7,Seroprevalence,17 - 66,95% CI,39 - 45,Ecuador,NA,NA,FALSE,NA,NA,NA,Jul 2018,Oct 2018,Jul 2018 - Oct 2018
a0ac948732f0656a4980f81341596e07,d38f3ffe5849c4caff43d4b3edb46b80,23230,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Patrick,NA,FALSE,60,2,Ecuador,General population,"Borbón, Maldonado, Timbiré, Santa Maria, Santo Domingo, Colon Eloy",1192,Community based,Both,NA,Oct,2018,NA,Jul,2018,NA,Adjusted,Age;Other,NA,Serology,Significant,NA,FALSE,NA,Both urban and rural areas,7,Risk factors,NA,NA,NA,Ecuador,NA,NA,FALSE,NA,NA,NA,Jul 2018,Oct 2018,Jul 2018 - Oct 2018
a0ac948732f0656a4980f81341596e07,7a4d5d75f9ce1936499ef2a68416aa88,23230,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Patrick,NA,FALSE,60,2,Ecuador,General population,"Borbón, Maldonado, Timbiré, Santa Maria, Santo Domingo, Colon Eloy",1192,Community based,Both,NA,Oct,2018,NA,Jul,2018,NA,Adjusted,Age;Other,NA,Serology,Not significant,NA,FALSE,NA,Both urban and rural areas,7,Risk factors,NA,NA,NA,Ecuador,NA,NA,FALSE,NA,NA,NA,Jul 2018,Oct 2018,Jul 2018 - Oct 2018
a0ac948732f0656a4980f81341596e07,3164ee664cf8c1cea8e6158624500bdd,23230,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Patrick,NA,FALSE,60,2,Ecuador,General population,"Borbón, Maldonado, Timbiré, Santa Maria, Santo Domingo, Colon Eloy",1192,Community based,Both,NA,Oct,2018,NA,Jul,2018,NA,Not adjusted,Age;Other,NA,Serology,Significant,NA,FALSE,NA,Both urban and rural areas,7,Risk factors,NA,NA,NA,Ecuador,NA,NA,FALSE,NA,NA,NA,Jul 2018,Oct 2018,Jul 2018 - Oct 2018
a0ac948732f0656a4980f81341596e07,71ba8aeeb427fd8457a26b120405b824,23230,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Patrick,NA,FALSE,60,2,Ecuador,General population,"Borbón, Maldonado, Timbiré, Santa Maria, Santo Domingo, Colon Eloy",1192,Community based,Both,NA,Oct,2018,NA,Jul,2018,NA,Not adjusted,Age;Other;Sex,NA,Serology,Not significant,NA,FALSE,NA,Both urban and rural areas,7,Risk factors,NA,NA,NA,Ecuador,NA,NA,FALSE,NA,NA,NA,Jul 2018,Oct 2018,Jul 2018 - Oct 2018
a0ac948732f0656a4980f81341596e07,0fa34fa418592d670bff77269915eac6,23230,Seroprevalence - NS1 BOB ELISA,Percentage (%),0,29,Central,25,33,95% CI,NA,NA,0,52,NA,NA,1126,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Region, Sex",FALSE,TRUE,Post outbreak,NA,Patrick,Estimated model parameter,FALSE,60,2,Ecuador,General population,"Borbón, Maldonado, Timbiré, Santa Maria, Santo Domingo, Colon Eloy",1126,Community based,Both,NA,Oct,2019,NA,Aug,2019,NA,NA,NA,NA,NA,NA,Adjusted,FALSE,NA,Both urban and rural areas,7,Seroprevalence,0 - 52,95% CI,25 - 33,Ecuador,NA,NA,FALSE,NA,NA,NA,Aug 2019,Oct 2019,Aug 2019 - Oct 2019
a0ac948732f0656a4980f81341596e07,db0e587ddfc37e7cf8b6a6c67910c1bd,23230,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Patrick,NA,FALSE,60,2,Ecuador,General population,"Borbón, Maldonado, Timbiré, Santa Maria, Santo Domingo, Colon Eloy",1126,Community based,Both,NA,Oct,2019,NA,Aug,2019,NA,Adjusted,Age;Other;Prior immunity to arboviruses,NA,Serology,Significant,NA,FALSE,NA,Both urban and rural areas,7,Risk factors,NA,NA,NA,Ecuador,NA,NA,FALSE,NA,NA,NA,Aug 2019,Oct 2019,Aug 2019 - Oct 2019
a0ac948732f0656a4980f81341596e07,3756fd27764ab9931e7d92a6ce02aba9,23230,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Patrick,NA,FALSE,60,2,Ecuador,General population,"Borbón, Maldonado, Timbiré, Santa Maria, Santo Domingo, Colon Eloy",1126,Community based,Both,NA,Oct,2019,NA,Aug,2019,NA,Adjusted,Age;Other;Sex,NA,Serology,Not significant,NA,FALSE,NA,Both urban and rural areas,7,Risk factors,NA,NA,NA,Ecuador,NA,NA,FALSE,NA,NA,NA,Aug 2019,Oct 2019,Aug 2019 - Oct 2019
0d94cbe0b157f9c2878b0fa68ad8dbf5,4ab262705f466ef6e4d923cfed6134da,23326,Seroprevalence - IgG,Percentage (%),0,6.48,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,725,Naive,47,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,sangeeta,Observed sample statistic,FALSE,NA,NA,Pakistan,NA,Faisalabad,725,Population based,Both,NA,NA,2019,NA,NA,2019,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,16,Seroprevalence,NA,NA,NA,Pakistan,NA,NA,FALSE,NA,NA,NA,2019,2019,2019
0d94cbe0b157f9c2878b0fa68ad8dbf5,a406831476e709eaf8c883e0ce1dbf79,23326,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,6.48,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,47,Naive,47,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,sangeeta,Observed sample statistic,FALSE,NA,NA,Pakistan,General population,Faisalabad,725,Population based,Both,NA,NA,2019,NA,NA,2019,NA,NA,Age;Occupation;Sex,NA,NA,NA,Naive,FALSE,NA,NA,16,Seroprevalence,NA,NA,NA,Pakistan,NA,NA,TRUE,NA,NA,NA,2019,2019,2019
0d94cbe0b157f9c2878b0fa68ad8dbf5,ee2f58b7af4d6340805dd4490076e961,23326,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,0.69,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,47,Naive,5,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,sangeeta,NA,FALSE,NA,NA,Pakistan,General population,Faisalabad,725,Population based,Both,NA,NA,2019,NA,NA,2019,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,16,Seroprevalence,NA,NA,NA,Pakistan,NA,NA,TRUE,NA,NA,NA,2019,2019,2019
910b5d9c53f1051ef250bd1c88b79dde,c65276d3116c4a6cd6914bf2da1b92c0,24034,Seroprevalence - Neutralisation/PRNT,NA,0,4,NA,NA,NA,NA,NA,NA,NA,NA,NA,Other,50,Naive,2,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,sangeeta,NA,FALSE,9,2,Cambodia,Children,Kampong Speu,770,Other,Both,NA,Aug,2018,NA,Jul,2018,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,18,Seroprevalence,NA,NA,NA,Cambodia,NA,NA,FALSE,NA,NA,NA,Jul 2018,Aug 2018,Jul 2018 - Aug 2018
62420e230ab222f9b836f13edfeab4a3,2c42493296d052ade57341d3bc795b29,24921,Reproduction number (Basic R0),No units,0,2.135,Central,2.07,2.2,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Next generation matrix,sangeeta,Estimated model parameter,FALSE,NA,NA,Unspecified,NA,NA,NA,NA,NA,30,Apr,2014,1,Oct,2013,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,23,Reproduction number,NA,95% CI,2.07 - 2.2,NA,NA,NA,FALSE,NA,NA,NA,1 Oct 2013,30 Apr 2014,1 Oct 2013 - 30 Apr 2014
8af45baeea19603a6e17b6dc93a5adde,98cac5941d0235c207736db5254cf204,26955,Reproduction number (Basic R0) - Sexual,No units,0,4.5537,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,Next generation matrix,Christian,Estimated model parameter,FALSE,NA,NA,El Salvador,General population,NA,NA,Population based,NA,NA,Apr,2016,NA,Oct,2015,Vector-human,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,71,Reproduction number,NA,NA,NA,El Salvador,NA,NA,FALSE,NA,NA,NA,Oct 2015,Apr 2016,Oct 2015 - Apr 2016
8af45baeea19603a6e17b6dc93a5adde,37d629b505326dd23414acce656df1f8,26955,Human delay - Exposure/Infection to Recovery/non-Infectiousness (inverse parameter),Per day,0,0.125,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,TRUE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Estimated model parameter,FALSE,NA,NA,El Salvador,General population,NA,NA,Population based,NA,NA,Apr,2016,NA,Oct,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,71,Human delay,NA,NA,NA,El Salvador,Exposure/infection to recovery/non-infectiousness,NA,FALSE,NA,NA,NA,Oct 2015,Apr 2016,Oct 2015 - Apr 2016
c4bdc14db93940ead8425ce1edb44c37,00b501f0733c98303d1c6f2a844b22d6,26971,Mosquito delay - extrinsic incubation period (inverse parameter),Per day,0,0.1,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,TRUE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Estimated model parameter,FALSE,NA,NA,Brazil,General population,NA,NA,Population based,NA,NA,Dec,2016,NA,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,72,Mosquito,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,Jan 2016,Dec 2016,Jan 2016 - Dec 2016
c4bdc14db93940ead8425ce1edb44c37,b0b34209b05624fd48f6fa156b4e1601,26971,Human delay - incubation period (inverse parameter),Per day,0,0.0833,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,TRUE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Estimated model parameter,FALSE,NA,NA,Brazil,General population,NA,NA,Population based,NA,NA,Dec,2016,NA,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,72,Human delay,NA,NA,NA,Brazil,Incubation period,NA,FALSE,NA,NA,NA,Jan 2016,Dec 2016,Jan 2016 - Dec 2016
c4bdc14db93940ead8425ce1edb44c37,04986f0853f055d7d011d13888ce9d64,26971,Human delay - infectious period (inverse parameter),Per day,0,NA,Unspecified,NA,NA,NA,NA,NA,0.114,0.333,NA,NA,NA,NA,NA,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,TRUE,FALSE,TRUE,Method,TRUE,FALSE,Unspecified,NA,Christian,Estimated model parameter,FALSE,NA,NA,Brazil,General population,NA,NA,Population based,NA,NA,Dec,2016,NA,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,72,Human delay,0.114 - 0.333,NA,NA,Brazil,Infectious period,NA,FALSE,NA,NA,NA,Jan 2016,Dec 2016,Jan 2016 - Dec 2016
4f0d91d88a94a556a1106409fc02aa0e,396aab7598eace03d23403fee891a476,28121,Seroprevalence - IgM,Percentage (%),0,5,Central,2.5,10,95% CI,NA,NA,NA,NA,NA,NA,141,NA,8,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,51,25,United States,Pregnant women,NA,141,Travel based,Female,NA,Aug,2016,NA,Jan,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,71,Seroprevalence,NA,95% CI,2.5 - 10,United States,NA,NA,FALSE,NA,NA,NA,Jan 2016,Aug 2016,Jan 2016 - Aug 2016
4f0d91d88a94a556a1106409fc02aa0e,4bea0bb52f6953f5b26ecc635136b01d,28121,Seroprevalence - Neutralisation/PRNT,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,141,NA,1,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,NA,FALSE,51,25,United States,Pregnant women,NA,141,Travel based,Female,NA,Aug,2016,NA,Jan,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,71,Seroprevalence,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,Jan 2016,Aug 2016,Jan 2016 - Aug 2016
66e0365ffed5c9c89b578b31223b994b,33def405aaf01b612284124e60f2c603,28411,Attack rate,Percentage (%),0,12,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,75,3,China,Other,NA,34,Travel based,Both,NA,Feb,2016,NA,Feb,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,Unspecified,72,Attack rate,NA,NA,NA,China,NA,NA,FALSE,NA,NA,NA,Feb 2016,Feb 2016,Feb 2016
83b062e87801de2884a090e1e96b4070,878c4fd29e1274f9d9101df2ab20b72f,31743,Seroprevalence - Neutralisation/PRNT,Percentage (%),0,30,Central,NA,NA,NA,NA,NA,NA,NA,NA,NA,20,NA,6,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,14,NA,Nigeria,Other,Igbo-Ora,20,Population based,Unspecified,NA,Oct,1975,NA,May,1975,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,Unspecified,71,Seroprevalence,NA,NA,NA,Nigeria,NA,NA,FALSE,NA,NA,NA,May 1975,Oct 1975,May 1975 - Oct 1975
886d0d5e30b14458bb7bba01c3e63b95,82eef2fd438dff94d7218a43d3e835bc,31925,Human delay - First detection of anti-ZIKV IgM to Last detection of anti-ZIKV IgM,Days,0,124,Mean,139,109,95% CI,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,Observed sample statistic,FALSE,70,15,United States,Persons under investigation,NA,59,Hospital based,Both,19,Sep,2017,13,Jul,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,64,Human delay,NA,95% CI,139 - 109,United States,First detection of anti-zikv igm to last detection of anti-zikv igm,NA,FALSE,NA,NA,NA,13 Jul 2016,19 Sep 2017,13 Jul 2016 - 19 Sep 2017
886d0d5e30b14458bb7bba01c3e63b95,e1e3da99c8a444f864a6a086b64c12a6,31925,Risk factors,NA,0,NA,NA,139,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,70,15,United States,Persons under investigation,NA,59,Hospital based,Both,19,Sep,2017,13,Jul,2016,NA,Unspecified,Infection,NA,Other,Significant,NA,FALSE,NA,NA,64,Risk factors,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,13 Jul 2016,19 Sep 2017,13 Jul 2016 - 19 Sep 2017
886d0d5e30b14458bb7bba01c3e63b95,baa88af414828dcb9f6c50ae2ad90cd9,31925,Risk factors,NA,0,NA,NA,139,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,70,15,United States,Persons under investigation,NA,59,Hospital based,Both,19,Sep,2017,13,Jul,2016,NA,Unspecified,Infection,NA,Other,Not significant,NA,FALSE,NA,NA,64,Risk factors,NA,NA,NA,United States,NA,NA,FALSE,NA,NA,NA,13 Jul 2016,19 Sep 2017,13 Jul 2016 - 19 Sep 2017
04e7217cc90642570c21961d88f7ef8e,822b8955259665be3803eb262328753e,31930,Seroprevalence - IgG,Percentage (%),0,0.55,Central,NA,NA,NA,NA,NA,NA,NA,NA,Other,182,NA,1,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,Observed sample statistic,FALSE,NA,NA,Brazil,Blood donors,Rio Grande do Sul,182,Hospital based,Both,6,Jan,2017,5,Dec,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,NA,NA,65,Seroprevalence,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,5 Dec 2016,6 Jan 2017,5 Dec 2016 - 6 Jan 2017
10ad9461b5bf0a1b434f242ee7b5ee24,08c28379215885c5d810fe386b7ba2f4,31933,Seroprevalence - IgG,Percentage (%),0,22.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,152,NA,34,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Other, Region, Sex",FALSE,FALSE,Unspecified,NA,Anna Vicco,Observed sample statistic,FALSE,80,0,Nigeria,Mixed groups,Abia,871,Hospital based,Both,NA,Nov,2021,NA,Dec,2020,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,66,Seroprevalence,NA,NA,NA,Nigeria,NA,NA,FALSE,NA,NA,NA,Dec 2020,Nov 2021,Dec 2020 - Nov 2021
10ad9461b5bf0a1b434f242ee7b5ee24,fb489103eaef3b429ed9b8193d1a4e62,31933,Seroprevalence - IgG,Percentage (%),0,18.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,300,NA,56,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Other, Region, Sex",FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,80,0,Nigeria,Mixed groups,Kaduna,871,Hospital based,Both,NA,Nov,2021,NA,Dec,2020,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,66,Seroprevalence,NA,NA,NA,Nigeria,NA,NA,FALSE,NA,NA,NA,Dec 2020,Nov 2021,Dec 2020 - Nov 2021
10ad9461b5bf0a1b434f242ee7b5ee24,a0da8d0b4a7309449d649ff50e8eee64,31933,Seroprevalence - IgG,Percentage (%),0,18.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,419,NA,82,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Other, Region, Sex",FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,80,0,Nigeria,Mixed groups,Nasarawa,871,Hospital based,Both,NA,Nov,2021,NA,Dec,2020,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,66,Seroprevalence,NA,NA,NA,Nigeria,NA,NA,FALSE,NA,NA,NA,Dec 2020,Nov 2021,Dec 2020 - Nov 2021
10ad9461b5bf0a1b434f242ee7b5ee24,22dbcdea9878c5c10fd67f96a0adf17b,31933,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,80,0,Nigeria,Mixed groups,"Abia, Kaduna, Nasarawa",871,Hospital based,Both,NA,Nov,2021,NA,Dec,2020,NA,Adjusted,Age;Infection during pregnancy;Other;Sex,NA,Serology,Not significant,NA,FALSE,NA,NA,66,Risk factors,NA,NA,NA,Nigeria,NA,NA,FALSE,NA,NA,NA,Dec 2020,Nov 2021,Dec 2020 - Nov 2021
10ad9461b5bf0a1b434f242ee7b5ee24,aa799e3338f82f040f21f6799bbecab2,31933,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,80,0,Nigeria,Mixed groups,"Abia, Kaduna, Nasarawa",871,Hospital based,Both,NA,Nov,2021,NA,Dec,2020,NA,Adjusted,Other,NA,Serology,Significant,NA,FALSE,NA,NA,66,Risk factors,NA,NA,NA,Nigeria,NA,NA,FALSE,NA,NA,NA,Dec 2020,Nov 2021,Dec 2020 - Nov 2021
10ad9461b5bf0a1b434f242ee7b5ee24,9b63e5400bd4fff9ed6cdf43d2186a68,31933,Seroprevalence - IgG,Percentage (%),0,NA,NA,NA,NA,NA,NA,NA,0,62.7,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Age, Other, Region, Sex",FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,80,0,Nigeria,Mixed groups,"Abia, Kaduna, Nasarawa",871,Hospital based,Both,NA,Nov,2021,NA,Dec,2020,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,66,Seroprevalence,0 - 62.7,NA,NA,Nigeria,NA,NA,FALSE,NA,NA,NA,Dec 2020,Nov 2021,Dec 2020 - Nov 2021
c5c2a35eb01d5d7802cf2fec411bef13,ce059a3d97c1de1030e47e0502f650fb,31965,Risk factors,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,NA,FALSE,NA,NA,Brazil,Pregnant women,Rio de Janeiro,94,Hospital based,Female,30,Jun,2017,1,Mar,2016,NA,Not adjusted,Infection during pregnancy,NA,Zika congenital syndrome/other birth defects,Significant,NA,FALSE,NA,NA,77,Risk factors,NA,NA,NA,Brazil,NA,NA,FALSE,NA,NA,NA,1 Mar 2016,30 Jun 2017,1 Mar 2016 - 30 Jun 2017
3881247d9eab99f1f59877e2e62edf39,57fde5cbad311556a41a3414a57278a1,705,Pregnancy loss probability,NA,0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,4,Naive,1,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,NA,FALSE,NA,NA,NA,Pregnant women,Veterans Health Administration in US and Caribbean,4,Hospital based,Female,31,Oct,2016,1,Dec,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,First trimester,NA,51,Other transmission parameters,NA,NA,NA,NA,NA,NA,FALSE,include,women,miscarriage,1 Dec 2015,31 Oct 2016,1 Dec 2015 - 31 Oct 2016
9dd9702ec6bf481964c6f543f140337d,8af3aa99256b3eaabfd53171a712cf07,1236,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,10,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,273,Naive,27,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Start outbreak,NA,Keith,Observed sample statistic,FALSE,0,0,France,Persons under investigation,French Guiana,291,Hospital based,Unspecified,NA,Jul,2016,NA,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Whole pregnancy,Unspecified,9,Other transmission parameters,NA,NA,NA,France,NA,NA,FALSE,include,women,microcephaly,Jan 2016,Jul 2016,Jan 2016 - Jul 2016
9dd9702ec6bf481964c6f543f140337d,18af3aa99256b3eaabfd53171a712cf07,1236,Pregnancy loss probability,Percentage (%),0,4,Unspecified,2,7,95% CI,NA,NA,NA,NA,NA,Confirmed,291,Naive,12,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Start outbreak,NA,Keith,Observed sample statistic,FALSE,0,0,France,Persons under investigation,French Guiana,291,Hospital based,Unspecified,NA,Jul,2016,NA,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Whole pregnancy,Unspecified,9,Other transmission parameters,NA,NA,2 - 7,France,NA,NA,FALSE,include,women,general pregnancy loss,Jan 2016,Jul 2016,Jan 2016 - Jul 2016
123456783anckbhdk29rdu74,481nbkdkjs42gfffhkky,1237,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,2.5,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,80,Naive,2,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Start outbreak,NA,Keith,Observed sample statistic,FALSE,0,0,France,Pregnant women,French Guiana,80,Hospital based,Female,1,Jan,2016,15,Jul,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,First trimester,Unspecified,10,Other transmission parameters,NA,NA,NA,France,NA,NA,FALSE,include,women,microcephaly,15 Jul 2016,1 Jan 2016,15 Jul 2016 - 1 Jan 2016
123456783anckbhdk29rdu74,481nbkdkjs42gfffhkky,1237,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,3.1,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,96,Naive,3,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Start outbreak,NA,Keith,Observed sample statistic,FALSE,0,0,France,Pregnant women,French Guiana,96,Hospital based,Female,1,Jan,2016,15,Jul,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Second trimester,Unspecified,10,Other transmission parameters,NA,NA,NA,France,NA,NA,FALSE,include,women,microcephaly,15 Jul 2016,1 Jan 2016,15 Jul 2016 - 1 Jan 2016
123456783anckbhdk29rdu74,481nbkdkjs42gfffhkky,1237,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,0,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,125,Naive,0,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Start outbreak,NA,Keith,Observed sample statistic,FALSE,0,0,France,Pregnant women,French Guiana,125,Hospital based,Female,1,Jan,2016,15,Jul,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Third trimester,Unspecified,10,Other transmission parameters,NA,NA,NA,France,NA,NA,FALSE,include,women,microcephaly,15 Jul 2016,1 Jan 2016,15 Jul 2016 - 1 Jan 2016
123456783anckbhdk29rdu74,481nbkdkjs42gfffhkky,1237,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,1.7,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,301,Naive,5,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Start outbreak,NA,Keith,Observed sample statistic,FALSE,0,0,France,Pregnant women,French Guiana,301,Hospital based,Female,1,Jan,2016,15,Jul,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Whole pregnancy,Unspecified,10,Other transmission parameters,NA,NA,NA,France,NA,NA,FALSE,include,women,microcephaly,15 Jul 2016,1 Jan 2016,15 Jul 2016 - 1 Jan 2016
123456783anckbhdk29rdu74,481nbkdkjs42gfffhkky,1237,Pregnancy loss probability,Percentage (%),0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,498,Naive,20,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Start outbreak,NA,Keith,Observed sample statistic,FALSE,0,0,France,Pregnant women,French Guiana,498,Hospital based,Female,1,Jan,2016,15,Jul,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Whole pregnancy,Unspecified,10,Other transmission parameters,NA,NA,NA,France,NA,NA,FALSE,include,women,miscarriage,15 Jul 2016,1 Jan 2016,15 Jul 2016 - 1 Jan 2016
79da21f30d75721f785b4a48a171d363,256d5ae29d406c3720ebedd72b2c8e81,1326,Pregnancy loss probability,Percentage (%),0,13.1,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,296,Unspecified,26,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Keith,Observed sample statistic,FALSE,NA,NA,Dominican Republic,Pregnant women,NA,1282,Population based,Female,NA,Apr,2017,NA,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Whole pregnancy,Unspecified,11,Other transmission parameters,NA,NA,NA,Dominican Republic,NA,NA,FALSE,include,women,miscarriage,Jan 2016,Apr 2017,Jan 2016 - Apr 2017
79da21f30d75721f785b4a48a171d363,a636b0869e0e069f23e0f85341730e3b,1326,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,0,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,296,Unspecified,0,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Keith,Observed sample statistic,FALSE,NA,NA,Dominican Republic,Pregnant women,NA,1282,Population based,Female,NA,Apr,2017,NA,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Whole pregnancy,Unspecified,11,Other transmission parameters,NA,NA,NA,Dominican Republic,NA,NA,FALSE,include,women,microcephaly,Jan 2016,Apr 2017,Jan 2016 - Apr 2017
5e2ef93e6eb88f4a459e0edfb1c649bf,f04d41a552221fbb884db209a156ee65,2704,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,4,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,442,NA,18,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,Observed sample statistic,FALSE,50,15,United States,Pregnant women,continental United States and Hawaii,442,Population based,Female,22,Sep,2016,15,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Whole pregnancy,Unspecified,40,Other transmission parameters,NA,NA,NA,United States,NA,NA,FALSE,include,women,microcephaly,15 Jan 2016,22 Sep 2016,15 Jan 2016 - 22 Sep 2016
5e2ef93e6eb88f4a459e0edfb1c649bf,2f04d41a552221fbb884db209a156ee65,2704,Pregnancy loss probability,Percentage (%),0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,442,NA,47,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,Observed sample statistic,FALSE,50,15,United States,Pregnant women,continental United States and Hawaii,442,Population based,Female,22,Sep,2016,15,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Whole pregnancy,Unspecified,40,Other transmission parameters,NA,NA,NA,United States,NA,NA,FALSE,include,women,general pregnancy loss,15 Jan 2016,22 Sep 2016,15 Jan 2016 - 22 Sep 2016
7d3c16380db081dbd5c7ecbd6ab90abd,4ed68b5a56c87b2c04abf2c41fdbb50c,2713,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,5.8,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,555,NA,32,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Other, Time",FALSE,FALSE,Unspecified,NA,Tristan Naidoo,Observed sample statistic,FALSE,46,18,France,Pregnant women,"Martinique, Guadeloupe, French Guiana",555,Population based,Female,27,Apr,2017,NA,Mar,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Whole pregnancy,Unspecified,41,Other transmission parameters,NA,NA,NA,France,NA,NA,FALSE,include,women,microcephaly,Mar 2016,27 Apr 2017,Mar 2016 - 27 Apr 2017
7d3c16380db081dbd5c7ecbd6ab90abd,14ed68b5a56c87b2c04abf2c41fdbb50c,2713,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,10.1,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,189,NA,19,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,Observed sample statistic,FALSE,46,18,France,Pregnant women,"Martinique, Guadeloupe, French Guiana",555,Population based,Female,27,Apr,2017,NA,Mar,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,First trimester,Unspecified,41,Other transmission parameters,NA,NA,NA,France,NA,NA,FALSE,include,women,microcephaly,Mar 2016,27 Apr 2017,Mar 2016 - 27 Apr 2017
7d3c16380db081dbd5c7ecbd6ab90abd,24ed68b5a56c87b2c04abf2c41fdbb50c,2713,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,3.2,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,252,NA,8,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,Observed sample statistic,FALSE,46,18,France,Pregnant women,"Martinique, Guadeloupe, French Guiana",555,Population based,Female,27,Apr,2017,NA,Mar,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Second trimester,Unspecified,41,Other transmission parameters,NA,NA,NA,France,NA,NA,FALSE,include,women,microcephaly,Mar 2016,27 Apr 2017,Mar 2016 - 27 Apr 2017
7d3c16380db081dbd5c7ecbd6ab90abd,34ed68b5a56c87b2c04abf2c41fdbb50c,2713,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,4.4,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,114,NA,5,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,Observed sample statistic,FALSE,46,18,France,Pregnant women,"Martinique, Guadeloupe, French Guiana",555,Population based,Female,27,Apr,2017,NA,Mar,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Third trimester,Unspecified,41,Other transmission parameters,NA,NA,NA,France,NA,NA,FALSE,include,women,microcephaly,Mar 2016,27 Apr 2017,Mar 2016 - 27 Apr 2017
7d3c16380db081dbd5c7ecbd6ab90abd,44ed68b5a56c87b2c04abf2c41fdbb50c,2713,Pregnancy loss probability,Percentage (%),0,2,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,555,NA,11,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,"Other, Time",FALSE,FALSE,Unspecified,NA,Tristan Naidoo,Observed sample statistic,FALSE,46,18,France,Pregnant women,"Martinique, Guadeloupe, French Guiana",555,Population based,Female,27,Apr,2017,NA,Mar,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Whole pregnancy,Unspecified,41,Other transmission parameters,NA,NA,NA,France,NA,NA,FALSE,include,women,miscarriage,Mar 2016,27 Apr 2017,Mar 2016 - 27 Apr 2017
7d3c16380db081dbd5c7ecbd6ab90abd,54ed68b5a56c87b2c04abf2c41fdbb50c,2713,Pregnancy loss probability,Percentage (%),0,5.8,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,189,NA,11,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,Observed sample statistic,FALSE,46,18,France,Pregnant women,"Martinique, Guadeloupe, French Guiana",555,Population based,Female,27,Apr,2017,NA,Mar,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,First trimester,Unspecified,41,Other transmission parameters,NA,NA,NA,France,NA,NA,FALSE,include,women,miscarriage,Mar 2016,27 Apr 2017,Mar 2016 - 27 Apr 2017
7d3c16380db081dbd5c7ecbd6ab90abd,64ed68b5a56c87b2c04abf2c41fdbb50c,2713,Pregnancy loss probability,Percentage (%),0,0,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,252,NA,0,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,Observed sample statistic,FALSE,46,18,France,Pregnant women,"Martinique, Guadeloupe, French Guiana",555,Population based,Female,27,Apr,2017,NA,Mar,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Second trimester,Unspecified,41,Other transmission parameters,NA,NA,NA,France,NA,NA,FALSE,include,women,miscarriage,Mar 2016,27 Apr 2017,Mar 2016 - 27 Apr 2017
7d3c16380db081dbd5c7ecbd6ab90abd,74ed68b5a56c87b2c04abf2c41fdbb50c,2713,Pregnancy loss probability,Percentage (%),0,0,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,114,NA,0,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,Observed sample statistic,FALSE,46,18,France,Pregnant women,"Martinique, Guadeloupe, French Guiana",555,Population based,Female,27,Apr,2017,NA,Mar,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Third trimester,Unspecified,41,Other transmission parameters,NA,NA,NA,France,NA,NA,FALSE,include,women,miscarriage,Mar 2016,27 Apr 2017,Mar 2016 - 27 Apr 2017
d07d34434dbadb0d9993bd878602afd7,5883162ce9dad8473c87cba496bc0fa8,3071,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Suspected,602,NA,76,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,NA,FALSE,NA,NA,Brazil,Pregnant women,NA,1501,Population based,Female,27,Feb,2016,19,Nov,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Whole pregnancy,Unspecified,43,Other transmission parameters,NA,NA,NA,Brazil,NA,NA,FALSE,exclude,infants,microcephaly,19 Nov 2015,27 Feb 2016,19 Nov 2015 - 27 Feb 2016
08bfd094ca1d40c16a719b49a8ab95b8,9d4009cebc96f4c6faac6fd7d510689c,4014,Pregnancy loss probability,Percentage (%),0,4.8,Central,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,134,NA,6,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,NA,FALSE,46,16,Brazil,Pregnant women,Rio de Janeiro state,134,Hospital based,Female,NA,May,2016,NA,Sep,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,58,Other transmission parameters,NA,NA,NA,Brazil,NA,NA,FALSE,include,women,miscarriage,Sep 2015,May 2016,Sep 2015 - May 2016
08bfd094ca1d40c16a719b49a8ab95b8,d68eaa129c3d39d7b15900438426e361,4014,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,3.4,Central,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,117,NA,4,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Brazil,Children,Rio de Janeiro state,117,Hospital based,Both,31,Jul,2016,1,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,58,Other transmission parameters,NA,NA,NA,Brazil,NA,NA,FALSE,include,women,microcephaly,1 Jan 2016,31 Jul 2016,1 Jan 2016 - 31 Jul 2016
4d6901acb622034e1ffcd94ac25c15f7,8f9e27ad8e455fcd46188c1695b41505,4324,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,NA,Central,NA,NA,NA,NA,NA,0.49,2.1,NA,Confirmed,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Unspecified,FALSE,NA,NA,Brazil,NA,Northeast Brazil,NA,Other,Unspecified,2,Apr,2016,15,Nov,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,First trimester,Unspecified,62,Other transmission parameters,0.49 - 2.1,NA,NA,Brazil,NA,NA,FALSE,exclude,women,microcephaly,15 Nov 2015,2 Apr 2016,15 Nov 2015 - 2 Apr 2016
09950ce8d486dc1c4fe74dd4c7816c30,f67ecacc0c498692ace62fbf6c510bb1,21374,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,92,Naive,7,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Other,TRUE,FALSE,Unspecified,NA,sangeeta,NA,FALSE,NA,NA,Brazil,Pregnant women,Rio de Janeiro,92,Other,Female,31,May,2016,1,Sep,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,3,Other transmission parameters,NA,NA,NA,Brazil,NA,NA,FALSE,include,women,microcephaly,1 Sep 2015,31 May 2016,1 Sep 2015 - 31 May 2016
09950ce8d486dc1c4fe74dd4c7816c30,1f67ecacc0c498692ace62fbf6c510bb1,21374,Pregnancy loss probability,Percentage (%),0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,92,Naive,1,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Other,TRUE,FALSE,Unspecified,NA,sangeeta,NA,FALSE,NA,NA,Brazil,Pregnant women,Rio de Janeiro,92,Other,Female,31,May,2016,1,Sep,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,3,Other transmission parameters,NA,NA,NA,Brazil,NA,NA,FALSE,include,women,general pregnancy loss,1 Sep 2015,31 May 2016,1 Sep 2015 - 31 May 2016
5a5a021b65c8d64f1e326a249e645adc,2e8ef82d7d46a333d3fb8a383e068975,5753,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,0.006,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Suspected,NA,NA,NA,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,0,0,Brazil,Children,Tocantins,NA,Hospital based,Both,NA,Dec,2016,NA,Jul,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,57,Other transmission parameters,NA,NA,NA,Brazil,NA,NA,FALSE,exclude,women,microcephaly,Jul 2015,Dec 2016,Jul 2015 - Dec 2016
94bf6af90298ebe57224bd5109d9accc,daabba610e4057345de9b9a27990953c,5902,Pregnancy loss probability,Percentage (%),0,1.3,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,1259,Unspecified,16,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Start outbreak,NA,Christian,Observed sample statistic,FALSE,46,12,Colombia,Pregnant women,Cali,1259,Hospital based,Female,NA,Jul,2016,NA,Oct,2015,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,Whole pregnancy,NA,58,Other transmission parameters,NA,NA,NA,Colombia,NA,NA,FALSE,include,women,miscarriage,Oct 2015,Jul 2016,Oct 2015 - Jul 2016
94bf6af90298ebe57224bd5109d9accc,82bbbfff1934d76ed47c9133ca11b3df,5902,Pregnancy loss probability,Percentage (%),0,2.3,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,499,Unspecified,10,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Start outbreak,NA,Christian,Observed sample statistic,FALSE,43,14,Colombia,Pregnant women,Villavicencio,499,Hospital based,Female,NA,Jul,2016,NA,Oct,2015,NA,NA,NA,NA,NA,NA,Unspecified,FALSE,Whole pregnancy,NA,58,Other transmission parameters,NA,NA,NA,Colombia,NA,NA,FALSE,include,women,miscarriage,Oct 2015,Jul 2016,Oct 2015 - Jul 2016
48cf7eadf6c38f5f47b97c2768727fcc,b3e90d141b450dcb24e589c32bf84dcb,6028,Pregnancy loss probability,Percentage (%),0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,300,NA,11,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Level of exposure,FALSE,FALSE,Mid outbreak,NA,Shazia Ruybal-Pesantez,NA,FALSE,NA,NA,France,Children,French Guiana,215,Mixed settings,Both,15,Jul,2016,1,Jan,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Whole pregnancy,NA,14,Other transmission parameters,NA,NA,NA,France,NA,NA,FALSE,include,women,general pregnancy loss,1 Jan 2015,15 Jul 2016,1 Jan 2015 - 15 Jul 2016
1b9624fc90f5237b0047c6950f24f770,afd7b5c3e70a9d6dd9567089c924cf7c,6072,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,7.1,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,98,NA,7,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Shazia Ruybal-Pesantez,Observed sample statistic,FALSE,2,0,Brazil,Children,Rio de Janeiro,98,Other,Both,NA,NA,2016,NA,NA,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Whole pregnancy,NA,17,Other transmission parameters,NA,NA,NA,Brazil,NA,NA,FALSE,include,women,microcephaly,2016,2016,2016
1173f493208452824e56f51f7e01789b,4c0cf7e58ca4dd27534bbd5fb108d713,6120,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,4.8,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Suspected,109,NA,5,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,End outbreak,NA,Shazia Ruybal-Pesantez,NA,FALSE,1,0,Brazil,Children,Tangará da Serra,109,Other,Both,31,Dec,2016,1,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,19,Other transmission parameters,NA,NA,NA,Brazil,NA,NA,FALSE,exclude,women,microcephaly,1 Jan 2016,31 Dec 2016,1 Jan 2016 - 31 Dec 2016
81f3c0cbef6ad673e799466f338a0ec9,c6ac54e934744abad11f0e540c4e6947,6241,Pregnancy loss probability,Percentage (%),0,0.83,Central,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,120,Naive,1,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,NA,Brazil,Persons under investigation,Mato Grosso do Sul,120,Population based,Unspecified,NA,Oct,2018,NA,Nov,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,Whole pregnancy,Unspecified,41,Other transmission parameters,NA,NA,NA,Brazil,NA,NA,FALSE,include,women,general pregnancy loss,Nov 2017,Oct 2018,Nov 2017 - Oct 2018
81f3c0cbef6ad673e799466f338a0ec9,705c49c8969a079fed7968b66689f2ce,6241,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,NA,Central,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,120,Naive,23,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,NA,Brazil,Persons under investigation,Mato Grosso do Sul,120,Population based,Unspecified,NA,Oct,2018,NA,Nov,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,Whole pregnancy,Unspecified,41,Other transmission parameters,NA,NA,NA,Brazil,NA,NA,FALSE,include,women,CZS,Nov 2017,Oct 2018,Nov 2017 - Oct 2018
81f3c0cbef6ad673e799466f338a0ec9,1705c49c8969a079fed7968b66689f2ce,6241,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,NA,Central,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,28,Naive,12,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,NA,Brazil,Persons under investigation,Mato Grosso do Sul,120,Population based,Unspecified,NA,Oct,2018,NA,Nov,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,First trimester,Unspecified,41,Other transmission parameters,NA,NA,NA,Brazil,NA,NA,FALSE,include,women,CZS,Nov 2017,Oct 2018,Nov 2017 - Oct 2018
81f3c0cbef6ad673e799466f338a0ec9,2705c49c8969a079fed7968b66689f2ce,6241,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,NA,Central,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,51,Naive,6,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,NA,Brazil,Persons under investigation,Mato Grosso do Sul,120,Population based,Unspecified,NA,Oct,2018,NA,Nov,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,Second trimester,Unspecified,41,Other transmission parameters,NA,NA,NA,Brazil,NA,NA,FALSE,include,women,CZS,Nov 2017,Oct 2018,Nov 2017 - Oct 2018
81f3c0cbef6ad673e799466f338a0ec9,3705c49c8969a079fed7968b66689f2ce,6241,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,NA,Central,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,40,Naive,4,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,NA,Brazil,Persons under investigation,Mato Grosso do Sul,120,Population based,Unspecified,NA,Oct,2018,NA,Nov,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,Third trimester,Unspecified,41,Other transmission parameters,NA,NA,NA,Brazil,NA,NA,FALSE,include,women,CZS,Nov 2017,Oct 2018,Nov 2017 - Oct 2018
6bb386a576da9ef46699ee6028fbd0bd,4fa2811b10fb82abe3356a15c325be98,6270,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,NA,Central,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,12,Naive,2,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,3,0,Spain,Persons under investigation,Barcelona,12,Population based,Unspecified,NA,Apr,2019,NA,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,43,Other transmission parameters,NA,NA,NA,Spain,NA,NA,FALSE,include,women,microcephaly,Jan 2016,Apr 2019,Jan 2016 - Apr 2019
d094bacd681a764c329c3a401c9e52a1,5bfd419c463f3d03ad23b3bde615a49d,6301,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,4.5,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,404,NA,18,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Richard Sheppard,Observed sample statistic,FALSE,1,0,United States,Persons under investigation,New York City,404,Hospital based,Unspecified,NA,Dec,2017,NA,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,14,Other transmission parameters,NA,NA,NA,United States,NA,NA,FALSE,exclude,women,microcephaly,Jan 2016,Dec 2017,Jan 2016 - Dec 2017
f8011399ffc38f5d2c9e0ded93f462d4,df235b2229955e764e7860ed983780a3,6427,Pregnancy loss probability,Percentage (%),0,3,Central,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,5673,Naive,172,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,NA,Colombia,Pregnant women,NA,5673,Population based,Female,31,Jul,2016,15,Jun,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Whole pregnancy,Both urban and rural areas,46,Other transmission parameters,NA,NA,NA,Colombia,NA,NA,FALSE,include,women,general pregnancy loss,15 Jun 2015,31 Jul 2016,15 Jun 2015 - 31 Jul 2016
f8011399ffc38f5d2c9e0ded93f462d4,1df235b2229955e764e7860ed983780a3,6427,Pregnancy loss probability,Percentage (%),0,8,Central,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,1192,Naive,97,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,NA,Colombia,Pregnant women,NA,5673,Population based,Female,31,Jul,2016,15,Jun,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,First trimester,Both urban and rural areas,46,Other transmission parameters,NA,NA,NA,Colombia,NA,NA,FALSE,include,women,general pregnancy loss,15 Jun 2015,31 Jul 2016,15 Jun 2015 - 31 Jul 2016
f8011399ffc38f5d2c9e0ded93f462d4,2df235b2229955e764e7860ed983780a3,6427,Pregnancy loss probability,Percentage (%),0,2,Central,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,4481,Naive,75,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,NA,Colombia,Pregnant women,NA,5673,Population based,Female,31,Jul,2016,15,Jun,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Second trimester; Third trimester,Both urban and rural areas,46,Other transmission parameters,NA,NA,NA,Colombia,NA,NA,FALSE,include,women,general pregnancy loss,15 Jun 2015,31 Jul 2016,15 Jun 2015 - 31 Jul 2016
417cecf144ec3a762df3bdf52ba517c4,beea28fda18f8d892234702335529737,6501,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,NA,Central,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,166,Naive,2,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,0,0,Kenya,Pregnant women,Mombasa,1236,Hospital based,Both,NA,Jul,2019,NA,Oct,2017,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,49,Other transmission parameters,NA,NA,NA,Kenya,NA,NA,FALSE,include,women,microcephaly,Oct 2017,Jul 2019,Oct 2017 - Jul 2019
1abd658ebf5c69e3f91de2f5ee4729f5,38dd6b9b907b76d1457f2e24b5172ad8,6521,Zika congenital syndrome (microcephaly) probability,NA,0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,11,NA,2,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Richard Sheppard,Observed sample statistic,FALSE,NA,NA,Spain,Pregnant women,Barcelona,11,Other,Unspecified,NA,Dec,2021,NA,May,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,5,Other transmission parameters,NA,NA,NA,Spain,NA,NA,FALSE,include,women,CZS,May 2016,Dec 2021,May 2016 - Dec 2021
1f1b70ca90d113f7d829fc35a0ce8292,4c6f9ecedfb5b347ce9641495b4e22ee,6547,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,3.7,Central,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,216,NA,8,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Thomas Rawson,Observed sample statistic,FALSE,NA,NA,Brazil,Pregnant women,Rio de Janeiro,216,Hospital based,Both,NA,Dec,2016,NA,Dec,2015,NA,NA,NA,NA,NA,NA,Naive,FALSE,Whole pregnancy,NA,37,Other transmission parameters,NA,NA,NA,Brazil,NA,NA,FALSE,include,women,microcephaly,Dec 2015,Dec 2016,Dec 2015 - Dec 2016
6a16685f40ec6c258b875ec6c9722374,a93c664d01d388c9aaac36ab6735f1e5,6658,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,8.8,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,102,NA,9,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Colombia,Pregnant women,NA,102,Hospital based,Female,NA,Jan,2017,NA,Oct,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Whole pregnancy,NA,40,Other transmission parameters,NA,NA,NA,Colombia,NA,NA,FALSE,include,infants,microcephaly,Oct 2015,Jan 2017,Oct 2015 - Jan 2017
6a16685f40ec6c258b875ec6c9722374,1a93c664d01d388c9aaac36ab6735f1e5,6658,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,25,NA,9,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Colombia,Pregnant women,NA,25,Hospital based,Female,NA,Jan,2017,NA,Oct,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,First trimester,NA,40,Other transmission parameters,NA,NA,NA,Colombia,NA,NA,FALSE,include,infants,microcephaly,Oct 2015,Jan 2017,Oct 2015 - Jan 2017
6a16685f40ec6c258b875ec6c9722374,2a93c664d01d388c9aaac36ab6735f1e5,6658,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,53,NA,5,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Colombia,Pregnant women,NA,53,Hospital based,Female,NA,Jan,2017,NA,Oct,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Second trimester,NA,40,Other transmission parameters,NA,NA,NA,Colombia,NA,NA,FALSE,include,infants,microcephaly,Oct 2015,Jan 2017,Oct 2015 - Jan 2017
6a16685f40ec6c258b875ec6c9722374,3a93c664d01d388c9aaac36ab6735f1e5,6658,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,30,NA,0,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Colombia,Pregnant women,NA,30,Hospital based,Female,NA,Jan,2017,NA,Oct,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Third trimester,NA,40,Other transmission parameters,NA,NA,NA,Colombia,NA,NA,FALSE,include,infants,microcephaly,Oct 2015,Jan 2017,Oct 2015 - Jan 2017
99c77c3525e6eac65421d44753b52599,8c8aabd9f580b8466e9f44f8d0b970e5,6670,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,8.7,Median,7.13,11.39,95% CrI,NA,NA,NA,NA,NA,Unspecified,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Tristan Naidoo,Estimated model parameter,FALSE,NA,NA,Brazil,General population,NA,NA,Population based,Female,31,Dec,2018,11,Aug,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,25,Other transmission parameters,NA,95% CrI,7.13 - 11.39,Brazil,NA,NA,FALSE,exclude,women,microcephaly,11 Aug 2015,31 Dec 2018,11 Aug 2015 - 31 Dec 2018
99c77c3525e6eac65421d44753b52599,2e34cc602939401edc0fe048e6840bc7,6670,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,0.07,Median,0.01,0.19,95% CrI,NA,NA,NA,NA,NA,Unspecified,NA,NA,NA,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,TRUE,Unspecified,NA,Tristan Naidoo,Estimated model parameter,FALSE,NA,NA,Nicaragua,General population,NA,NA,Population based,Female,21,Nov,2016,27,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,25,Other transmission parameters,NA,95% CrI,0.01 - 0.19,Nicaragua,NA,NA,FALSE,exclude,women,microcephaly,27 Jan 2016,21 Nov 2016,27 Jan 2016 - 21 Nov 2016
455ba0171bfbea674583fde554d77117,0c96cc38857bb867327378ef8462017e,6686,Pregnancy loss probability,NA,0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,4,Naive,1,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Spain,Pregnant women,NA,195,Travel based,Female,NA,Feb,2020,NA,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Whole pregnancy,NA,58,Other transmission parameters,NA,NA,NA,Spain,NA,NA,FALSE,include,women,miscarriage,Jan 2016,Feb 2020,Jan 2016 - Feb 2020
0b1ce30eec008cf30a7c4cb4e9fd2b47,9ec563565fb50379041fc3c5d0d88bd3,6810,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,38.5,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,NA,104,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Keith Fraser,Observed sample statistic,FALSE,NA,NA,Brazil,Pregnant women,"Salvador, Bahia",104,Hospital based,Female,NA,Feb,2016,NA,Nov,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Urban area,6,Other transmission parameters,NA,NA,NA,Brazil,NA,NA,FALSE,exclude,women,CZS,Nov 2015,Feb 2016,Nov 2015 - Feb 2016
cd02529de9493c6f3c7bc83f51c0b234,aeeb0b92d8628b5cd96ce8a7df156f8d,6823,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,0,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Suspected,616,Naive,0,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Keith Fraser,NA,FALSE,NA,NA,Colombia,Pregnant women,NA,616,Other,Female,2,Apr,2016,9,Aug,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Third trimester,Both urban and rural areas,7,Other transmission parameters,NA,NA,NA,Colombia,NA,NA,FALSE,include,women,microcephaly,9 Aug 2015,2 Apr 2016,9 Aug 2015 - 2 Apr 2016
6a677ea79002eceef507bcc3ff9de36f,bedd7ab61ad0cb143edde9165b813e5f,6952,Pregnancy loss probability,Percentage (%),0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,6,Naive,1,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,sangeeta,Observed sample statistic,FALSE,NA,NA,Brazil,Pregnant women,São Paulo,6,Hospital based,Female,NA,Sep,2016,NA,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,9,Other transmission parameters,NA,NA,NA,Brazil,NA,NA,FALSE,include,women,miscarriage,Jan 2016,Sep 2016,Jan 2016 - Sep 2016
6a677ea79002eceef507bcc3ff9de36f,f6ce56e6126e96ea9323583c6ac36e11,6952,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,0,Other,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,6,Naive,0,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,sangeeta,Observed sample statistic,FALSE,NA,NA,Brazil,Pregnant women,São Paulo,6,Hospital based,Female,NA,Sep,2016,1,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,9,Other transmission parameters,NA,NA,NA,Brazil,NA,NA,FALSE,include,women,CZS,1 Jan 2016,Sep 2016,1 Jan 2016 - Sep 2016
311c697f2f8aa80e9723301df75c2187,a617b26ceaa5f4791ee939c168e57dfc,6971,Pregnancy loss probability,NA,0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,546,Naive,11,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,sangeeta,Observed sample statistic,FALSE,NA,NA,France,Pregnant women,"Guadeloupe, Martinique, French Guiana",546,Other,Female,24,Nov,2016,2,Mar,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Whole pregnancy,NA,11,Other transmission parameters,NA,NA,NA,France,NA,NA,FALSE,include,women,miscarriage,2 Mar 2016,24 Nov 2016,2 Mar 2016 - 24 Nov 2016
311c697f2f8aa80e9723301df75c2187,2767cd86007de63ed6811023bd4e0468,6971,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,320,Naive,17,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,sangeeta,Observed sample statistic,FALSE,NA,NA,France,Children,"Guadeloupe, Martinique, French Guiana",320,Other,Both,24,Nov,2016,2,Mar,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Whole pregnancy,NA,11,Other transmission parameters,NA,NA,NA,France,NA,NA,FALSE,include,women,microcephaly,2 Mar 2016,24 Nov 2016,2 Mar 2016 - 24 Nov 2016
7e64522ef510188b04652cca6a5306af,9e41c3eb37964f56378c00b7ddebb707,6993,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,24.7,Central,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,219,Naive,53,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,sangeeta,Observed sample statistic,FALSE,NA,NA,Brazil,Pregnant women,Rio de Janeiro,219,Hospital based,Both,NA,Jun,2017,NA,Sep,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Whole pregnancy,NA,13,Other transmission parameters,NA,NA,NA,Brazil,NA,NA,FALSE,exclude,"newborns referred for potential ZIKV exposure based on abnormal prenatal ultrasonographic findings suggestive of fetal ZIKV infection, maternal nonspecific
viral symptoms, or laboratory assay results positive for ZIKV during pregnancy (most were referred for ZIKV+ mothers)",microcephaly,Sep 2015,Jun 2017,Sep 2015 - Jun 2017
4d00b82bdbd1841e77ebb311c97545c3,dff36aae1fb3fbe2b6895a020469f0d7,7050,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,11.33,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed or suspected,26066,Unspecified,2952,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,Brazil,General population,NA,26066,Population based,Unspecified,NA,Jan,2018,NA,May,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,65,Other transmission parameters,NA,NA,NA,Brazil,NA,NA,FALSE,exclude,surveillance reports with ns of infected women and nx of CZS cases,CZS,May 2015,Jan 2018,May 2015 - Jan 2018
4d00b82bdbd1841e77ebb311c97545c3,45661c8f8d2b7f1416c1540f67c5873f,7050,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,1.24,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed or suspected,19993,Unspecified,248,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,Colombia,General population,NA,19993,Population based,Unspecified,NA,Jan,2018,NA,May,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,65,Other transmission parameters,NA,NA,NA,Colombia,NA,NA,FALSE,exclude,surveillance reports with ns of infected women and nx of CZS cases,CZS,May 2015,Jan 2018,May 2015 - Jan 2018
4d00b82bdbd1841e77ebb311c97545c3,e7435aa72e9a3147eb70b72457ac0a3b,7050,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,9.9,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed or suspected,1414,Unspecified,140,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,Guatemala,General population,NA,1414,Population based,Unspecified,NA,Jan,2018,NA,May,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,65,Other transmission parameters,NA,NA,NA,Guatemala,NA,NA,FALSE,exclude,surveillance reports with ns of infected women and nx of CZS cases,CZS,May 2015,Jan 2018,May 2015 - Jan 2018
4d00b82bdbd1841e77ebb311c97545c3,0bdc00767ebdbad5f440598aac079fb6,7050,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,8.8,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed or suspected,966,Unspecified,85,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,Dominican Republic,General population,NA,966,Population based,Unspecified,NA,Jan,2018,NA,May,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,65,Other transmission parameters,NA,NA,NA,Dominican Republic,NA,NA,FALSE,exclude,surveillance reports with ns of infected women and nx of CZS cases,CZS,May 2015,Jan 2018,May 2015 - Jan 2018
4d00b82bdbd1841e77ebb311c97545c3,4582d33a738ac2c41c1875f96bbd3191,7050,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,1.16,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,4047,Unspecified,47,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,United States,General population,Puerto Rico,4047,Population based,Unspecified,NA,Jan,2018,NA,May,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,65,Other transmission parameters,NA,NA,NA,United States,NA,NA,FALSE,exclude,surveillance reports with ns of infected women and nx of CZS cases,CZS,May 2015,Jan 2018,May 2015 - Jan 2018
4d00b82bdbd1841e77ebb311c97545c3,2abcddc98dacc2f3335c0768cb9eeb2c,7050,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,0.35,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,5667,Unspecified,20,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,Mexico,General population,NA,5667,Population based,Unspecified,NA,Jan,2018,NA,May,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,65,Other transmission parameters,NA,NA,NA,Mexico,NA,NA,FALSE,exclude,surveillance reports with ns of infected women and nx of CZS cases,CZS,May 2015,Jan 2018,May 2015 - Jan 2018
4d00b82bdbd1841e77ebb311c97545c3,67294299a1c588f710583404e50ce63b,7050,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,9.05,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,210,Unspecified,19,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,Costa Rica,General population,NA,210,Population based,Unspecified,NA,Jan,2018,NA,May,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,65,Other transmission parameters,NA,NA,NA,Costa Rica,NA,NA,FALSE,exclude,surveillance reports with ns of infected women and nx of CZS cases,CZS,May 2015,Jan 2018,May 2015 - Jan 2018
4d00b82bdbd1841e77ebb311c97545c3,3d587b46c087429c6d7662e451a5c55a,7050,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,8.02,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed or suspected,212,Unspecified,17,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,Panama,General population,NA,212,Population based,Unspecified,NA,Jan,2018,NA,May,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,65,Other transmission parameters,NA,NA,NA,Panama,NA,NA,FALSE,exclude,surveillance reports with ns of infected women and nx of CZS cases,CZS,May 2015,Jan 2018,May 2015 - Jan 2018
4d00b82bdbd1841e77ebb311c97545c3,bd14c386e8ee78e09cdd4f41a7c80706,7050,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,3.67,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,463,Unspecified,17,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,Trinidad and Tobago,General population,NA,463,Population based,Unspecified,NA,Jan,2018,NA,May,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,65,Other transmission parameters,NA,NA,NA,Trinidad and Tobago,NA,NA,FALSE,exclude,surveillance reports with ns of infected women and nx of CZS cases,CZS,May 2015,Jan 2018,May 2015 - Jan 2018
4d00b82bdbd1841e77ebb311c97545c3,13a6f7787060b87b05cd591bef5dc763,7050,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,1.54,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,912,Unspecified,14,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,Ecuador,General population,NA,912,Population based,Unspecified,NA,Jan,2018,NA,May,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,65,Other transmission parameters,NA,NA,NA,Ecuador,NA,NA,FALSE,exclude,surveillance reports with ns of infected women and nx of CZS cases,CZS,May 2015,Jan 2018,May 2015 - Jan 2018
4d00b82bdbd1841e77ebb311c97545c3,452a2e6c952f4aaa348cba342e551cd4,7050,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,7.41,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,189,Unspecified,14,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,Bolivia,General population,NA,189,Population based,Unspecified,NA,Jan,2018,NA,May,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,65,Other transmission parameters,NA,NA,NA,Bolivia,NA,NA,FALSE,exclude,surveillance reports with ns of infected women and nx of CZS cases,CZS,May 2015,Jan 2018,May 2015 - Jan 2018
4d00b82bdbd1841e77ebb311c97545c3,b3e00623a2a5420cffbd47a4bc54b017,7050,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,1.17,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed or suspected,681,Unspecified,8,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,Honduras,General population,NA,681,Population based,Unspecified,NA,Jan,2018,NA,May,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,65,Other transmission parameters,NA,NA,NA,Honduras,NA,NA,FALSE,exclude,surveillance reports with ns of infected women and nx of CZS cases,CZS,May 2015,Jan 2018,May 2015 - Jan 2018
4d00b82bdbd1841e77ebb311c97545c3,d3c4d9d723ccac815193ddaa844a02cd,7050,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,0.6,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,830,Unspecified,5,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,France,General population,Martinique,830,Population based,Unspecified,NA,Jan,2018,NA,May,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,65,Other transmission parameters,NA,NA,NA,France,NA,NA,FALSE,exclude,surveillance reports with ns of infected women and nx of CZS cases,CZS,May 2015,Jan 2018,May 2015 - Jan 2018
4d00b82bdbd1841e77ebb311c97545c3,e082e2bdf96d2b1dd129de1334b0a5b1,7050,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,0.61,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,815,Unspecified,5,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,France,General population,Guadeloupe,815,Population based,Unspecified,NA,Jan,2018,NA,May,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,65,Other transmission parameters,NA,NA,NA,France,NA,NA,FALSE,exclude,surveillance reports with ns of infected women and nx of CZS cases,CZS,May 2015,Jan 2018,May 2015 - Jan 2018
4d00b82bdbd1841e77ebb311c97545c3,87305da9e006413d361025afceee53ac,7050,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,1.02,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed or suspected,391,Unspecified,4,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,El Salvador,General population,NA,391,Population based,Unspecified,NA,Jan,2018,NA,May,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,65,Other transmission parameters,NA,NA,NA,El Salvador,NA,NA,FALSE,exclude,surveillance reports with ns of infected women and nx of CZS cases,CZS,May 2015,Jan 2018,May 2015 - Jan 2018
4d00b82bdbd1841e77ebb311c97545c3,3ca01939e336fad90d36455dc3fee760,7050,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,0.18,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,1117,Unspecified,2,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,Nicaragua,General population,NA,1117,Population based,Unspecified,NA,Jan,2018,NA,May,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,65,Other transmission parameters,NA,NA,NA,Nicaragua,NA,NA,FALSE,exclude,surveillance reports with ns of infected women and nx of CZS cases,CZS,May 2015,Jan 2018,May 2015 - Jan 2018
4d00b82bdbd1841e77ebb311c97545c3,1334f0662f351edb4063f92d9235d939,7050,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,6.45,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed or suspected,31,Unspecified,2,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,Paraguay,General population,NA,31,Population based,Unspecified,NA,Jan,2018,NA,May,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,65,Other transmission parameters,NA,NA,NA,Paraguay,NA,NA,FALSE,exclude,surveillance reports with ns of infected women and nx of CZS cases,CZS,May 2015,Jan 2018,May 2015 - Jan 2018
4d00b82bdbd1841e77ebb311c97545c3,b7e3bbb6f260154f75dd7e8cd405f720,7050,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,0.05,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,2211,Unspecified,1,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,France,General population,French Guiana,2211,Population based,Unspecified,NA,Jan,2018,NA,May,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,65,Other transmission parameters,NA,NA,NA,France,NA,NA,FALSE,exclude,surveillance reports with ns of infected women and nx of CZS cases,CZS,May 2015,Jan 2018,May 2015 - Jan 2018
4d00b82bdbd1841e77ebb311c97545c3,9a00cf4eb326f20fed36ae4da3c67e16,7050,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,4.55,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed or suspected,22,Unspecified,1,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,Haiti,General population,NA,22,Population based,Unspecified,NA,Jan,2018,NA,May,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,65,Other transmission parameters,NA,NA,NA,Haiti,NA,NA,FALSE,exclude,surveillance reports with ns of infected women and nx of CZS cases,CZS,May 2015,Jan 2018,May 2015 - Jan 2018
4d00b82bdbd1841e77ebb311c97545c3,279ba0efe0574db8e859d594d0647924,7050,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,2.08,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,48,Unspecified,1,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,St. Martin (French part),General population,NA,48,Population based,Unspecified,NA,Jan,2018,NA,May,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,65,Other transmission parameters,NA,NA,NA,St. Martin (French part),NA,NA,FALSE,exclude,surveillance reports with ns of infected women and nx of CZS cases,CZS,May 2015,Jan 2018,May 2015 - Jan 2018
4d00b82bdbd1841e77ebb311c97545c3,dcf258acba225f392c11173cc7c1105a,7050,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,3.13,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,32,Unspecified,1,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,Barbados,General population,NA,32,Population based,Unspecified,NA,Jan,2018,NA,May,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,65,Other transmission parameters,NA,NA,NA,Barbados,NA,NA,FALSE,exclude,surveillance reports with ns of infected women and nx of CZS cases,CZS,May 2015,Jan 2018,May 2015 - Jan 2018
4d00b82bdbd1841e77ebb311c97545c3,c4d3be7ea6d3a72f068cecf14d59b9b2,7050,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,0,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed or suspected,3463,Unspecified,0,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,Venezuela,General population,NA,3463,Population based,Unspecified,NA,Jan,2018,NA,May,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,65,Other transmission parameters,NA,NA,NA,Venezuela,NA,NA,FALSE,exclude,surveillance reports with ns of infected women and nx of CZS cases,CZS,May 2015,Jan 2018,May 2015 - Jan 2018
4d00b82bdbd1841e77ebb311c97545c3,6c30ad4eba876fc323bf0b03b452f2d2,7050,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,0,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed or suspected,712,Unspecified,0,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,Jamaica,General population,NA,712,Population based,Unspecified,NA,Jan,2018,NA,May,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,65,Other transmission parameters,NA,NA,NA,Jamaica,NA,NA,FALSE,exclude,surveillance reports with ns of infected women and nx of CZS cases,CZS,May 2015,Jan 2018,May 2015 - Jan 2018
4d00b82bdbd1841e77ebb311c97545c3,ecc8093c7454c7cc9e83f0e0b17a9533,7050,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,0,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,279,Unspecified,0,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,Peru,General population,NA,279,Population based,Unspecified,NA,Jan,2018,NA,May,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,65,Other transmission parameters,NA,NA,NA,Peru,NA,NA,FALSE,exclude,surveillance reports with ns of infected women and nx of CZS cases,CZS,May 2015,Jan 2018,May 2015 - Jan 2018
4d00b82bdbd1841e77ebb311c97545c3,c510cfbd15885aeb1497ec61345d48b0,7050,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,0,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,30,Unspecified,0,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,Curaçao,General population,NA,30,Population based,Unspecified,NA,Jan,2018,NA,May,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,65,Other transmission parameters,NA,NA,NA,Curaçao,NA,NA,FALSE,exclude,surveillance reports with ns of infected women and nx of CZS cases,CZS,May 2015,Jan 2018,May 2015 - Jan 2018
4d00b82bdbd1841e77ebb311c97545c3,7acf133e5a7ce4da2e722d84fe4b92a8,7050,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,0,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,1,Unspecified,0,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,Belize,General population,NA,1,Population based,Unspecified,NA,Jan,2018,NA,May,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,65,Other transmission parameters,NA,NA,NA,Belize,NA,NA,FALSE,exclude,surveillance reports with ns of infected women and nx of CZS cases,CZS,May 2015,Jan 2018,May 2015 - Jan 2018
4d00b82bdbd1841e77ebb311c97545c3,a082711ac02021b913e3e66fdd768328,7050,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,0,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed or suspected,13,Unspecified,0,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,Dominica,General population,NA,13,Population based,Unspecified,NA,Jan,2018,NA,May,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,65,Other transmission parameters,NA,NA,NA,Dominica,NA,NA,FALSE,exclude,surveillance reports with ns of infected women and nx of CZS cases,CZS,May 2015,Jan 2018,May 2015 - Jan 2018
4d00b82bdbd1841e77ebb311c97545c3,6e16deea22a85ab4d9a5314ed192b13e,7050,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,0,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed or suspected,3,Unspecified,0,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,St. Vincent and the Grenadines,General population,NA,3,Population based,Unspecified,NA,Jan,2018,NA,May,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,65,Other transmission parameters,NA,NA,NA,St. Vincent and the Grenadines,NA,NA,FALSE,exclude,surveillance reports with ns of infected women and nx of CZS cases,CZS,May 2015,Jan 2018,May 2015 - Jan 2018
4d00b82bdbd1841e77ebb311c97545c3,b6e5ab14e16d06869016ff7a81c9d124,7050,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,0,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed or suspected,16,Unspecified,0,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,Antigua and Barbuda,General population,NA,16,Population based,Unspecified,NA,Jan,2018,NA,May,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,65,Other transmission parameters,NA,NA,NA,Antigua and Barbuda,NA,NA,FALSE,exclude,surveillance reports with ns of infected women and nx of CZS cases,CZS,May 2015,Jan 2018,May 2015 - Jan 2018
4d00b82bdbd1841e77ebb311c97545c3,56865a1075881cd925452864fb9b6253,7050,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,0,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,286,Unspecified,0,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,Virgin Islands (U.S.),General population,NA,286,Population based,Unspecified,NA,Jan,2018,NA,May,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,65,Other transmission parameters,NA,NA,NA,Virgin Islands (U.S.),NA,NA,FALSE,exclude,surveillance reports with ns of infected women and nx of CZS cases,CZS,May 2015,Jan 2018,May 2015 - Jan 2018
4d00b82bdbd1841e77ebb311c97545c3,4c303f0a7b2e8782c6040e2ba250719a,7050,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,0,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed or suspected,10,Unspecified,0,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,Sint Maarten (Dutch part),General population,NA,10,Population based,Unspecified,NA,Jan,2018,NA,May,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,65,Other transmission parameters,NA,NA,NA,Sint Maarten (Dutch part),NA,NA,FALSE,exclude,surveillance reports with ns of infected women and nx of CZS cases,CZS,May 2015,Jan 2018,May 2015 - Jan 2018
4d00b82bdbd1841e77ebb311c97545c3,d1d39c2c8fa8aec0cac6c632f777dfb0,7050,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,0,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed or suspected,84,Unspecified,0,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,Unspecified,General population,Saint Lucia,84,Population based,Unspecified,NA,Jan,2018,NA,May,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,65,Other transmission parameters,NA,NA,NA,NA,NA,NA,FALSE,exclude,surveillance reports with ns of infected women and nx of CZS cases,CZS,May 2015,Jan 2018,May 2015 - Jan 2018
4d00b82bdbd1841e77ebb311c97545c3,5342a1419d4698625a987899c44fb861,7050,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,0,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,11,Unspecified,0,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Christian,Observed sample statistic,FALSE,NA,NA,France,General population,Saint Barthelemy,11,Population based,Unspecified,NA,Jan,2018,NA,May,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,65,Other transmission parameters,NA,NA,NA,France,NA,NA,FALSE,exclude,surveillance reports with ns of infected women and nx of CZS cases,CZS,May 2015,Jan 2018,May 2015 - Jan 2018
3dcc8dc8da34f8090b42c9fa700994f5,8f55025a551d501b3114632df0f07870,7165,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,NA,Central,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,21,NA,3,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Vietnam,Pregnant women,Ho Chi Minh City,21,Hospital based,Female,NA,Nov,2017,NA,Mar,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Both urban and rural areas,39,Other transmission parameters,NA,NA,NA,Vietnam,NA,NA,FALSE,include,women,microcephaly,Mar 2016,Nov 2017,Mar 2016 - Nov 2017
361cf35736e8028b22645c6b7222c6d4,cd5d48527e8a9b991981cfd29870da82,7452,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,11,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed or suspected,800,Unspecified,87,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,TRUE,Other,FALSE,FALSE,Post outbreak,NA,Ruth,Observed sample statistic,FALSE,0,0,Dominican Republic,Children,NA,800,Hospital based,Both,NA,NA,NA,NA,NA,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,34,Other transmission parameters,NA,NA,NA,Dominican Republic,NA,NA,FALSE,exclude,infants,microcephaly,2016,Unspecified,2016 - Unspecified
c7479ca2f32e53785e4175baf13fdd35,4ee34fc9ad07248c66b2d300120acadd,7503,Pregnancy loss probability,Percentage (%),0,0,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,44,Unspecified,0,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,46,13,Brazil,Pregnant women,"Jundiai, São Paulo",44,Hospital based,Female,23,Aug,2017,1,Mar,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Whole pregnancy,Unspecified,36,Other transmission parameters,NA,NA,NA,Brazil,NA,NA,FALSE,include,women,general pregnancy loss,1 Mar 2016,23 Aug 2017,1 Mar 2016 - 23 Aug 2017
c7479ca2f32e53785e4175baf13fdd35,cb2bac2686d8993b77ac4641bdcc03fc,7503,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,4.5,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,44,Unspecified,2,Yes - on another platform,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,NA,Brazil,Children,"Jundiai, São Paulo",44,Hospital based,Unspecified,23,Aug,2017,1,Mar,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Whole pregnancy,Unspecified,36,Other transmission parameters,NA,NA,NA,Brazil,NA,NA,FALSE,include,women,microcephaly,1 Mar 2016,23 Aug 2017,1 Mar 2016 - 23 Aug 2017
d93c3ef5cbabf453d8db711d207be6ba,1aef45188ab2f48c388c507d9a3b8a49c,10125,Zika congenital syndrome (microcephaly) probability,NA,0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,70,NA,0,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,United States,Pregnant women,New York,70,Hospital based,Both,NA,Apr,2016,NA,Mar,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Whole pregnancy,NA,35,Other transmission parameters,NA,NA,NA,United States,NA,NA,FALSE,exclude,women,microcephaly,Mar 2016,Apr 2016,Mar 2016 - Apr 2016
d93c3ef5cbabf453d8db711d207be6ba,aef45188ab2f48c388c507d9a3b8a49c,10125,Pregnancy loss probability,NA,0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,70,NA,1,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,United States,Pregnant women,New York,70,Hospital based,Both,NA,Apr,2016,NA,Mar,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Whole pregnancy,NA,35,Other transmission parameters,NA,NA,NA,United States,NA,NA,FALSE,exclude,women,general pregnancy loss,Mar 2016,Apr 2016,Mar 2016 - Apr 2016
2b30136400c9151556fcb111791f5d7c,cda5efdcc18fd3ab8d3385e8282070f4,10318,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,129,Naive,3,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,NA,FALSE,NA,NA,France,Pregnant women,western French Guiana,129,Hospital based,Unspecified,NA,Sep,2016,NA,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Unspecified,43,Other transmission parameters,NA,NA,NA,France,NA,NA,FALSE,include,women,microcephaly,Jan 2016,Sep 2016,Jan 2016 - Sep 2016
f300993bfc19c4e5a616e68ba8788c9a,3e2ae8d2b5ed845ddc22e2d73b91ae88,10509,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,70.7,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,75,Naive,53,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,NA,NA,Brazil,Pregnant women,"Campina Grande, Paraíba",75,Hospital based,Unspecified,NA,Dec,2018,NA,Mar,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Whole pregnancy,Unspecified,44,Other transmission parameters,NA,NA,NA,Brazil,NA,NA,FALSE,exclude,infants,microcephaly,Mar 2016,Dec 2018,Mar 2016 - Dec 2018
16061fbbe0c375600e99753de4d6b332,d104d1fb0aa37376e2d903ed34d99778,10681,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,33,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Suspected,127,Naive,42,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,0,0,Brazil,Children,"Public hospital Salvador, Bahia",127,Hospital based,Unspecified,31,Jan,2017,1,Jan,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Urban area,47,Other transmission parameters,NA,NA,NA,Brazil,NA,NA,FALSE,exclude,infants,microcephaly,1 Jan 2015,31 Jan 2017,1 Jan 2015 - 31 Jan 2017
16061fbbe0c375600e99753de4d6b332,357c6e7f8392b33e32266ffa178787dc,10681,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,5,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Suspected,43,Naive,2,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Ruth,Observed sample statistic,FALSE,0,0,Brazil,Children,"Private hospital Salvador, Bahia",43,Hospital based,Unspecified,31,Jan,2017,1,Jan,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,Urban area,47,Other transmission parameters,NA,NA,NA,Brazil,NA,NA,FALSE,exclude,infants,microcephaly,1 Jan 2015,31 Jan 2017,1 Jan 2015 - 31 Jan 2017
e881b261b1e18369fccd39933b8e1803,643cfaacbf51c6e244989968ff238506,10741,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,2.6,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,114,NA,3,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Tristan Naidoo,Observed sample statistic,FALSE,0,0,United States,Pregnant women,"Ponce, Puerto Rico",114,Population based,Both,28,Feb,2020,1,May,2017,NA,NA,NA,NA,NA,NA,NA,FALSE,Whole pregnancy,Unspecified,17,Other transmission parameters,NA,NA,NA,United States,NA,NA,FALSE,include,women,microcephaly,1 May 2017,28 Feb 2020,1 May 2017 - 28 Feb 2020
3d71ab514a8703a670cc1102bc1fe841,26a7f223beaa3402bdc3dad6797cd215,10760,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,33.3,Unspecified,4.3,77.7,95% CI,NA,NA,NA,NA,NA,Confirmed,6,NA,2,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Mid outbreak,NA,Anna-Maria Hartner,NA,FALSE,NA,NA,Honduras,Pregnant women,Alonso Suazo Health Center,6,Hospital based,Female,31,Dec,2016,NA,Jul,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,21,Other transmission parameters,NA,95% CI,4.3 - 77.7,Honduras,NA,NA,FALSE,include,women,microcephaly,Jul 2016,31 Dec 2016,Jul 2016 - 31 Dec 2016
16f0839c030f154c5e687dfa312f6228,086f8e4b7e5bf246bf650b2330b99768,10965,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,7,Central,1.5,19.1,95% CI,NA,NA,NA,NA,NA,Confirmed,43,NA,3,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Post outbreak,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Brazil,Pregnant women,Central-West,43,Hospital based,Unspecified,NA,Apr,2019,NA,Jan,2017,NA,NA,NA,NA,NA,NA,Naive,FALSE,Whole pregnancy,Unspecified,48,Other transmission parameters,NA,95% CI,1.5 - 19.1,Brazil,NA,NA,FALSE,include,women,microcephaly,Jan 2017,Apr 2019,Jan 2017 - Apr 2019
fc3908ad78bf05be6d5ab4c097943edc,3818b2b0782845430212e805da6d83e0,11048,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,48,NA,2,Unspecified,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,NA,FALSE,NA,NA,Brazil,Pregnant women,São Paulo state,48,Hospital based,Unspecified,23,Aug,2017,1,Mar,2016,NA,NA,NA,NA,NA,NA,Naive,FALSE,Whole pregnancy,Unspecified,49,Other transmission parameters,NA,NA,NA,Brazil,NA,NA,FALSE,include,women,microcephaly,1 Mar 2016,23 Aug 2017,1 Mar 2016 - 23 Aug 2017
42535e4e2d58aee0d50104f300f36aeb,f63f325d1e3200c78cb09ece690aaa5b,11297,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,2.5,Central,1.2,5.2,95% CI,NA,NA,NA,NA,NA,Confirmed,278,Naive,7,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,Time,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Brazil,Pregnant women,Pernambuco (Recife),376,Hospital based,NA,NA,Jun,2017,NA,Dec,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Whole pregnancy,NA,28,Other transmission parameters,NA,NA,1.2 - 5.2,Brazil,NA,NA,FALSE,include,women,microcephaly,Dec 2015,Jun 2017,Dec 2015 - Jun 2017
42535e4e2d58aee0d50104f300f36aeb,1f63f325d1e3200c78cb09ece690aaa5b,11297,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,1.8,Central,0.2,10,95% CI,NA,NA,NA,NA,NA,Confirmed,38,Naive,1,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,Time,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Brazil,Pregnant women,Pernambuco (Recife),38,Hospital based,NA,NA,Jun,2017,NA,Dec,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,First trimester,NA,28,Other transmission parameters,NA,NA,0.2 - 10,Brazil,NA,NA,FALSE,include,women,microcephaly,Dec 2015,Jun 2017,Dec 2015 - Jun 2017
42535e4e2d58aee0d50104f300f36aeb,2f63f325d1e3200c78cb09ece690aaa5b,11297,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,2.2,Central,0.7,6.6,95% CI,NA,NA,NA,NA,NA,Confirmed,86,Naive,3,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,Time,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Brazil,Pregnant women,Pernambuco (Recife),86,Hospital based,NA,NA,Jun,2017,NA,Dec,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Second trimester,NA,28,Other transmission parameters,NA,NA,0.7 - 6.6,Brazil,NA,NA,FALSE,include,women,microcephaly,Dec 2015,Jun 2017,Dec 2015 - Jun 2017
42535e4e2d58aee0d50104f300f36aeb,3f63f325d1e3200c78cb09ece690aaa5b,11297,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,3.8,Central,1.8,7.8,95% CI,NA,NA,NA,NA,NA,Confirmed,154,Naive,7,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,Time,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Brazil,Pregnant women,Pernambuco (Recife),154,Hospital based,NA,NA,Jun,2017,NA,Dec,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Third trimester,NA,28,Other transmission parameters,NA,NA,1.8 - 7.8,Brazil,NA,NA,FALSE,include,women,microcephaly,Dec 2015,Jun 2017,Dec 2015 - Jun 2017
db48a2b1aee3fbbc11f437729a9547b5,8ea158f5057408a87ff987c47bf4eb0b,11565,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,3.6,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,83,Naive,3,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Brazil,Pregnant women,Jundiai Hospital Medical school,83,Hospital based,NA,30,Jun,2019,1,Mar,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,22,Other transmission parameters,NA,NA,NA,Brazil,NA,NA,FALSE,include,women,microcephaly,1 Mar 2016,30 Jun 2019,1 Mar 2016 - 30 Jun 2019
780815fe64804464acaa5b325cf2297f,13aace39a83faaae2d8f1d45c2126d25,11900,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,780,NA,15,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Brazil,Pregnant women,NA,780,Hospital based,NA,NA,NA,2016,NA,NA,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Whole pregnancy,NA,60,Other transmission parameters,NA,NA,NA,Brazil,NA,NA,FALSE,include,women,microcephaly,2016,2016,2016
208a8475f9a0841188d814c1c5dd5d82,0189da90b4ca92941dd0aabd8a6af5f8,11966,Pregnancy loss probability,NA,0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,171,Naive,10,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Colombia,Pregnant women,Valle del Cauca,171,Population based,Female,NA,Jan,2017,NA,Nov,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Whole pregnancy,NA,19,Other transmission parameters,NA,NA,NA,Colombia,NA,NA,FALSE,include,women,miscarriage,Nov 2015,Jan 2017,Nov 2015 - Jan 2017
208a8475f9a0841188d814c1c5dd5d82,4fc266d4792e9bec51d7c23a3a98a363,11966,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,4.5,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,154,Naive,7,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Colombia,Pregnant women,Valle del Cauca,154,Population based,Female,NA,Jan,2017,NA,Nov,2015,NA,NA,NA,NA,NA,NA,NA,FALSE,Whole pregnancy,NA,19,Other transmission parameters,NA,NA,NA,Colombia,NA,NA,FALSE,include,women,microcephaly,Nov 2015,Jan 2017,Nov 2015 - Jan 2017
208a8475f9a0841188d814c1c5dd5d83,14fc266d4792e9bec51d7c23a3a98a364,11966,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,29,NA,3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Colombia,Pregnant women,Valle del Cauca,29,Population based,Female,NA,Feb,2018,NA,Dec,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,First trimester,NA,19,Other transmission parameters,NA,NA,NA,Colombia,NA,NA,FALSE,include,women,microcephaly,Dec 2016,Feb 2018,Dec 2016 - Feb 2018
208a8475f9a0841188d814c1c5dd5d84,24fc266d4792e9bec51d7c23a3a98a365,11966,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,75,NA,3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Colombia,Pregnant women,Valle del Cauca,75,Population based,Female,NA,Mar,2019,NA,Jan,2017,NA,NA,NA,NA,NA,NA,NA,FALSE,Second trimester,NA,19,Other transmission parameters,NA,NA,NA,Colombia,NA,NA,FALSE,include,women,microcephaly,Jan 2017,Mar 2019,Jan 2017 - Mar 2019
208a8475f9a0841188d814c1c5dd5d85,34fc266d4792e9bec51d7c23a3a98a366,11966,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,NA,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,50,NA,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,Colombia,Pregnant women,Valle del Cauca,50,Population based,Female,NA,Apr,2020,NA,Feb,2018,NA,NA,NA,NA,NA,NA,NA,FALSE,Third trimester,NA,19,Other transmission parameters,NA,NA,NA,Colombia,NA,NA,FALSE,include,women,microcephaly,Feb 2018,Apr 2020,Feb 2018 - Apr 2020
ae93ad638c20da01df017fd710c74827,c6ae59b76121e58c5b2b0966d1739dff,12074,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,5.26,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,95,NA,5,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Anna Vicco,NA,FALSE,NA,NA,United States,Pregnant women,"Miami, Florida",95,Population based,NA,31,Dec,2017,1,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Whole pregnancy,NA,17,Other transmission parameters,NA,NA,NA,United States,NA,NA,FALSE,include,women,microcephaly,1 Jan 2016,31 Dec 2017,1 Jan 2016 - 31 Dec 2017
589113438977f42b28267909f31a3b27,e1b4171c121cc3ef75f68b0db65372ad,18620,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,5.2,Central,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,77,NA,4,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,4,0,Brazil,Pregnant women,"Manaus, Amazonas",77,Hospital based,Both,NA,Jun,2018,NA,Mar,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Whole pregnancy,Unspecified,67,Other transmission parameters,NA,NA,NA,Brazil,NA,NA,FALSE,include,women,microcephaly,Mar 2016,Jun 2018,Mar 2016 - Jun 2018
ada10966edd699ce65a3ccc7dc305234,3705aa46a029090714b08ea33eb0ba86,18800,Pregnancy loss probability,Percentage (%),0,4.7,Central,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,115,NA,5,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Colombia,Pregnant women,NA,115,Population based,Both,NA,Mar,2019,NA,Feb,2017,NA,NA,NA,NA,NA,NA,NA,FALSE,First trimester,Unspecified,68,Other transmission parameters,NA,NA,NA,Colombia,NA,NA,FALSE,include,women,general pregnancy loss,Feb 2017,Mar 2019,Feb 2017 - Mar 2019
ada10966edd699ce65a3ccc7dc305234,9b5b4aa3b795b60f1fe58b91fbee95c9,18800,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,0,Central,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,93,NA,0,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Colombia,Pregnant women,NA,93,Population based,Both,NA,Mar,2019,NA,Feb,2017,NA,NA,NA,NA,NA,NA,NA,FALSE,First trimester,Unspecified,68,Other transmission parameters,NA,NA,NA,Colombia,NA,NA,FALSE,include,women,microcephaly,Feb 2017,Mar 2019,Feb 2017 - Mar 2019
1c2c8981e131e55c2b122659ea0500d0,3b965c17873adbba84f8ea07403184c2,19021,Pregnancy loss probability,Percentage (%),0,0,Central,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,12,NA,0,Yes - as an attachment,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Thailand,Pregnant women,"Bueng Kan, Mudkahan provinces",12,Population based,Female,NA,Jan,2020,NA,May,2018,NA,NA,NA,NA,NA,NA,NA,FALSE,Second trimester; Third trimester,Unspecified,69,Other transmission parameters,NA,NA,NA,Thailand,NA,NA,FALSE,include,women,miscarriage,May 2018,Jan 2020,May 2018 - Jan 2020
bbf610ed03ecc1d374463c5ff3cb4707,f2f9cd9080806180240602ede86be5c4,31944,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,15.8,Central,3.4,39.6,95% CI,NA,NA,NA,NA,NA,Confirmed,19,Naive,3,NA,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Spain,Pregnant women,NA,19,Travel based,Female,NA,Feb,2019,NA,Jan,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Whole pregnancy,NA,76,Other transmission parameters,NA,95% CI,3.4 - 39.6,Spain,NA,NA,FALSE,include,women,CZS,Jan 2016,Feb 2019,Jan 2016 - Feb 2019
cd7747a19c63ccd50800b039c7e531ea,0d4b3df7493d664abb0c92f7954dca9e,31965,Zika congenital syndrome (microcephaly) probability,Percentage (%),0,49,Central,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,110,Naive,54,Not available,NA,FALSE,NA,NA,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,Unspecified,NA,Kelly M,Observed sample statistic,FALSE,NA,NA,Brazil,Children,Rio de Janeiro,110,Hospital based,Female,30,Jun,2017,1,Mar,2016,NA,NA,NA,NA,NA,NA,NA,FALSE,Unspecified,NA,77,Other transmission parameters,NA,NA,NA,Brazil,NA,NA,FALSE,exclude,infants,microcephaly,1 Mar 2016,30 Jun 2017,1 Mar 2016 - 30 Jun 2017
